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PART A. INFLUENCE OF SIDE CHAIN CONFORMATION ON THE 
MECHANISM(S) OF GLYCOSYLATION REACTIONS 
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CHAPTER 1. INTRODUCTION 
Portions of the text and figures in this chapter were reproduced or adapted from: Adero, 
P. O.; Amarasekara, H.; Wen, P.; Bohé, L.; Crich, D., The Experimental Evidence in 
Support of Glycosylation Mechanisms at the SN1–SN2 Interface. Chem Rev 2018, 118, 
8242–8284. Copyright © 2018, American Chemical Society. 
1.1 Background and Significance 
Carbohydrates and saccharides are closely related types of molecules that mainly 
consist of the elements carbon (C), hydrogen (H), and oxygen (O) and have the empirical 
formula Cx(H2O)y. The prefix glyco- is used to denote carbohydrate-related fields, such 
as glycoscience, glycobiology, glycans, etc. Chemically, carbohydrates can be 
considered as polyhydroxy aldehydes and ketones that are often decorated with other 
functional groups, such as amines, thiol groups, carboxylic acids, etc. Open chain 
monosaccharides, the smallest building blocks of carbohydrates, undergo intramolecular 
reactions of an alcohol with the aldehyde or ketone, typically forming a 5- or 6-membered 
cyclic hemiacetal or hemiketal. The stereogenic center newly formed during the 
cyclization reaction is called the anomeric center, and the two stereoisomers are denoted 
as α- and β-anomers (Scheme 1). 
 
Scheme 1. Equilibration of Acyclic and Cyclic Forms of Aldohexoses Illustrated for D-
Glucopyranose. 
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Amplifying structural diversity and complexity, the monomer units combine to form 
dimeric, oligomeric, and polymeric structures, in which the monomers are linked to each 
other via an anomeric carbon and a hydroxyl or a heteroatomic group of another monomer 
unit (Figure 1a).1  
 
Figure 1. Examples of Regio- and Stereoisomeric Disaccharides. 
Characteristically, carbohydrates contain multiple types of functional groups, even 
in their monomeric form, spread over around the carbohydrate ring. These spatially 
proximal functional groups can mutually interact and influence each other, thereby 
complicating the ability to predict reactivity. With their inherent structural complexity, 
carbohydrates have unique physical and biological properties and widely occur in 
biological systems. Therefore, carbohydrates are the most abundant class of 
biomolecules among the three other major classes of macromolecules, known as nucleic 
acids, proteins, and lipids. 
1.2 Origin and Basic Roles of Carbohydrates 
Initializing the biosynthesis process, plants and cyanobacteria use atmospheric 
carbon dioxide and energy from sunlight for the photosynthesis of carbohydrates and to 
generate molecular oxygen. In this process, during photosynthetic light reactions, 
radiation energy is conserved in the form of chemical energy as adenosine triphosphate 
(ATP) and of reducing power as adenine dinucleotide phosphate (NADPH) (Figure 2). In 
4 
 
the CO2 fixing process known as the Calvin cycle, carbohydrates are generated from the 
reduction of CO2 and H2O. These carbohydrates serve both photosynthesizing and non-
photosynthesizing organisms as an energy storage source to provide cellular energy and 
as a key component of the cell wall, to which they provide structural support.2  
 
Figure 2. Structures of Adenosine Triphosphate (ATP) and Nicotinamide Adenine 
Dinucleotide Phosphate (NADPH). 
1.2.1 Function as Energy Source and Structural Components 
Recognition of the significance of carbohydrates as energy storage materials and 
as structural components dates back to the nineteenth century when the contributions of 
Emil Fischer in the determination of the basic concepts related to carbohydrate chemistry, 
i.e., structure and relative configuration of carbohydrates, was instrumental.3-4 The 
process of energy production via oxidative carbohydrate metabolism is essentially the 
reverse process of photosynthesis. However, in general, carbohydrate metabolism is a 
highly complex process in which glucose-6-phosphate is considered as the key 
intermediate to several metabolic pathways (Figure 3).1  
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Figure 3. Carbohydrate Metabolism via Glucose-6-Phosphate as the Key Intermediate. 
In plants, potential energy is stored as starch, a biopolymer of glucose with 1,4-α-
glycosidic linkages. Further, ubiquitous structural components of plants are made of 
cellulose, which is also a biopolymer of glucose with 1,4-β-glycosidic linkages. Higher 
level animals and other organisms such as fungi, bacteria, etc. consume these plant 
materials and produce energy, mainly in the form of high energy molecules like ATP, via 
a series of processes called cellular respiration. Further, this process generates glucose 
as an intermediate, which can undergo further metabolism to generate ATP and other 
important biomolecules via glycolysis. Like in plants, excess glucose is stored in the form 
of glycogen, a multi-branched bio-polymer of glucose, through a process called 
glycogenesis. On the other hand, structural components such as the exoskeletons of 
arthropods and cell walls of fungi are made of chitin, a biopolymer of N-
acetylglucosamine, which is also a derivative of glucose.1 
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1.3 Biological and Medicinal Importance of Carbohydrates 
Despite the recognition of the basic functions of carbohydrates, interest in 
carbohydrate-related research was sparse until the 1960s. Recognition of the wide-
spread occurrence and biological significance of complex carbohydrates in 
glycoconjugates that exist in soluble form or as basic constituents of all cell membranes 
triggered the rapid growth of carbohydrate-related sciences.2, 5 In particularly, the 
important roles of glycoconjugates in cellular communication processes have been key 
to the increased interest in the carbohydrate field as now the study of the biology related 
to complex carbohydrate moieties of glycoconjugates has become a burgeoning field in 
cell-biology, named as glycobiology. 
1.3.1 Significance of Glycoconjugates in Biology 
Although carbohydrates can exist without being attached to any other type of 
biomolecule, they often tend to form more complex and important glycoconjugates by 
linking with non-carbohydrate natural products. These glycoconjugates consist of a vast 
range of sizes from small molecules to large polymeric structures. Smaller size 
glycoconjugates have significant importance in the pharmaceutical industry as they often 
exhibit therapeutic properties. In addition, pharmaceuticals, such as cardiac glycosides, 
galectin therapeutics, macrolides, drugs for diabetes mellitus, and anthracyclines, are 
some important classes of smaller sized glycoconjugates used in medicine.6 Structurally, 
these molecules are glycosylated to different extents, embedding different physical, 
chemical, and biological properties. Glycans, the glycosyl parts of these conjugates, 
affect the properties of these glycoconjugates and can impart better pharmacodynamic 
and pharmacokinetic properties.1, 7-10 
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On the other hand, larger sized glycoconjugates are made by the combination of 
complex glycans with proteins and lipids, forming glycoproteins and glycolipids, 
respectively.1-2 Glycoproteins and glycolipids are the two main components of the outer 
surface of the mammalian cells, where glycoproteins are involved in a range of functions, 
including several important biological processes, such as cell-cell adhesion, cell growth, 
viral replication, parasitic infections, etc.2 Glycolipids are one of the key components of 
cellular energy production and the cellular recognition process as markers. 
1.3.1.1 Glycoproteins, Glycolipids, and Glycocalyx 
Before moving on to the details of the biological significance of carbohydrates, it is 
worth discussing the structure and occurance of glycoconjugates. Based on function and 
location, polysaccharide moieties of glycoconjugates consist of up to 20 monosaccharide 
units. For example, intracellular glycoproteins contain up to mono- or disaccharides, while 
the glycoproteins of eukaryotic cell membranes contain larger oligosaccharides.1 These 
glycoconjugates are embedded into the lipid bilayer of the cell membrane in a way that 
these moieties are exposed to the extracellular side of the cell membrane (Figure 4).  
 
Figure 4. Glycoproteins and Glycolipids on the Lipid Bi-Layer of the Cell Membrane. 
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Further, glycoproteins can accommodate from one to several oligosaccharide 
units.11 The linkages between these oligosaccharides and proteins have three major 
types, the N-glycosidic bonds, the O-glycosidic bonds, and the ethanolamine phosphate 
linkages (Figure 5). Moreover, these oligosaccharides are decorated with additional 
glycostructures, forming a carbohydrate coating called the glycocalyx.12 This 
polysaccharide layer can extend to more than 100 nm.1 
 
Figure 5. Major Types of Linkages in Glycoproteins. 
On the other hand, glycolipids are made by the combination of a lipid part and a 
carbohydrate moiety, and these complex lipids are amphiphilic in nature. Generally, the 
lipophilic part is built from either N-acylsphingosine or 1,2-di-O-diacylglycerol, whereas 
the hydrophilic part consists of phosphate groups in the cases of glycerophospholipids or 
sphingophospholipids and of carbohydrates in the cases of glycoglycerolipids and 
glycosphingolipids.13-14 Glycolipids are found in both plants and mammals; for example, 
glycosphingolipids are found in eukaryotic cell membranes and the lipophilic elements of 
these glycolipids are N-acetylsphingosine (Figure 6), called ceramide.15 
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Figure 6. Structure of Ceramide. 
Despite the role of individual glycoconjugates, the nano-dimensional glycocalyx as 
a whole plays a critical role in cellular communication processes; hence, glycocalyx has 
great significance in glycobiology. The glycocalyx of a particular cell consists of a 
characteristic and unique glycosylated pattern governing the type of the cell, the 
developmental status of the cell, and the disease condition of the cell or organ.1, 16-18 
Moreover, such structural patterns change with dynamic processes, such as cell 
differentiation, cell degeneration, and other pathological modifications.1, 17 
Carbohydrate-rich cell surfaces mediate the docking of foreign species, such as 
cells, molecules, or even pathogens. During these adhesion processes, carbohydrate-
specific proteins, known as lectins,19-21 interact with the glycan epitopes of a foreign 
species via carbohydrate recognition domains (CRD),22 and these interactions are 
typically of a non-covalent nature.23 These lectins are often integral membrane proteins 
with their CRDs facing the exterior of cells or the luminal space of organelles.1, 22 In 
addition to the roles of lectins, carbohydrates present in the glycocalyx function as 
multivalent ligands. The three-dimensional structure, the stereochemistry of functional 
groups, and the supramolecular environment of these polysaccharide arrays of the 
glycocalyx are critical factors controling the efficient recognition, receptor binding, and 
biological signals induced by protein-carbohydrate signaling.1, 24-25 However, the details 
of the molecular interactions of cellular communication processes are not yet fully 
understood.  
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1.3.2 Importance of Carbohydrates in Cellular Signaling Processes 
Cellular signaling is an important part of cell communication, which governs almost 
all the intercellular and extracellular communication processes.26 It allows millions of cells 
to work together in order to maintain the critical biological functions of living organisms. 
Efficient signal receipt and response are key attributes of cellular signaling, which govern 
vital functions, such as development, immunity, and tissue repair mechanisms.27-28 
Further, errors in cellular signaling and signal processing can result in serious disease 
conditions, such as cancer, autoimmunity, and diabetes, etc.29-31 Therefore, it is crucial 
to understand cellular signaling processes for the diagnosis and treatment of such 
diseases. 
1.3.2.1 Why Carbohydrates for Cellular Signaling ? 
As discussed earlier, compared to the other classes of biomolecules, 
carbohydrates encompass an enormous structural diversity and complexity, providing a 
larger data storage capacity. Presumably, this unique structural feature is the major factor 
that governs the participation of carbohydrates in cellular communication.1 However, as 
noted above, the mechanism of cellular communication via glycoconjugates is not 
completely resolved. In that aspect, some researchers are in search of a ‘glycocode’ 
similar to the genetic code,32 while others are in search for novel functional principles to 
explain the unique roles of glycans in cellular communication. Overall, a deeper 
understanding of the three-dimensional structure of polysaccharides and their molecular 
dynamics under physiological conditions is essential to gain a better knowledge of the 
cellular communication mechanisms.1 
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1.3.2.2 Blood Group Classification and Other Cellular Communications 
Blood group classification is a classic example of the significance of carbohydrate 
determinants in cell-recognition processes. Based on the structures of carbohydrate 
determinants, there are four types of blood groups present in humans (Figure 7). These 
structural determinants are small oligosaccharide units present in the glycoproteins, 
glycolipids, and soluble oligosaccharides, and these molecular structures are called 
blood-group antigens. Further, there are two types of structural modifications known as 
A- and B-type antigens, leading to blood groups A and B, respectively. When, both A- 
and B-antigens are present, the blood is AB type. In the absence of these structural 
modifications, A and B, the blood group is called phenotype O or H. Despite small 
differences in the structure, differences in the carbohydrate chains of blood cells have a 
significant impact on the properties of the blood. Therefore, the ABO blood group 
classification plays a vital role in safe blood transfusion, preventing the accidental mixing 
of different blood types, which can cause severe or even fatal complications.  
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Figure 7. Minimal Determinant Saccharides of ABO Blood Group Classification. 
Beyond the application of glycoconjugates in normal cells, some glycoconjugates 
are frequently found in the nervous system and are involved in cell-cell recognition, 
myelination, and neurotransmission.33 Polysialic acids and sulfated glucuronyl 
glycoconjugates are characteristic nervous systems glycans.34 Further, the anionic form 
of sulfated glucuronyl glycoconjugates is found in the myelin-associated glycoprotein and 
protein zero (P0), the most abundant glycostructure of myelin.1, 35 
Overall, carbohydrates are involved in myriad important biological functions that 
are essential for the survival of living organisms. Therefore, the knowledge of the 
structure and biology related to these molecules is essential in understanding the related 
physiological functions and thus, for the prevention, diagnosis, and the treatment of 
diseases. 
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1.3.3 The Significance of Carbohydrates in Therapeutics 
Glycotheraputics is an emerging field of medicinal chemistry, focusing on the 
development of carbohydrate-based drugs.1 Anti-adhesion drugs, influenza drugs, and 
carbohydrate-based vaccines are a few important classes of the therapeutics that are 
used in modern medicine. 
1.3.3.1 Anti Adhesion Drugs 
The interactions between cell surface carbohydrates and proteins such as lectins 
of the pathogen surface are involved in the adhesions of toxins, viruses, bacteria, or 
parasites onto a healthy host cell surface.36-38 In most infectious diseases, the adhesion 
process is a prerequisite for initiating the infection by docking the pathogen onto the host 
cell surface.39 Molecules involving adhesion and related processes are the virulence 
factors of a pathogenic organism. Therefore, the blocking or inhibition of these factors, 
such as the blocking of bacterial lectins by the administration of natural or synthetic 
carhohydrate derivatives to compete with carbohydrate adhesion receptors of host 
cells,40  are the basis of the anti-adhesion drugs. These types of therapeutics are mild 
and, therefore, safer compared to the stronger antibiotics used in bacterial infections. 
Moreover, the development of drug resistivity is minimal in these type of medicines 
because they do not kill or retard the growth of the pathogenic organisms. Therefore, the 
chances of evolving new drug-resistant strains of pathogenic organisms is reduced. 
1.3.3.2 Influenza Drugs 
Another important class of therapeutics based on carbohydrate derivatives is 
influenza drugs, belonging to the antiviral drug category. These drugs are neuramindase 
inhibitors which can inhibit the neuramindaze enzymes in the virus, preventing the 
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replication of the virus. These drugs are constructed based on the structure of natural 5-
N-acetyl neuraminic acid derivatives. 4-amino-Neu5Ac2en 1141 and 4-guanidinium-
Neu5Ac2en 1242 are two common examples of neuraminidase-inhibitory influenza drugs 
in the market (Figure 8). 
 
Figure 8. Neuraminic acid glycals as influenza drugs. 
1.3.3.3 Carbohydrate Vaccines 
Carbohydrate vaccines came into the picture as the surface of many pathogenic 
organisms are decorated with a thick coating of oligo- or polysaccharide layers in the 
forms of glycoconjugates or other types of polysaccharides. Depending on the type of 
pathogen, these saccharides have unique structural and chemical features to function as 
biomarkers in recognition events.1 Therefore, these antigenic carbohydrates are critical 
in the development of disease-specific vaccines. Further, they are highly efficient as 
therapeutics in the prevention of many disease conditions and, therefore, have gained  a 
serious attention from the scientific community.43-44 
Initially, bacterial vaccines were designed only on the grounds of cell-surface 
polysaccharide arrays. However, such vaccines mostly induce the production of 
immunoglobulin M (IgM) and have low efficiency. On the other hand, smaller sized 
oligosaccharide-based vaccines with more specific glycan units have also been tested. 
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Unfortunately, due to their smaller sizes, these vaccines lack strong antigenic properties. 
To overcome these problems, smaller oligosaccharides and proteins have been linked 
together for use as therapeutics. These structural modifications have resulted in a 
remarkable increase in immunogenicity and specificity against many diseases.1 During 
the last two decades, many conjugated vaccines came into the market to battle against 
several bacterial infections. Notably, Haemophilus influenza type b has a success rate of 
more than a 95 %. Moreover, conjugate vaccines were successfully used in several other 
bacterial diseases, such as Salmonella typhi , Neisseria meningiditis, and Streptococcus 
pneumoniae.45 
1.4 Synthesis of Oligosaccharides 
Obtaining pure samples of complex carbohydrates is essential to the study of their 
biology and beyond. Extraction from natural sources, such as pathogens, is one of the 
classical methods, but it has several practical difficulties, such as those associated with 
organism culturing and purification of complex carbohydrate mixtures.46-47 Laboratory 
synthesis is the best solution to avoid those problems, and thus, the development of 
efficient synthetic routes, whether chemical or enzymatic, is in substantial demand. 
The efficient synthesis of oligosaccharides requires a precise control of stereo- and 
regioselectivity over a sequence of glycosylation reactions. In this aspect, enzymatic 
synthesis of oligosaccharides from small-unprotected carbohydrates is very attractive. 
Mild reaction conditions and the lack of protecting group manipulation are the key 
advantages of highly regio- and stereoselective enzyme based glycosylations.48 In 
addition, enzymatic methods can be utilized in multi-step oligosaccharide synthesis using 
a set of different enzymes in one pot. However, the high cost of reagents, the lack of 
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glycosyltransferases for many carbohydrate analogues, and the feedback inhibition of the 
enzymes by the products retard the rapid use of this method in oligosaccharide 
synthesis.48-49 A combination of chemical and enzymatic glycosylation is another useful 
approach in oligosaccharide synthesis. This combinatorial approach promises great 
control of oligosaccharide synthesis because two methods can be utilized in distinct 
stages of the synthesis based on the requirements and the limitations of enzymatic and 
chemical methods.50 
1.4.1 Chemical Approach to the Synthesis of Oligosaccharides 
The glycosylation reaction is central to the synthesis of oligosaccharides and 
glycoconjugates. During the last few decades, an enormous number of different chemical 
glycosylation methods have been developed. These methods include the use of distinctly 
protected glycosyl donors with a variety of leaving groups, various types of promoters, a 
range of different solvents, and different additives, such as electrophile scavengers, 
bases, and acids. Therefore, the synthesis of oligosaccharides and glycoconjugates is 
enriched with a range of different glycosylation methods.1, 51 Although there are many 
different glycosylation methods for a particular type of glycosidic bond formation, it is often 
hard to determine if one particular method has an advantage over another.52 Among the 
several approaches of regio- and stereoselective glycosidic bond formation, modulating 
reactivity by protecting group manipulation is one of the widely used methods. This 
method is based on the varying reactivities of different glycosyl donors. Thus, depending 
on the protecting group system, different glycosyl donors have different reactivities and 
thus different relative reactivity values (RRV). In oligosaccharide synthesis, Wong’s work 
is instrumental as his group has assembled a large pool of different glycosyl donors and 
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categorized them based on their RRV values. Further, based on these RRV values, 
Wong’s group developed a software to choose the sequence of glycosyl donors for 
carrying out oligosaccharide synthesis. In addition to the selection of donors, based on 
the RRV values, the software facilitates the selection of acceptors with free hydroxyl 
groups. This strategy allows for the sequential activation of a set of glycosyl donors with 
varying reactivity (RRV values) in one pot. This method is called programmable one-pot 
oligosaccharide synthesis (Scheme 2-a).53 The main advantage of this method is that it 
allows for the activation of a more-reactive donor in the presence of a less-reactive donor. 
However, intensive protecting group manipulation is a major drawback of the one-pot 
programmable synthesis.47 
The pre-activation one-pot oligosaccharide synthesis method is a significant 
improvement to overcome intensive protecting group manipulations associated with the 
programmable one-pot method. In the preactivation method, the starting glycosyl donor 
is irreversibly activated prior to the introduction of the acceptor. After obtaining the first 
glycosylated product, it is then used in another preactivation-glycosylation step to obtain 
the second glycosylated product, and this sequence of reactions is carried forward until 
the desired oligosaccharide is obtained (Scheme 2-b).54 This strategy is independent of 
complex protecting group strategies because the whole glycosylation sequence is 
controlled by the preactivation step of every glycosylation reaction. This preactivation 
strategy is successfully automated in smaller-sized oligosaccharide synthesis, yet this 
solution phase chemistry is difficult to apply in an automated system for the synthesis of 
larger-sized oligosaccharides.55 Further, this method can lead to complex oligosaccharide 
mixtures, resulting in difficulties in purification.47  
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Inspired by the oligonucleotide and peptide synthesis, the Seeberger group 
introduced an automated solid phase synthesis to build oligosaccharides. In this strategy, 
a monosaccharide unit is first attached to a polymer support via a linker, and then this 
whole group is subjected to a sequence of successive glycosylation reactions to obtain 
the desired oligosaccharide bond to the polymer support. Finally, the polymer support 
and the protecting groups are cleaved to obtain the desired oligosaccharide (Scheme 2-
c).56-57  
 
Scheme 2. Oligosaccharide Synthesis Strategies a. Programmable One-Pot, b. 
Preactivation One-Pot, c. Automated Solid-Phase. 
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1.5 Glycosylation Reactions 
Regardless of the different strategies used in oligosaccharide assembly, control of 
the glycosylation reaction is central to achieving better regio- and stereoselectivities of 
oligosaccharide synthesis. Accordingly, the higher demand of efficient and 
stereoselective glycosylation reactions is one of the key challenges in glycoscience.58 
Glycosylation is a process in which the anomeric sp3 carbon of a glycosyl donor is 
substituted by an incoming acceptor nucleophile, forming a new carbon-heteroatom bond 
known as a glycosidic bond (Scheme 3).The systematic development of such reactions 
critically depends on the knowledge of their mechanisms and the conformational 
dynamics of the glycosyl donors and acceptors, as well as other variables, such as 
temperature, solvent, additives, activators, catalysts, etc.59-62 Insight into the glycosylation 
reactions can lead to the robust advancement of current glycosylation methods and to the 
introduction of efficient and greener reaction methodologies. Moreover, the criticality of 
the mechanistic aspects drives the increased interest towards developing novel methods 
for probing glycosylation mechanism(s) and extending the investigations towards 
understanding the factors affecting glycosylation reactions.  
 
Scheme 3. General Glycosylation Reaction. 
Before moving on to the details of complex glycosylation reactions, a brief 
consideration of the mechanism(s) of substitution reactions is important. In general, 
substitution reactions can be described by two extreme reaction mechanisms, known as 
dissociative (unimolecular-SN1) and associative (bimolecular-SN2) reaction pathways. In 
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the former, the leaving group departs to form an electrophilic intermediate, which then 
undergoes a nucleophilic substitution reaction with an appropriate nucleophile to form the 
substitution products. In the latter, the incoming nucleophile associates with the 
electrophilic center to form a penta-coordinated transition state followed by the departure 
of the leaving group in a concerted fashion, leading to the formation of the substituted 
products. Importantly, the two extremes are spanned by loosely or tightly associated ion 
pair mechanisms. However, mechanistic evidence for locating a particular reaction on the 
mechanistic spectrum is limited; hence, the demand for conducting physical organic type 
studies of such reactions is substantially higher. 
1.5.1 Mechanism of Glycosylation Reactions 
Glycosylation reactions can be considered as a subset of nucleophilic substitution 
reactions taking place at sp3 carbon atom (anomeric center), which is bonded to the 
ethereal ring oxygen of, usually, 5-membered (furanosyl) or 6-membered (pyranosyl) 
rings. The glycosyl donor, which usually carries an electrophilic reaction center, can exist 
either in one or both of the two possible anomers. Activation of the glycosyl donor leads 
to the formation of a putative intermediate, glycosyl oxocarbenium ion located at the 
center of the SN1-SN2 continuum between the α- and β- ion pairs, whether they are tightly 
associated ion pairs (contact ion pair - CIP) or loosely associated ion pairs (solvent-
separated ion pair - SSIP) (Scheme 4). The concept of the ion pair mechanism for the 
chemical glycosylation reactions was first introduced by Rhind-Tutt and Vernon.63 Later, 
Lemieux and coworkers introduced a more graphical form of this ion pair mechanism.64 
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Scheme 4. SN1-SN2 Continuum for the Ion Pair Mechanism of Glycosylation Reactions.  
1.5.1.1 Approach to Probing the Glycosylation Mechanisms 
According to Horenstein,65 until recent years, most mechanistic studies of 
glycosylation reactions were based on studying the hydrolysis reactions of the glycosidic 
bond. For the mechanisms of glycosidic bond formation, with a few previous 
exceptions,63, 66-68 scientists mostly relied on stereochemical evidence and favored 
oxocarbenium ion centric dissociative pathways. However, the uncritical use of 
stereochemical evidence alone for describing the mechanisms is not a reliable practice. 
Thus, later researchers expanded their studies of  glycosidic bond formation mechanisms 
to include the isolation and characterization of intermediates and kinetic studies as well 
as those of substituent effects, preferentially, in terms of linear free energy relationships.69 
Such studies are, however, limited in number; thus, there remains a significant need for 
mechanistic studies. 
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1.5.2 Carbenium Ions and Oxocarbenium Ions in Glycosylation 
The glycosyl oxocarbenium ion is the most widely invoked intermediate in 
glycosylation mechanisms. However, the evidence supporting such intermediates is 
limited, and therefore, those rationales are frequently suspect, particularly in cases where 
alternative explanations are available for explaining the stereochemical outcomes of 
glycosylation reactions. Therefore, it is critical to evaluate the existence, stability, and 
roles of oxocarbenium ions in glycosylation reactions, particularly from a physical organic 
chemistry perspective. Thus, before searching for physical evidence to support the 
existence of stable glycosyl oxocarbenium ions, the viability of the formation of 
oxocarbenium ions and the influence of substituents on the stability of oxocarbenium ions 
are analyzed under glycosylation reaction conditions.  
In 1937, the Meerwein group first isolated and characterized oxocarbenium ions, 
which were formed by the reaction of aldehydes and ketones with triethyloxonium 
tetrafluoroborate.70-71 Later, Rakhmankulov et al. reviewed non-carbohydrate 
oxocarbenium ions,72 typically considered as resonance stabilized carbenium ions from 
α-oxygen (Scheme 5). In carbohydrate chemistry, apart from the α-oxygen, there are 
multiple C-O bonds at the β- and more remote positions of the carbohydrate framework; 
however, the influence of those substituents on the stability of glycosyl oxocarbenium ion 
is little considered. Therefore, evaluation of the oxocarbenium ion stabilities in the 
presence of different substituents on both the α- and β- positions is very important.69 
 
Scheme 5. a. Carbenium Ion and b. Resonance Stabilized Oxocarbenium Ion. 
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Computed hydride ion affinities (HIA) in gas phase reported by Keeffe and More 
O’Ferrall can be considered to estimate the relative stabilities and reactivities of 
carbenium ions (Table 1). As shown in Table 1, for both methoxymethyl and ethyl cations, 
the addition of extra methyl groups increases the stability in a comparable manner. 
Further, in the absence of β- and more remote C-O bonds, simple oxocarbenium ions 
have stability comparable with allylic and benzylic cations. Motivated from the conclusions 
of hydride ion affinity study, the Bennet and Withers groups compared the spontaneous 
hydrolysis of substituted cyclohexenyl mono- and dinitrophenyl ethers with 
correspondingly substituted mono- and dinitrophenyl glycosides. They observed that the 
glycosides and corresponding allylic ethers showed analogous kinetic parameters in their 
spontaneous hydrolysis experiments. Moreover, these allylic ethers undergo hydrolysis 
by certain glycosidase enzymes, indicating the analogous nature of the intermediates 
involved in these hydrolysis reactions. 
Table 1.  Computed Relative Hydride Ion Affinities (HIA) with Respect to tert-Butyl 
Cation (kcal.mol-1). 
 
 
 
 
 
 
 
 
Carbocation ΔHIA (g) 
MeCH2+ 33.8 
Me2CH+ 14.7 
Me3C+ 0 
MeOCH2+ 2.1 
MeOC(Me)H+ -15.7 
MeOCMe2+ -26.7 
PhCH2+ 5.0 
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A measure of a barrier to rotation around the C-O bond is an alternative method to 
estimate the stabilities of oxocarbenium ions. The Winstein group determined a barrier of 
18.4 kcal mol-1 for the syn-anti equilibration of 7-methoxy-7-norbonyl cation 13 using 
variable-temperature (VT) NMR spectroscopy in fluorosulfonic acid (Scheme 6), and, 
further, they estimated a 19.5 kcal mol-1 barrier for that of 2-methoxy-2-norbonyl cation.73 
In addition, Olah et al. estimated 60% π-character in oxocarbenium ions derived by 
alkylation and or protonation of aldehydes and ketones using 17O, 1H, and 13C chemical 
shift values.74-75 Overall, it is evident that, in the absence of remote electron-withdrawing 
groups, the electron delocalization from α-oxygen is prominent and has a significant 
impact on the stability of carbenium ions. 
 
Scheme 6.  Barrier to Rotation About the C-O π Bond in the 7-Methoxy-7-norbornyl 
Carbenium Ion. 
However, when the electron delocalization from α-oxygen is structurally prohibited, 
adjacent carbenium ion is destabilized by the negative inductive effect of the α-oxygen 
atom. This destabilization can be investigated using the relative rates of hydrolysis 
experiments, proceeding via carbenium ions or oxocarbenium ion intermediates. 
Therefore, Meyer’s and Martin’s study on the relative rates of solvolysis of series of 
tosylates in 80% EtOH at 25 °C is instructive. According to their study, the relative rates 
of solvolysis decrease in the order of 1-adamantanyl tosylate 14, 1-adamantanyl-2-oxa 
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tosylate 15, and its 3-cyano derivative 16 (Figure 9).76 These relative rates of hydrolysis 
can be attributed to the relative stabilities of the intermediate oxocarbenium ions. The 
formation of the 1-adamantanyl carbenium ion is relatively favored compared to its 2-oxa 
derivative because 1-adamantanoyl-2-oxa oxocarbenium ion (double bond on a 
bridgehead) is not favored as such oxocarbenium ions have substituents, which are 
distorted from the plane of the π-bond (C=O bond), violating Bredt’s rule. Therefore, in 
the absence of resonance stabilization by α-oxygen, the carbenium ion is destabilized by 
the negative inductive effect of that oxygen atom. Further, the 3-cyano derivative has the 
lowest relative rate among three compounds, indicating that the cyano group boosts the 
negative inductive effect of α-oxygen by withdrawing electrons from the oxygen atom 
towards the C-N bond.  
 
Figure 9. Relative Rate Constants of Solvolysis of 1-Adamantanyl Tosylate 14, 2-Oxa-
1-adamantanyl Tosylate 15, and 3-Cyano-2-oxa-1-adamantanyl Tosylate 16. 
In addition, the thermal stabilities and reactivities of these compounds during 
column purification also follow the similar reactivity patterns observed in hydrolysis 
experiments. Overall, when the resonance stabilization of nascent carbenium ions is less 
feasible due to either steric reasons or/and the negative inductive effects of adjacent 
electron-withdrawing groups, the formation of carbenium ions is highly unfavorable. This 
critical discussion of the stability of simple oxocarbenium ions is very important as 
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analogous analysis can be applied to carbohydrate systems to predict the possible 
intermediates of glycosylation reactions and, therefore, to deduce glycosylation 
mechanisms. 
1.5.2.1 Influence of C-O Bonds on the Stability of Glycosyl Oxocarbenium 
Ions 
In contrast to simple aliphatic oxocarbenium ions, carbohydrate-based 
oxocarbenium ions have β- and multiple remote C-O bonds. Further, the hydroxyl groups 
of these C-O bonds can be protected by different types of protecting groups with various 
properties, such as electron-withdrawing, electron-donating, sterically hindered, and 
hydrogen bonding. In general, due to the electron-withdrawing nature of these C-O bonds, 
they exert a significant influence on the stability of the nascent carbenium ion; hence, the 
ease of formation of carbenium ions is critically dependent on these C-O bonds. 
In order to estimate the stability of oxocarbenium ions, the relative rates of 
solvolysis reactions proceeding via carbenium ion intermediates can be investigated. 
Starting with non-carbohydrate analogues, a study of the solvolysis of secondary 2-
nobornyl tosylates by Lambert et al. is instructive. It was observed that the relative rate of 
solvolysis of 2-endo-norbornyl tosylate 17 at 25 °C is 3000-fold faster than that of the 3-
endo-acetoxy-2-endo-norbornyl tosylate 18 (Figure 10).77 Later, in a similar type of study 
by the Kirmse group, it was demonstrated that the rate of solvolysis of 2-endo-norbornyl 
brosylate 19 at 25 °C was 105-fold faster in comparison to that of the brosylate 20 where 
the 6-methylene group is substituted with a ring oxygen atom (Figure 10).78 In both 
comparisons, the retardation of the reaction rates can be attributed to the destabilization 
of nascent oxocarbenium ion intermediates due to the electron density removal by 
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adjacent electron-withdrawing atoms. Overall, when the neighboring group participation 
from β-C-O bonds is not plausible, there is a significant negative impact on the stabilities 
of carbenium ions due to the electron-withdrawing nature of such β-C-O bond. Similar 
effects are applicable in carbohydrate systems.  
 
Figure 10.  Influence of β-C-O Bonds on the Relative Rates of Solvolysis. 
The influence of β- and more remote C-O bonds on the stability of glycosyl 
oxocarbenium ions has been estimated using different approaches. Employing the 
relative rates of glycoside hydrolysis as a measure of the oxocarbenium ion stability, 
Overend et al.  studied the kinetics of acid-catalyzed hydrolysis of a series of methyl 
glycosides (Table 2).79  Similarly, but in a more detailed approach, the Withers group 
studied the spontaneous hydrolysis of 2,4-dinitrophenyl glycosides (Table 3).80 According 
to these studies, whether it is spontaneous hydrolysis of nitrophenyl glycosides or acid-
catalyzed hydrolysis of methyl glycosides, 2-deoxy analogues are the most reactive 
glycosides. In the Withers study, due to the extreme reactivity of 2-deoxy 2,4-dinitrophenyl 
glycoside, it was observed that this glycoside was unstable even upon the attempted 
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column purification. Overall, the reactivity orders of the hydrolysis experiments for these 
two series of compounds follow the trend 2-deoxy >> 4-deoxy > 3-deoxy ~ 6-deoxy.69 
Table 2. Relative Rates of Acid-Catalyzed Hydrolysis of Methyl Glycosides in 2 N HCl at 
58 oC. 
 
 
 
 
 
 
 
 
Table 3. Relative Rates of Spontaneous Hydrolysis of 2,4-Dinitrophenyl Glycosides in 
25 mM sodium phosphate buffer (pH 6.5) and 0.40 M KCl at 37 oC. 
Glycoside krel 
 
1.0 
 
4.0 
 
4.7 
 
22.4 
Glycoside krel 
 
1 
 
20 
 
40 
 
2090 
(In 0.1 N HCl) 
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In another important study, Crich et al. conducted a series of glycosylation 
reactions of phenyl thiomethyl glycosyl donors in the presence of external acceptors and 
N-iodosuccinimide and triflic acid as the promotor in dichloromethane at -30 °C, and 
observed the formation of alkoxymethyl glycosides in good yield (Scheme 7).81 These 
products were probably formed by a nucleophilic substitution at the external 
oxocarbenium ion intermediate, suggesting that the external oxocarbenium ion does not 
fragment to form a glycosyl oxocarbenium ion 23. The destabilization of glycosyl 
oxocarbenium ion by β- and remote C-O bonds could be the prime reason for this 
observation. 
 
Scheme 7.  Substitution of a Phenylthiomethyl Glycoside without Fragmentation. 
NMR-spectroscopic characterization of simple oxocarbenium ions was reported by 
several laboratories,82-83 yet the detection and proper characterization of glycosyl 
oxocarbenium ions were not achieved until 2016. The enormous effort to characterize 
oxocarbenium ions using NMR spectroscopy reveals the difficulties associated with the 
observation of transient oxocarbenium ions, particularly glycosyl oxocarbenium ions with 
β-C-O bonds. Therefore, even if they exist, due to their highly reactive nature, they may 
have extremely short lifetimes compared to the NMR time scale. These observations 
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further explain the significance of β- and more remote C-O bonds on the stability of 
oxocarbenium ions. However, despite all these difficulties, in 2016 the Blériot group was 
able to successfully characterize glycosyl oxocarbenium ions using 13C and 1H NMR 
spectroscopy in HF/SbF5 media, i.e., a super acid medium. It is important to note that all 
the carbonyl oxygen atoms of per-acetylated 2-deoxy-glucopyranoside and 2-bromo-2-
deoxy glucopyranoside oxocarbenium ions were protonated, and they occupied 4E and 
4H5 conformations, respectively (Scheme 8).84-85   
 
Scheme 8.  Generation and Characterization of Glycosyl Oxocarbenium Ions in Super-
Acidic Media. 
Though it is not a direct formation of oxocarbenium ions from a glycoside, in an 
important attempt to detect glycosyl oxocarbenium ions spectroscopically, Woerpel and 
coworkers generated simple monobenzyloxy tetrahydropyranosyl dioxacarbenium ions 
via the alkylation of corresponding lactones. NMR studies revealed that these 
oxocarbenium ions occupy half-chair conformations (Figure 11). Importantly, they 
observed that the electron-withdrawing 4-benzyloxy analogue prefers the pseudo axial 
benzyloxy group due to stereo-electronic reasons, while 4-methyl analogous prefers 
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pseudo equatorial methyl groups due to their steric factors. These observations 
consistently reveal the significance of β- and remote substituents and their relative 
configuration on the stability of oxocarbenium ions.86 
 
Figure 11. Conformational Changes of 1-Alkoxyoxocarbenium Ions as a Function of the 
Nature of the Substituents. 
The inability of NMR spectroscopy to detect glycosyl oxocarbenium ions suggests 
that the lifetimes of glycosyl oxocarbenium ions are short on the NMR timescale. 
However, in the late 1980s, Jencks and Amyes were able to determine the lifetimes of 
the glucosyl oxocarbenium ion in water at 25 °C by diffusion-controlled trapping of 
glycosyl oxocarbenium ions using azides as external nucleophiles in a series of solvolysis 
experiments of α-azido ethers.87 According to Jencks and co-authors, the lifetime of the 
glucopyranosyl oxocarbenium ion is 1 Χ 10-12 s (Table 4). Later, Bennet and co-workers 
showed that the same oxocarbenium ion has the lifetime 2.5 Χ 10-12 s.88 These lifetimes 
are so short that the diffusional equilibration is unlikely. Further, the Bennet group was 
able to determine the lifetimes of α- and β- ion pairs of 2-deoxyglycopyranosyl 
oxocarbenium ions as 1.4 Χ 10-12 s and 2.7 Χ 10-12 s, respectively (Table 4).89-90 Further, 
they concluded that the 2-deoxyglycopyranosyl oxocarbenium ion is not completely 
solvent equilibrated in an aqueous medium. Following a similar type of azide clock 
reaction, Horenstein and Brunner determined the lifetimes of sialyl oxocarbenium ions as 
≥ 3 Χ 10-11 s (Table 4).91  Overall, the extremely short lifetimes of these glycosyl 
oxocarbenium ions in water convey that the existence of such intermediates in an 
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aqueous medium is highly unlikely. Extrapolating these conclusions, survival of glycosyl 
oxocarbenium ions in non-polar organic solvents is extremely unlikely, and the use of 
such intermediates in corresponding mechanistic rationales is debatable. However, if the 
evidence supports the existence of glycosyl oxocarbenium ions, it is important to consider 
the other factors influencing the glycosylation reactions in order to rationalize such 
species as the intermediates of glycosylation reactions. 
Table 4.  Oxocarbenium Ion Lifetimes in Water. 
Oxocarbenium ions Estimated lifetime (s) 
 
1 × 10-12 (Jencks), 2.5 ×10-12 (Bennet) 
 
1.4 × 10-11 (α)a and 2.7 × 10-11 (β)a 
 
≥ 3 × 10-11 
a First formed intermediate is SSIP:M complex where M = 4-bromoisoquinoline 
All in all, it is evident that the use of naked oxocarbenium ions, without valid 
evidence in the interpretation of the stereochemical outcomes of glycosylation reactions, 
is not a reliable approach in practicing the state of the art determination of the 
glycosylation reaction mechanisms. Therefore, it is important to explore evidence to 
predict the other possible intermediates in glycosylation reactions. In the search for other 
intermediates, the scientific community focuses their attention on possibilities of the 
existence of covalently bonded glycosyl intermediates, and several multidisciplinary 
laboratories have worked on the identification, isolation, and characterization of such 
important species. 
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1.5.3 Other Intermediates or the Related Transition States in Glycosylations 
The simplest form of glycosylation reactions proceeds via the direct displacement 
of the leaving group by the acceptor nucleophile. However, such glycosylation reactions92 
are extremely rare, and more often glycosylation reactions proceed via complex reaction 
pathways. Typically, the glycosyl donor is activated by a promoter, increasing the 
nucleofugacity of the leaving group. With the departure of the activated leaving group, 
another similar species, which is derived from the promoter or is an external additive, 
attacks the electrophilic center, forming a relatively unstable intermediate. Then, this 
transient intermediate undergoes nucleophilic attack from the acceptor nucleophile to 
form the final glycoside (Scheme 4). In fact, there is ample evidence to support the 
formation of covalently bonded intermediates rather than glycosyl oxocarbenium ions. 
Isolation of this kind of intermediate was first reported by the Igarashi group in 1970 when  
they were able to isolate α-gluco- and α-mannosyl perchlorate generated by the reaction 
of α- or β- configured gluco- and mannopyranosyl chlorides 30 and 32, respectively 
(Scheme 9).93 In another important work, Schuerch and co-workers activated per-O-
benzylated α-glucopyranosyl bromide to give the corresponding sulfonates, which were 
characterized using NMR spectroscopy.94-98  
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Scheme 9. Formation of 2-Chloro-2-deoxy-gluco- and Mannopyranosyl Perchlorates. 
In many common glycosylation reactions, the promoters are derived from triflates 
containing electrophiles, or triflates are being used as additives. In such reaction 
conditions, depending on the nature and the protecting group strategy of the glycosyl 
donor, the formation of glycosyl triflate intermediates is highly plausible. In an important 
series of low-temperature NMR studies, the Crich group was able to identify and 
characterize mannosyl triflates as the first ever spectroscopic evidence to support the 
formation of covalently bonded glycosyl triflates as glycosylation reaction intermediates. 
Further, they explained the role of that intermediate in controlling the stereoselectivities 
of mannosylation reactions (Scheme 10).69, 99  
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Scheme 10. Formation and Characterization of Mannopyranosyl Triflates. 
In addition, based on glycosylation reaction conditions, the formation of several 
other glycosyl intermediates has been detected and characterized using spectroscopic 
methods. Among those intermediates, bromides,64, 100-101 fluorides,102 sulfonium ions,103 
phosphonium ions,104 and isouronium ions105 are worth mentioning (Figure 12).69 
 
Figure 12. Covalently Bonded Activated Glycosyl Donors. 
Manipulation of the solvent system is a common practice in regio- and 
stereoselective glycosylation reactions. In particular, acetonitrile-based solvent systems 
can increase the stereoselectivities of many glycosylations. These increased 
stereoselectivities are rationalized in terms of the formation of axial nitrilium ion 
intermediates (Figure 13). These intermediates then undergo SN2 or SN2-like reaction 
pathways to form glycosides with higher equatorial selectivity. The existence of such 
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intermediates is supported by the evidence from trapping experiments and NMR 
spectroscopy.69, 106-108 
 
Figure 13. Nitrilium ions as Intermediates of Glycosylation Reactions. 
During the discussion of glycosylation reaction mechanisms, the formation and 
stability of putative glycosyl oxocarbenium ions were considered. Further, the discussion 
was extended to describe the covalently bonded intermediates in glycosylation reactions. 
However, each glycosylation reaction is such a unique sequence of reaction steps that 
the formation of intermediates, whether oxocarbenium ions or covalently-bonded 
intermediates, is governed by multiple factors, such as the type and configuration of 
substituents, side chain conformation, reaction temperature, reaction solvents, etc. 
Therefore, from a mechanistic perspective, it is very important to consider the influence 
of such factors in controlling glycosylation reactions. 
1.6 Influence of Type and the Configuration of Substituents and Ring 
Conformation 
In the above discussion, the influence of C-O bonds on the stabilities of 
oxocarbenium ions is surveyed as a function of the substituted position of C-O bonds in 
the carbohydrate ring. Similar but more specific studies have been conducted by the Bols 
and Crich groups, and specifically, their studies on the significance of side-chain 
conformation on the stability of oxocarbenium ions have been instrumental. They studied 
the kinetics of the spontaneous hydrolysis of bicyclic dinitrophenyl glycosides, where they 
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have imposed a selected configuration to the pyranoside side chain by introducing a rigid 
bicyclic system. From these studies, they were able to find the relative reactivities of 
different side chain conformations. Importantly, enforcement of the trans-gauche (tg) 
conformation to the side chain of the pyranoside leads to the lowest relative rate of 
hydrolysis compared to the other staggered conformers, gauche-gauche (gg) and 
gauche-trans (gt). These observations imply that the electron-withdrawing nature of the 
C5-O6 bond of the tg conformer makes it difficult to hydrolyze the 2,4-dinitrophenyl 
glycosides (Table 5).109-110 Later, the Bols group attributed the decrease in the rate of 
hydrolysis to the torsional effects because they observed that the replacement of O6 with 
a methylene group can lead to moderate β-selectivities between armed thioglycoside 
donors and disarmed 4,6-O-benzylidine protected donors in the corresponding 
glycosylation reactions. They suggested that this selective β-glycoside formation is 
caused by the preferential formation of axial triflate intermediates due to the 
destabilization of oxocarbenium ions by the torsional effect of benzylidene protection.111 
However, the Crich group later showed that this model, in which O6 is replaced by a 
methylene group, is not a good model to evaluate the 4,6-O-benzylidene effect as it 
completely disregards the extra torsional interactions that arise due to the methylene 
group, leading to the overestimation of the torsional effects. Further, they confirmed that 
there is a torsional component, yet the stereoelectronic effect of the structurally imposed 
tg conformation has a significant impact on the rate and the selectivities of glycosylation 
reactions.110 
 
38 
 
Table 5.  Relative Rates of Spontaneous Hydrolysis of Conformationally locked 
Dinitrophenyl Glycosides at pH 6.5 at 37 oC.109-110 
Substrate Config 
krel 
(glu) 
Substrate Config 
krel 
(gal) 
 
tg 1 
 
tg 1 
 
gt 2.1 
 
gt 1.4 
 
gg 3.6 
 
gg 2.5 
 
- 11.1 
 
- 5.9 
Further, from the hydrolysis experiments, it is clear that galactopyranosides are 
relatively more reactive than the corresponding gluco-analogues, implying that the axial 
substituents stabilize the formation positive charge (Table 5). As an alternative to the 
study of the hydrolysis of glycosides, studying the glycosylation of thioglycoside donors 
is also significant and informative. In that aspect, the Wong and Ley groups contributed 
extensively by providing relative reactivity values (RRVs) of the glycosylation reactions of 
a broad range of thioglycosides with different substituents and configurations.53, 112 (Table 
6) Further, electron-withdrawing protecting groups such as esters decrease the relative 
reactivity values in comparison to the corresponding ether protecting groups (Table 6). 
These observations draw parallels with the observations and conclusions of hydrolysis 
experiments of glycosides. 
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Table 6.  Selected Examples of Wong Relative Reactivity Values (RRVs) for the 
Activation of Thioglycosides by NIS-TfOH in Dichloromethane at Room Temperature. 
Substrate RRV Substrate RRV 
 
1 
 
28.9 
 
7.2 x 104 
 
24.1 
 
1.7 x 104 
 
17.6 
 
185.4 
 
13.1 
 
118.7 
 
5.7 
 
102.0 
 
2.7 
 
67.1 
 
1.7 
 
31.4 
 
1.3 
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Through-space-electrostatic stabilization of oxocarbenium ions of pseudo-axial 
substituents is one of the key rationales used to explain the increased anomeric reactivity 
of carbohydrates with axial substituents over their equatorial counterparts. Due to the 
transient nature of oxocarbenium ions, direct measurements of the influence of protecting 
groups on oxocarbenium ion stability are difficult to obtain. Alternatively, piperidinium ions 
can be used as model compounds for oxocarbenium ions to study the stability of 
oxocarbenium ions. The Bols group employed the changes of pKa values in a range of 
mono- and bicyclic piperidinium ions to estimate the stability of substituted piperidinium 
ions as a function of substituents, the orientation of the substituents, and the conformation 
of the cyclic piperidinium ions.113 They observed that the unsubstituted piperidinium ions 
have the highest pKa while the introduction of electron-withdrawing groups leads to a 
decrease in the pKa values. Further, the axial electron-withdrawing substituents have a 
higher pKa value compared to their equatorial counterparts. A set of substituent constants 
were derived in pH units by calculating the difference between the pKa of unsubstituted 
piperidinium ion and that of the substituted ammonium ions. Since the piperidinium ions 
with axial hydroxyl groups have higher pKa values compared to those of the equatorially 
substituted ones, the derived substituent constants of the former have smaller 
magnitudes while the latter have relatively higher values (Table 7). 
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Table 7.  Axial and Equatorial Substituent Effects on the Base Strength (σs) of 
Piperidinium Derivatives in Water at 25 °Ca. 
R group 
    
OH 1.3 0.5 0.6 0.2 
F 2.3 1.5 1.0 - 
COOMe 1.2 0.2 - - 
CONH2 1.5 1.3 - - 
COO- 0.5 -0.2 0.2 - 
CN 2.8 3.0 - - 
CH2OH 0.4 0.5 - - 
aσs values in pH units and they were calculated from the equation, ∑σs = pKa 
(unsubstituted amine) - pKa (substituted amine). 
These observations clearly demonstrate that the axial groups have a higher 
stabilization of developing positive charge compared to equatorial substituents. This 
stabilization is possibly a cumulative effect of the through-space electrostatic stabilization 
of positive charge by the axial hydroxyl groups and of the fact that the axial OH groups 
are not in a preferential configuration to withdraw the electron density from the nascent 
oxocarbenium ions to destabilize the positive charge. Further, in a series of hydrolysis 
experiments, a directly proportional relationship was observed between the sum of 
substituent constants for a given 2,4-dinitrophenyl glycoside versus the negative 
logarithm of the rate constants of their spontaneous hydrolysis (Figure 14).113-114  
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Figure 14.  Plot of Negative Logarithm of the Rate Constant for Spontaneous 
Hydrolysis of 2,4-Dinitrophenyl Glycosides versus the Sum of their Stereoelectronic 
Constants for the Substrate.113 
Application of this concept in studying the influence of protecting groups on the 
stability of glycosyl oxocarbenium ions further demonstrates that the electron-donating 
group and axial C-O bond of the glycosyl donor stabilizes the formation of oxocarbenium 
ions compared to their counterparts.115 Thus, the conclusions of the study of pKa values 
using piperidinium models show parallel results to the reactivity pattern of glycosylations 
of the corresponding thioglycosides (Figure 15).53, 69 Overall, the knowledge of factors 
influencing the glycosylation reactions, particularly the type of protecting groups, the 
configuration of ring C-O bonds, and the side-chain conformation, are of critical 
importance in mechanistic studies in carbohydrate chemistry. 
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Figure 15. Comparison of the Relative Reactivity of Glycosyl Donors with the pKa of the 
Corresponding Piperidinium Ions 
1.7 Neighboring Group Participation 
When considering the factors affecting glycosylation reactions, neighboring group 
participation116 is one of the key concepts which is regularly invoked in explaining stereo-
controlled glycosylation reactions. This concept has been invoked in a range of 
contexts.117-118 In carbohydrate chemistry, this concept can be explained in terms of the 
nucleophilic participation by the oxygen atom of acyloxy group adjacent to the anomeric 
center (usually, 2-O-position), by forming a dioxalenium ion to stabilize the glycosyl 
carbenium ions.119-120 The intermediate dioxalenium ion can undergo a nucleophilic 
substitution reaction with a nucleophile in SN2 fashion to form 1,2-trans glycosides, or it 
can be trapped as an orthoester, which can eventually rearrange in the presence of an 
acid or a Lewis acid,121 forming the 1,2-trans glycoside (Scheme 11). When the reaction 
rate is increased by the participation of the neighboring group, the phenomenon is called 
anchimeric assistant.122 The intermediate dioxalenium ions have been characterized 
using NMR spectroscopy119 as well as X-ray crystallography,123 providing strong evidence 
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to support the concept of neighboring group participation. The formation of β-galacto- and 
glucopyranosides and α-mannopyranosides are few common examples for the 
stereoselective neighboring group participation.124-125 In addition to the neighboring group 
participation by the protecting groups at the 2-position, the functional groups located at 
more distal positions to the anomeric center, such as 3-, 4-, and even 6-positions, have 
been invoked to explain the stereochemical outcomes of glycosylation reactions as 
‘stereodirecting participation by remote groups’. However, this latter rationale is not well 
supported by experimental evidence, rather the opposite, i.e. the unlikely nature of long 
range participation, is supported by mechanistic studies.126 Overall, when the participating 
groups are present at the 2-position, neighboring group participation is a well-established 
explanation, whereas, stereodirecting participation by remote groups is a controversial 
concept.126-131 
 
Scheme 11. Neighboring Group participation by 2-O-position Acyl Group. 
1.8 Overall goals 
The advancement of the glycobiology and glycochemistry fields depends critically 
on the introduction of efficient glycosylation methods and the optimization of current 
glycosylation reactions. Thus, insight into glycosylation reaction mechanisms is key to the 
success in carbohydrate related sciences. 
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Therefore, this thesis focuses on the mechanisms of glycosylation reactions and 
the factors influencing those reactions. In describing the glycosylation mechanisms, 
exploration of the evidence locating glycosylation reactions on the SN1-SN2 continuum of 
the ion pair mechanisms is crucial. The conformation and configuration of substituents 
have a critical roles in regulating glycosylation mechanisms. Therefore, evaluation of the 
influence of side-chain conformation on the anomeric reactivity is the first goal of this 
thesis. The accurate determination of side-chain conformation is highly dependent on the 
accuracy of experimental limiting coupling constants; hence, derivation of an accurate set 
of limiting coupling constants using model compounds was considered as the first goal. 
Then the application of the limiting coupling constants for the calculation of the side chain 
conformation of pyranosides and subsequence correlation of the side chain conformation 
with anomeric reactivity and selectivity is considered in the second project. A further goal 
of this thesis is the elucidation of sialidation mechanisms via kinetic studies. 
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CHAPTER 2. SYNTHESIS OF CONFORMATIONALLY LOCKED GALACTO- AND 
GLUCO-CONFIGURED CIS- AND TRANS-BICYCLIC DECANE DERIVATIVES AS 
MODEL COMPOUNDS FOR THE DETERMINATION OF LIMITING 3JH,H COUPLING 
CONSTANTS 
Portions of the text and figures in this chapter were reproduced or adapted from: 
Amarasekara, H.; Dharuman, S.; Kato, T.; Crich, D., Synthesis of Conformationally-
Locked cis- and trans-Bicyclo[4.4.0] Mono-, Di-, and Trioxadecane Modifications of 
Galacto- and Glucopyranose; Experimental Limiting 
3
JH,H Coupling Constants for the 
Estimation of Carbohydrate Side Chain Populations and Beyond. J. Org. Chem., 2018, 
83, 881–897. Copyright © 2018, American Chemical Society. 
2.1 Introduction 
The conformational dynamics of glycosyl donors, whether of the pyranoside or 
furanoside ring itself or of the side chain, have a significant influence on the reactivity and 
selectivity of glycosylation reactions.109-110, 132-139 The conformationally mobile side chain 
is usually considered as a mixture of three staggered conformers (Figure 16). These 
conformers are described as gauche-gauche (gg), gauche-trans (gt), and trans-gauche 
(tg), in which the first and second descriptors denote the spatial relationship of O6 with 
respect to the ring oxygen O5 and C4, respectively. The mole fractions (fgg, fgt, and ftg) of 
these conformers can be calculated using the experimental 3JH5,H6R and 3JH5,H6S coupling 
constants, given the availability of the accurate limiting coupling constants of the three 
ideal staggered conformers.140-141 
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Figure 16. The Ideal Staggered Conformations of the Side Chain of Hexopyranoses 
(Methyl α-D-Glucopyranoside), and the Limiting Coupling Constants Describing Them. 
The accuracy of the limiting coupling constants, whose values critically depend on 
the electronegativity and the configuration of the substituents attached to the coupled 
system,142-143 is the most vital factor in determining accurate side chain conformational 
populations for a given system. Thus, the selection of the accurate limiting coupling 
constants has a significant influence on the correlation between structure and reactivity. 
Initially, the limiting coupling constants (3JR,gg - 3JS,tg)  were derived by the 
parameterization of Karplus144 and Haasnoot-Altona145 equations. However, as 
summarized by Bock and Duus,60 the accuracy of  the parameterized limiting coupling 
constants depends on the underlying models. Later, those limiting coupling constants 
were revisited by several other authors.146-148 Derivation of the experimental limiting 
coupling constants from model compounds is another approach. Adopting that approach, 
Bock and Duus used the C1-C2 bond of the 1,5-anhydroalditol 38 (gg), 39 (tg) and 40 (tg) 
as models of the C5-C6 bond to experimentally determine the limiting coupling constants 
(Figure 17).60 Here, it is important to note that compounds 39 and 40 have an 
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enantiomeric relationship to the actual tg conformation of D-pyranoses, and therefore, 
despite the actual pro-6R and pro-6S relationships, H6S and H6R were assigned as shown 
in Figure 17 for the ease of comparison. Further, Serianni and coworkers used pyruvate 
acetals 41 (gg), 43 (tg), and trans-2,5-(bishydroxymethyl)-1,4-dioxane 42 (gt) derivatives 
as models in deriving the limiting coupling constants (Figure 17).147 In addition, earlier 
models149 44 (gg) and 45 (gt), with more conformationally mobile bicyclic frameworks, 
show significantly different limiting coupling constants from those of the more recent 
model compounds (Figure 17). Further, their conformational purity is ambiguous due to 
the mobile nature of the 9-membered ring containing the C5-C6 and C6-O6 bonds. 
Therefore, these early models 44 and 45 were discarded. Consideration of the gg and tg 
conformations of more recent models indicate that there are considerable differences 
between the limiting coupling constants reported by different authors (Figure 17). Further, 
in the absence of model 45, there is only one model for the gt conformation. Overall, there 
are many inconsistencies in the limiting coupling constants reported by different authors, 
and the computed conformational populations from them include negative conformational 
populations for one of the three conformers. 
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Figure 17. Literature Models for the gg, gt, and tg Conformers.  
The accurate determination of the side chain conformational population is 
important in several ongoing projects in the Crich laboratory,150-151 necessitating re-
evaluation of the viability of using the literature limiting coupling constants. As discussed 
above, the discrepancies in the limiting coupling constants introduced by different authors 
and the negative populations calculated from those limiting coupling constants are 
indicative of possible errors in the data set. To address these problems, the synthesis 
and analysis of a series of conformationally rigid oxabicyclo[4.4.0]decane model 
compounds 46-57 were carried out to provide reliable limiting coupling constants (Figure 
18). This series of compounds consists of both galacto- and gluco-configured systems 
such that, ideally, it can also be used to compare the effect of the orientation of the 
substituents, which are not directly attached to the coupled system (Figure 18). 
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Figure 18. Oxa-, Dioxa-, and Trioxadecalins for the Determination of Limiting 3JH,H 
Coupling Constants About the C5-C6 bond in Galacto- and Glucopyranosides. 
However, several potential problems are associated with these bicyclic model 
compounds, such as i) the conformational purity of the cis-fused model compounds and 
of the compounds with 1,3-diaxial interactions; ii) the derivation of coupling constants from 
the tetrasubstituted models for use in modeling the trisubstituted side chains in 
hexopyranoses; iii) a combination of i) and ii). Therefore, another series of compounds 
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58-63 were prepared for comparison purposes (Figure 19). The verification of the 
literature data was anticipated by the comparison of literature models 38 and 39 with the 
models 61 and 58, respectively. Further, the comparative analysis of these four 
compounds is useful in the evaluation of the influence of the ether-type protecting groups 
on the coupling constants. It is important to note that similar to compounds 39 and 40, the 
C2-C1 bond of compounds 58-60 have a pseudoenantiomeric relationship with the side 
chain (C5-C6) of D-sugars, and therefore, regardless of the absolute denotation of pro-
6R and pro-6S, H6R and H6S are denoted as depicted in the Figure 19 for ease of 
comparison. 
 
Figure 19. Bicyclic Model Systems for Comparison of Coupling Constants Between Tri- 
and Tetrasubstituted Systems. 
2.2 Results and Discussion 
2.2.1 Chemistry and Synthesis 
Compounds 47,152 48,110 51,110 53,109 55,109 57153, 61154, 62,155 and 63155 are 
literature compounds that were synthesized as described in the literature. Dr. Suresh 
Dharuman and Dr. Takayuki Kato, whome I thank, carried out the synthesis of some 
literature models as well as some new model compounds. Literature compounds 58-60156-
157 were prepared using alternative protocols as outlined in the Scheme 12 and 13. Thus, 
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the treatment of S-Phenyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-deoxy-1-thia-β-D-
glucopyranoside 64158 with tributylstannane in the presence of AIBN in benzene gave 1,5-
anhydroglucitol 58 in 72% yield (Scheme 12).  
 
Scheme 12. Synthesis of Compound 58. 
The synthesis of compounds 59 and 60 was started with the Zemplen 
deacetylation of an anomer mixture of 2, 3, 4, 6-tetra-O-acetyl-1-C-allyl-D-glucopyranose 
65159 (α:β = 1:0.2) with sodium methoxide in methanol followed by benzylidine protection 
using benzaldehyde dimethyl acetal in the presence of camphor sulfonic acid in 
acetonitrile and finally, benzyl protection with benzyl bromide and sodium hydride in DMF 
to give 59 and 60 in 6% and 55% yield, respectively, over three steps (Scheme 13).  
 
Scheme 13. Synthesis of Compounds 59-60. 
Synthesis of Compounds 46, 49, 54, and 56 carried out as shown in Scheme 14. 
Thus, methyl 2,3-O-methyl,4,6-O-p-methoxybenzylidene-α-D-glucopyranoside 66160 was 
treated with sodium cyanoborohydride in the presence of HCl161-162 to give 71% of the 6-
O-p-methoxybenzyl ether 67, followed by the oxidation using the Dess-Martin protocol163 
to give ketone 68 in 85% yield. Grignard reaction with allylmagnesium chloride in THF at 
0 oC then gave the 4-C-allyl galacto- and glucopyranosides 69 and 70 in 54 and 19% 
yield, respectively.  The galacto- and gluco isomers were separately methylated by 
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treating them with sodium hydride and methyl iodide to give compounds 71 and 72. The 
p-methoxybenzyl groups were cleaved with CAN to give alcohols 73 and 74.  Dess Martin 
oxidation of the galacto-isomer 73 gave an aldehyde 75, which was then treated with 
vinylmagnesium bromide in THF at -78 oC to give an 81% overall yield of an inseparable 
mixture (1.5:1) of the allylic alcohols 77 and 78. The mixture of two isomers, 77 and 78, 
was subjected to a sequence of reactions including ring-closing metathesis with the 
second generation Grubbs catalyst164 to give 79 and 80 in 60% and 37%, respectively. 
The isomers were individually subjected to hydrogenation to give 81 and 82, followed by 
methylation with sodium hydride and methyl iodide to give 49 and 46, respectively. The 
configuration at the 6-position of the bicyclic compounds 49 and 46 was assigned with 
the help of 1H-NMR spectral analysis. Thus, a comparative 1H-NMR analysis between 
compound 46 and 49 over three solvents reveals that two compounds have average 
3JH5,H6 coupling constants of 3.2 Hz and 9.2 Hz, respectively. Based on the magnitude of 
the coupling constants, the smaller 3JH5,H6 coupling constant of compound 46 asigned to 
the axial-equatorial (a,e) coupling between equatorial H6 and H5 proton, while the larger 
3JH5,H6 coupling constant of compound 49 is assigned to the axial-axial (a,a) coupling 
between axial H6 and H5 proton. Therefore, equatorial H6 of compound 46 and axial H6 of 
compound 49 are then assigned as H6S and H6R, respectively. The strong nOe correlation 
between methoxy groups at 4- and 6-positions of compound 46, indicating 1,3-diaxial type 
interractions, also reveals the configuration of the methoxy group at 6-position (Figure 
22). 
 Analogous to the synthesis of compounds 46 and 49, the gluco-isomer 74 was 
used to synthesize the stereoisomers, 54 and 56. Thus, oxidation of alcohol 74 gave an 
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aldehyde 76, followed by the treatment with vinyl magnesium bromide gave 
diastereoisomers 83 and 84 in 12 and 48% yields, respectively. Compounds 83 and 84 
were then individually subjected to a sequence of ring-closing metathesis reactions to 
obtain 85 and 86, respectively. The hydrogenation of individual isomers 85 and 86 gave 
alcohols 87 and 88, respectively, and finally, the methylation of 87 and 88 gave 54 and 
56, respectively. Following a similar type of 1H-NMR analysis as for bicyclic models 46 
and 49, the relative configurations at the 6-position of compounds 54 and 56 were 
assigned. 
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Compounds 50 and 52 were synthesized as described in Scheme 15. Thus, Dess 
Martin oxidation of methyl 6-O-benzyl-2,3-di-O-methyl-α-D-glucopyranoside 89165 gave 
ketone 90, which was then subjected to Grignard addition with allylmagnesium chloride 
in THF at 0 oC to obtain the 4-C-allyl galacto and 4-C-allyl-glucopyranosides 91 and 92 in 
60% and 22% yield, respectively. The individual isomers were separately methylated 
using sodium hydride and methyl iodide to give the methyl ethers 93 and 94. The 
compounds 93 and 94 were separately subjected to ozonolysis followed by reductive 
work up to give the 4-C-(2-hydroxyethyl) derivatives 95 and 96, respectively, in good 
yields. The galacto-isomer 95was treated with toluenesulfonyl chloride in pyridine to give 
the tosylate 97 in 66% yield. Tosylate 97 was then subjected to hydrogenolysis, and 
subsequent treatment with sodium hydride gave 50 in 80% yield. Following a similar 
sequence of reactions via mesylate 98, the gluco-isomer 96 was transformed to the 
bicyclic compound 52 (Scheme 15). Attempted tosylation of 96 using different reaction 
conditions gave unstable tosylate 99 that decomposed on silica gel column 
chromatography and on standing to give cis-fused dioxyabicyclo-[4.3.0]-nonane 
derivative 100 in varying yields (Scheme 15). Compound 100 was also observed during 
the mesylation-hydrogenation-ring closing sequence of compound 96, as a single 
diastereoisomer. The structure of 100 was deduced based on the HMBC and multiple 
nOe measurements. Thus, 2D-HMBC-NMR analysis of compound 100 showed 
correlations between H3 and H7 protons and H3 and H8 protons, indicating that C8 is 
attached to the oxygen at the 3-position, given that C4 is linked to the C7 position (Figure 
20). In addition, the nOe analysis of the compound 100 revealed the correlations of H7 
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with H2 and H6R protons and H7’ with H6R and H6S protons and the methyl group at O5, 
supporting the proposed structure of compound 100 (Figure 21). 
 
Scheme 15.  Synthesis of the Bicyclic Pyranosides 50 and 52. 
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Figure 20. HMBC Correlations of Compound 100. 
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Figure 21. nOe Correlations of Compound 100. 
2.2.2 Determination of Coupling Constants and Influence of Solvent and 
Protecting Groups on the Coupling Constants 
The 1H-NMR spectra of model compounds 46-58 were recorded in C6D6, CDCl3, 
and CD3OD. All the coupling constants were extracted from the experimental spectra, 
except for those compounds with second-order spectra complicated by the presence of 
virtual couplings. In such cases, first order coupling constants were extracted from 
simulated 1H-NMR spectra with the help of the spectral simulation tool, DAISY in the 
Bruker Topspin 3.5 software package. Analysis of the total set of coupling constants for 
compounds 46-58 shows minimal to no effect on the coupling constants across the three 
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solvents. Therefore, 1H-NMR spectra of compounds 59-63 were only recorded in CDCl3. 
In addition, 3JH1,H2 coupling constants obtained in CDCl3 for the benzylidine and 2,3-O-
benzyl protected compounds 58 and 61 do not differ significantly from the 3JH1,H2 coupling 
constants reported by Bock and Duus for the parent compounds, 39 and 38, in D2O. 
These observations suggest that the inclusion of a benzylidine ring or 2,3-O-benzyl 
protection or different NMR solvents does not have a significant influence on 3JH1,H2 
coupling constants of 38, 39, 58, and 61 (Table 8 and 9).  
The complete set of coupling constants for compounds 46-57 and 58-63 are 
tabulated in Tables 8 and 9, respectively. Further, 3JH5,H6R and 3JH5,H6S  coupling constants 
of the compounds 46-58 and 61, and literature compounds 38-45, are categorized into 
three Tables 10, 11, and 12, wherein each table consists of two sub sections: a first 
section for the 3JH5,H6R coupling constants and a second section for the 3JH5,H6S coupling 
constants. Moreover, in Tables 10-12, the coupling constants of the galacto-configured 
compounds precede those of the gluco-compounds. 
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Table 9. Coupling Constants (3JH,H and 2JH,H) Recorded in C6D6, CDCl3 and CD3OD for 
58-63. 
Entry Cmpd Solvent 
Coupling Constant 3JH,H and 2JH,H 
1ax, 2 1eq, 2 1-vis 2,3 3,4 4,5 5,6R 5,6S 6-vis 
1 58 
C6D6 5.7 10.6 11.2 8.7 9.1 9.3 5.0 10.2 10.3 
CDCl3 5.7 10.5 11.3 8.9 9.1 9.3 5.0 10.2 10.4 
CD3OD 5.6 10.5 11.2 8.7 9.1 9.3 5.0 10.2 10.3 
2 59 CDCl3 9.6 - - 8.4 9.3 9.3 5.0 10.3 10.4 
3 60 CDCl3 5.8 - 8.6 8.6 N/D N/D N/D N/D N/D 
4 61 CDCl3 1.1 2.2 12.5 3.3 9.9 9.5 4.8 9.9 10.3 
5 62 CDCl3 1.1 - - 2.9 9.9 9.5 4.8 9.9 10.3 
6 63 CDCl3 - 1.5 - 3.3 9.9 9.5 4.8 9.9 10.3 
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Table 10.  3JH5,H6R and 3JH5,H6S Coupling Constants for gg Conformers. 
a) Unless otherwise stated, the C5-C6 bond is considered.  b)  Deduced correction factor 
for the presence of the additional C-C bond.  c) Validity of compounds for further 
consideration as discussed in the text. d) Measured in D2O. 
  
Entry 
Cmpd 
(bond)a 
Config 
Ring 
fusion 
C6 
Subst 
Correction 
(Hz)b 
Experimental and 
(corrected) 
3JH5,H6 values (Hz) 
Commentc 
C6D6 CDCl3 CD3OD 
H5,H6R 
1 47 galacto cis CH2 na 1.9 1.8 1.7 exclude 
2 52 gluco cis CH2 na 1.7 1.7 1.7 exclude 
3 61(C1,C2) - - CH2 na nd 1.1 nd include 
4 38(C1,C2) - - CH2 na 0.9d   include 
5 41 galacto cis CH2 na 1.8d   exclude 
6 44 gluco - CH2 na 5.4   exclude 
H5,H6S 
7 46 galacto trans CH -0.5 
3.2 
(2.7) 
3.0 
(2.5) 
3.2 
(2.7) 
exclude 
8 47 galacto cis CH2 na 1.6 1.8 1.6 exclude 
9 53 gluco trans CH -0.5 
2.6 
(2.1) 
2.6 
(2.1) 
2.6 
(2.1) 
include 
10 52 gluco cis CH2 na 1.6 1.6 1.6 exclude 
11 61 - - CH2 na nd 2.2 nd include 
12 38(C1,C2) - - CH2 na 2.2d   include 
13 41 - cis CH2 na 1.8d   exclude 
14 44 gluco - CH2 na 1.2   exclude 
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Table 11.  3JH5,H6R and 3JH5,H6S Coupling Constants for gt Conformers. 
Entry 
Cmpd 
(bond)a 
Config. 
Ring 
fusion 
C6 
Subst 
Correction 
(Hz)b 
Experimental and 
(corrected) 
3JH5,H6 values (Hz) 
Commentc 
C6D6 CDCl3 CD3OD 
H5,H6R 
1 49 galacto trans CH +2.0 
9.2 
(11.2) 
9.2 
(11.2) 
9.2 
(11.2) 
include 
2 55 gluco trans CH +2.0 
9.2 
(11.2) 
9.0 
(11.0) 
9.2 
(11.2) 
include 
3 42(C1,C2) - - CH2 na 10.7d   include 
4 45 gluco - CH2  9.5   exclude 
H5,H6S 
5 48 galacto cis CH -0.5 
3.2 
(2.7) 
3.2 
(2.7) 
3.1 
(2.6) 
include 
6 54 gluco cis CH -0.5 
3.0 
(2.5) 
3.1 
(2.6) 
3.1 
(2.6) 
include 
7 42(C1,C2) - - CH2 na 2.5d   include 
8 45 gluco  CH2 na 1.5   exclude 
a) Unless otherwise stated, the C5-C6 bond is considered.  b)  Deduced correction factor 
for the presence of the additional C-C bond.  c) Validity of compounds for further 
consideration as discussed in the text. d) Measured in D2O. 
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Table 12.  3JH5,H6R and 3JH5,H6S Coupling Constants for tg Conformers. 
Entry 
Cmpd 
(bond)a 
Config. 
Ring 
fusion 
C6 
Subst 
Correction 
(Hz)b 
Experimental and 
(corrected) 
3JH5,H6 values (Hz) 
Commentc 
C6D6 CDCl3 CD3OD 
H5,H6R 
1 50 galacto trans CH2 na 4.8 4.4 4.7 include 
2 51 galacto cis CH 0 3.0 3.1 3.1 exclude 
3 56 gluco cis CH 0 2.8 2.8 2.7 exclude 
4 57 gluco trans CH2 na 4.9 4.7 4.7 include 
5 
58 
(C1,C2) 
- trans CH2 na 5.7 5.7 5.6 exclude 
6 39 - - CH2 na 5.5d   exclude 
7 40 - - CH2 na 5.6d   exclude 
8 43 gluco trans CH2 na 5.0d   include 
9 
58 
(C5,C6) 
gluco trans CH2 na 5.0 5.0 5.0 include 
H5,H6S 
10 50 galacto trans CH2 na 10.5 10.1 10.3 include 
11 57 gluco trans CH2 na 10.3 10.1 10.2 include 
12 
58 
(C1,C2) 
- trans CH2 na 10.6 10.5 10.5 exclude 
13 39 - - CH2 na 10.8d   exclude 
14 40 - - CH2 na ~10d   exclude 
15 43 gluco trans CH2 na ~10.3d   include 
16 
58 
(C5,C6) 
gluco trans CH2 na 10.2 10.2 10.2 include 
a) Unless otherwise stated, the C5-C6 bond is considered.  b)  Deduced correction factor 
for the presence of the additional C-C bond.  c) Validity of compounds for further 
consideration as discussed in the text. d) Measured in D2O. 
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2.2.3 Analysis of Bicyclic Models 9-20. 
The validity of these bicyclic model compounds, representing the three ideal 
staggered conformations of the pyranose side chain, critically depends on the 
conformational purity of their bicyclic framework (pure chair-chair conformation) as shown 
in Figure 18. Out of twelve compounds (Figure 18), six have the trans-decalin 
configuration. Since there are no significant variations in the coupling constant pattern 
(Table 8), compounds 49, 50, 53, 55, and 57 are considered as pure staggered 
conformers. Further, X-ray crystal structures of literature compounds, (e.g., CCDC: 
HEGREQ) which have < 2° deviation from the dihedral angle of the ideal tg conformation 
(about C5-C6 bond), further reveals that compound 57 is a suitable model for the ideal tg 
conformation. Comparison of the coupling constant pattern, particularly, axial-equatorial 
(a,e) coupling constants between H7 and H8, and H8 and H9, of the compound 49 with 
its diastereoisomer 46 (Table 8), reveals that there is a considerable discrepancy 
between those coupling constants. These differences may arise due to the plausible steric 
interactions of 1,3-diaxial methoxy groups present at C4 and C6 and/or the unfavorable 
dipolar interactions of those two methoxy groups present in compound 46. Despite the 
deviations in coupling constants, nOe relationships indicate that compound 46 has a 
chair-like conformation (Figure 22). However, the considerable differences in coupling 
constants between compounds 46 and 49 provide enough evidence to conclude that 
compound 46 is not a suitable model for the ideal gg conformation, as the 1,3-diaxial 
interactions are sufficient to distort the bicyclic ring of compound 46. Extrapolating from 
these observations, it can be predicted that the 4,6-di-O-methylated galactopyranoside 
and its derivatives have a very low or zero population of gg conformation.
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Figure 22. nOe Interactions and Coupling Constants (Mean Values Across the Three 
Solvents) for 46 and 56. 
On the other hand, cis-decalins 47, 48, 51, 52, 54, and 56 are considered as more 
conformationally mobile systems due to the cis-fused ring junction of the two rings, and 
therefore, need careful examination. Despite the fact that the deviations in the coupling 
constants of the cis-decalin models are minimal (Table 9), previous crystalographic data 
from the two 4,6-O-benzylidine protected galactopyranoside166 reveal the torsion angles 
of 67° and 68° for O5-C5-C6-O6 and of 52° and 52° for C4-C5-C6-O6, are enough 
evidence for the exclusion of benzylidine acetals 47 and the literature model 41 from 
further consideration as the ideal gg conformations. Since the 3JH5,H6R and 3JH5,H6S 
coupling constants of compound 52 are almost identical with those of compound 47 
(Table 10), compound 52 is also considered as a non-reliable model of the ideal gg 
conformation. According to the full set of coupling constant analysis of compounds 54 and 
56 (Table 8), there are only minor differences in their conformations. Further, the nOe 
analysis of compound 56 does not indicate any evidence for the distortion of the structure 
of 56 from the ideal cis-bicyclic framework (Figure 22). However, the 3JH5,H6R coupling 
constant of 56 has a significant deviation from the corresponding coupling constants 
measured from trans-bicyclic models, 50 and 57, leading to the exclusion of compound 
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56 from consideration. Moreover, compound 51 has a 3JH5,H6R coupling constant 
comparable to that of compound 56, even after applying the suitable correction factors 
for the presence of an additional C-C bond (the derivation of correction factors is 
discussed below). Therefore, compound 51 is also excluded from further consideration. 
Importantly, gt models 48 and 54  have similar 3JH5,H6S coupling constants, and also those 
values are comparable to the corresponding coupling constants of the literature 
compound 42, leading to the inclusion of cis-decalin derivatives 48 and 54 in the final data 
set. Overall, out of six cis-fused bicyclic models, compounds 47, 51, 52, and 56 were 
excluded from further consideration, leaving compounds 48 and 54 for further analysis. 
Another interesting observation from analysis of the coupling constants is that 
regardless of the cis- or trans-fused nature of the ring junction, the 3JH2,H3 coupling 
constants of galacto compounds 46-51 are 10.0 ± 0.1 Hz, while gluco-configured 
compounds 52-57 show only 9.4 ± 0.2 Hz for the corresponding coupling constants (Table 
8). The ~0.5 Hz increase in the galacto-series can be explained by the β-effect noted by 
Altona and Haasnoot, who noted that when one of the two hydrogens of a pair of 
antiperiplanar hydrogens is also antiperiplanar to an electron-withdrawing C-X bond in 
the β-position of antiperiplanar spin system, the coupling constant between two 
antiperiplanar hydrogens increases (Figure 23).167 
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Figure 23. Comparison of 3J2,3 Vicinal Coupling Constants between Selected Galacto-
Models (with the Altona-Haasnoot β-Effect) and Gluco-Models (without the β-Effect). 
2.2.3.1 Comparison of the 1,5-Anhydrohexitols and the 4,6-O-Acetals as 
Models for the tg Conformation 
Two different sets of limiting coupling constants are available for the tg 
conformation. One can be extracted from the  H1,H2 spin system and the other from the 
H5,H6 spin system. Comparison of the tg models 39 and 40 with the 4,6-O-alkylidene 
model 43 indicates that there are considerable differences between the two sets of 
coupling constants. Further, the internal comparison of those two sets of coupling 
constants within compound 58 also reveals clear differences in the coupling constants 
between the two types of spin systems (Figure 24). 
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Figure 24.  Internal Comparison of 3JH,H Coupling Constants in the 4,6-O-Benzylidene 
Protected 1,5-Anhydrohexitol 58. 
A decision must, therefore, be made as to which of the two is the most reliable 
model. Based on the close analogy of the H5,H6 spin systems between compounds 43, 
57, 58, and 61 and the ideal tg conformation of the pyranose side chain, and the similarity 
of  the 3JH5,H6R and 3JH5,H6S coupling constants between these models and the bicyclic 
model 50, the H5,H6 spin system of models 43, 57, 58, 61, and 50 were selected over the 
H1,H2 spin system of compounds 39, 40, and 58. In addition, the similarity of the 3JH5,H6 
coupling constants between the acetal-containing models and compound 50 reveals that 
the influence of the acetal functionality on the 3JH5,H6 coupling constants is minimal. 
2.2.4 Systematic Classification and Derivation of Correction Factors for the Use 
of Tetrasubstituted Stereodiads as Models for the Trisubstituted Side Chain of 
Pyranosides. 
The exocyclic C6-O6 bond of the hexopyranose side chain is trisubstituted 
whereas the bicyclic model compounds 46, 48, 49, 51, 53-56 are tetrasubstituted. 
Therefore, the influence of the extra C-C bond of the tetrasubstituted models should be 
considered. According to Altona and Haasnoot, extra substituents do not require a 
correction for (a,e) and (e,e) coupling constants. However, in one of their two alternative 
interpretations of their data set, they proposed a + 0.4 Hz correction factor for the (a,a) 
coupling constant.167 In the coupling constant analysis of compounds 46-57, considerable 
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differences are observed between the tri- and tetrasubstituted spin systems with the same 
side chain conformation, necessitating careful attention to the influence of the additional 
C-C bond. 
In order to derive correction factors with minimal systematic errors, a closer 
examination of the selected structures of the tri- and tetrasubstituted models is required. 
Thus, a systematic classification of these model compounds was considered. All the 
configurations of the bicyclic model compounds, whether erythro or threo, can be 
classified into three different Newman projections, leading to the total of six different 
conformations, of which II and III are pseudoenantiomeric (Figure 25). In addition, it is 
important to note that the bicyclic model compounds cannot be included in two of the 
configurations (I and V) shown in Figure 25, as those classes of configurations consist of 
antiperiplanar R and R’ groups. However, for the completion of the data classification, 
those two classes are also included in this study.  
 
Figure 25.  Staggered Conformations about the C5-C6 Bonds in the Bicyclic Models 46-
57 and other 4,6-O-Acetals, the C2-C1 Bonds in the 1,5-Anhydrohexitols, and the C1-C2 
Bonds in the 1,4-Dioxanes 42, 101 and 102.  In the Tetrasubstituted Stereodiads R′ is an 
Alkyl Group, while in the Trisubstituted Systems R’ is a Hydrogen Atom. 
All staggered conformations about the C5-C6 bond of the tetrasubstituted models 
46, 48, 49, 51, and 53-56 are categorized into Newman projections from I to VI (Table 
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13). Similarly, staggered conformations about the C5-C6 bond of trisubstituted 
compounds, 47, 50, 52, and, 57 and about the C2-C1 bond of compounds 38-40, 58, and 
61 can be categorized into Newman projections I to VI (Table 13). In the trisubstituted 
systems, R’ is a hydrogen atom; therefore, they consist of only one stereogenic center. 
Consequently, for trisubstituted systems, projections I and IV are identical as are II and 
V, and III and VI. In addition, for comparison purposes, two other literature compounds, 
cis-2,3-dimethyl-1,4-dioxane 101 and trans-2,3-dimethyl-1,4-dioxane 102, whose 
Newman projection about C1-C2 bonds belong to projections III and VI, respectively, 
were considered (Figure 26).168-169 It is important to note that the vicinal coupling 
constants between chemically identical protons of these two compounds were obtained 
by the analysis of 13C side bands at low temperature.168-169 
 
Figure 26.  cis- and trans-2,3-Dimethyl-1,4-dioxanes 101 and 102. 
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Comparison of the models from Table 13 entries 2 and 3, affords the correction 
factor for (a,a) coupling constant about the C1-C2 bonds of tri- and tetrasubstituted 
compounds of category I. Similarly, comparison of the models from Table 13 entries 6 
and 7, entries 8 and 11, entries 1 and 13, entries 6 and 14, and entries 8 and 16 leads to 
the correction factors for the classes II to VI (Table 14). In these comparisons, systematic 
errors are minimized as the correction factors are derived within the same class of 
compounds. The correction factors range from -0.5 Hz to +2.0 Hz. The largest value 
belongs to (a,a) couplings and is consistent with the suggestions of Altona and 
Haasnoot.167 Finally, these derived correction factors are applied to the coupling 
constants measured from the model compounds (Table 10-12). 
Table 14.  Derivation of Correction Factors for Use with Tetrasubstituted Models. 
Config Project Type 
Correction Derivation 
Correction 
(Hz)a 
Relevant 
Models 
Trisubs 
cmpd, 
J (Hz) 
Tetrasubs 
cmpd, 
J (Hz) 
erythro I (a,a) 58, 10.5 59, 9.6 +1.0 - 
erythro II (e,e) 61, 2.2 63, 1.5 +0.5 - 
erythro III (a,e) 42, 2.5 101, 3.2 -0.5 46, 48, 53, 54 
Threo IV (a,e) 58, 5.7 60, 5.8 0 51, 56 
Threo V (a,e) 61, 1.1 62, 1.1 0 - 
Threo VI (a,a) 42, 10.7 102, 8.5 +2.0 49, 55 
aCorrection factors are rounded to the nearest 0.5 Hz. 
2.2.5 Selection of gg, gt, and tg Model Compounds and Limiting Coupling 
Constants 
2.2.5.1 gg Conformation 
According to the discussion in Section 2.2.3, literature compound 41 and the 
bicyclic models 46, 47, and 52 are considered as non-ideal models of the pure gg 
conformation and, therefore, are excluded from further consideration. Further, literature 
compound 44 is excluded as it has a significantly different 3JH5,H6R coupling constant from 
75 
 
all the others in Table 10, probably due to the distortions  in the bicyclic structure of 
compound 7 as noted in Section 2.1. After the application of appropriate correction 
factors, gluco-configured trans-bicyclic model 53 and literature model 38 and it’s 
benzylidene derivative 61 were selected as the appropriate models to represent the pure 
gg conformation. Thus, coupling constants 1.0 and 2.2 Hz are suggested as the limiting 
3JH5,H6R and 3JH5,H6S coupling constants, respectively (Table 15, entry 1). 
2.2.5.2 gt Conformation 
As per Section 2.1, the conformational purity of compound 45 is ambiguous, and 
the coupling constants derived from this compound are significantly different from all other 
models of the gt conformation (Table 11). Therefore, it is concluded that compound 45 is 
not a suitable model to represent the pure gt conformation. After the application of suitable 
correction factors, bicyclic compounds 49 and 55 together with the monocyclic model 42 
were chosen as the best models to describe the pure gt conformation, and thus the 
derived limiting 3JH5,H6R coupling constant is 11.0 Hz (Table 15, entry 1). After application 
of the correction factors, compounds 48 and 54 are in greater agreement with the 3JH5,H6S 
coupling constant read from the monocyclic model 42, and hence, the limiting 3JH5,H6S  
coupling constant is determined to be 2.5 Hz (Table 15, entry 1). 
2.2.5.3 tg Conformation 
As per the discussion in Section 2.2.3, compounds 51 and 56 are considered as 
inadequate models of the pure tg conformation and, therefore, are excluded from further 
consideration. Further, it is concluded that the H1, H2 spin system of the compounds 39, 
40, and 58 are also inadequate models. On the other hand, the tg conformation about 
C5-C6 bonds of compounds 50, 57, 58, and literature model 43 were considered as 
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suitable models to represent the tg conformation. Therefore, the limiting 3JH5,H6R and 
3JH5,H6S coupling constants of the tg conformation are assigned values of 4.8 and 10.2 Hz, 
respectively (Table 15, entry 1). 
Table 15. Literature and Recommended Limiting Coupling Constants. 
Entry Source 
3JH5,H6R 3JH5,H6S 
gg gt tg gg gt tg 
1 This work 1.0 11.0 4.8 2.2 2.5 10.2 
2 Haasnoot–Altona145 0.9 10.7 5.0 2.8 3.1 10.7 
3 Bock-Duus60 0.9 10.7 5.5 2.2 2.5 10.7 
4 Serianni (expt)147 1.8 10.7 5.0 1.8 2.5 10.3 
5 Serianni (calc)147 0.8 9.9 4.5 1.3 1.5 10.8 
6 Nishida170 1.7 10.8 4.1 2.2 2.4 11.1 
2.2.6 Evaluation of Limiting Coupling Constants for the Application of Side Chain 
Population Calculations 
2.2.6.1 Comparison of Newly Derived Limiting Coupling Constant with the 
Literature Values 
As discussed above, several earlier set of limiting coupling constants are available 
for the gg, gt, and tg conformations. Those literature coupling constants were derived 
from the Hassnoot-Altona equation,145 experimentally using models 38-4060 and 41-43147, 
and a similar set of benzylidene acetals,170 and computationally using 41-43147 and are 
presented in Table 15. The limiting data obtained from this work is presented in Table 
15, entry 1. Considering the data for 3JH5,H6R, the newly introduced data for gg, gt, and tg 
conformations (Table 15, entry 1) closely resemble the data obtained from the Haasnoot-
Altona equations (Table 15, entry 2), whereas the experimentally derived 3JH5,H6R 
coupling constant for the gg conformation from compound 41 and the same coupling 
constant computed for gt conformation from compound 42 deviate the most from data 
derived here (Table 15, entry 4 and 5). With regards to the 3JH5,H6S  limiting coupling 
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constants, the data derived for compounds 38-40 (Table 15, entry 3) have the closest 
agreement with the data from this study. 
2.2.6.1 Application of the Recommended Limiting Coupling Values in the 
Calculation of Hexopyranoside Side Chain Populations.  
In order to evaluate the reliability of the new limiting coupling constants, the 
experimental 3JH5,H6R and JH5,H6S coupling constants measured by Bock and Duus60 for 
methyl α-D-glucopyranoside (5.5 and 2.4 Hz), methyl β-D-glucopyranoside (6.1 and 2.5 
Hz), and methyl β-D-galactopyranoside (7.5 and 4.8 Hz), respectively, were applied 
together with the limiting coupling constants from Table 15 to solve equations 1-3.  
3JH5,H6R = 3JR,ggfgg + 3JR,gtfgt + 3JR,tgftg         (eq. 1) 
3JH5,H6S = 3JS,ggfgg + 3JS,gtfgt + 3JS,tgftg         (eq. 2) 
1 = fgg + fgt + ftg            (eq. 3) 
Solution of the three equations gave the side chain populations of the test 
substrates. A comparison of the side chain populations calculated using new limiting 
coupling constants (Table 16, entry 1) and those which were calculated using literature 
limiting coupling constants (Table 16, entries 2-6) are presented in Table 16. 
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Table 16.  Calculated Side Chain Populations Using Different Sets of Limiting Coupling 
Constants. 
Entry Source 
Me α-D-Glca Me β-D-Glca Me β-D-Gala 
gg gt tg gg gt tg gg gt tg 
1 This work 54 45 1 48 50 2 16 53 31 
2 Haasnoot – Altona 57 50 -7 50 56 -6 19 58 23 
3 Bock-Duus 53 47 1 46 52 2 17 54 29 
4 Serianni (experimental) 56 40 4 49 47 4 16 53 31 
5 Serianni (calculated) 42 47 11 35 54 12 5 59 36 
6 Nishida 57 41 1 50 48 2 16 56 28 
aCoupling constants of Bock and Duus:60 Me α-D-Glc, 3JH5,H6R = 5.5 Hz, 3JH5,H6S = 2.4 Hz; 
Me β-D-Glc, 3JH5,H6R = 6.1 Hz, 3JH5,H6S = 2.5 Hz; Me β-D-Gal, 3JH5,H6R = 7.5 Hz, 3JH5,H6S = 
4.8 Hz, were used to calculate the populations. 
The absence of negative populations is an indication that the new set of limiting 
coupling constants is reliable for use in the determination of side chain conformational 
populations of hexopyranose systems. As described above, negative populations are 
usually caused by either i) the application of inaccurate limiting coupling constants,60 or 
ii) the existence of the non-ideal conformers.146-148 Therefore, the absence of negative 
populations with the new data set suggests that the equilibration between the three ideal 
staggered conformations of the side chain is an adequate model to describe the 
hexopyranoside side chains. 
2.2.7 Application to Higher Carbon Sugars and Beyond. 
Beyond the application of the new data set in the calculation of pyranose side chain 
populations, it can be applied to any terminal vicinal diol systems and corresponding 
ethers (i.e., HO-CH2-CHOH-R’ and R’O-CH2-CHOHR’’ groups, respectively). Further, the 
limiting coupling constant derived from compounds 48, 49, 53, 54, and 55 can be directly 
applied to internal vicinal diols (i.e., RCHOH-CHOH-R’ group) without using correction 
factors. Such moieties are often found in higher carbon sugars, such as bacterial 
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heptopyranosides,171-174 octulosonic, and non-ulosonic acids,175-176 and acyclic 
polyols.177-178 In addition, the coupling constants derived from the trisubstituted systems 
50 and 57 can be applied to internal vicinal diols after the application of suitable correction 
factors. 
2.3 Conclusions 
A series of cis- or trans-fused bicyclo-[4.4.0]-octane type bicyclic compounds were 
synthesized as the models for ideal gg, gt, and tg conformations. After a critical analysis 
of the complete set of data, some compounds were excluded based on their deviation 
from the ideal chair-chair conformation. Consideration of another series of compounds 
along with some literature compounds facilitated the derivation of correction factors in the 
application of tetrasubstituted models, permitting them to be used as the models for 
trisubstituted systems. Ultimately, a new set of limiting coupling constants was introduced 
for the calculation of pyranoside side chain populations, and the reliability of the new data 
set was evaluated by applying it to literature compounds. The absence of negative 
populations calculated from the new data set, in comparison to the previously reported 
limiting coupling constants, provides strong evidence that the new data set is suitable for 
use as the limiting coupling constants. More importantly, the derivation of a reliable set of 
limiting coupling constants sets the background to an accurate determination of side chain 
conformational populations of hexopyranosides, which will eventually help to understand 
the relationship between conformation and mechanistic aspects of carbohydrate 
chemistry. In addition, applications of these limiting coupling constants can be extended 
to analyze the side chain conformations of the higher carbon sugars and even acyclic 
vicinal diols by applying an appropriate set of correction factors. Finally, the new set of 
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limiting data should serve the field of computational chemistry by providing reliable and 
advisory information for the development of new methods and tools for predicting the side 
chain population of carbohydrates.179 
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CHAPTER 3. INFLUENCE OF THE PROTECTING GROUPS ON THE SIDE CHAIN 
POPULATIONS AND ON THE GLYCOSYLATION REACTIONS 
Portions of the text and figures in this chapter were reproduced or adapted from: 
Dharuman, S.; Amarasekara, H.; Crich, D., Interplay of Protecting Groups and Side Chain 
Conformation in Glycopyranosides. Modulation of the Influence of Remote Substituents 
on Glycosylation?. J. Org. Chem., 2018, 83, 10334–10351. Copyright © 2018, American 
Chemical Society. (Direct link: https://pubsdc3.acs.org/doi/full/10.1021/acs.joc.8b01459) 
3.1 Introduction 
The protecting group array of glycosyl donors has a significant influence on the 
reactivity and stereoselectivity of the corresponding glycosylation reactions.180-187 
Particularly, the configuration of protecting groups has a critical impact on anomeric 
reactivity (Sections 1.4.2.1 and 1.5). Ring conformation is another important factor that 
influences the anomeric reactivity. Thus, cyclic conformations with the maximum number 
of axial substituents (or pseudo-axial groups) have a higher anomeric reactivity compared 
to those with fewer axial substituents. This reactivity difference is clearly shown in the 
acid-catalyzed hydrolysis of methyl glycosides (Figure 27).188-191 Thus, methyl 
glucopyranoside 103 with all equatorial hydroxyl groups has a significantly smaller relative 
rate compared to that of bicyclic glucopyranoside 104 with all axial hydroxyl groups. 
 
Figure 27. Effect of C-O Bond Orientation on the acid-catalyzed hydrolysis of methyl 
glycosides in 2 M HCl at 60 °C.191-192 
The side chain conformation, that can be described as three staggered 
conformations (gg, gt, and tg), also has a significant influence on anomeric reactivity due 
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to the differing electron-withdrawing nature of the three conformations. Out of the three 
conformations, the tg conformation has the lowest reactivity as it has a highly electron-
withdrawing antiperiplanar relationship between C5-O5 and C6-O6 bonds.109-110, 176 Work 
by Vasquez and coworkers using NMR and CD methods showed that the anomeric 
configuration and the nature of the aglycone can influence the side chain populations,193-
197 and this study further demonstrates the significance of interplay between glycosidic 
bond and the side chain conformation. 
Apart from the well-known influence of the electron-withdrawing or donating nature 
of the protecting groups on the anomeric reactivity and selectivity,69, 92, 198-201 protecting 
groups can modulate the side chain conformation, exerting an additional impact on the 
anomeric reactivity and selectivity. However, this interplay between protecting group array 
and the side chain conformation has not yet been studied in a systematic manner. 
Therefore, in this project, the influence of protecting groups on the modulation of side 
chain conformation and the consequent impact on the anomeric reactivity is studied. Due 
to the spatial and through bond proximity of the 4- and 6- protecting groups, the 
interactions between those groups are possibly the strongest forces, which influence the 
side chain conformation of pyranosides. Thus, two series of galacto- and gluco- 
thiopyranosides with different 4-O- protecting groups were prepared (Figure 28). To 
facilitate the unambiguous spectral assignment, 6S-deuterio analogues of these two 
series were also prepared (Figure 28). The 1H-NMR spectra of these compounds were 
recorded in both C6D6 and CDCl3 to examine the influence of the solvent on the side chain 
conformation. Further, 6-O-derivatives of gluco- thiopyranosides and their 6S-deuterio 
isotopomers were prepared to investigate the interplay between 6-position protecting 
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groups and the side chain conformation. This series also facilitates the comparative 
analysis of the influence of protecting groups on the side chain conformations between 
4- and 6-derived glucopyranosides. 
3.2 Results and Discussion 
3.2.1 Experimental Design and Synthesis 
Assuming that interactions between O4 and O6 protecting groups can be 
investigated by changing the O4 protecting group while keeping a constant protecting 
group at O6 of galacto- and gluco- pyranosides, or the inverse, 2,3,6-tri-O-benzyl-β-D-
thiogalactopyranoside 105 (Figure 28)202 and 2,3,4-tri-O-benzyl-β-D-
thioglucopyranoside 107 (Figure 28)203 were synthesized using literature protocols as 
the starting precursors of series 1 and 3 (Figure 29). 
 
Figure 28. Structure of Compounds 105, 106, and 107 and their 6S-Deuterio 
Analogues. 
For the convenience of the synthesis, literature compound 2,3,6-tri-O-benzyl-β-D-
thioglucopyranoside 106 (Figure 28)204 was prepared by the inversion of the 4-hydroxy 
group of its galacto-isomer 105. Thus, treatment of compound 105 with 
trifluoromethanesulfonic anhydride (Tf2O) and pyridine at 0 °C in DCM, followed by SN2 
displacement of 4-O-triflate with sodium benzoate gave benzoate ester 129 in 71% yield 
in two steps. The reaction of benzoate 129 with sodium metal (cat.) in methanol then 
gave alcohol 106 in good yield (Scheme 16). Compound 107 was prepared as an ethyl 
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thioglycoside while the other two compounds, 105 and 106, were obtained as phenyl 
thioglycosides. This is primarily due to the convenience of the synthesis, and, as implied 
by the final analysis of population data, no corrections were required for using different 
types of thioglycosides. 
 
Scheme 16. Synthesis of Phenyl 2,3,6-tri-O-benzyl-β-D-thioglucopyranoside 106. 
Accurate determination of side chain population is critical in correlating side chain 
conformation with the anomeric reactivity.  Therefore, rigorous assignment of the pro-6S 
and pro-6R diastereotopic hydrogens is necessary and can be achieved by the synthesis 
of 6S-deutereio isotopomers of compounds 105-107 (6S-D-105 to 6S-D-107). The 
synthesis of 6S-D-105 and 6S-D-107 was carried out as outlined in Scheme 17 and 18, 
while 6S-deuterio glucopyranoside 6S-D-106 was synthesized analogously to the 
synthesis of 106 using its C4-epimer, 6S-deuterio galactopyranoside 6S-D-105 (Scheme 
16). Unambiguous synthetic routes involving the exoselective quenching of the radicals 
at the 6-position of 1,6-anhydropyranoses205-209 were utilized in preference to shorter 
routes involving asymmetric reduction of 6-aldehydo pyranoses because of their 
unambiguous nature.210-212 Thus, 2,3,4-tri-O-acetyl-1,6-anhydro-D-galactose 108 was 
converted to bromide 109 in 75% yield, following the literature protocol.207 This reaction 
was carried out in the environmentally friendly solvent, α,α,α-trifluromethylbenzene,213 
replacing CCl4; this modification was previously employed in the synthesis of the 
corresponding gluco-derivative 115.150 Radical debromination of 109 using tributyltin 
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deuteride, which was prepared according to Neumann et al.,214 then gave 6S-deuterio 
anhydrogalactose 110 in good yield. Zemplen deacetylation of 110 then gave a triol, 
which on reaction with acetic anhydride in the presence of sulfuric acid gave 
peracetylated 6S-dueterio galactopyranoside 111 in 81% yield over two steps. The 
reaction of compound 111 with thiophenol in the presence of boron trifluoride-diethyl 
etherate complex in DCM then gave thioglycoside 112 in a moderate yield. Zemplen 
deacetylation and subsequent benzylidene protection afforded diol 113 in 71% yield in 
two steps. Di-benzylation of free hydroxy groups with sodium hydride and benzyl bromide 
afforded compound 114 in 81% yield. Finally, regioselective ring opening of benzylidine 
acetal 113 using sodium cyanoborohydride gave 4-hydroxy galacto thiopyranoside 6S-
D-105 in 72% yield (Scheme 17).  
 
Scheme 17.  Synthesis of Phenyl 2,3,6-tri-O-benzyl-6S-deuterio-β-D-
thiogalactopyranoside 6S-D-105. 
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The synthesis of deuterio analogue 6S-D-107 began with 6S-deuterio 1,6-
anydroglucose 115.150, 205-206 Thus, compound 115 was treated with trimethylsilyl 
ethanethiol and zinc iodide215 followed by the acetylation to give peracetylated-6S-
deuterio thioglucopyranoside 116 in moderate yield. A series of standard transformations, 
Zemplen deacetylation, tritylation, benzylation, and acid-catalyzed deprotection of trityl 
group in the presence of acetic acid, were carried out to obtain compound 6S-D-107 
(Scheme 18). 
 
Scheme 18.  Synthesis of Ethyl 2,3,4-tri-O-benzyl-6S-deuterio-β-D-thioglucopyranoside 
6S-D-107. 
Dr. Suresh Dharuman, whom I thank, carried out the synthesis of 4-O-derived 
galactopyranosides to study the influence of substituents at the 4-position on the side 
chain conformation of galactopyranoside. Thus, compound 105 and its 6S-deuterio 
isotopomer 6S-D-105 were converted to a series of 4-O-esters 117-124 (Figure 29, 
Series 1) via standard esterification protocols using the relevant acid anhydride or acid 
chloride in the presence of pyridine (Scheme 19). 
 
Scheme 19. Synthesis of 4-O-Esters of 105 and 6S-D-105. 
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Benzyl ether 125216 (Figure 29, Series 1) and its deuterio isotopomer 6S-D-125 
were prepared from the corresponding alcohols 105 and 6S-D-105 using literature 
protocols.216 The 4-O-(2,2,2-trifluoroethyl) ether 126 and its 6S-deuterio isotopomer 6S-
D-126 were obtained by the triflation of 106 and 6S-D-106 with triflic anhydride and 
pyridine followed by the SN2 displacement of the triflates with sodium trifluoroethoxide in 
DMF (Scheme 20).  
 
Scheme 20.  Synthesis of Phenyl 2,3,6-tri-O-benzyl-4-O-(2,2,2-trifluoroethyl)-β-D-
thiogalactopyranoside 126 and the Corresponding 6S-Deuterio Analog 6S-D-126. 
Similar to the galacto- series, glucose 4-O-derivatives were synthesized to probe 
the influence of 4-O- protecting groups on the side chain conformation of 
glucopyranosides (Figure 29, Series 2). Thus, compound 106 and its 6S-deuterio 
isotopomer 6S-D-106 were converted to a series of ester 127, 128 and 130 using 
standard reaction protocols as described for the galacto- 4-O-series (Scheme 21). 
 
Scheme 21. Synthesis of 4-O-esters of 106 and 6S-D-106. 
Benzyl ether 131217 was prepared using the literature protocol while its 6S-deuterio 
analogues 6S-D-131 was prepared by the benzylation of the corresponding alcohol 6S-
D-106 in the presence of benzylbromide and sodium hydride in DMF (Scheme 22). 
88 
 
Benzoate esters 129 and 6S-D-129 were obtained as intermediate products during the 
synthesis of alcohols 106 and 6S-D-106 (Scheme 16), respectively.  
 
Scheme 22. Synthesis of 4-O-Benzyl Ether 6S-D-106. 
Finally, the synthesis of 6-O-derived thioglucopyranosides was carried out to 
investigate the influence of 6-O-substituents on the side chain conformation of 
glucopyranosides (Figure 29, Series 3). Thus, 6-hydroxy thioglucopyranoside 107 and 
its deuterio analogue 6S-D-107 were converted to a series of 6-O-esters 132-138 and 
their deuterio analogues 6S-D-132 - 6S-D-138 as described in the synthesis of the series 
1 derivatives (Scheme 23). 
 
Scheme 23. Synthesis of 6-O-esters of 107 and 6S-D-107. 
Benzyl ether 140217 and its deuterio isotopomer 6S-D-140 was prepared from the 
relevant alcohols 107 and 6S-D-107 using literature protocols.217 In the synthesis of 6-O-
carbamate analogues, treatment of alcohols 107 and 6S-D-107 with phenyl isocyanate 
and pyridine afforded corresponding carbamate 139 and 6S-D-139, respectively, in good 
yields (Scheme 24).  
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Scheme 24. Synthesis of Ethyl 2,3,4-tri-O-benzyl-6-O-(N-phenylcarbamoyl)-β-D-
thioglucopyranoside 139 and the Corresponding 6S-Deuterio Analogue 6S-D-139. 
3.2.2 Measurement of Coupling Constants and Influence of Solvent 
The 1D- and 2D-NMR spectra of alcohols 105-107 and their derivatives 117-140 
along with the corresponding 6S-deuterio analogues were recorded in 
perdeuteriobenzene and CDCl3. The comparison of 1H-NMR spectra between non-
deuterio and the corresponding deuterio analogues enabled rigorous assignment of pro-
6S and pro-6R protons; here after they are denoted as H6R and H6S, respectively. All first-
order coupling constants were extracted from the 1H-NMR spectra, while second-order 
spectra complicated by the virtual coupling were simulated with the help of the spectral 
simulation tool in the MestRenove 9.0 suite of programs, and the coupling constants were 
determined based on the simulated spectra. 
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Figure 29. 4- and 6-Hydroxy Galacto- and Gluco- Thiopyranosides and their Derivatives 
of Series 1-3. 
The 1H-NMR spectral data of compounds 105-107 and 117-140 (Figure 29) are 
classified into three tables (Table 17, 18, and 19). Table 17 represents the chemical shifts 
and the corresponding coupling constants of the H5, H6R, and H6S spin system of the 4-
O-substituted galactopyranoside series. Similarly, the corresponding chemical shifts and 
the coupling constants of 4-O- and 6-O- derived glucopyranoside series are presented in 
Table 18 and 19, respectively. For ease of comparison, depending on the trends in the 
side chain conformation, alcohols are categorized first followed by the ethers and finally 
the esters. 
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Table 17. 1H Chemical Shifts, 3JH,H Coupling Constants and Side Chain Populations for 
Compounds 105 and 117-126 in CDCl3 and C6D6. 
 4-O-Subs 
Chem Shift, 
ppma 
3J5,6, Hza Population, %a 
H6R H6S J5,6R J5,6S gg gt tg 
105 H 
3.78 
(3.72) 
3.81 
(3.75) 
5.8 
(6.1) 
5.7 
(5.8) 
25.6 
(21.9) 
31.8 
(34.4) 
42.6 
(43.7) 
125 PhCH2 
3.65 
(3.57) 
3.67 
(3.66) 
Nd 
(5.7) 
nd 
(7.4) 
nd 
(13.2) 
nd 
(22.6) 
nd 
(64.2) 
126 CF3CH2 
3.69 
(3.55) 
3.74 
(3.68) 
5.5 
(5.7) 
7.7 
(7.6) 
12.8 
(11.7) 
19.1 
(21.7) 
68.0 
(66.7) 
117 Ac 
3.64 
(3.47) 
3.55 
(3.42) 
6.0 
(6.1) 
6.7 
(6.5) 
15.8 
(16.4) 
29.0 
(31.0) 
55.2 
(52.6) 
118 Me3CCO 
3.62 
(3.49) 
3.49 
(3.42) 
6.1 
(6.0) 
6.7 
(6.8) 
14.8 
(15.0) 
30.1 
(28.6) 
55.1 
(56.4) 
121 PhCO 
3.69 
(3.53) 
3.59 
(3.49) 
5.8 
(6.1) 
6.8 
(6.6) 
17.0 
(15.6) 
26.5 
(30.5) 
56.5 
(53.9) 
122 p-MeC6H4CO 
3.68 
(3.56) 
3.57 
(3.52) 
5.9 
(6.2) 
6.8 
(6.5) 
16.0 
(15.4) 
27.5 
(32.0) 
56.5 
(52.5) 
123 p-MeOC6H4CO 
3.69 
(3.57) 
3.59 
(3.54) 
6.1 
(6.2) 
6.5 
(6.4) 
16.4 
(16.2) 
31.0 
(32.5) 
52.6 
(51.3) 
124 p-O2NC6H4CO 
3.69 
(3.47) 
3.56 
(3.42) 
5.7 
(5.6) 
7.2 
(7.0) 
14.8 
(17.3) 
23.6 
(23.5) 
61.6 
(59.1) 
119 CF3CO 
3.67 
(3.39) 
3.49 
(3.36) 
5.6 
(5.7) 
8.3 
(8.1) 
7.1 
(7.7) 
17.3 
(19.2) 
75.6 
(73.0) 
120 Cl3CCO 
3.71 
(3.43) 
3.59 
(3.46) 
5.7 
nd 
8.2 
nd 
6.9 
nd 
18.8 
nd 
74.3 
nd 
aChemical shift, coupling constants, and populations in CDCl3 (Chemical shift, coupling 
constants, and populations in C6D6).
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Table 18.  1H Chemical Shifts, 3JH,H Coupling Constants and Side Chain Populations for 
Compounds 106 and 127-131 in CDCl3 and C6D6. 
 4-O-Subs 
Chem Shift, 
ppma 
3J5,6, Hza Population, %a 
H6R H6S J5,6R J5,6S gg gt tg 
106 H 
3.76 
(3.60) 
3.80 
(3.64) 
5.3 
(5.3) 
4.1 
(3.7) 
43.1 
(46.2) 
34.5 
(36.4) 
22.4 
(17.4) 
131 PhCH2 
3.73 
(3.63) 
3.80 
(3.63) 
4.8 
(nd) 
1.9 
(nd) 
65.2 
(nd) 
40.0 
(nd) 
-5.3 
(nd) 
127 Ac 
3.58 
(3.54) 
3.58 
(3.58) 
nd 
(5.8) 
nd 
(3.2) 
nd 
(45.3) 
nd 
(43.9) 
nd 
(10.8) 
129 PhCO 
3.65 
(3.58) 
3.65 
(3.62) 
nd 
(6.0) 
nd 
(2.9) 
nd 
(45.7) 
nd 
(47.3) 
nd 
(7.0) 
128 CF3CO 
3.58 
(3.30) 
3.61 
(3.37) 
4.7 
(4.3) 
3.6 
(3.5) 
52.9 
(57.6) 
30.8 
(27.2) 
16.3 
(15.2) 
130 PhSO2 
3.51 
(3.69) 
3.71 
(3.81) 
5.6 
(5.3) 
2.1 
(2.0) 
55.9 
(59.6) 
47.1 
(44.6) 
-3.0 
(-4.2) 
aChemical shift, coupling constants, and populations in CDCl3 (Chemical shift, coupling 
constants, and populations in C6D6).
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Table 19. 1H Chemical Shifts, 3JH,H Coupling Constants and Side Chain Populations for 
Compounds 107 and 132-140 in CDCl3 and C6D6. 
 6-O-Subs 
Chem Shift, 
ppma 
3J5,6, Hza population, %a 
H6R H6S J5,6R J5,6S gg gt tg 
107 H 
3.71 
(3.58) 
3.87 
(3.69) 
4.8 
(nd) 
2.7 
(nd) 
59.0 
(nd) 
36.1 
(nd) 
4.9 
(nd) 
140 PhCH2 
3.69 
(3.61) 
3.76 
(3.61) 
5.0 
(nd) 
1.9 
(nd) 
63.3 
(nd) 
42.0 
(nd) 
-5.3 
(nd) 
132 Ac 
4.20 
(4.26) 
4.33 
(4.43) 
5.4 
(5.4) 
2.4 
(2.2) 
55.5 
(57.0) 
43.7 
(44.6) 
0.9 
(-1.7) 
133 Me3CCO 
4.12 
(4.23) 
4.44 
(4.55) 
5.6 
(5.7) 
1.8 
(2.1) 
58.2 
(54.9) 
48.6 
(48.2) 
-6.8 
(-3.0) 
135 PhCO 
4.46 
(4.51) 
4.65 
(4.65) 
nd 
(5.6) 
nd 
(2.3) 
nd 
(54.3) 
nd 
(46.2) 
nd 
(-0.5) 
136 p-MeC6H4CO 
4.40 
(4.68) 
4.59 
(4.54) 
5.5 
(5.7) 
2.2 
(2.2) 
56.1 
(54.1) 
45.6 
(47.7) 
-1.7 
(-1.8) 
137 p-MeOC6H4CO 
4.58 
(4.56) 
4.41 
(4.69) 
5.5 
(5.6) 
2.3 
(2.2) 
55.3 
(55.1) 
45.2 
(46.7) 
-0.4 
(-1.7) 
138 p-O2NC6H4CO 
4.44 
(4.40) 
4.62 
(4.56) 
5.4 
(5.6) 
2.2 
(2.3) 
57.0 
(54.3) 
44.6 
(46.2) 
-1.7 
(-0.5) 
134 CF3CO 
4.32 
(4.05) 
4.54 
(4.24) 
6.3 
(6.3) 
2.1 
(2.2) 
49.0 
(48.2) 
54.2 
(53.8) 
-3.3 
(-2.0) 
139 PhNHCO 
4.37 
(4.46) 
4.40 
(4.43) 
nd 
(4.6) 
nd 
(2.5) 
nd 
(62.5) 
nd 
(35.1) 
nd 
(2.4) 
aChemical shift, coupling constants, and populations in CDCl3 (Chemical shift, coupling 
constants, and populations in C6D6).
Comparison of the coupling constants recorded in the two solvent systems (C6D6 
and CDCl3) (Table 17-19) reveals that there are no systematic changes in the coupling 
constants upon changing the solvent. This observation is consistent with the previous 
study of the bicyclic model systems (Chapter 2),179 suggesting that the type of the solvent 
has a minimum effect on the side chain conformation. Therefore, coupling constants 
measured in one solvent can be applied in the other solvent, for the cases wherein the 
1H-NMR spectra recorded in one of the two solvents is not adequately resolved to 
determine the coupling constants. However, careful analysis of 18 compounds whose 1H-
NMR were measured in both the solvents, thus of 36 different sets of coupling constants, 
indicate that there are unsystematic differences in the coupling constants over the two 
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solvent systems. Consideration of those small differences in coupling constants allows 
an error limit of 0.4 Hz to be derived, which is in agreement with the digital resolution of 
the 1H-NMR spectra of 0.38 Hz. Comparison of 3JH5, H6R and 3JH5, H6S coupling constants 
between 2,3,4,6-tetra-O-benzyl-protected thiophenyl glucoside 131 and 2,3,4,6-tetra-O-
benzyl-protected thioethyl glucoside 140 reveals that the differences in the coupling 
constants are less than the error limit, 0.4 Hz; leading to the conclusion that the nature of 
the thioglycoside moiety has no influence on the coupling constant in question. 
3.2.3 Calculation of Side Chain Populations and Associated Errors 
The side chain populations of all compounds were calculated using experimental  
3JH5,H6R and 3JH5,H6S coupling constants obtained from compounds 105-107 and 117-140 
with the help of equations 1-3 (Chapter 2, Section 2.2.6.2), given the experimental 
limiting 3JR,gg - 3JS,tg coupling constants of the pure gg, gt, and tg conformations derived 
using a series of conformationally rigid bicyclic models (Chapter 2).179 After a 
comparative analysis of the coupling constants with the corresponding populations, the 
0.4 Hz error limit in coupling constants is estimated to correspond to a 5% error in the 
side chain populations, and that error limit is applicable to all the populations presented 
in Tables 17-19. Further, Tables 18 and 19 contain small negative populations of the tg 
conformation; however, as they are within the 5% error limit, these negative populations 
are considered as either zero or very close to it. Therefore, these negative values do not 
represent any physical meaning, and thus, further explanations are not required. 
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3.2.4 Estimation of Correction Factors for Coupling Constants Induced by the 
Electronegativity of Protecting Groups 
As the primary goal of this project is to study the interplay between protecting 
groups and the side chain conformation and the consequent influence on the anomeric 
reactivity, the vicinal 3JH5,H6R and 3JH5,H6S coupling constants used in the calculation of 
side chain populations should not be affected by the electron-withdrawing/donating nature 
of the substituent across the series. However, it is widely accepted that vicinal coupling 
constants can be decreased by the presence of electronegative groups in the coupled 
system.142-143, 145, 218 Nevertheless, the change in the coupling constant due to the 
replacement of an ether group by an ester group is not significant.142, 219-220 Interestingly, 
in the H3,H4 spin system, replacing one of the two ether functionalities at the 3- and 4-
positions with an ester group, leads to a 0.5 Hz increase in the 3JH3,H4 coupling constant 
in both the galacto- and gluco- analogues with fixed gauche or trans relationships 
between the coupled protons (Figure 30). Further, this increase in the coupling constants 
is independent of the solvent, C6D6 or CDCl3. However, in freely rotating spin systems, 
which have closer homology to the H5,H6 spin systems of compounds 107 and 132-140, 
the difference in the coupling constant due to the replacement of an ether by an ester is 
as small as 0.1 Hz (Figure 30).219 Since this difference is within the error limit (0.4 Hz), 
no corrections were made for the coupling data in Table 19. 
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Figure 30.  Comparison Between the Influence of Ether and Ester Groups on Vicinal 
Coupling Constants 
Usually, the influence on coupling constant caused by changing an ether to an 
ester at the β-position of a coupled system is insignificant; as is evident from the 
unchanged nature of experimental 3JH2,H3 coupling constant upon changing the 4-O-
substituents of both galacto- and gluco- pyranosides (Figure 30). Thus, compounds 106 
and 127-131 (Series 2), and 107 and 132-140 (Series 3) do not require any corrections 
for the influence of the nature of the 4-O-substituents. Further, comparison of the 3JH2,H3 
coupling constants between the galacto- and gluco- series reveals that the 3JH2,H3 coupling 
constants of the galacto- series are ~0.4 Hz higher than those of the gluco- series (Figure 
30). This difference in the coupling constants can be attributed to the β-effect noted by 
Haasnoot and Altona as described in Chapter 2, Section 2.2.3.167 Considering the H5,H6 
spin system of the galactopyranosides, a comparable relationship can be found between 
H5, H6R and O4 atoms of the gt conformation and the H5, H6S, and O4 atoms of the tg 
conformations (Figure 31). However, this kind of configurational relationship is not found 
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in the glucopyranoside systems. Considering the previous study on rigid bicyclic models, 
the comparison of 3JH5,H6 coupling constants in the galactopyranosides with the 
corresponding coupling constants of the glucopyranosides reveals that there is no 
significant difference in the coupling constants between these two systems (Chapter 2, 
Table 8).179 Therefore, it is concluded that the β-effect has no significant influence on the 
3J5H,H6R coupling constant of the gt conformation and the 3J H5,H6S coupling constant of tg 
conformations of the galacto- series. Nevertheless, any possible minor influence from the 
Haasnoot and Altona β-effect on the galactopyranosides may cause overestimation of 
the gt and tg populations at the cost of gg populations (Table 17), compared to the 
corresponding glucopyranosides (Table 18). Overall, any residual effects will influence 
all the compounds systematically, and in the final analysis, no corrections of the coupling 
constants originating from the changes in the electronegativity of the substituents or by 
the Haasnoot and Altona β-effect were deemed necessary. 
 
Figure 31. Configurations Possibly Subject to the Altona-Haasnoot β-Effect 
3.2.5 Influence of Substituents on the Side Chain Population of Pyranoses 
3.2.5.1 4-O-Substituents of Galactopyranosides (Series 1) 
Here, the side chain populations of 4-O-H derivative 105 and its ethers and esters 
are considered. Thus, the side chain population of alcohol 105 is calculated to be gg 
(~25%), gt (~32%), and tg (~43%) (Table 17 and Figure 32). Considering the 5% error 
in the side chain population, benzyl ether 125 and trifluoroethyl ether 126 have the almost 
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same side chain populations, gg (~13%), gt (~23%), and tg (~66%). Comparison of 
population data between alcohol 105 and ethers 125 and 126 reveals that the conversion 
of a 4-alcohol to a 4-O-ether has a significant impact on the side chain conformation 
(Table 17 and Figure 32). Particularly, the 4-hydroxy derivative 105 has relatively higher 
populations of the gg and gt conformations, in comparison to those of the 4-O-ethers (125 
and 126), whereas, the tg population of alcohol 105 is markedly lower compared to the 
corresponding ethers. These differences between the two types of compounds are 
possibly due to the unfavorable steric interactions between 4-O-benzyl/trifluoroethyl 
group and the 6-O-benzyl group of the ethers 125 and 126 or are the results of the 
favorable hydrogen bonding interactions between 4-hydroxy group and O6 atom of 
alcohol 105. Since typical glycosylation reactions do not involve glycosyl donors with 
unprotected hydroxyl groups and the differences of the side chain population of alcohol 
and the ethers are significantly higher, from here on benzyl ether 125 is considered as 
the reference for comparing the population data of 4-O-derivatives of the galacto- series 
(Series 1). 
Esterification of alcohol 105 gave the alkanoyl esters 117 and 118 and aroyl esters 
121-124. Comparison of the side chain of these esters with the ether 125 reveals that 
they are considerably different from each other; particularly, the gg populations of the 
ether 125 and the esters, 117,118, and 121-124 are similar, but as a whole, the tg 
population has ~10% decrease in favor of the gt population on changing ether to ester 
transformation (Table 17 and Figure 32). The trifluoroacetyl and trichloroacetyal 
protection of the 4-hydroxy group of alcohol 105 provided a separate set of esters 119 
and 120, respectively. The population analysis of those two esters shows a significant 
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decrease in the gg conformation in favor of tg conformations (Table 17 and Figure 32). 
Further, internal comparison among the esters reveals a significant increase in the tg 
population (~73%) of highly electron-withdrawing esters 119 and 120, while a reduction 
of both the gt and gg conformations with respect to the other esters 117, 118, and 121-
124 (Table 17 and Figure 32). Although the magnitude is relatively smaller, the 4-O-p-
nitrobenzoate 124 follows the same population trend as of the more electron-withdrawing 
trichloroacetate 119 and trifluoroacetate 120, suggesting that the increase in the tg 
population is a result of an increase in the electron-withdrawing nature of the 4-O-
substituents. 
 
Figure 32. Summary of Modulations in Side Chain Population as a Function of 4-O- 
Protecting Groups of Galactopyranosides. 
3.2.5.2 4-O-Substituents of Glucopyranosides (Series 2) 
Similar to the 4-O- galactopyranoside series, derivatization of 4-O-H 
glucopyranoside 106, forming 4-O- benzyl ether 131 results in a significant change in the 
side chain population. Particularly, the tg population decreases in favor of the gg and of 
the gt conformations to a relatively smaller extent (Table 18 and Figure 34). Considering 
the spatial relationship of the O4 and O6 atoms, this pattern in the conformational change 
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is analogous to that of the glactopyranoside series. Specifically, in the galactopyranoside 
series, gg conformation has syn-pentane type interactions between O4 and O6, while in 
the glucopyranoside series the tg conformation has such a type of interactions between 
the same atoms. In both the cases, conversion of an alcohol to an ether results in a 
decrease in the population of the conformer with syn-pentane type configuration (gg of 
galacto- series and tg of gluco- series). As explained in the galacto- series, these 
conformational changes are caused by the increased steric interaction of syn-pentane 
type configuration during the conversion of alcohol to ether and/or the favorable hydrogen 
bonding between the 4-hydroxyl group and the O6 atom of alcohols 105 and 106 (Figure 
33).  
 
Figure 33.  syn-Pentane Conformations of the Galacto- and Glucopyranoses. 
Similar to the galacto- series, in the gluco- series, 4-O-benzyl ether 131 was used 
as the reference for comparing the influence of 4-O- protecting groups on the side chain 
conformation. The esters, 4-O-acetate 127 and 4-O-benzoate 129 have similar side chain 
populations, adopting smaller gg population and a relatively higher tg population 
compared to benzyl ether 131. When the electron-withdrawing nature of 4-O-protecting 
group increases, for example in the case of trifluoroacetate 128, the tg population 
increases, while the gg and tg populations are decreased with respect to alcohol 131. 
Considering the side chain population of benzene sulfonate 130, it has completely 
different side chain population compared to all other esters. Particularly, unlike to the 
101 
 
other esters, sulfonate ester 130 does not occupy the tg conformation (Table 18 and 
Figure 34), possibly due to the strongly unfavorable syn-pentane interactions arise by the 
steric clash between the bulky 4-O-sulfonate group and the 6-O-benzyl group of the tg 
conformation. This decrease in the tg population results in an increase of gg population 
of 4-O-sulfonate 130 compared to acetate 127 and benzoate 129 (Table 18 and Figure 
34). 
 
Figure 34. Summary of Modulations in Side Chain Population as a Function of 4-O- 
Protecting Groups of Glucopyranosides. 
3.2.5.3 6-O-Substituents of Glucopyranosides (Series 3) 
Unlike to the side chain modulations observed in galacto- and gluco- derivatives 
with respect to the 4-O-protecting groups, derivatization at the 6-position of 2,3,4-tri-O-
benzyl glucopyranoside does not exert a significant influence on the side chain of 
glucopyranosides 132-140 (Table 19). Yet, some interesting changes in the side chain 
populations are worth mentioning. Specifically, 6-hydroxy glucopyranoside 107 and 
corresponding 6-carbamate derivative 139 have a small positive tg population, in spite of 
the sterically unfavorable syn-pentane type interactions of the tg conformation. These 
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small positive populations may be results of the hydrogen bonding interactions of the 4-
OH group and 4-carbamate functionality with the O6 atom of the alcohol 107 and 
carbamate 140, respectively. In addition, installation of an electron-withdrawing 
trifluoroacetyl group at the 6-position results in an increase of the gt population at the cost 
of the gg population. Overall, this series does not indicate any significant changes in the 
side chain population, suggesting that a parallel study on the 6-O-galactopyranosides 
was not required. 
3.2.6 Influence of the Side Chain Population on Anomeric Reactivity 
The changes in the side chain population with respect to the 4-O-protecting groups 
of both the galacto- and gluco- pyranosides are summarized in Figures 32 and 34. As 
the population changes are small, the energy differences related to those conformational 
changes are estimated a less than 1 kcal mol-1. The relatively small differences in side 
chain populations on changes of protecting group are such that any interpretation of their 
origin would be questionable. Moreover, these population changes are difficult to 
calculate using computational software packages.221-224 Despite the small magnitude of 
the protecting group-induced changes in the conformation, some general conclusions can 
be drawn. 
Regardless of the type of the pyranoside, whether galacto- or gluco-, the 
replacement of an arming199 protecting group at the 4-O-position by a disarming ester 
group results in a decrease in anomeric reactivity. This reduced reactivity is visible in 
typical glycosylation reactions involving the activation of thioglycoside,53 or in the SN2-
type substitution reactions of an anomeric chloride/bromide92 by an acceptor nucleophile. 
These diminished reactivities of ether-ester transformations are rationalized in the view 
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of the destabilization of nascent positive charge or the partial positive charge at the 
anomeric reaction center (Chapter 1, Section 1.4.1, Scheme 4).53, 69, 80, 113, 199, 225 
According to the population data (Table 17 and Figure 32), in the galactopyranoside 
series, the disarming effect caused by the introduction of the ester groups could be 
moderated by changes in the side chain population. This is because, the introduction of 
an alkanoyl or an aroyl ester in the place of benzyl ether increases the population of the 
moderately reactive gt conformer at the expense of least reactive tg conformer and so 
partially compensates the electron-withdrawing destabilization effects introduced by the 
ester functionality. Analysis of the data in Table 18 and Figure 34 reveals that, in the 4-
O-glucopyranoside series, the replacement of the benzyl ether by an alkanoyl or aroyl 
ester increases the population of the least reactive tg conformer while decreasing that of 
the most reactive gg conformer. Therefore, in contrast to the galactopyranoside series, 
substitution of an ether by an ester causes modulation of the side chain population in a 
way that the change in side chain conformation supports the added electron-withdrawing 
effect from the ester functionality, decreasing the anomeric reactivity of the 4-O-ester 
derivatives present in the gluco- series. 
For both galacto- (Table 17 and Figure 32) and gluco- (Table 18 and Figure 34) 
series, the replacement of 4-O-ether by a strongly electron-withdrawing trifluoroacetate 
ester (trichloroacetate group in the galactopyranoside series), increases the population 
of the most electron-withdrawing (least-reactive) tg conformation, enhancing the electron-
withdrawing effect introduced by the trifluoroacetyl and trichloroacetyl esters. In addition 
a 4-O-sulfonyl group, which has been utilized in numerous glycosylation reactions as a 
sterodirecting protecting group at the 4-position of 2,6-dideoxyglycopyranosyl donors,226 
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and of the 3-,4-, and 6-positions of the several other pyranosyl donors,227-228 does not 
significantly change the side chain conformation of glucopyranosyl donors when 
compared to the corresponding 4-O-benzyl ethers (Table 18 and Figure 34). This 
suggests that the reduced anomeric reactivity and related stereoselectivities seen on 4-
O-sulfonylation are solely caused by the electron-withdrawing effect of this protecting 
group. 
Overall, the modulations of the side chain population as a function of 4-O-alkanoyl 
and aroyl ester groups are not adequate to explain the anomeric reactivities and 
selectivities observed in compounds 121-124229 and the related analogues,230 which were 
previously rationalized using the controversial concept of remote group participation.126-
131 Similar to 4-O- derivatives, the unchanged nature of the side chain conformation with 
respect to 6-O-protecting groups of the 2,3,4-tri-O-benzyl glucopyranosides suggests that 
the side chain conformation does not play any significant role in controlling the anomeric 
reactivity and selectivities observed during the corresponding glycosylation reactions.231-
233 
3.3 Conclusions 
In the 2,3,6-tri-O-benzyl galactopyranoside series, replacing a benzyl ether at the 
4-position with an alkanoyl or aroyl ester results in small but consistent changes in the 
population of the three staggered conformations; particularly, the moderately reactive gt 
conformation is increased at the expense of the least reactive tg conformation. This 
suggests that the reduced reactivity of the galactopyranoside, due to the electron-
withdrawing effects enforced by the ether-ester transformation, is moderated by the 
conformational changes in the galactopyranoside side chain. In contrast to the 
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galactopyranoside series, in the corresponding glucopyranoside series, the ether-ester 
transformation results in an increase in the least reactive tg conformation, suggesting that 
such transformations complement the increased electron-withdrawing effects introduced 
by the ester group. With the substitution of strongly electron-withdrawing trifluoroacetyl 
groups at the 4-position of both the galacto- and gluco- series, the least reactive tg 
population is increased, suggesting that the trifluoroacetyl groups at the 4-position 
support the electron-withdrawing nature of the ester by modulating the side chain 
population. Overall, the changes in the side chain populations are small, but they have 
systematic patterns. It is important to note that these changes in the side chain 
conformation are studied in the glycosyl donors; the likelihood is that these changes can 
be significant at the stage of the transition state, in which a partial positive charge is 
developed at the ring oxygen. Therefore, this study opens gates to investigate the 
glycosylation mechanism at the level of the transition state with a novel viewpoint; the 
interplay between protecting groups and the side chain population, and the corresponding 
influence on the anomeric reactivity and selectivity. Such studies are currently underway 
in the Crich group. 
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PART B. INVESTIGATION OF SIALIDATION REACTION 
MECHANISM(S) BY KINETIC STUDIES 
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CHAPTER 4. INTRODUCTION 
4.1 Background and Significance 
Sialic acids are a group of nonulosonic acids composed of nine carbon keto aldonic 
acids and are considered as the most structurally diverse class among the large pool of 
carbohydrates.234 Naturally occurring sialic acids are in different forms and different sialyl 
linkages, by which they are linked to various glycans.235 A few examples of important 
sialic acid glycans are shown in Figure 35a. Out of about 50 sialic acid derivatives found 
in nature,236-237 N-acetylneuraminic acid (Neu5Ac) is the most common member (Figure 
35b). Considering the type of glycosidic bonds, equatorial (2→3) and (2→6) bonds with 
galactopyranose and equatorial (2→8) and (2→9) bonds with other sialic acid derivatives 
are widely observed in natural Neu5Ac glycans. After Neu5Ac, N-glycolyl neuraminic acid 
(Neu5Gc) is the most studied sialic acid derivative; it is found in extremely low quantities 
in human cells (Figure 35b). However, Neu5Gc derivatives are abnormally expressed in 
human cancer cells, and it is believed that Neu5Gc has key biological roles in mammalian 
evolution.1, 238-239 In addition, the 5-deamino 5-hydroxy sialic acid, KDN,240 is also found 
in various types of human cells in minor quantities (Figure 35b), and has similar types of 
glycosidic bonds, as of those found in other derivatives of sialic acid.241 legionaminic acid 
(Leg) and pseudaminic acid (Pse) are also important derivatives of sialic acid (Figure 
35b), which are found in microorganisms242-244 responsible for several disease conditions 
in humans.245-248 
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Figure 35. a. Examples of Naturally Occurring Sialic Acid Glycosides; b. Natural 
Variants of Sialic Acid: Neu5Ac, Neu5Gc, KDN, Leg, and Pse. 
4.1.1 Biological and Medicinal Significance of Sialic Acid Derivatives 
Sialic acid derivatives play significant roles in various types of normal and 
pathological processes in vertebrates and higher invertebrates. They are often found at 
the terminal, non-reducing end of glycoconjugate chains connected to the surface of the 
cells and soluble proteins.2, 5, 237 The sialic acid glycosides are involved in the normal 
developmental stage of animals and also mediate binding of the pathogens and toxins to 
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host cells.5, 249-253 During pathogenesis, the sialic acid binding proteins of pathogen bind 
to the sialic acid glycans of the host. These sialyl glycans have been carried with the host 
over a longer period of time, albeit they are detrimental to the host. Therefore, the 
presence of another set of interactions is important to facilitate the adhesion of the 
pathogen to the host. A recent study reveals a critical function of sialic acid glycans, 
known as molecular mimicry, by which the pathogen itself is decorated with sialic acid 
glycosides, mimicking the host cell surface. These glycans on the pathogen promote the 
interaction between the pathogen and the host,250-254 by binding with intrinsic receptors, 
such as selectins and siglecs in vertebrate cells.39, 251-253, 255 The following paragraph 
summarizes a few examples of this kind of pathogen-host interactions mediated by sialic 
acid glycosides. 
Malaria is one of the most widespread infectious diseases in the tropical and sub-
tropical regions in the world. During pathogenesis, merozoites of Plasmodium falciparum 
bind to red blood cells via sialic acid glycans. However, humans are not vulnerable to 
Plasmodium reichnowii, which is another type of malaria parasite that usually infects 
chimpanzees. The difference between the glycan chains of humans and chimpanzees 
leads to selective interactions from the binding proteins of the two types of pathogens, P. 
falciparum and P. reichnowii, respectively.256 Sialic acids also play pivotal roles in several 
bacterial pathogens, which express them as capsular lipopolysaccharides (O-antigens) 
and polysaccharides (K-antigens). For example, Neisseria meningitides group B and C 
and Escherichia coli strain K1 carries sialic acid oligosaccharides and is involved in 
meningitis infection.257 Apart from those pathogens, Campylobacter jejuni (Food-borne 
gastroenteritis), Helicobacter pylori (peptic ulcers),258-259 and Vibrio cholera (cholera 
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disease) also use sialic acid containing glycans in invading the host. Overall, sialic acid 
derived oligosaccharides are involved in a range of critical biological phenomena 
accountable for many different health conditions. Therefore, the structure elucidation and 
synthesis of these sialic acid containing glycans are of critical importance in biology and 
chemistry. 
4.2 Sialidation Reactions and Recent Advances in Sialic Acid Chemistry 
The higher demand and the difficulties associated with the isolation from natural 
sources necessitate the development of efficient and stereoselective synthetic methods 
to obtain sialic acid containing oligosaccharides and glycoconjugates. In the Neu5Ac 
series, naturally occurring equatorial glycosides are called α-glycosides, while the axial 
ones are β-glycosides. The α- or β- representation is based on the Rosanoff 
nomenclature which refers to the bottom-most stereogenic center of sugars in their 
Fischer projections.260 Traditionally, the natural α-glycosides are considered as one of the 
most challenging types of glycosides to form, and accordingly, this area has been widely 
investigated and reviewed.261-269 
4.2.1 Approaches to Selective Sialidation 
Under thermodynamic conditions, over a wide range of pH, N-acetylneuraminic 
acid (Neu5Ac) equilibrates in water, to form >90:10 (β:α) mixture of anomers (Scheme 
18).270-271 Similarly, the methyl glycosides of Neu5Ac equilibrate under acidic conditions, 
preferring the axial or β-sialoside.272-273 Consequently, kinetic conditions must be 
employed to obtain the equatorial or α-sialosides. 
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Scheme 25. Anomer Equilibration of Neu5Ac in Aqueous Medium.   
Among the multiple factors influencing sialidation reactions, steric hindrance at the 
fully substituted anomeric carbon, the highly electron-withdrawing capacity of the 
carboxylic group, and the unsubstituted carbon atom at the 3-position favoring the 
formation of the eliminated byproduct (glycal), are the key factors which retard the efficient 
and stereoselective formation of α-sialosides. In addition, the unsubstituted carbon at the 
3-position constrains the use of neighboring group participation. Overall, the presence of 
the carboxylate group and the unsubstituted nature of the C-3 position lead to competitive 
elimination, forming glycal (Scheme 26) and/or to poor stereoselectivity, forming 
undesired α-anomer. 
Mainly, two synthetic approaches have been utilized to overcome the difficulties 
associated with α-O-sialidation;263 indirect sialydation,274 and direct sialydation.275-276 In 
the case of the former, a pre-introduced participating group, mostly at the 3-position, is 
manipulated to achieve the desired α-sialosides. The subsequent removal of the auxiliary 
together with its introduction steps, mostly via glycal intermediates,277 make the indirect 
method less efficient,261-268 and therefore the direct method has gained the priority in 
sialoside synthesis. Therefore, this thesis is focused on direct sialydation reactions 
(Scheme 26). In the direct sialidation approach, traditionally, 2-chloro derivatives of N-
acetyl sialic acid donors have commonly been used. In 1965, Meindl et al. were first 
reported sialidation reactions of 5-acetamido-4,7,8,9-tetra-O-acetyl-2-chloro-β-D-
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neuraminic acid donor using Koenigs-Knorr reaction conditions in the presence of 
Ag2CO3 with moderate yields (30-50%).278 The use of the free carboxylic acid can lead to 
several problems, thus, Kuhn et al. used methyl ester protected sialyl donors, and those 
donors were later employed in many synthesizes.263 Methyl ester derived 2-chloro 
neuraminate derivatives have been activated using the classical Koenigs-Knorr method 
as well as the Helferich modification, where Hg(CN)2/HgBr2 were used as the 
promoter.263, 278 Moreover, 2-bromo sialyl donors were used in the presence of 
Hg(CN)2/HgBr2 as the activator.279 Many types of promotors, such as ZnBr2, ZnCl2, 
Zn(OTf) 2, SnCl2, Sn(OTf)2,280 phase transfer catalysts,281-282 AgOTf,283-284 and silver 
zeolite,285 etc. were investigated in the glycosylation of 2-halo sialyl donors, with varying  
yields and selectivities.   
 
Scheme 26. Sialidation Reactions of Peracetylated Neu5Ac. 
 Among many different types of glycosyl donors employed in sialidation reactions, 
the most widely employed are thio alkyl (ethyl, methyl, and more recently adamantanyl) 
and thio aryl (phenyl and substituted phenyl) glycosides.263 Excellent chemical stability 
together with the mild activation conditions (using soft thiophilic promotors)286  make these 
thioglycosyl donors more versatile and the most employed precursors in oligosaccharide 
synthesis. Another advantage of using thiosialosides is that they can easily be 
transformed into several other leaving groups, such as sulfoxides and phosphates. Due 
to the wide spread applications of thioglycosides, this field has been reviewed on 
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numerous occasions.286-294 Among the many different promotors (activators) employed in 
glycosylation reactions, N-iodosuccinimide/trifluoromethanesulfonic acid (NIS/TfOH), 
methyl trifluoromethanesulfonate (MeOTf), trimethylsilyl trifluoromethanesulfonate 
(TMSOTf), and dimethyl(methylthio) sulfonium trifluoromethanesulfonate (DMTST) have 
been widely used in the activation of thiosialosides.263 Sialyl phosphates263, 295-296 and 
xanthates263, 297-298 are two other types of donors, which have been widely employed in 
glycosylation reactions with varying yields and selectivities.266 More recently, 
glycosylation reactions of sialyl imidates and sialyl sulfoxides299 were investigated. The 
Yu group introduced N-phenyltrifluoroacetamidates as a potent class of sialyl donors,300 
yet the synthesis and isolation of a stable trichloroacetamidates is a challenging task. 
Moreover, S-benzoxazolyl thioglycosides were recently added to the toolbox of sialidation 
reactions.301-302 Overall, during the last few decades, the sialic acid related 
glycochemistry field underwent a remarkable development and has been reviewed 
several times.263, 266, 303 
4.2.1.1 Influence of N5 Protecting Group on Reactivity and Selectivity 
In 1998, Boons and Demchenko discovered that the N5 protecting group has a 
significant influence on both the reactivity of sialyl donors and their anomeric selectivities. 
This investigation is considered as on of the most influential findings in the sialic acid field 
during the last 15 years.304 Consequently, it has been reviewed several times,305-306 yet a 
brief discussion of their results is valuable. According to Boons and Demchenko, the 
addition of an extra acetyl group to the N5 of the peracetylated Neu5Ac donors (N,N-
diacetyl donors) increases the anomeric reactivity compared to that of the parent N-
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monoacetylated sialyl donors upon activation with NIS/TfOH in acetonitrile at -40 °C 
(Scheme 27).  
 
Scheme 27. Comparison of Sialidation of N-Acetyl and N,N-Diacetyl Thiosialyl Donors.  
Originally, a precise rationale for the increased reactivity of N,N-diacetyl sialyl 
donor was not available, but Boons et al. suggested that the decreased nucleophilicity of 
the imide group could be the reason for the higher reactivity of N,N-diacetyl donor 
compared to the N-acetyl donor.307 Another explanation was advanced by the Kononov 
group, who proposed that the changes in the supramolecular aggregation induced by the 
alterations in the hydrogen bonding network with respect to the N5 protecting system may 
be the prime reason for this reactivity difference.308  
Later, several other 5-amido and 5-imido protected sialyl donors, such as N-Boc 
acetamide sialosides309 and N-benzoyl-N-acetyl sialyl donors310 were employed in 
glycosylation reactions. Further, the Sugimoto group used phthalimide-protected sialyl 
donors in the synthesis of de-acetyl GM2 ganglioside analogues,311 and later, the Fukase 
group took advantage of the phthalimide protecting group in conjunction with the N-
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phenyltrifluoroacetimidate sialyl donors to obtain higher α-selectivity.312 Other than these 
N5-variants, the use of N-trifluoroacetamide313-317 and N-trichloroethylcarbonate (Troc)312, 
318-320 sialyl donors can be considered as significant improvements in comparison to the 
native 5-acetamido donors. Moreover, several other carbamate and amide protecting 
groups, such as the allyloxycarbonyl,321 tert-butoxycarbonyl,322 trichloroacetamide,321  
benzyloxycarbonyl,321, 323 and 9-fluorenylmethylcarbonyl were explored in sialidation 
reactions, but did not deliver the anticipated results. 
Following an initial report by the Unverzagt group,324 the reactivity and anomeric 
selectivity of the glycosylation of 5-azido protected sialyl donors were investigated by 
several other groups.325-328 Despite the reduced reactivity and selectivity of 5-azido sialyl 
donors in their glycosylations with secondary and hindered alcohols,328 excellent reactivity 
and good yields were obtained from the glycosylation of  5-azido sialyl donors with 9-
hydroxy sialic acid acceptors.326 The increased selectivity is attributed to the low steric 
bulk of the azido group and its ability to stabilize the nitrilium ion intermediates, facilitating 
SN2-like reactions pathways. 
4.2.1.2 Influence of Cyclic Protecting Group on Reactivity and Selectivity 
Other than the simple N5 protecting groups employed in sialidation reactions, 
several different cyclic protecting groups were explored.304 Among those cyclic protecting 
groups, 4-O,5-N-oxazolidinone protected sialyl donors introduced by the Takahashi329 
and De Meo330 groups and corresponding N-acetyl derivative introduced by the Crich 
group331-332 are considered as the most significant improvements in sialidation reactions 
in recent years. According to the Takahashi group, silidation reactions of the 4-O,5-N-
oxazolidinone protected donors with primary alcohols and 8-OH free oxazolidinone 
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protected sialyl acceptors in dichloromethane at -78 °C afforded higher yields and α-
selectivities compared to the corresponding N-acetyl and N,N-diacetyl sialyl donors 
(Scheme 28).329 Another important feature of the silidation reactions of these bicyclic 
donors is that they do not afford 2,3-glycal biproducts, thereby increasing the yields of the 
desired sialosides. With these promising results, the Takahashi group employed this 
protecting system in oligosaccharide synthesis.329, 333-335 Shortly after the report by 
Takahashi and co-workers, the De MeO group also reported α-selective and glycal-free 
sialidation reactions of oxazolidinone protected donors in the presence of NIS/TfOH 
promotor-combination in acetonitrile at -40 °C.330 
 
Scheme 28. Glycosylation of 4-O,5-N-Oxazolidinone Protected Sialyl Donor. 
For the N-acetyl version of oxazolidinone donors introduced by the Crich group, a 
combination of NIS/TfOH was used to activate those phenylthioglycoside sialyl donors in 
a mixture of dichloromethane and at -40 °C.331 However, later, Crich and co-workers were 
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able to obtain better results by using 1-adamantanyl thioglycoside donors in the presence 
of same activating system, but at a lower temperature, -78 °C.336 Apart from the excellent 
α-selectivity and glycal free nature of these sialidation reactions, the significant feature of 
this variant compared to the other oxazolidinone protected donors is that the N-acetyl 
oxazolidinone group can easily be deprotected under milder reaction conditions (i.e. 
sodium methoxide in methanol at room temperature) to obtain the natural N-acetyl 
neuraminic acid derivatives (Scheme 29).331 Other than the oxazolidinone protecting 
group, 4,5-O-carbonate protecting groups in KDN donors,337 5-N,7-O-oxazinone-
protected neuraminic acid donors,338 and tricyclic neuraminic acid donors were studied in 
glycosylation reactions.339 
 
Scheme 29. Glycosylation Reaction of N-acetyl 4-O,5-N-oxazolidinone Protected Sialyl 
Donor and The Deprotection of Oxazolidinone Group. 
4.3 Mechanistic Aspects of Sialidation Reactions 
Despite the significant improvements in the sialic acid field, the demand for even 
efficient sialidation conditions is high due to the increasing complexity of newly advancing 
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biologically important oligosaccharides. Yet, the lack of insight into sialidation 
mechanisms is one of the biggest challenges that retards the designing of optimal 
sialidation methods. Therefore, knowledge of sialidation mechanisms and the factors 
affecting sialidation reactions is of critical importance.  
4.3.1 Evaluation of Sialyl-Oxocarbenium Ions Participating in Sialylation 
Reactions 
As discussed in Chapter 1 (Section 1.4.2), the most frequently invoked 
intermediates in glycosylation reactions are glycosyl oxocarbenium ions. However, the 
possibility that the stereoselective sialidation reactions proceed via oxocarbenium ion 
intermediates is very low (Scheme 30). Because, according to the Scheme 30, there is 
no preferential steric factor controlling the stereoselective nucleophilic attack on either 
face of the two interconverting half-chair conformations - more stable 5H4-all axial half-
chair conformation or the less stable 4H5- all equatorial conformation.139 These stability 
differences between the two half-chair conformations are attributed to stereoelectronic 
effects as discussed in Chapter 1 (Section 1.5). Moreover, analysis of the boat 
conformations also leads to similar conclusions (Scheme 30). In addition, as noted in 
Table 4 (Section 1.4.2.1), the lifetime of sialyl oxocarbenium ions in water is very short 
(≥ 3 Χ 10-11), suggesting that such intermediates may not be stabilized in non-polar 
organic solvents like dichloromethane. Overall, invoking sialyl oxocarbenium ion 
intermediates to explain sialidation reaction mechanisms without reasonable evidence is 
not a reliable practice, and therefore, the analysis of other factors is crucial.   
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Scheme 30. Stereoelectronic and Steric Considerations for the reactivity of 
Interconverting Sialyl oxocarbenium Ion.  
In an important series of experiments, the Crich group studied the stability of sialyl 
oxocarbenium ions as a function of their protecting groups; particularly, N5 protecting 
groups, using mass spectral methods (electrospray ionization).139 They reported that the 
minimum cone voltage of 78 V was required for the fragmentation of simple N-acetyl sialyl 
phosphate 173, forming sialyl oxocarbenium ion. On the other hand, cyclic protecting 
groups, such as oxazolidinone- and N-acetyloxazolidinone-protected sialyl phosphates 
required minimum cone voltages of 93 and 83 V, respectively. These experiments clearly 
demonstrated that the introduction of cyclic protecting groups increases the minimum 
cone voltages required for the fragmentation of sialyl phosphates (Figure 36).  
Accordingly, the formation of oxazolidinone protected oxocarbenium ion 125 is less 
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favored compared to that of simple N-acetyl oxocarbenium ion 124, leading to the 
conclusion that the oxazolidinone protected sialyl donors favor bimolecular SN2 or SN2-
like reactions via covalent or contact ion pair type intermediates. Simple N-acetyl sialyl 
donors on the other hand favor SN1 or SN1-like reaction pathways, possibly via sialyl 
oxocarbenium ion type intermediates. 
 
Figure 36. Cone Voltages for Fragmentation of Sialyl Phosphates. 
The decreased stability of oxazolidinone-protected oxocarbenium ions is best 
explained by the higher electron-withdrawing nature of oxazolidinone group due to the 
alignment of its C4-O4 and C5-N5 bond dipoles in the mean plane of the pyranose ring, 
reinforcing the intrinsic electron-withdrawing nature of those two bond dipoles (Figure 
37).  
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Figure 37. Orientations of key dipole moments of 4-O,5-N-oxazolidinone protecting 
group in thiosialosides (side chain is omitted for clarity). 
This explanation is further supported by comparative analysis of the dipole 
moments between cyclic and acyclic protecting groups, where the cyclic and acyclic 
protecting groups have larger and smaller dipole moments, respectively (Figure 38).139, 
340-342 The influence of the 4-O,5-O-carbonate group on the reactivity the KDN series can 
also be rationalized in a similar manner. However, an alternative explanation has been 
advanced by the Kononov group for the varying stereoselectivities as a function of 
protecting groups (Section 4.2.2.1).308 
 
Figure 38. Dipole moment of Cyclic and Acyclic Protecting Groups in Debye units 
(μ).139, 340-342 
4.3.2 Solvent Effects and Participation of Solvents in Sialylation Reactions 
In the 1980s, the Hasegawa group introduced acetonitrile or acetonitrile-based 
mixtures of solvents, after which such solvents have been very widely used in sialidation 
reactions.343-344 In the presence of acetonitrile, α-sialidation is favored and this outcome 
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is rationalized in terms of the participation of acetonitrile, forming a β-glycosyl-nitrilium 
ion, (Figure 37, 129) and subsequent nucleophilic attack from the glycosyl acceptor in an 
SN2 fashion, forming α-O-sialoside. Nevertheless, for many years, no evidence for 
nitrilium ions was available, albeit the formation of a similar type of intermediate, the diaryl 
sulfoxide adduct of sialyl oxocarbenium ion, was reported (Figure 39, 130).345 
Nevertheless, in a recent study by the Crich group, evidence for the formation of nitrilium 
ion intermediates was revealed as described in this thesis ( Chapter 6).346 Apart from 
acetonitrile, the De Meo group has explored alternative participating solvents in sialidation 
reactions.347 
 
Figure 39. Sialyl Nitrilium and Sulfoxnium Ions. 
4.4 Overall Goals. 
The introduction of novel and efficient sialidation methodologies requires an in-
depth understanding of their mechanisms, and thus, mechanistic investigations have 
drawn serious attention from physical organic chemists. In particular, locating sialidation 
reactions on the SN1-SN2 continuum is one of the main goals of these mechanistic 
studies.  
Conducting kinetic experiments is one of the most reliable approaches of deriving 
rate parameters and thus locating reactions on SN1-SN2 continuum. Therefore, direct 
kinetic experiments of sialidation reactions were considered as the first goal of this study, 
wherein the focus was on probing the influence of the acceptor and acetonitrile 
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concentrations. As an alternative to direct kinetic experiments, competition kinetic 
experiments of sialyl donors were considered as the second goal with the emphasis on 
the investigation of the influence of the acceptor and acetonitrile concentrations and of 
protecting groups. The identification, isolation, and characterization of intermediates 
involve in sialidation reactions are also considered under this goal.  
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CHAPTER 5. INVESTIGATION OF THE SIALIDATION REACTION MECHANISM(S) 
VIA LOW-TEMPERATURE KINETIC EXPERIMENTS 
5.1 Introduction 
As summarized in Chapter 4, sialic acids are an extremely important class of 
carbohydrates and their synthesis requires a detailed description of sialidation 
mechanisms. Therefore, pseudo-first-order kinetic experiments were undertaken to 
elucidate the sialidation mechanism(s). To investigate kinetic parameters, conducting 
pseudo kinetic experiments and measuring initial rates of those experiments is 
considered as one of the most reliable and practical methods.158, 348-350 In pseudo-first-
order kinetic experiments, reaction conditions of a second order reaction are adjusted in 
such a way that the reaction appears to be first order with respect to one of the two 
reaction components while the order with respect to the other component appears to be 
zero (Equation 4-6).351 This method is a common experimental design to determine the 
kinetics of second order reactions.349 
Consider a bimolecular reaction with reactants, A and B that forms the product P: 
A+B  P, 
When the initial concentration of B is significantly higher than that of A, the rate 
law can be written as,  
dP/dt = 𝑘′[A], where 𝑘’ = 𝑘[B] = pseudo-first-order rate constant    (eq. 4) 
By the application of equation 4 to sialidation reactions in the presence of a large 
excess of the donor, the rate equation can be represented as, 
d[Glycoside]/dt = 𝑘′[Acceptor], Where, 𝑘’ = 𝑘[Donor]      (eq. 5) 
In addition, when acetonitrile is used as a solvent in glycosylation reactions, the 
participation of acetonitrile in the form of nitrilium ions is frequently postulated (Chapter 
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4, Section 4.3.2). To incorporate acetonitrile in the rate equation, an equilibrium between 
the oxocarbenium ion and glycosyl nitrilium ion (Scheme 31) is considered. 
 
Scheme 31. Equilibrium Between Glycosyl Oxocarbenium Ion and Glycosyl Nitrilium 
Ion. 
Thus, the rate equation 4 can be modified as, 
dP/dt = 𝑘′′[Acetonitrile], where k’’ = kKeq [Oxocarbenium ion][Acceptor]            (eq. 6) 
The error associated with the initial rate measurements is minimal because those 
rates are measured at the beginning of the reaction, where the reaction rate is maximum. 
Further, change in the concentration of the limiting reagent is minimal, and thus, the 
influence of concentration changes on the rate constant is negligible. The higher accuracy 
of initial rates is another advantage as such rates are derived from the most linear part 
(initial part of the curve) of the exponential curve from the concentration versus time 
relationship.348 
 Two series of pseudo-first-order kinetic experiments with respect to the acceptor 
were conducted at a constant concentration of N-acetyl oxazolidinone protected sialyl 
donor (both α- and β- donors are used in separate series of reactions). These experiments 
provide the information required to determine the molecularity of the acceptor in 
sialidation reactions, and thus, to elucidate the sialidation mechanism(s). The influence 
of acetonitrile was also examined using two other series of kinetic experiments of both α- 
and β- sialyl donors, in which the percentage of acetonitrile in dichloromethane was varied 
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and the corresponding rate parameters were determined at constant donor and acceptor 
concentrations. These experiments provide the information necessary to derive the 
sialidation mechanism(s) in the presence of acetonitrile as an additive. 
5.2 Results and Discussion 
5.2.1 Hypothesis and Experimental Design 
N-Acetyl-5-N,4-O-oxazolidinone protected adamantanyl β-thiosialoside 183β was 
synthesized following literature protocol.336 Likewise, N-acetyl-5-N,4-O-oxazolidinone 
protected adamantanyl α-thiosialoside 183α was prepared from 1-adamantanyl 
thiosialoside 180 (Scheme 32).352 Thus, the treatment of compound 180 with Boc2O gave 
N-Boc sialoside 181, which upon deacetylation with NaOMe in MeOH followed by the 
cleavage of Boc group in the presence of HCl in methanol and the introduction of 5-N,4-
O-oxazolidinone group by treating with 4-nitrophenyl chloroformate in the presence of 
NaHCO3 in H2O/MeCN (1:1) gave compound 182 in 34% yield in four steps. The 
treatment of 182 with Ac2O and pyridine followed by the N-acetylation using AcCl and 
EtN(i-Pr)2 finally gave N-acetyl-5-N,4-O-oxazolidinone protected adamantanyl α-
thiosialoside 183α in 84%. 
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Scheme 32. Synthesis of N-Acetyl-5-N,4-O-oxazolidinone protected adamantanyl α-
Thiosialoside. 
Sialidation reactions are multicomponent reactions, which typically involve sialyl 
donor, acceptor, a combination of promotors (NIS/TfOH), solvent (DCM) or a mixture of 
solvents (DCM/MeCN), and acid-washed molecular sieves (AW-300), an in situ drying 
agent (Scheme 33 and 34). Therefore, these reactions are heterogeneous in nature, and 
thus, the sampling of known volumes from the reaction mixtures is not practically possible. 
To get around this problem, an internal standard (ISD), methyl 2-phthalimido-2-deoxy-β-
D-glucopyranoside 184 (Figure 40),353 which is inert under sialidation reaction conditions 
and has a UHPLC-MS trace independent from those of all other reaction components, 
was employed in situ, such that, the relative concentration of the products with respect to 
the internal standard can be determined from an unknown volume of the reaction mixture. 
 
Figure 40. Structure of Methyl 2-phthalimido-2-deoxy-β-D-glucopyranoside. 
5.2.2 Pseudo Kinetic Experiments of Sialidation Reactions 
5.2.2.1 Influence of Acceptor Concentration 
A series of pseudo-first-order kinetic experiments with respect to the glycosyl 
acceptor, 2-propanol, was conducted on N-acetyl-5-N,4-O-oxazolidinone protected 
adamantanyl β-thiosialoside 183β donor in dichloromethane at -78 °C (Scheme 33). 
Thus, the acceptor concentration was varied as 0.022, 0.028, 0.034, 0.039 and 0.045 mol 
dm-3, while maintaining a constant concentration of glycosyl donor (0.056 mol dm-3). 
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Then, the initial rate of product formation was determined by sampling the reactions over 
20 minutes (starting from t = 0 min), while the conversion of glycosyl donor to product 
remained <10% that this conversion limit was not exceeded, was determined by the NMR 
analysis of the crude reaction mixture obtained on quenching the reaction with 
triethylamine at the end of the sampling (t = 20.5 min) and the subsequent work-up as 
described in the experimental section. 
 
Scheme 33. Pseudo-First-Order Kinetic Experiment of α- and β-Thiosialosyl Donors. 
All aliquots were analyzed using an ultra-high-performance liquid chromatography 
(UHPLC) coupled mass spectrometer (ESI-MS) equipped with a tunable ultra-violet (TUV) 
detector (Figure 41). The samples were monitored at the wavelength (λ) of 205 nm as it 
is highly sensitive (λmax) to acetate and amide functional groups present in the reaction 
components. According to the Beer-Lambert law, absorbance is directly proportional to 
concentration; hence, individual peak areas of the TUV-trace are measurements of the 
concentration of the corresponding reaction components. 
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Figure 41. ESI-MS Coupled UPLC Analysis of Kinetic Experiments as Illustrated for the 
Pseudo-first-order Kinetic Experiment with Respect to the Donor (0.056 mol dm-3) and 
Acceptor (0.034 mol dm-3); aESI-MS trace at t = 2 min; b-hTUV traces at different time 
points. 
The integrated absorbance signal of the α-O-sialoside to that of the internal 
standard gave the relative concentration of the α-O-sialoside with respect to the internal 
standard at a given time point (Table 20). The relative concentrations of α-O-sialoside at 
different time points were plotted, and the relative rate of the sialidation reaction at that 
particular acceptor concentration was determined from the gradient of the graph (Figure 
42a). Using this protocol, the relative rates of sialidation reactions at different acceptor 
concentrations were determined (Table 21), and the plots of these rates against acceptor 
concentrations were obtained (Figure 42b). It was found that, when the concentration of 
the accepter increased, the relative rate of α-O-sialoside formation increased in a linear 
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manner. The formation of β-O-sialoside on the other hand was much slower as it was not 
detected by TUV detector in most reaction samples. Consequently, only the kinetics of α-
O-sialidation were considered in this study. This low rate of formation of β-anomer was 
expected as N-acetyl-5-N,4-O-oxazolidinone protected thiosialyl donors are well known 
for their excellent α-selectivity (Chapter 4, Section 4.2.1.2).329-331, 336 
Table 20. Change in the Relative Concentration of α-O-Sialoside as a Function of Time 
at the Wave Length of 205 nm a.  
Time/min TUV Response of α-O-Sialoside/TUV Response of ISD 
(λ = 205 nm) 
2 0.0000 
5 0.0144 
8 0.0148 
11 0.0400 
14 0.0500 
20 0.0744 
aIllustrated for glycosylation of β-thiosialyl donor (0.056 mol dm-3) with the acceptor, 2-
proponol (0.028 mol dm-3). 
Table 21. Relative Rate of α-O-Sialoside Formation as a Function of Acceptor 
Concentration for the Glycosylation of β-Thiosialyl Donor 183β.  
Concentration/mol dm-3 Relative Rate of Reaction/min-1 
0.022 0.0004 
0.028 0.0042 
0.034 0.0055 
0.039 0.0066 
0.045 0.0072 
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Figure 42. The Influence of Acceptor Concentration on α-O-Sialidation of β-Thiosialyl 
Donor 183β; a. Relative Concentration of Product w.r.t. Internal Standard (ISD) vs time 
([2-PrOH] = 0.028 M) and b. Relative Rate vs Concentration of 2-PrOH. 
Analogously to the β-thiosialyl donor, kinetic experiments were also conducted 
with the N-acetyl-5-N,4-O-oxazolidinone protected adamantanyl α-thiosialoside 183α, for 
which relative rates with respect to different acceptor concentrations are presented in 
Table 22 and plotted in Figure 43. Similar to the β-thiosialyl donor, the rate of α-O-
glycosylation of α-thiosialyl donor was increased with the increase of acceptor 
concentration, in a linear manner, demonstrating a linear relationship between acceptor 
concentration and the rate of α-O-glycosylation reactions. As with the β-thiosialyl donor, 
the formation of β-O-sialoside was again insignificant in many reaction samples. 
Therefore, in this series also, only the kinetics of α-O-sialidation were considered. 
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Table 22. Relative Rate of α-O-Sialoside Formation as a Function of Acceptor 
Concentration for the Glycosylation of α-Thiosialyl Donor 183α.  
Concentration/mol dm-3 Rate of Reaction/min-1 
0.022 0.0020 
0.028 0.0030 
0.034 0.0040 
0.039 0.0120 
0.045 0.0180 
 
Figure 43. The Influence of Acceptor Concentration on α-O-Sialoside Formation from 
the α-Thiosialyl Donor. 
5.2.2.2 Influence of Acetonitrile Percentage 
The influence of acetonitrile on the kinetics of both β- and α-sialyl donors was 
investigated by varying the acetonitrile percentage from 0 to 40% in dichloromethane 
while choosing constant acceptor and donor concentrations of 0.028 mol dm-3 and 0.056 
mol dm-3, respectively (Scheme 34).  
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Scheme 34. Sialidation Reactions of Thiosialyl Donor with 2-Propanol at Different 
Percentages of Acetonitrile in Dichloromethane. 
Except for the changes in the reaction solvent, these experiments were conducted 
analogously to the kinetic experiments discussed in the Section 5.2.1.1. In these two 
series also β-O-sialoside formation was not detectable by TUV-detector, and therefore 
only the relative rates of α-O-sialidation were taken into account in the final analysis. The 
change in the relative concentration of the α-O-sialoside product as a function of time is 
illustrated for the glycosylation of β-sialyl donor 183β in 10% acetonitrile in 
dichloromethane. The data are tabulated (Table 23) and also represented in graphical 
format (Figure 44a). Analogously to the previous experiments (Section 5.2.1.1), the 
gradient of the graph gave the relative rate of α-O-sialidation at 10% acetonitrile in 
dichloromethane (Figure 44a). Similarly, the relative rates of α-O-sialidation of donor 
183β at different acetonitrile percentages were calculated (Table 24), and the 
corresponding graphical representation is shown in the Figure 44b. To investigate the 
influence of acetonitrile percentage on sialidation reactions as a function of anomeric 
configuration of the starting thiosialyl donor, another series of kinetic experiments was 
conducted using α-thiosialyl donor 183α, and the kinetic data is presented in Table 25 
and plotted in Figure 45. Analogously to the β-thiosialyl donor, this series also 
demonstrated a linear relationship between acetonitrile percentage and the rate of α-O-
sialidation. 
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Table 23. Change in the Relative Concentration of α-O-Sialoside as a Function of 
Timea.  
Time/min TUV Response of α-O-sialoside/TUV Response of ISD 
2 0.0000 
5 0.0000 
8 0.0336 
11 0.0859 
14 0.0837 
17 0.1143 
20 0.1301 
aIllustrated for glycosylation of β-thiosialyl donor (0.056 mol dm-3) with the acceptor 2-
propanol (0.028 mol dm-3) in 10% CH3CN in dichloromethane. 
Table 24. Relative Rate of α-O-Sialoside Formation as a Function of Acetonitrile 
Percentage in Dichloromethane. 
Percentage of Acetonitrile Rate of Reaction/min
-1
 
0.0 0.004 
10.0 0.008 
20.0 0.014 
30.0 0.031 
40.0 0.044 
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Figure 44. The Influence of Acetonitrile Percentage on the Formation of α-O-Sialoside in 
the Glycosylation of β-Thiosialyl Donor 183β; a. Relative Concentration of Product w.r.t. 
Internal Standard (ISD) vs time (10% Acetonitrile in DCM) and b. Relative Rate vs 
Percentage of Acetonitrile in Dichloromethane. 
Table 25. Relative Rate of α-O-Sialoside Formation as a Function of Acetonitrile 
Percentage in the Glycosylation of α-Thiosialyl Donor 183α.  
Percentage of Acetonitrile Rate of Reaction/min
-1
 
0.0 0.002 
10.0 0.013 
20.0 0.023 
30.0 0.040 
40.0 0.038 
a.
 
 
b. 
 
y = 0.008x - 0.0237
0.0000
0.0400
0.0800
0.1200
0.1600
0 5 10 15 20 25
re
l.
c
o
n
c
e
n
tr
a
ti
o
n
 o
f 
α
-O
-g
ly
c
o
s
id
e
(p
ro
d
u
c
t)
time/ min
rel [α-O-Sialoside]
y = 0.001x - 0.000
0.000
0.010
0.020
0.030
0.040
0.050
0.0 10.0 20.0 30.0 40.0 50.0
R
a
te
 o
f 
p
ro
d
u
c
t 
fo
rm
a
ti
o
n
 /
m
in
-1
% of Acetonitrile
Relative Rate
136 
 
 
Figure 45. The Influence of Acetonitrile Percentage on the Formation of α-O-Sialoside 
in the Glycosylation of α-Thiosialyl Donor (183α). 
5.2.3 Discussion 
5.2.3.1 Influence of Acceptor Concentration on Glycosylation of β- and α-
Thiosialyl Donors 
For the reaction of thiosialoside 183β, the linear increase in the relative rate of α-
O-sialidation with respect to the increase of the acceptor concentration (Figure 42b) 
reveals that the rate of α-O-sialidation is dependent on the concentration of acceptor; 
thus, the order with respect to the acceptor is one. Therefore, the formation of α-O-
sialoside from β-thiosialyl donor 183β can be considered as a bimolecular reaction that 
follows the SN2 or SN2-like reaction mechanism. Similarly, the kinetics of the reaction of 
α-thiosiayl donor 183α with 2-proponol also demonstrated the rate of α-O-sialidation to 
linearly increase with the increase of the acceptor concentration (Table 3 and Figure 43), 
revealing the bimolecular nature of such reactions and their SN2 or SN2-like reaction 
mechanisms. As both the sialyl donors 183α and 183β of opposite anomeric 
configuration, lead to the same stereochemical outcome by bimolecular reaction 
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pathways, the rapid formation of a common intermediate is indicated. The most likely 
intermediate is the sialyl triflate when the reaction is conducted in dichloromethane alone 
as solvent (Scheme 35). Due to the anomeric effect, the axial triflate (β-sialyl triflate) is 
more stable than its equatorial counterpart (α-sialyl triflate), and therefore, the major 
nucleophilic substitution should take place on the β-sialyl triflate in an SN2 or SN2-like 
fashion forming the α-O-sialoside (Scheme 35). The formation of the α-sialyl triflate is not 
shown in Scheme 35 as such intermediates are not required by the evidence presented 
here. 
 
Scheme 35. Proposed Mechanism of α-O-Sialidation Reactions. 
5.2.3.2 Influence of Acetonitrile Concentration on Glycosylation of β- and α-
Thiosialyl Donors 
Kinetic experiments with both the β- and α-thiosialyl donors (183β and 183α) 
reveal that the concentration of acetonitrile in dichloromethane affects the rate of 
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formation of the α-O-sialoside 185α. In particular, increasing the percentage of 
acetonitrile from 0 to 40 % in dichloromethane resulted in a linear increase in the relative 
rate of the α-O-sialidation reaction (Table 5 and 6, and Figure 44b and 45). When the 
percentage of acetonitrile is doubled within the range of 10 to 30%, the rate of α-O-
silidation was approximately increased by a factor of two (Table 5 and 6). The linear 
increase in the rate can be explained using equation 6, in which the rate and the 
concentration of acetonitrile have a directly proportional relationship. Specifically, with the 
increase in the acetonitrile percentage, the concentration of the sialyl nitrilium ion 
increases due to the shift of the equilibrium between sialyl oxocarbenium ions and 
nitrilium ion intermediates (Scheme 31). As explained for the sialyl triflate intermediates, 
the axial/β-sialyl nitrilium ion (Scheme 36) is more stable than its equatorial counterpart 
due to the anomeric effect. Thus, the β-sialyl nitrilium ions should undergo nucleophilic 
substitution reactions in an SN2 or SN2-like fashion, forming α-O-sialosides (Scheme 36). 
Overall, these observations further demonstrate the significance of additives in 
glycosylation reactions, where those additives participate in the formation of more 
reactive and stereoselective glycosyl intermediates.  
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Scheme 36. Mechanism of α-O-sialidation in the Presence of Acetonitrile as a Co-
Solvent. 
5.3 Error Analysis and Limitations 
In some experiments, the relative concentrations obtained as a function of time 
have a considerable number of outliers, or they reach a plateau. Hence in those 
situations, the most linear plots were generated using a fewer number of data points that 
were in the best agreement to obtain the most linear average-trend line (R2-value ~ 0.9) 
(Figure 46). This may decrease the accuracy of the data set. 
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Figure 46.  Relative Concentration of Product w.r.t. Internal Standard (ISD) vs time (β-
thiosialyl donor - 40% Acetonitrile in DCMa); aGradient of the graph is determined using 
the most linear part of the curve. 
The errors in the data set may related to the sampling of these extremely moisture 
and temperature sensitive reactions. The multicomponent nature of these sialidation 
reactions also has a significant influence on the sampling. In particular, molecular sieves, 
which was used in situ as the drying agent of the reaction mixture, can interfer with the 
withdrawing of reaction aliquots as well as the releasing of the samples into the quenching 
vials. Atmospheric moisture is another factor, which can alter the outcome of the 
glycosylation reactions as a trace amount of moisture can robustly undergo nucleophilic 
reactions with the activated glycosyl donor, resulting in a complex reaction mixture. 
Overall, the prime reason for the errors associated with these kinetic experiments can be 
summarized as the offline monitoring of the kinetic experiments, i.e., individual reactions 
were sampled and quenched before their analysis; and therefore, unlike the real-time 
analysis, the data obtained may consist of a considerable degree of errors. 
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5.4 Conclusions 
The sialidation mechanism was investigated using several series of pseudo-first-
order kinetic experiments of both the α- and β- anomers of the 5-N,4-O-oxazolidinone 
protected sialyl donor. Irrespective of the anomeric configuration of the donor, the relative 
rate of the α-O-sialidation was increased with the increase of the acceptor concentration, 
suggesting that the sialidation reactions are strongly concentration dependent with regard 
to the acceptor. Therefore, it is concluded that the formation of the α-O-glycoside follows 
SN2 or SN2-like kinetics, where the reaction proceeds via covalently bonded sialyl triflate 
or contact ion pair type intermediates, respectively. In another two series of kinetic 
experiments with both the - and α- sialyl donors, the rate of sialidation reactions was 
linearly increased with the increase of the percentage of acetonitrile in dichloromethane. 
This is a strong evidence for the participation of acetonitrile during the sialidation 
reactions via β-sialyl nitrilium ions (Chapter 6, Section 6.1.1),346 on which an SN2 or SN2-
like nucleophilic attack takes place. Overall, this study reveals that the α-O-sialidation 
reactions are concentration dependent on the acceptor as well as the additive, 
acetonitrile; thus, mechanistically, these reactions follow SN2 or SN2-like reaction 
pathways via sialyl triflates or sialylnitrilium ions, respectively. Therefore, to obtain better 
α-O-selectivity in sialidation reactions, maintaining the highest possible concentration 
with respect to both acceptor and sialyl donor and also utilizing participating solvents 
such as acetonitrile are highly recommended. 
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CHAPTER 6. PROBING THE MECHANISM(S) OF SIALIDATION REACTIONS WITH 
CATION CLOCKS 
Portions of the text and figures in this chapter were reproduced or adapted from: 
Amarasekara, H.; Crich, D., Synthesis and intramolecular glycosylation of sialyl mono-
esters of o-xylylene glycol. The importance of donor configuration and nitrogen protecting 
groups on cyclization yield and selectivity; isolation and characterization of a N-sialyl 
acetamide indicative of participation by acetonitrile. Carbohydr Res., 2016, 83, 113–120. 
Copyright © 2016, Elsevier Ltd. 
6.1 Introduction 
Competition kinetic experiments, which are commonly used in organic 
chemistry,354 and can be a reliable method of studying reaction mechanisms. In 
glycoscience, the Jencks group introduced the azide clock reaction to estimate the 
lifetime of glycosyl oxocarbenium ions in aqueous media (Chapter 1, Section 1.4.2.1).87 
However, this azide clock reaction is not applicable to glycosylation reactions conducted 
in organic solvents at low temperatures. In another approach, by analogy to well-
established radical clock reactions,355 the Crich group developed cyclization of 2-O-(2-
trimethylsilylmethallyl) glycosyl donors as clock reaction and utilized it in the investigation 
of the kinetics (cation clock kinetics) of manno- and glucopyranosyl systems.356-357 In their 
study, the ratio of each glycoside, whether α- or β-, to the combined amount of cyclization 
products were determined as a function of acceptor concentration. For example, this 
experiment revealed that the β-O-mannosylation of 4,6-O-benzylidene protected 
mannopyranosyl donors is highly dependent on acceptor concentration; hence, such 
reactions follow SN2 or SN2-like reaction pathways. The α-O-mannosylation, one the other 
hand, did not indicate any significant dependence on the acceptor concentration, 
revealing SN1 or SN1-like reaction mechanisms (Scheme 37). The consistency of results 
obtained with the cation clock experiments and a series of kinetic isotope experiments 
indicates the reliability of the cation clock method.358 Taking inspiration from the cation 
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clock studies on the manno- and gluco- systems,356-357 this chapter decribed the 
development of a cation clock reaction to investigate the mechanism of sialidation 
reactions.  
 
Scheme 37. Cation Clock Kinetics of Mannosylation Reactions. 
6.2 Experimental Design, Chemistry, and Discussion 
The intramolecular Sakurai reaction employed in the manno and glucopyranosyl 
systems21,22 is not readily extended to the sialic acid series because of i) the lack of 
available alcohol for appendage of the allylsilane, and ii) the incompatibility of the 
allylsilane with typical sialidation conditions. Attention was therefore focused on the 
introduction of intramolecular alcohols linked to the carboxylate group as the 
intramolecular nucleophile.  Ester groups favor the trans-configuration359-360  and the 
barrier to cis-trans isomerization is estimated as 12 kcal mol-1 (Scheme 38).361 Therefore, 
a 4-hydroxybutyl ester, which forms an eight-membered cyclic lactone362-363 on cyclization 
directly from the ground state of the ester, was considered as the shortest alcohol-based 
clock precursor. To accelerate the cyclization, unsaturation was introduced into the butyl 
chain in the form of an aromatic ring, giving rise to the 2-hydroxymethylbenzyl esters 
selected for study. 
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Scheme 38. The Barrier to Rotation Between cis- and trans-Esters. 
6.2.1 Synthesis 
Compound 190336 was treated with lithium iodide in pyridine at reflux311, 364-365 to 
deprotect the methyl ester and obtain carboxylic acid 191 in 68% yield, which was then 
coupled with   benzene-1,2-dimethanol in the presence of dicyclohexylcarbodiimide and 
N-hydroxybenzotriazole, to afford ester 192, in 70% yield (Scheme 39). Then anomer 
180352 of 190 was similarly converted to the carboxylic acid 193 in 73% yield by the 
treatment with lithium iodide in pyridine at refluxing condition. As an alternative route for 
the synthesis of 193, compound 180 was saponified followed by re-installation of the 
acetyl groups in 73% overall yield. This saponification followed by reacetylation route was 
not successful in the case of compound 190 as it gave lactones as the byproducts during 
the acetylation step. Following the coupling protocol described for anomer 191, 
compound 193 gave xylylene ester 194 in 35% yield. The reduced yield from the 
esterification of the axial carboxylic acid 193 compared to that of equatorial carboxylic 
acid 191 indicates the lower reactivity of axial acid owing to its higher steric hindrance. 
Similar to the demethylation and de-esterification protocols employed in compounds 190 
and 180, the N-acetyl-oxazolidinone and isothiocyanate derivatives 183β336 and 197366 
were demethylated and coupled to form the esters 196 and 199, via the intermediates 
195 and 198, in 53 and 43% overall yields, respectively (Scheme 39). Considering 
relative inaccessibility of 180,352 no attempt was  made to study the α-anomers of 
compounds 196 and 199.  
145 
 
 
Scheme 39. Synthesis of Sialic Acid Esters for Cyclization. 
6.2.2 Intramolecular Glycosylation Reactions 
With regards to the cyclization reactions, first, the N-acetyl-β-thioglycoside 192 
was activated using N-iodosuccinimide and triflic acid in dichloromethane at -40 °C in the 
presence of acid washed molecular sieves to give the diolides 200α and 200β in 58% 
combined yield and 1:2.4 (200α:200β) ratio (Scheme 40). The anomer of 192, compound 
194, was activated using a similar procedure to afford diolides 200α and 200β in 76% 
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combined yield and 1:5 (200α:200β) ratio (Scheme 40). The 5-N-acetyl-5-N,4-O-
oxazolidinone protected thiosialoside 196 was similarly activated using N-
iodosuccinimide and triflic acid to obtain diolides 201α and 201β in 42% combined yield 
and 1:0.4 (201α:201β) ratio (Scheme 40). Finally, similar activation of the isothiocyanate 
199 gave corresponding diolides 202α and 202β in 20 % yield and 1:0.7 (202α:202β) 
ratio (Scheme 40). Competing intermolecular glycosylation reactions were observed by 
mass spectrometry during all cyclization reactions, although the dimeric species could not 
be isolated pure and characterized due to the complexity of the multiple stereoisomers. 
These intermolecular self-condensations were the major pathway for the N-
acetyloxazolidinone 196 and especially the isothiocyanate 199 as opposed to the 
acetamides 192 and 194. The lower yields of diolides observed with donors 196 and 199 
are reproducible. 
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Scheme 40. Intramolecular Glycosylation Reactions. 
The anomeric configuration of 200α and 200β was assigned on the basis of the 
3JC,H heteronuclear coupling constants as typically applied in sialic acid chemistry.367-370 
Accordingly, 200α displays a 3JC,H coupling of 6.5 Hz between the axial hydrogen at C3 
and the carbonyl carbon at C1, while the 200β exhibits a 3JC,H coupling of 0 Hz (Scheme 
40).  
The configuration of compounds 201α and 201β was assigned by 3JC,H coupling 
constant, and the structure of 201α was further confirmed by x-ray crystallographic 
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analysis (Figure 47 - CCDC 149904). The cis-conformation of lactone 201α was revealed 
from the crystal structure and is consistent with that of medium-size lactones as originally 
discussed by the Huisgen group.363 The configuration of anomers 202α and 202β was 
established by converting them to the corresponding acetamides 200α and 200β by 
reacting with thioacetic acid,366, 371-376 followed by comparison with the above standards 
by UHPLC analysis. 
 
Figure 47. X-ray Crystal Structure of 201α. 
The anomeric configuration of the donors 192 and 194, and the change of the 
protecting group system from acetyl through oxazolidinone to isothiocyanate (Scheme 
40, donors 192, 196, and 199, respectively) have a significant effect on the anomeric 
selectivity and yields of the cyclization reactions. Donors 192 and 194 have a higher 
preference to form the axial glycoside 200β. However, the preference for the axial 
glycoside 200β is higher, in the cyclization of 194 than of the equatorial thioglycosyl donor 
192, indicating that the major part of the intramolecular sialidation reactions does not 
involve a common oxocarbenium ion type intermediate. A significant fraction of inverted 
product may form via intramolecular displacement of the activated thioglycoside in SN2 
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fashion. Accordingly, the activation of sialyl donor 192 with NIS/TfOH system377 is 
anticipated to form iodosulfonium ion intermediate 203, followed by an intramolecular 
nucleophilic attack from the alcohol in an SN2 fashion, via a transition state 204, which 
ultimately gives diolide 200α (Scheme 41). In similar fashion, the activation of donor 194 
forms predicted intermediate 205, which then undergo intramolecular nucleophilic attack 
by the alcohol providing 200β via transition state 206 (Scheme 41). It is important to note 
that transition states 205 and 206 do not imply synchronicity of bond cleavage (C-S) and 
bond formation (C-O), nor the extent to which the transition states are “exploded”. The 
ester groups are drawn with the preferred trans-configuration assuming that relaxation to 
the cis-configuration on the formation of diolides, crystallographically revealed in 201α, 
occurs after cyclization. The increased axial selectivity during the cyclization of donor 194 
compared to donor 192 can be attributed to the extra stabilization of transition state 206 
in comparison to 204 by the anomeric effect. 
 
Scheme 41. Proposed Reaction Pathways for the Formation of Diolides 200α and 200β 
through SN2-Like Mechanisms. 
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In the formation of 200α and 200β, the less than perfect stereoselectivity indicates 
the complex nature of the cyclization reactions of donors 192 and 194. The competing 
reaction pathways involve the dissociation of activated thioglycosides 203 and 205, 
forming sialyl oxocarbenium type intermediates that often are stabilized in the form of 
glycosyl triflates,82, 99, 378 and of disulfonium ions as suggested by the Ellervik group.379 
The cyclization reactions of axial thiosialyl donors 192, 196, and 199, 
oxazolidinone 196 and isothiocyanate 199 show greater equatorial selectivity than the 
acetamide protected donor 192 (Scheme 40). This is consistent with earlier work on N-
acetyloxazolidinone331, 336 and iso-thiocyanate366 protected sialyl donors. These 
protecting group-dependent selectivities can be described in terms of the sialidation 
mechanism, according to which the more electron-withdrawing oxazolidinone and 
isothiocyanate groups destabilize any oxocarbenium ions and lead to a greater proportion 
of the concerted path. 
6.2.3 Cation Clock Kinetic Experiments 
After investigating the intramolecular glycosylation reactions, the clock precursors 
were used in competition kinetics experiments with external acceptor 2-propanol. 
Accordingly, the thiosialyl donors 192, 194, 196, and 199 were individually activated using 
TfOH/NIS system in dichloromethane at -40 °C in the presence of a known quantity of 2-
propanol as the external acceptor and stirred for 2 h at -40 °C. The reactions were 
quenched at the same temperature, worked up, and concentrated to obtain the crude 
reaction mixtures. The crude reaction mixtures were analyzed using UHPLC coupled ESI-
MS at 205 nm. This wavelength was selected because it is sensitive to the ester and 
amide functional groups present in the reaction components and the internal standard. 
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Following the same protocol, a series of kinetic experiments were carried out on each 
sialyl donor by changing the acceptor concentration. All the kinetic experiments were 
conducted at significantly low donor concentration (0.008 mol dm-3) to minimize the 
intermolecular self-condensation among donor molecules. The crude reaction mixtures 
from multiple kinetic experiments with each sialyl donor were combined and purified by 
silica gel chromatography to obtain pure samples of the O-sialosides 207α to 209β 
(Figure 48), whose configuration was assigned based on the 3JC,H coupling constants. 
 
Figure 48. O-Sialosides Isolated from Competition Kinetic Experiments. 
6.2.3.1 N-Acetyl β-Sialyl Donor (202β) at -40 °C 
Activation of β-thiosialyl donor 192 by the general procedure for cation clock 
experiments (Section 6.1.4) led to the formation of α- and β-O-sialosides 207α and 207β, 
respectively, along with two cyclized products 200α and 200β (Table 26). The ratio of 
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each O-sialoside to the total amount of cyclized products 200α and 200β was determined 
as a function of the acceptor (2-propanol) concentration, resulting in the data tabulated in 
Table 26 and plotted in Figure 49. 
Table 26. O-Sialidation in Competition with Cyclization (peracetylated-β-thioglycoside 
donor). 
 
 
aExperimental conditions: NIS (2.4 equiv), TfOH (1 equiv.) at -40 °C; molecular sieves 
AW-300 MS; bNumber of equivalents (concentration in mol dm-3) cMolar ratios were 
determined by UHPLC/UV/MS 
 
.
Entry 2-PrOHb α-gly/cycl β-gly/cycl 
207α/(200α+200β)c 207β/(200α+200β)c 
1 1.5(0.012) 0.085 0.053 
2 2(0.016) 0.120 0.067 
3 2.5(0.020) 0.149 0.081 
4 3(0.024) 0.216 0.108 
5 3.5(0.028) 0.238 0.118 
6 4(0.032) 0.249 0.123 
7 5(0.040) 0.322 0.179 
8 8(0.064) 0.399 0.186 
9 10(0.80) 0.438 0.184 
10 15(0.120) 0.512 0.182 
11 20(0.160) 0.547 0.162 
12 30(0.240) 0.466 0.160 
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Figure 49. Ratios of α- and β-O-Sialosides to Cyclized Products as a Function of 
Acceptor Concentration at -40 0C (β-donor). 
 According to Figure 49, the relative rates of both the α- and β-O-sialidation 
reactions increase with the increase of acceptor concentration. After the addition of 5 
equivalents (0.040 mol dm-3) of the acceptor, the relative rate of β-O-sialidation reached 
a plateau, whereas that of α-O-sialidation continued to increase until the acceptor 
concentration reached 20 equivalents (0.240 mol dm-3). Both the α- and β-O-sialidation 
reactions appear to be dependent on the acceptor concentration. However, the α-O-
sialidation reaction demonstrates a higher concentration dependence with respect to the 
acceptor. Since the main focus of this study is to probe the α-O-sialidation mechanism, 
here on the priority is given to α-O-sialidation reaction. The nearly linear relationship 
between the acceptor concentration and relative rate of α-O-sialidation indicates first-
order kinetics with regards to the acceptor concentration; hence, the α-O-sialidation 
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reaction should follow SN2 or SN2-like pathways via covalent sialyl triflate or contact ion 
pair type intermediates. These results are consistent with the direct kinetic experiments 
on sialidation reactions discussed in Chapter 5. 
6.2.3.2 N-Acetyl α-Sialyl Donor at -40 °C 
Similarly, the anomer of compound 192, α-sialyl donor 194 was employed in a 
series of competition kinetic experiments using the general protocol for cation clock 
experiments (Section 6.2.3). Since, typical glycosylation reactions do not involve more 
than 10 equivalents of the acceptor, in this series, the amount of acceptor was varied 
from 1.5 to only 10 equivalents (0.800 M). The kinetic data are presented in Table 27 and 
plotted in Figure 50. 
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Table 27. O-Sialidation in Competition with Cyclization (peracetylated-α-thioglycoside 
donor). 
 
 
aExperimental conditions: NIS (2.4 equiv), TfOH (1 equiv.) at -40 °C; molecular sieves 
AW-300 MS; bNumber of equivalents (concentration in mol dm-3) cMolar ratios were 
determined by UHPLC/UV/MS
 
Entry a iPrOHb 
α-gly/cycl β-gly/cycl 
207α/(200α+200β)c 207β/(200α+200β)c 
1 1.5(0.012) 0.126 0.034 
2 2(0.016) 0.162 0.055 
3 2.5(0.020) 0.207 0.059 
4 3(0.024) 0.201 0.062 
5 3.5(0.028) 0.305 0.095 
6 4(0.032) 0.301 0.095 
7 5(0.040) 0.386 0.139 
8 8(0.064) 0.517 0.240 
9 10(0.80) 0.656 0.322 
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Figure 50. Ratios of α- and β-O-Sialosides to Cyclized Products as a Function of 
Acceptor Concentration at -40 0C (α-donor). 
To compare the kinetics between thiosialyl donors 192 and 194, the data from the 
two series were plotted on the same graph (Figure 51). No significant changes in the 
relative rates of sialidation reactions, whether α-O- or of β-O-sialidation, were observed. 
The analogy between the kinetics of two sialyl donors reveals that their mechanism is 
independent from the starting anomeric configuration, and both donors follow similar 
reaction pathways. In particular, α-O-sialidation of both donors 192 and 194 follow SN2 
or SN2-like mechanisms most likely via axial sialyl triflate intermediate. This similarity 
between the two sialyl donors is consistent with the previous study of direct kinetic 
experiments on sialidation reactions (Chapter 5). 
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Figure 51. Comparison of Relative Rates Between α- and β-Thiosialyl Donors as a 
Function of Acceptor Concentration at -40 0C. 
6.2.3.3 N-Acetyl 5-N,4-O-Oxazolidinone β- Sialyl Donor at -40 °C 
Application of the general cation clock protocol (Section 6.2.3) to the N-acetyl-5-
N,4-O-oxazolidinone protected β-thiosialyl donor resulted in O-sialosides 208α and 208β, 
along with cyclized products 201α and 201β.  The ratio of each O-glycoside 208α or 208β 
to the combined amount of cyclization products 201α and 201β was determined as a 
function of 2-propanol concentration, resulting in the data presented in Table 28 and 
tabulated in Figure 52. 
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Table 28. O-Sialidation in Competition with Cyclization (N-Acetyl-oxazolidinone-β-
Thioglycoside Donor). 
 
 
 
aExperimental conditions: NIS (2.4 equiv), TfOH (1 equiv.) at -40 °C; molecular sieves 
AW-300 MS; bNumber of equivalents (concentration in mol dm-3) cMolar ratios were 
determined by UHPLC/UV/MS. 
 
Entrya i-PrOHb 
α-gly/cycl β-gly/cycl 
208α/(201α+201β)c 208β/(201α+201β)c 
1 1.5(0.012) 0.183 0.000 
2 2(0.016) 0.357 0.048 
3 2.5(0.020) 0.454 0.103 
4 3(0.024) 0.571 0.105 
5 3.5(0.028) 0.574 0.301 
6 4(0.032) 0.613 0.232 
7 5(0.040) 0.768 0.348 
8 6(0.048) 0.787 0.436 
9 8(0.064) 0.892 0.697 
10 9(0.072) 0.907 0.672 
11 10(0.80) 0.957 0.611 
12 15(0.120) 1.165 0.781 
13 20(0.160) 1.462 0.828 
14 25(0.200) 1.907 0.919 
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Figure 52. Ratios of α- and β-O-Sialosides to Cyclized Products as a Function of 
Acceptor Concentration at -40 0C (N-Acetyl-oxazolidinone-protected-β-donor). 
According to Figure 52, the rates of both the α- and β-O-sialidation reactions are 
dependent on the acceptor concentration; the α-O-sialidation has higher selectivity 
compared to that of the β-O-sialidation. The relative rate of β-O-sialidation is almost 
unchanged beyond ~8.0 eq of the acceptor; however, the kinetics at such extreme molar 
ratios of the acceptor are not important as such amounts are not utilized in typical 
glycosylation reactions. Also, the very high concentrations of 2-propanol in the latter 
experiments means that the polarity of the reaction solvent is considerably changed, and 
therefore the reaction mechanism can also be altered. 
6.2.3.4 5-Isothiocyanate-protected β-Thiosialyl Donor at -40 °C 
The competition kinetics of 199 with the highly electron-withdrawing isothiocyanate 
group resulted in O-sialosides 209α and 209β together with cyclization products 202α 
and 202β. The ratio of individual glycoside 209α or 209β to the total amount of cyclization 
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products 202α and 202β were calculated as a function of 2-propanol concentration, 
resulting in the data tabulated in Table 29 and plotted in Figure 53. 
Table 29. O-Sialidation in Competition with Cyclization (Isothiocyanato-β-thioglycoside 
donor). 
 
 
 
 
 
 
 
 
 
aExperimental conditions: NIS (2.4 equiv), TfOH (1 equiv.) at -40 °C; molecular sieves 
AW-300 MS; bNumber of equivalents (concentration in mol dm-3) cMolar ratios were 
determined by UHPLC/UV/MS. 
Entrya i-PrOH (M conc)b 
α-gly/cycl β-gly/cycl 
209α/(202α+202β)c 209β/(202α+202β)c 
1 1.5(0.012) 0.418 0.000 
2 2(0.016) 0.591 0.077 
3 2.5(0.020) 0.976 0.208 
4 3(0.024) 1.133 0.564 
5 3.5(0.028) 1.217 0.546 
6 4(0.032) 1.352 0.838 
7 5(0.040) 1.463 0.907 
8 6(0.048) 1.520 1.266 
9 8(0.064) 1.623 1.761 
10 10(0.800) 1.448 2.019 
11 15(0.120) 1.820 2.645 
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Figure 53. Ratios of α- and β-O-glycosides to cyclized products as a function of 
nucleophile concentration at -40 0C (Isothiocyanato-protected-β-donor). 
As depicted in Figure 53, similar to the N-acetyl-oxazolidinone-protected β-
thiosialyl donor, the rates of both the α- and β-O-sialidation reactions are dependent on 
the acceptor concentration, and the α-O-sialidation has higher preference compared to 
that of the β-O-sialidation. However, after the addition of 8 equivalents of 2-propanol, the 
selectivity of the sialidation reaction was changed, preferring the formation of the β-O-
sialoside over α-O-sialoside. Such changes in the reactivity may be due to changes in the 
reaction mechanism with the introduction of extreme amounts of 2-propanol to the 
reaction medium. 
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Since the main focus is on the kinetics of α-O-sialidation reactions, the relative 
rates of α-O-sialoside formation from donors 3, 9, and 199 were tabulated in Table 30 
and plotted on one graph (Figure 54) for ease of comparison. 
Table 30. Comparison of O-Sialidation of N-Acetyl, N-Acetyl-oxazolidinone and 
Isothiocyanato Protected Donors (β-donors) in Competition with Cyclization. 
aExperimental conditions: NIS (2.4 equiv), TfOH (1 equiv.) at -40 °C; molecular sieves 
AW-300 MS; bNumber of equivalents (concentration in mol dm-3) cMolar ratios were 
determined by UHPLC/UV/MS. 
 
 
Entry a iPrOH (M conc)b α-gly/cycl α-gly/cycl α-gly/cycl 
 
207α/(200α+200β)c 208α/(201α+201β)c 209α/(202α+202β)c 
1 1.5(0.012) 0.085 0.182 0.418 
2 2(0.016) 0.120 0.357 0.591 
3 2.5(0.020) 0.149 0.454 0.976 
4 3(0.024) 0.216 0.571 1.133 
5 3.5(0.028) 0.238 0.574 1.217 
6 4(0.032) 0.249 0.613 1.352 
7 5(0.040) 0.322 0.768 1.463 
8 6(0.048) - 0.787 1.520 
9 8(0.064) 0.399 0.892 1.623 
10 10(0.800) 0.438 0.907 1.448 
11 15(0.120) 0.512 0.957 1.820 
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Figure 54. Comparison of Kinetics of Different Sialyl Donors at -40 0C. 
As depicted in Figure 54, the influence of acceptor concentration on the rate of α-
O-sialidation reactions increases from the N-acetyl to N-acetyl-oxazolidinone to 
isothiocyanate protected donors. This trend reveals that the increase of the electron-
withdrawing nature of the protecting group enhances the dependence on acceptor 
concentration, consistent with increased SN2 or SN2-like reaction pathways via covalently 
bonded axial sialyl triflates or β-contact ion pair-type intermediates (Scheme 42). In other 
words, when the electron-withdrawing nature of the protecting group increases, the 
formation of oxocarbenium type intermediates is disfavored; thus, the equilibrium shifts 
towards the covalent or contact ion-pair type intermediates that favor SN2 of SN2-like 
mechanisms. 
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Scheme 42. Equilibration of a β-Sialyl Triflate with a β-Contact Ion Pair and Solvent-
Separated Ion Pair. 
6.2.4 Influence of Nitrile Solvents on Sialidation Reactions 
Acetonitrile is one of the most widely used solvents in sialidation reactions263, 269 
typically resulting in better α-selectivities. The rationale for the enhanced stereoselectivity 
involves the formation of β-sialyl nitrilium ions followed by SN2-like nucleophilic attack 
(Chapter 4, Section 4.3.2). However, no direct evidence for the formation of the nitrilium 
adduct has been reported. 
Treatment of sialyl donor 194 with N-iodosuccinimide and triflic acid in a mixture 
of dichloromethane and acetonitrile (7:3) at – 40 °C, resulted in the formation of the 200β 
and two new compounds in the UHPLC and ESI-MS (m/z 643) analysis ultimately 
assigned as diastereomers of structure 210 (Scheme 43). Chromatographic purification 
of the crude reaction mixture gave 40% of 200β and the impure Ritter product 210 in ~6% 
yield. Attempted silica gel chromatographic purification of 210 resulted in isolation of the 
hydrolyzed product 211 in 4% yield (Scheme 43). The anomeric configuration of amide 
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211 was identified from the JC1,H3ax coupling constant of 0 Hz. The formation of 200β as 
a single isomer can be explained by direct displacement of the activated thioglycoside 
205 by an intramolecular nucleophile, consistent with the cyclization reactions in 
dichloromethane (Scheme 40 and 41). Overall, the isolation of the axial Ritter product 
211 is stong evidence in support of the formation of β-sialyl nitrilium ions, which then 
undergo displacement reactions with nucleophiles in an SN2-like pathway to form the 
equatorial glycosides (Chapter 5, Scheme 36).346 
 
Scheme 43. Formation and Isolation of a Ritter Type Amide from the Sialidation in the 
Presence of Acetonitrile. 
6.3 Conclusions 
The yields and stereoselectivities of the cyclization reactions of donors 192, 194, 
196, and 199 are informative. Comparison of the stereoselectivities of the donors 192 and 
194 suggests that the intramolecular glycosylation of these donors take place mainly via 
an SN2-like pathway. Further, the protecting group system of sialyl donors has a 
significant influence on the yields and selectivities of cyclization reactions. The rate of α-
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selective cyclization increases in a more pronounced manner with the introduction of 
more electron-withdrawing protecting groups, revealing the formation of β-sialyl triflate 
and subsequent SN2 or SN2-like cyclization reactions. In terms of yields of cyclization 
reactions, the N-acetyl-oxazolidinone and isothiocyanate protected systems gave low 
yields in their cyclization reactions due to the competing intermolecular glycosylations 
between two donor molecules. 
Finally, in an important experiment, cyclization reaction of the N-acetyl donor 194 
in the presence of acetonitrile as a co-solvent in dichloromethane resulted in the formation 
of a Ritter-type amide strongly supporting the formation of a sialyl nitrilium ion, which has 
been postulated as a key intermediate during sialidation reactions in the presence of 
acetonitrile.343, 380  
Overall, this study reveals that the α-O-sialidation reaction proceeds via SN2 or 
SN2-like mechanisms, involving β-sialyl triflate or nitrilium ion intermediates. With the 
introduction of more electron-withdrawing protecting groups, corresponding sialidation 
reactions move more to the SN2 or SN2-like end of the mechanistic spectra. 
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CHAPTER 7. CONCLUSIONS 
A series of oxabicyclo[4.4.0]decane derivatives were synthesized as models to 
represent the ideal gg, gt, and tg conformations of the pyranoside side chain. Analysis of 
the complete data set leads to the exclusion of several compounds on the grounds of 
non-ideal conformations. The remaining models were employed to derive a set of limiting 
coupling constants. These limiting coupling constants were used to determine the side 
chain populations of several literature compounds. The absence of negative populations 
in the analysis supports the viability of the new limiting coupling constants. The new 
limiting coupling constants also can be applied to calculate the side chain conformation 
of higher carbon sugars and even vicinal diols with the application of appropriate 
correction factors. The information from this study may also serve the computational 
chemistry field by providing reliable data with which to develop computational methods 
for the calculation of side chain conformations. 
Application of the new limiting data set to three series of 4-O-derivatives of galacto- 
and glucopyranosides and 6-O-analogues of glucopyranosides gave their side chain 
populations as a function of different protecting groups. Despite the fact that the changes 
in the side populations are small, they can modulate the major effects exerted by electron-
withdrawing or donating groups. In particular, the electron-withdrawing effects of 4-O-
esters of galactopyranosides are moderated by a change in the side chain conformation 
to the more reactive gg and tg conformers. The side chain conformation of 4-O-esters of 
glucopyranosides, on the other hand, reinforces the electron-withdrawing effects of the 
esters. For both the galacto- and glucopyranose 4-O-series, the introduction of highly 
electron-withdrawing esters, such as trifluoro or trichloro esters, changes the side chain 
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population to support the electron-withdrawing effect of the ester. No significant 
modulatory effects were observed in the glucopyranose 6-O- series with regards to the 
change in protecting groups. 
Pseudo-first-order kinetic experiments with respect to the glycosyl acceptor were 
conducted with both α- and β- anomers of an N-acetyl-4-O,5-N-oxazolidinone protected 
sialyl donor. Both donors demonstrated a strong dependence on the acceptor 
concetration for the formation of the α-O-sialoside, revealing first order kinetics with 
respect to the acceptor. Thus, an overall SN2 or SN2-like reaction mechanism via a β-
sialyl triflate intermediate is proposed. Kinetic experiments at constant donor and 
acceptor concentration with varied amounts of acetonitrile as a co-solvent in 
dichloromethane revealed that the concertation of acetonitrile has a significant influence 
on the rate of α-O-sialidation reactions. This is a clear indication of the participation of 
acetonitrile, probably in the form of a β-sialyl nitrilium ion, favoring SN2 or SN2-like 
reactions in the formation of α-O-sialosides. Overall, this study recommends using the 
highest possible concentrations of glycosyl donor and acceptor and employing acetonitrile 
as an additive in sialidation reactions to obtain better α-selectivity. 
A cation clock reaction was developed to probe the sialidation reaction 
mechanism(s). Thus, a series of sialyl donors (cation clock precursors) having different 
protecting groups at 5-N- or 4-O,5-N-positions were prepared, and their cyclization 
reactions were investigated. For the cyclization of α- and β- N-acetyl thiosialyl donors, an 
SN2 type reaction mechanism was proposed on the basis of the results. Cyclization yields 
from N-acetyl-oxazolidinone and isothiocyanate precursors were only moderate, rather 
favoring dimer formation. A series of competition kinetic experiments of these cation clock 
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precursors demonstrated that the rate of α-O-sialidation is strongly dependent on the 
acceptor concentration and that this influence is amplified with the increasing electron-
withdrawing effect of the protecting groups (N-acetyl to N-acetyl-oxazolidinone to 
isothiocyanate, respectively). Thus, an SN2 or SN2-like mechanism is proposed for the 
formation of α-O-sialosides especially in the presence of more electron-withdrawing 
protecting groups. Attempted kinetic experiments in the presence of acetonitrile revealed 
the formation of cyclic imidates, which upon purification by silica gel chromatography gave 
an axial anomeric acetamide; strong evidence for the formation of β-nitrilium ions in the 
presence of acetonitrile. Thus, an SN2-like reaction pathway via a β-sialyl nitrilium ion is 
proposed for the formation of α-O-sialosides under these conditions. Overall, the results 
are consistent with the direct kinetic experiments; thus, employing N-acetyl-oxazolidinone 
or isothiocyanate protected sialyl donors with a maximum possible overall concentration 
in acetonitrile containing solvent mixture is recommended to secure a better α-selectivity.  
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CHAPTER 8. EXPERIMENTAL SECTION 
General Experimental. 
Commercial reagents were used without further purification unless otherwise 
stated. Commercially available anhydrous solvents were used for moisture sensitive 
reactions unless otherwise stated. Molecular sieves were activated using Buchi glass 
oven B-585 kugelrohr at 254 °C overnight. Anhydrous CH2Cl2 and CH3CN were dried over 
4 Å and 3 Å molecular sieves respectively for use in glycosylation reactions. All extracts 
were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced 
pressure at ~ 35 °C. Flash column chromatographic purifications were carried out over 
silica gel unless otherwise stated. HPLC purifications were performed on Varian prep star 
HPLC using an Agilent DYNAMAX SI-column (5 µm, 21.4 x 250 mm) at ambient 
temperature with a flow rate of 21.5 mL/min. UHPLC analysis was performed with a BEH 
C18 1.7 μm (2.1 × 100 mm) column equipped with LC-MS and TUV (205 nm) detector. 
NMR spectra were recorded in CD3OD, CDCl3, or C6D6 with 400, 500, or 600 MHz 
instruments unless otherwise stated. The DAISY 1D-NMR spectra simulation tool in the 
TopSpin 3.5 pl 7 or MestReNova 9.0 suite of programs was used to simulate 1H-NMR 
spectra. ESI-HRMS were recorded using a Waters LCT Premier Xe time of flight mass 
spectrometer. Specific rotations were recorded on an automatic polarimeter with a path 
length of 100 mm in the solvent specified. 
Methyl 4,6-O-Benzylidene-2,3-di-O-methyl-α-D-galactopyranoside (47). 
Compound 47 was synthesized following literature protocol.152 In CHCl3: 1H NMR 
(600 MHz, CDCl3) δ 7.52 – 750 (m, 2H), 7.37 – 7.29 (m, 3H), 5.54 (s, 1H), 4.98 (d, J = 
3.5 Hz, 1H), 4.34 (dd, J = 3.5, 1.3 Hz, 1H), 4.26 (dd, J = 12.5, 1.8 Hz, 1H), 4.07 (dd, J = 
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12.5, 1.8 Hz, 1H), 3.78 (dd, J = 10.1, 3.5 Hz, 1H), 3.67 (dd, J = 10.1, 3.5 Hz, 1H), 3.63 
(td, J = 1.8, 1.3 Hz, 1H), 3.52 (s, 3H), 3.50 (s, 3H), 3.44 (s, 3H). 
In C6D6: 1H NMR (600 MHz, C6D6) δ 7.71 – 7.70 (m, 2H), 7.15 – 7.03 (m, 3H), 5.27 
(s, 1H), 4.75 (d, J = 3.5 Hz, 1H), 4.06 (dd, J = 12.2, 1.6 Hz, 1H), 3.80 (dd, J = 10.1, 3.5 
Hz, 1H), 3.77 (dd, J = 3.6, 1.1 Hz, 1H), 3.62 (dd, J = 10.1, 3.6 Hz, 1H), 3.44 (dd, J = 12.2, 
1.9 Hz, 1H), 3.28 (s, 3H), 3.18 (s, 3H), 3.10 (s, 3H), 3.05 (ddd, J = 1.9, 1.6, 1.1 Hz, 1H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 7.49 – 7.47 (m, 2H), 7.36 – 7.30 (m, 3H), 
5.59 (s, 1H), 4.95 (d, J = 2.4 Hz, 1H), 4.45 (dd, J = 2.2, 1.1 Hz, 1H), 4.15 (dd, J = 12.5, 
1.6 Hz, 1H), 4.12 (dd, J = 12.5, 1.7 Hz, 1H), 3.66 – 3.65 (m, 2H), 3.64 (ddd, J = 1.7, 1.6, 
1.1 Hz, 1H), 3.46 (s, 3H), 3.44 (s, 3H), 3.41 (s, 3H). 
Methyl 4,8‐Anhydro‐7‐deoxy‐2,3,6‐tri‐O‐methyl‐α‐D‐glycero‐D‐galacto‐
octopyranoside (48). 
Compound 48 was synthesized following literature protocol.110  In CHCl3: 1H NMR 
(600 MHz, CDCl3) δ 4.95 (d, J = 3.7 Hz, 1H), 4.13 (ddd, J = 11.9, 4.8, 1.7 Hz, 1H), 4.00 
(dd, J = 3.2, 0.8 Hz, 1H), 3.68 (dd, J = 10.0, 3.7 Hz, 1H), 3.68 (dd, J = 3.2, 0.8, 1H), 3.55 
(dd, J = 10.0, 3.2 Hz, 1H), 3.52 (s, 3H), 3.49 (s, 3H), 3.47 (s, 3H), 3.41(s, 3H), 3.40 (ddd, 
J = 12.6, 11.7, 2.2, 1H), 3.34 (ddd, J = 11.9, 4.5, 3.2 Hz, 1H), 1.98 (dddd, J = 12.6, 12.4, 
11.9, 4.8 Hz, 1H), 1.74 (dddd, J = 12.4, 4.5, 2.2, 1.7 Hz, 1H). 
In C6D6: 1H NMR (600 MHz, C6D6) δ 4.81 (d, J = 3.7 Hz, 1H), 3.88 (dd, J = 10.0, 
3.7 Hz, 1H), 3.80 (ddd, J = 11.6, 4.8, 1.8 Hz, 1H), 3.71 (d, J = 3.2 Hz, 1H), 3.57 (dd, J = 
10.0, 3.2 Hz, 1H), 3.29 (s, 3H), 3.27 (s, 3H), 3.22 (dd, J = 3.2, 0.8 Hz, 1H), 3.22 (s, 3H), 
3.10 (s, 3H), 2.92 (ddd, J = 12.7, 11.6, 2.2 Hz, 1H), 2.80 (ddd, J = 11.8, 4.5, 3.2 Hz, 1H), 
2.10 (dddd, J = 12.7, 12.5, 11.8, 4.8 Hz, 1H), 1.31 (dddd, J = 12.5, 4.5, 2.2, 1.8 Hz, 1H). 
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In CD3OD: 1H NMR (600 MHz, CD3OD) δ 4.90 (d, J = 3.7 Hz, 1H), 4.01 (dd, J = 
3.1, 0.7 Hz, 1H), 4.00 (ddd, J = 11.7, 4.9, 1.7 Hz, 1H), 3.77 (dd, J = 3.2, 0.7 Hz, 1H), 3.58 
(dd, J = 10.1, 3.7 Hz, 1H), 3.52 (dd, J = 10.1, 3.2 Hz, 1H), 3.45 (ddd, J = 12.0, 4.6, 3.1 
Hz, 1H), 3.44 (s, 3H), 3.42 (ddd, J = 12.5, 11.7, 2.0 Hz, 1H), 3.41 (s. 6H), 3.39 (s, 3H), 
1.86 (dddd, J = 12.5, 12.4, 12.0, 4.9 Hz, 1H), 1.71 (dddd, J = 12.4, 4.6, 2.0, 1.7 Hz, 1H). 
Methyl 4,8-Anhydro-7-deoxy-2,3,6-tri-O-methyl-β-L-glycero-D-galacto-
octopyranoside (51). 
Compound 51 was prepared using literature protocol.110   In CHCl3: 1H NMR (600 
MHz, CDCl3) δ 4.86 (d, J = 3.6 Hz, 1H), 4.00 (dd, J = 3.4, 1.1 Hz, 1H), 3.84 (ddd, J = 11.4, 
5.3, 1.3 Hz, 1H), 3.71 (ddd, J = 13.1, 11.4, 2.6 Hz, 1H), 3.67 (dd, J = 10.1, 3.6 Hz, 1H), 
3.61 (dd, J = 3.1, 1.1 Hz, 1H), 3.52 (dd, J = 10.1, 3.4 Hz, 1H), 3.52 (s, 3H), 3.49 – 3.46 
(m, 4H), 3.42 (s, 3H), 3.39 (s, 3H), 1.97 (dddd, J = 14.3, 13.1, 5.2, 2.8 Hz, 1H), 1.65 (dddd, 
J = 14.3, 3.7, 2.6, 1.3 Hz, 1H). 
In C6D6: 1H NMR (600 MHz, C6D6) δ 4.84 (d, J = 3.6 Hz, 1H), 4.15 (dd, J = 3.4, 1.1 
Hz, 1H), 4.00 (dd, J = 10.1, 3.6 Hz, 1H), 3.76 – 3.69 (m, 3H), 3.40 (ddd, J = 3.0, 2.9, 2.8 
Hz, 1H), 3.37 (s, 3H), 3.27 (s, 3H), 3.19 (s, 3H), 3.00 (s, 3H), 2.05 (dddd, J = 14.1, 13.0, 
7.6, 2.8 Hz, 1H), 1.36 (dddd, J = 14.1, 2.9, 2.8, 1.1 Hz, 1H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 4.89 (d, J = 3.6 Hz, 1H), 4.01 (dd, J = 
3.4, 1.1 Hz, 1H), 3.73 (ddd, J = 11.3, 5.4, 1.2 Hz, 1H), 3.68 (ddd, J = 13.2, 11.4, 2.1 Hz, 
1H), 3.62 (dd, J = 3.1, 1.1 Hz, 1H), 3.60 (dd, J = 10.1, 3.6 Hz, 1H), 3.50 (dd, J = 10.1, 3.4 
Hz, 1H), 3.47 (ddd, J = 3.1, 3.0, 2.9 Hz, 1H), 3.46 (s, 3H), 3.41 (s, 3H), 3.40 (s, 3H), 3.40 
(s, 3H), 1.95 (dddd, J = 14.3, 13.0, 5.4, 2.9 Hz, 1H), 1.67 (dddd, J = 14.3, 3.0, 2.8, 1.2 
Hz, 1H). 
178 
 
Methyl 4,8-Anhydro-7-deoxy-2,3,6-tri-O-methyl-α-D-glycero-D-gluco-
octopyranoside (53). 
Compound 53 was synthesized using the literature protocol.381 In CHCl3: 1H NMR 
(600 MHz, CDCl3) δ 4.89 (d, J = 3.6 Hz, 1H), 3.75 (ddd, J = 11.6, 5.5, 1.5 Hz, 1H). 3.72 
(ddd, J = 3.6, 2.6, 2.2 Hz, 1H), 3.69 (ddd, J = 12.7, 11.6, 2.2 Hz, 1H), 3.60 (s, 3H), 3.56 
(dd, 10.1, 8.9 Hz, 1H), 3.54 (dd, 10.1, 2.6 Hz, 1H), 3.50 (s, 3H), 3.46 (dd, J = 9.4, 8.9 Hz, 
1H), 3.43 (s, 3H), 3.42 (s, 3H), 3.28 (dd, J = 9.4, 3.6 Hz, 1H), 1.98 (dddd, J = 14.5, 3.6, 
2.2, 1.5 Hz, 1H), 1.71 (dddd, J = 14.5, 12.7, 5.5, 2.2 Hz, 1H). 
In C6D6: H NMR (600 MHz, C6D6) δ 4.71 (d, J = 3.6 Hz, 1H), 3.96 (dd, J = 10.1, 
9.2 Hz, 1H), 3.83 (dd, J = 9.4, 9.2 Hz, 1H), 3.73 (ddd, J = 12.7, 11.4, 2.5 Hz, 1H), 3.68 (s, 
3H), 3.63 (dd, J = 10.1, 2.6 Hz, 1H), 3.55 (ddd, J = 11.4, 5.4, 1.5 Hz, 1H), 3.40 (ddd, J = 
3.6, 2.6, 2.5 Hz, 1H), 3.27 (s, 3H), 3.26 (s, 3H), 3.24 (dd, J = 9.4, 3.6 Hz, 1H), 3.16 (s, 
3H), 1.45 (dddd, J = 14.1, 3.6, 2.5, 1.5 Hz, 1H), 1.38 (dddd, J = 14.1, 12.7, 5.4, 2.5 Hz, 
1H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 4.88 (d, J = 3.7 Hz, 1H), 3.70 (ddd, J = 
11.5, 5.6, 1.5 Hz, 1H), 3.70 (ddd, J = 3.6, 2.6, 2.4 Hz, 1H), 3.64 (ddd, J = 12.8, 11.5, 2.2 
Hz, 1H), 3.53 (s, 3H), 3.52 (dd, J = 10.1, 2.6 Hz, 1H), 3.48 (dd, J = 10.1, 9.0 Hz, 1H), 3.47 
(s, 3H), 3.43 (s, 3H), 3.40 (s, 3H), 3.36 (dd, J = 9.5, 9.0 Hz, 1H), 3.19 (dd, J = 9.5, 3.7 Hz, 
1H), 1.95 (dddd, J = 14.5, 3.6, 2.2, 1.5 Hz, 1H), 1.74 (dddd, J = 14.5, 12.8, 5.6, 2.4 Hz,1H). 
Methyl 4,8-Anhydro-7-deoxy-2,3,6-tri-O-methyl-β-L-glycero-D-gluco-
octopyranoside (55). 
Compound 55 was synthesized following literature protocol.381  In CHCl3: 1H NMR 
(600 MHz, CDCl3) δ 4.87 (d, J = 3.7 Hz, 1H), 4.00 (ddd, J = 11.9, 5.3, 1.5 Hz, 1H), 3.61 
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(s, 3H), 3.52 (s, 3H), 3.50 (t, J = 9.3 Hz, 1H), 3.47 (s, 3H), 3.45 (s, 3H), 3.42 (dd, J = 9.6, 
9.0 Hz, 1H), 3.42 (ddd, J = 12.9, 11.9, 2.3 Hz, 1H), 3.30 (ddd, J = 11.0, 9.0, 5.1 Hz, 1H), 
3.24 (dd, J = 9.3, 3.7 Hz, 1H), 2.98 (dd, J = 9.3, 9.6 Hz, 1H), 2.04 (dddd, J = 13.2, 5.1, 
2.3, 1.5 Hz, 1H), 1.55 (dddd, J = 13.2, 12.9, 11.0, 5.3 Hz, 1H). 
In C6D6: 1H NMR (600 MHz, C6D6) δ 4.65 (d, J = 3.7 Hz, 1H), 3.74 (t, J = 9.2 Hz, 
1H), 3.62 – 3.60 (ddd, J = 11.8, 5.2, 1.6 Hz, 1H), 3.59 (s, 3H), 3.57 (dd, J = 9.7, 9.4 Hz, 
1H), 3.27 (s, 3H), 3.22 (s, 3H), 3.19 (s, 3H), 3.17 (dd, J = 9.2, 3.7 Hz, 1H), 2.99 (dd, J = 
9.7, 9.2 Hz, 1H), 2.99 (ddd, J = 11.0, 9.0, 5.1 Hz, 1H), 2.98 (ddd, J = 12.7, 11.8, 2.4 Hz, 
1H), 1.51 (dddd, J = 13.1, 5.1, 2.4, 1.6 Hz, 1H), 1.40 (dddd, J = 13.1, 12.7, 11.0, 5.2 Hz, 
1H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 4.85 (d, J = 3.8 Hz, 1H), 3.94 (ddd, J = 
11.8, 5.2, 1.6 Hz, 1H), 3.51 (s, 6H), 3.45 (s, 3H), 3.42 (ddd, J = 12.8, 11.9, 2.3 Hz, 1H), 
3.39 (s, 3H), 3.37 (dd, J = 9.4, 9.3 Hz, 1H), 3.33 (ddd,  J = 10.8, 9.2, 4.8 Hz, 1H), 3.31 (t, 
J = 9.2 Hz, 1H), 3.20 (dd, J = 9.4, 3.8 Hz, 1H), 2.96 (dd, J = 9.4, 9.3 Hz, 1H), 2.06 (dddd, 
J = 13.2, 4.8, 2.3, 1.6 Hz, 1H), 1.48 (dddd, J = 13.2, 12.8, 10.8, 5.2, 1H). 
Methyl 4,6-O-Benzylidene-2,3-di-O-methyl-α-D-glucopyranoside (57). 
Compound 57 was synthesized by following the literature protocol.153  In CHCl3: 
1H NMR (600 MHz, CDCl3) δ 7.51 – 7.48 (m, 2H), 7.39 – 7.33 (m, 3H), 5.54 (s, 1H), 4.86 
(d, J = 3.7 Hz, 1H), 4.28 (dd, J = 10.2, 4.7 Hz, 1H), 3.81 (ddd, J = 10.1, 9.6, 4.7 Hz, 1H), 
3.73 (dd, J = 10.2, 10.1 Hz, 1H), 3.69 (dd, J = 9.3, 9.2 Hz, 1H), 3.64 (s, 3H), 3.55 (s, 3H), 
3.53 (dd, J = 9.6, 9.3 Hz, 1H), 3.45 (s, 3H), 3.30 (dd, J = 9.2, 3.7 Hz, 1H). 
In C6D6: 1H NMR (600 MHz, C6D6) δ 7.65 – 7.61 (m, 2H), 7.21 – 7.18 (m, 2H), 7.15 
– 7.11 (m, 1H), 5.37 (s, 1H), 4.63 (d, J = 3.7 Hz, 1H), 4.16 (dd, J = 10.2, 4.9 Hz, 1H), 3.90 
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(dd, J = 10.3, 9.6, 4.9 Hz, 1H), 3.88 (t, J = 9.2 Hz, 1H), 3.56 (s, 3H), 3.52 (dd, J = 10.3, 
10.2 Hz, 1H), 3.50 (dd, J = 9.6, 9.2 Hz, 1H), 3.28 (s, 3H), 3.21 (dd, J = 9.2, 3.7 Hz, 1H), 
3.06 (s, 3H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 7.48 – 7.45 (m, 2H ), 7.38 – 7.32 (m, 
3H), 5.57 (s, 1H), 4.91 (d, J = 3.6 Hz, 1H), 4.21 (dd, J = 9.3, 4.0 Hz, 1H), 3.75 (t, J = 10.3 
Hz, 1H), 3.73 – 3.68 (m, 1H), 3.58 – 3.53 (m, 5H, H-4, OCH3), 3.49 (s, 3H), 3.43 (s, 3H), 
3.32 (dd, J = 9.5, 3.6, 1H). 
1,5-Anhydro-2,3-di-O-benzyl-4,6-O-benzylidene-D-glucitol (58). 
A mixture of S-phenyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-deoxy-1-thia-β-D-
glucopyranoside 64382 (0.025 g, 0.046 mmol), tributylstannane (18.7 µL, 0.069 mmol), 
and azobisisobutyronitrile (catalytic) in anhydrous benzene (0.5 mL) was sparged with Ar 
and heated to reflux overnight. Then the reaction mixture was concentrated and 
partitioned between hexane and acetonitrile, and the acetonitrile layer was concentrated 
under vacuum. The crude residue was purified by silica gel chromatography, eluting with 
hexane/ ethylacetate (19:1 to 9:1), to afford 58 (14.5 mg, 72%) with spectral date 
consistent with the literature.383  In CHCl3: 1H NMR (600 MHz, CDCl3) 7.51 – 7.48 (m, 
2H), 7.41 – 7.27 (m, 13H), 5.56 (s, 1H), 4.96 (d, J = 11.4 Hz, 1H), 4.84 (d, J = 11.4 Hz, 
1H), 4.81 (d, J = 11.6 Hz, 1H), 4.66 (d, J = 11.6 Hz, 1H), 4.32 (dd, J = 10.4, 5.0 Hz, 1H), 
4.01 (dd, J = 11.3, 5.7 Hz, 1H), 3.75 (dd, J = 9.1, 8.9 Hz, 1H), 3.68 (dd, J = 10.2, 10.3 Hz, 
1H), 3.66 (ddd, J = 10.5, 8.9, 5.7 Hz, 1H), 3.62 (dd, J = 9.1, 9.3 Hz, 1H), 3.37 (ddd, J = 
10.2, 9.3, 5.0 Hz, 1H), 3.33 (dd, J = 11.3, 10.5 Hz, 1H). 
In C6D6: 1H NMR (600 MHz, C6D6) δ 7.63 (dd, J = 8.1, 0.9 Hz, 2H), 7.42 (dd, J = 
7.9, 0.9 Hz, 2H), 7.27 – 7.17 (m, 7H), 7.15 – 7.07 (m, 4H), 5.31 (s, 1H), 5.04 (d, J = 11.8 
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Hz, 1H), 4.85 (d, J = 11.8 Hz, 1H), 4.62 (d, J = 11.9 Hz, 1H), 4.43 (d, J = 11.9 Hz, 1H), 
4.17 (dd, J = 10.2, 5.0 Hz, 1H), 3.87 (dd, J = 11.2, 5.7 Hz, 1H), 3.68 (dd, J = 9.1, 8.7 Hz, 
1H), 3.56 (ddd, J = 10.6, 8.7, 5.7 Hz, 1H), 3.47 (dd, J = 9.1, 9.3 Hz, 1H), 3.44 (t, J = 10.2 
Hz, 1H), 3.14 (ddd, J = 10.1, 9.3, 5.0 Hz, 1H), 3.09 (dd, J = 11.2, 10.6 Hz, 1H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 7.48 – 7.45 (m, 2H), 7.37 – 7.22 (m, 
13H), 5.58 (s, 1H), 4.88 (d, J = 11.5 Hz, 1H), 4.79 (d, J = 11.5 Hz, 1H), 4.73 (d, J = 11.6 
Hz, 1H), 4.66 (d, J = 11.6 Hz, 1H), 4.23 (dd, J = 10.3, 5.0 Hz, 1H), 4.04 (dd, J = 11.2, 5.6 
Hz, 1H), 3.70 (dd, J = 9.1, 8.7 Hz, 1H), 3.68 (dd, J = 10.2, 10.3 Hz, 1H), 3.63 (ddd, J = 
10.5, 8.7, 5.6 Hz, 1H), 3.60 (dd, J = 9.1, 9.3 Hz, 1H), 3.35 (ddd, J = 10.2, 9.3, 5.0 Hz, 1H), 
3.31 (dd, J = 11.2, 10.5 Hz, 1H). 
1-Allyl-2,3-di-O-benzyl-4,6-O-benzylidene-1-deoxy-β-D-glucopyranose (59) and 1-
Allyl-2,3-di-O-benzyl-4,6-O-benzylidene-1-deoxy-α-D-glucopyranose (60). 
A mixture of 2,3,4,6-tetra-O-acetyl-1-C-allyl-D-glucopyranose 65384 (α:β = 1:0.2, 
0.40 g, 1.1 mmol) and NaOMe (cat.) in anhydrous methanol (5.0 mL) was stirred at room 
temperature under argon for 5 h before quenching with Amberlyst-15 (pH~5). Then the 
reaction mixture was filtered and concentrated to dryness. The residue was dissolved in 
anhydrous acetonitrile (7.8 mL) followed by addition of benzaldehyde dimethyl acetal 
(0.24 mL, 1.6 mmol) and campher sulfonic acid (0.012 g, 0.05 mmol). The reaction 
mixture was stirred at room temperature overnight under argon, before it was quenched 
by adding triethylamine (0.35 mL) and concentrated to dryness. The crude residue (0.238 
g, 0.81 mmol) was dissolved in anhydrous DMF (4.1 mL) and cooled to 0 °C before 60% 
NaH in mineral oil (0.100 g, 2.44 mmol) was added followed by benzyl bromide (288 µL, 
2.44 mmol). The reaction mixture was stirred at room temperature overnight under argon, 
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then cooled to 0 °C before quenching with water. The reaction mixture was partitioned 
between ethyl acetate and H2O, the organic layer was separated, washed with brine, 
dried over anhydrous Na2SO4, and concentrated to dryness. The residue was purified 
using silica gel column chromatography, eluting with hexanes/ethyl acetate (20:1 to 10:1), 
to afford 59 (0.022 g, 6%) and 60 (0.210 g, 55%), both with spectral data consistent with 
the literature.  
(59).157 1H NMR (600 MHz, CDCl3) δ 7.52 – 7.49 (m, 2H), 7.41 – 7.27 (m, 13H), 
5.91 – 5.83 (m, 1H), 5.59 (s, 1H), 5.12 – 5.07 (m, 2H), 5.01 (d, J = 11.2 Hz, 1H), 4.97 (d, 
J = 10.8 Hz, 1H), 4.80 (d, J = 11.2 Hz, 1H), 4.65 (d, J = 10.8 Hz, 1H), 4.35 (dd, J = 10.4, 
5.0 Hz, 1H), 3.85 (dd, J = 9.3, 8.4 Hz, 1H), 3.72 (t, J = 10.3 Hz, 1H), 3.67 (t, J = 9.3 Hz, 
1H), 3.49 (ddd, J = 9.6, 7.2, 3.3 Hz, 1H), 3.42 (ddd, J = 10.3, 9.3, 5.0 Hz, 1H), 3.38 (dd, 
J = 9.6, 8.4 Hz, 1H), 2.61 (dddt, J = 14.8, 6.4, 3.3, 1.6 Hz, 1H), 2.30 (dtt, J = 14.8, 7.4, 
1.1 Hz, 1H). 
(60).155, 157 1H NMR (600 MHz, CDCl3) δ 7.54 – 7.52 (m, 2H), 7.43 – 7.29 (m, 13H), 
5.80 (ddt, J = 17.0, 10.2, 6.9 Hz, 1H), 5.60 (s, 1H), 5.18 – 5.11 (m, 2H), 4.96 (d, J = 11.4 
Hz, 1H), 4.85 (d, J = 11.4 Hz, 1H), 4.80 (d, J = 11.7 Hz, 1H), 4.67 (d, J = 11.7 Hz, 1H), 
4.31 – 4.24 (m, 1H), 4.11 (ddd, J = 8.3, 7.2, 5.8 Hz, 1H), 3.94 – 3.88 (m, 1H), 3.79 (dd, J 
= 8.6, 5.8 Hz, 1H), 3.73 – 3.65 (m, 3H), 2.57 (br t, J = 7.1 Hz, 2H). 
1,5-Anhydro-4,6-O-benzylidene-2,3-di-O-benzyl-D-mannitol (61). 
Compound 61 was synthesized using literature protocol.154 1H NMR (600 MHz, 
CDCl3) 7.60-7.20 (m, 15H); 5.56 (s, 1H); 4.85-4.65 (d x4, J = 12.5, 12.1 Hz, 4H); 4.29 (dd, 
4.8, 10.3 Hz, 1H); 4.26 (dd, 9.9 Hz, 9.5 Hz, 1H); 4.07 (dd, 12.5, 2.2 Hz, 1H); 3.86 (t, 9.9, 
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10.3 Hz, 1H); 3.28 (m, 1.1, 2.2, 3.3 Hz, 1H); 3.68 (dd, 3.3, 9.9 Hz, 1H); 3.44 (dd, 12.5, 1.1 
Hz, 1H); 3.34 (dt, 9.9, 4.8 Hz, 1H). 
1-Allyl-2,3-di-O-benzyl-4,6-O-benzylidene-1-deoxy-β-D-mannopyranose (62). 
Compound 62 was synthesized as described in literature.155 1H NMR (600 MHz, 
CDCl3) d 7.20-7.60 (m, 15H); 5.69 (m, 1H); 5.66 (s, 1H); 5.10, 4.71 (d x2, J = 12.5 Hz, 
2H); 5.08-5.02 (m, 2H); 4.95, 4.78 (d x2, J = 12.5 Hz, 2H); 4.30 (dd, J = 4.8, 10.3 Hz, 1H); 
4.27 (dd, J = 9.9, 9.5 Hz, 1H); 3.87 (t, J = 9.9,10.3 Hz, 1H); 3.82 (br.d, J = 1.1, 2.9 Hz, 
1H); 3.75 (dd, J = 2.9, 9.9 Hz, 1H); 3.64 (t, J = 1.1, 7.0 Hz, 1H); 3.40 (dt, J = 9.5, 9.9, 4.8 
Hz, 1H, H5); 2.48 (m, 1H); 2.28 (m, 1H). 
1-Allyl-2,3-di-O-benzyl-4,6-O-benzylidene-1-deoxy-α-D-mannopyranose (63). 
Compound 26 was synthesized as described in literature.155 1H NMR (600 MHz, 
CDCl3) d 7.10-7.60 (m, 15H); 5.65 (s, 1H); 5.60 (m, 1H); 5.02 (dd, J = 9.2, 1.1 Hz, 1H); 
4.95 (dd, J = 16.9, 1.1 Hz, 1H); 4.81 (d, J = 12.5 Hz, 1H); 4.74 (s, 2H); 4.65 (d, J = 12.5 
Hz, 1H); 4.27 (dd, J = 9.9, 9.5 Hz, 1H); 4.21 (dd, J = 4.8, 10.3 Hz, 1H); 4.04 (dt, J = 1.5, 
7.7 Hz, 1H); 3.84 (dd, J = 3.3, 9.9 Hz, 1H); 3.83 (t, J = 9.9, 10.3 Hz, 1H); 3.69 (dd, J = 
1.5, 3.3 Hz, 1H); 3.60 (dt, J = 9.5, 9.9, 4.8 Hz, 1H); 2.42 (m, 1H); 2.17 (m, 1H). 
Methyl 6-O-(p-Methoxybenyl)-2,3-di-O-methyl-α-D-glucopyranoside (67). 
To a stirred solution of compound 66160 (6.5 g, 18.9 mmol) and NaCNBH3 (5.97 g, 
94.9 mmol) in dry THF (100 mL) was added 2 M HCl in diethyl ether at 0 °C. After 0.5 h 
at 0 °C, the reaction mixture was poured into an ice-cold solution of saturated aqueous 
NaHCO3. The aqueous phase was extracted with EtOAc. The combined extracts were 
washed with saturated aqueous 1 N HCl , dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. The crude compound was purified by silica gel 
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column chromatography, eluting with hexanes/ethyl acetate 1:1, to yield 67 (4.6g, 71%) 
as a colorless oil. [α] 22 = +82.3 (c 1.05, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.16 (d, J 
= 8.6 Hz, 2H), 6.76 (d, J = 8.6 Hz, 2H), 4.76 (d, J = 3.5 Hz, 1H), 4.44 (d, J = 11.8 Hz, 1H), 
4.40 (d, J = 11.8 Hz, 1H), 3.67 (s, 3H), 3.64 – 3.55 (m, 3H), 3.53 (s, 3H), 3.46 – 3.41 (m, 
1H), 3.38 (s, 3H), 3.37 (t, J = 9.4 Hz, 1H), 3.33 (s, 3H), 3.26 (br s, 1H), 3.14 (dd, J = 9.3, 
3.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 159.1, 130.0, 129.2, 113.7, 113.7, 97.3, 83.0, 
81.6, 73.1, 70.5, 70.0, 69.1, 61.0, 58.4, 55.1, 55.1. HRMS (ESI) m/z calcd for C17H26O7Na 
[M+Na]+, 365.1576; found, 365.1580. 
Methyl 6-O-(p-Methoxybenzyl)-2,3-di-O-methyl-α-D-xylo-hexopyranosid-4-ulose 
(68).  
Dess-Martin periodinane (4.48 g, 10.7 mmol) was added to a mixture of alcohol 67 
(2.80 g, 8.2 mmol) in anhydrous CH2Cl2 (94 mL) at room temperature. The reaction 
mixture was stirred overnight before addition of CH2Cl2 (80 mL) and a mixture of saturated 
aqueous NaHCO3, saturated aqueous Na2S2O3 and water (1:1:1, 120 mL). The reaction 
mixture was then stirred for another 0.5 h before the organic layer was separated. The 
organic layer was dried over anhydrous Na2SO4 and concentrated to dryness. The 
residue was purified over silica gel, eluting with hexanes/ethyl acetate (2:1 to 1:2), to 
obtain the ketone 68 (2.4 g, 85%). [α] 22 D = +71.2 (c 2.00, CH2Cl2); 1H NMR (600 MHz, 
CDCl3) δ 7.26 – 7.22 (m, 2H), 6.87 – 6.83 (m, 2H), 5.02 (d, J = 3.5 Hz, 1H), 4.53 (d, J = 
11.7 Hz, 1H), 4.47 (d, J = 11.7 Hz, 1H), 4.24 (dd, J = 6.2, 3.5 Hz, 1H), 4.09 (d, J = 10.2 
Hz, 1H), 3.85 (dd, J = 10.9, 3.5 Hz, 1H), 3.78 (s, 3H), 3.64 (dd, J = 11.0, 6.2 Hz, 1H), 3.57 
(s, 3H), 3.53 (s, 3H), 3.52 – 3.51 (m, 1H), 3.51 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 
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201.8, 159.2, 129.9, 129.3, 113.7, 97.6, 84.5, 82.4, 73.3, 72.6, 67.2, 60.2, 59.7, 56.1, 
55.2; HRMS (ESI) m/z calcd for C17H24O7Na [M+Na]+, 363.1420; found, 363.1415. 
Methyl 4-C-Allyl-6-O-(p-methoxybenzyl)-2,3-di-O-methyl-α-D-galactopyranoside 
(69) and Methyl 4-C-Allyl-6-O-(p-methoxybenzyl)-2,3-di-O-methyl-α-D-
glucopyranoside (70).  
A freshly prepared solution of allyl magnesium chloride in THF (1 M, 30 mL, 30.0 
mmol) was added to a solution of ketone 68 (2.50 g, 7.3 mmol) in anhydrous THF (36 mL) 
at 0 °C. Then the reaction mixture was stirred at 0 °C until the completion as indicated by 
TLC (50% ethyl acetate in hexane). The reaction was quenched by addition of saturated 
aqueous NH4Cl and extracted with ethyl acetate. The combined organic layers were dried 
over anhydrous Na2SO4 and concentrated to dryness. The resultant residue (30:31 = 8:3) 
was purified by silica gel chromatography, eluting with hexanes/ethyl acetate (7:3 to 1:1), 
to give 69 (1.52 g, 54 %) and 70 (0.53 g, 19 %) as colorless oils. 
(69). [α] 22 D = +89.6 (c 1.50, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 7.24 – 7.22 (m, 
2H), 6.86 – 6.83 (m, 2H), 5.70 (ddt, J = 17.5, 10.2, 7.5 Hz, 1H), 5.04 (dd, J = 10.2, 1.5 
Hz, 1H), 4.99 (dd, J = 17.0, 1.6 Hz, 1H), 4.87 (d, J = 3.7 Hz, 1H), 4.54 – 4.49 (d, J = 11.7 
Hz, 1H), 4.44 (d, J = 11.7 Hz, 1H), 3.77 (s, 3H), 3.76 – 3.69 (m, 3H), 3.66 (dd, J = 9.5, 3.7 
Hz, 1H), 3.58 (s, 3H), 3.47 (s, 3H), 3.39 (s, 3H), 3.38 (d, J = 9.5 Hz, 1H), 3.16 (br s, 1H), 
2.61 (dd, J = 14.2, 7.4 Hz, 1H), 2.14 (dd, J = 14.2, 7.6 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 159.3, 132.6, 129.6, 129.5, 118.8, 113.8, 97.6, 80.1, 79.0, 76.1, 73.3, 69.6, 68.8, 
61.3, 58.8, 55.3, 55.2, 39.9; HRMS (ESI) m/z calcd for C20H30O7Na [M+Na]+, 405.1889; 
found, 405.1888. 
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(70).  [α] 22 D = +67.9 (c 2.20, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.24 – 7.22 
(m, 2H), 6.86 – 6.84 (m, 2H), 6.02 – 5.86 (m, 1H), 5.13 – 5.06 (m, 2H), 4.82 (d, J = 3.7 
Hz, 1H), 4.46 (d, J = 11.2 Hz, 1H), 4.43 (d, J = 11.5 Hz, 1H), 3.91 (dd, J = 7.1, 5.2 Hz, 
1H), 3.78 (s, 3H), 3.72 (dd, J = 9.7, 5.3 Hz, 1H), 3.60 – 3.54 (m, 1H′), 3.58 (s, 3H), 3.47 
(s, 3H), 3.46 (d, J = 10.1 Hz, 1H), 3.42 (s, 3H), 3.25 (dd, J = 10.0, 3.9 Hz, 1H), 2.90 (br s, 
1H), 2.58 (dd, J = 14.4, 6.2 Hz, 1H), 2.31 (dd, J = 14.5, 8.5 Hz, 1H′); 13C NMR (100 MHz, 
CDCl3) δ 159.2, 134.5, 129.8, 129.2, 118.0, 113.7, 97.2, 85.7, 80.0, 74.9, 73.0, 71.8, 68.7, 
61.8, 58.8, 55.2, 55.0, 34.1; HRMS (ESI) m/z calcd for C20H30O7Na [M+Na]+, 405.1889; 
found, 405.1882. 
Methyl 4-C-Allyl-6-O-(p-methoxybenzyl)-2,3,4-tri-O-methyl-α-D-galactopyranoside 
(71).  
To a stirred solution of alcohol 69 (1.5 g, 3.92 mmol) in dry DMF (10 mL) was 
added NaH (60%, 313 mg, 7.84 mmol) followed by MeI (0.49 mL, 7.84 mmol) dropwise 
at 0 °C (ice-water bath). The reaction mixture was stirred at 0 °C for 0.5 h before TLC (60 
% ethyl acetate in hexane) showed completion. The reaction mixture was quenched with 
water, extracted with EtOAc, and washed with brine solution. The combined organic 
extracts were dried over anhydrous Na2SO4 and concentrated under vacuum. Column 
chromatography on silica gel (eluent: 40% ethyl acetate in hexane) afforded 71 (1.3 g, 
84%) as a colorless oil. [α] 22 = +86.9 (c 1.40, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.24 
– 7.22 (m, 2H), 6.86 – 6.84 (m, 2H), 5.80 – 5.67 (m, 1H), 5.14 – 5.04 (m, 2H), 4.89 (d, J 
= 3.6 Hz, 1H), 4.54 (d, J = 11.7 Hz, 1H), 4.40 (d, J = 11.7 Hz, 1H), 3.82 (dd, J = 7.1, 2.8 
Hz, 1H), 3.80 – 3.75 (m, 1H), 3.77 (s, 3H),  3.68 (dd, J = 10.0, 3.7 Hz, 1H), 3.56 (s, 3H), 
3.54 – 3.47 (m, 2H), 3.50 (s, 3H), 3.42 (s, 6H), 2.97 (dd, J = 13.6, 7.8 Hz, 1H), 2.15 (dd, 
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J = 13.6, 7.1 Hz, 1H); 13C NMR (101 MHz, CDCL3) δ 170.5, 159.1, 132.2, 130.3, 129.1, 
119.3, 113.7, 97.4, 80.9, 80.2, 79.3, 73.0, 72.1, 68.5, 61.8, 58.6, 55.2, 52.8, 33.7; HRMS 
(ESI) m/z calcd for C21H32O7Na [M+Na]+, 419.2046; found, 419.2039. 
Methyl 4-C-Allyl-6-O-(p-methoxybenzyl)-2,3,4-tri-O-methyl-α-D-glucopyranoside 
(72).  
NaH (60%, 0.08 g, 1.9 mmol) followed by MeI (0.12 ml, 1.9 mmol) were added to 
a stirred solution of 70 (0.37 g, 1.0 mmol) in anhydrous DMF (3.4 ml) at 0 °C. The reaction 
mixture was stirred at room temperature for 0.5 h. The reaction was quenched with H2O 
after cooling to 0 °C, and extracted with ethyl acetate, and the organic layers were washed 
with brine and dried over anhydrous Na2SO4 before evaporation to dryness. The resultant 
residue was purified by silica gel chromatography, eluting with hexane/ethyl acetate (9:1 
to 7:3) to afford 72 (0.30 g, 80%) as a colorless oil. [α] 22 D = +61.4 (c 1.0, CH2Cl2); 1H 
NMR (400 MHz, CDCl3) δ 7.26 – 7.21 (m, 2H), 6.89 – 6.83 (m, 2H), 5.94 (dddd, J = 17.1, 
10.1, 8.8, 5.2 Hz, 1H), 5.07 (dd, J = 17.2, 1.0 Hz, 1H), 5.02 – 4.95 (m, 1H), 4.83 (d, J = 
4.0 Hz, 1H), 4.53 (d, J = 11.6 Hz, 1H), 4.43 (d, J = 11.6 Hz, 1H), 4.04 (d, J = 8.0 Hz, 1H), 
3.79 (s, J = 3.8 Hz, 3H), 3.76 – 3.65 (m, 2H), 3.63 – 3.56 (m, 4H), 3.51 – 3.48 (m, 3H), 
3.46 (s, 3H), 3.38 – 3.32 (m, 4H 1H), 2.38 (dd, J = 15.2, 8.7 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 159.17, 135.00, 130.68, 129.08, 116.79, 113.82, 96.98, 81.44, 80.89, 78.57, 
73.06, 71.31, 68.93, 60.70, 58.92, 55.38, 55.07, 50.81, 32.86; HRMS (ESI) m/z calcd for 
C21H32O7Na [M+Na]+, 419.2046; found, 419.2045. 
Methyl 4-C-Allyl-2,3,4-tri-O-methyl-α-D-galactopyranoside (73). 
To a stirred solution of 71 (1.2 g, 3.03 mmol) in CH3CN (120 mL) was added a 
solution of CAN (8.3g, 15.13 mmol) in water (35 mL) at 0 oC. The reaction mixture was 
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stirred at room temperature for 15 min, then diluted with CH2Cl2 and washed with water. 
The combined organic phases were dried, concentrated, and purified by silica gel column 
chromatography (eluent: 60% EtOAc in hexane) to give 73 (0.9 g, 80%) as a colorless oil. 
[α] 22 D = +84.0 (c 1.85, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 5.73 (ddt, J = 17.3, 10.1, 
7.4 Hz, 1H, -CH=CH2), 5.18 (dd, J = 17.0, 1.4 Hz, 1H, -CH=CH2), 5.15 (d, J = 102, 1.2 
Hz, 1H, -CH=CH2), 4.91 (d, J = 3.7 Hz, 1H), 3.90 (dd, J = 11.9, 6.3 Hz, 1H), 3.74 – 3.71 
(m, 1H′), 3.69 (dd, J = 10.0, 3.7 Hz, 1H), 3.63 (dd, J = 6.3, 3.0 Hz, 1H), 3.55 (s, 3H), 3.50 
(s, 3H), 3.49 (d, J = 9.8 Hz, 1H), 3.46 (s, 3H), 3.39 (s, 3H), 3.03 (dd, J = 13.9, 7.3 Hz, 1H, 
-CH2-CH=CH2), 2.65 (d, J = 7.3 Hz, 1H), 2.19 (dd, J = 13.9, 7.6 Hz, 1H, -CH2-CH=CH2); 
13C NMR (150 MHz, CDCl3) δ 131.9, 119.6, 97.8, 81.0, 80.2, 80.1, 71.7, 61.9, 61.0, 58.8, 
55.3, 52.8, 33.6; HRMS (ESI) m/z calcd for C13H24O6Na [M+Na]+, 299.1471; found, 
299.1476. 
Methyl 4-C-Allyl-2,3,4-tri-O-methyl-α-D-glucopyranoside (74).  
A solution of CAN (2.05 g, 3.74 mmol) in H2O (8.9 mL) was added to a mixture of 
72 (0.30 g, 0.75 mmol) in CH3CN (31.3 mL) at 0 °C, and the resulting mixture was stirred 
for 15 min at room temperature. The reaction mixture was diluted with CH2Cl2 and washed 
with water, before it was dried over anhydrous Na2SO4 and concentrated to dryness. The 
crude residue was purified by column chromatography over silica gel, eluting with 
hexane/ethyl acetate (1:1 to 1:4), to obtain alcohol 74 (0.16 g, 78%) as a colorless oil. [α] 
22
 D
 = +112.3 (c 0.4, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 5.96 (dddd, J = 17.2, 10.1, 8.5, 
5.3 Hz, 1H), 5.11 (dd, J = 17.2, 1.1 Hz, 1H), 5.03 (dd, J = 10.1, 0.7 Hz, 1H), 4.80 (d, J = 
4.0 Hz, 1H), 3.89 (dd, J = 7.8, 4.1 Hz, 1H), 3.82 – 3.72 (m, 2H), 3.69 (d, J = 9.8 Hz, 1H), 
3.59 (s, 3H), 3.49 (s, 3H), 3.43 (s, 3H), 3.40 (s, 3H), 3.33 (dd, J = 9.7, 4.0 Hz, 1H), 2.73 
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– 2.67 (m, 1H), 2.42 (dd, J = 15.3, 8.5 Hz, 1H), 2.06 (br s, 1H); 13C NMR (150 MHz, CDCl3) 
δ 134.77, 117.04, 97.20, 81.53, 81.45, 78.85, 72.00, 61.52, 60.60, 58.96, 55.26, 51.30, 
32.15; HRMS (ESI) m/z calcd for C13H24O6Na [M+Na]+, 299.1471; found, 299.1475. 
Methyl 4-C-Allyl-7,8-dideoxy-2,3,4-tri-O-methyl-α-D-glycero-D-galacto-7-en-
octopyranoside and Methyl 4-C-Allyl-7,8-dideoxy-2,3,4-tri-O-methyl-β-L-glycero-D-
galacto-7-en-octopyranoside (77 and 78). 
To a stirred solution of alcohol 73 (300 mg, 1.08 mmol) in CH2Cl2 (11.0 mL) was 
added Dess–Martin periodinane (690 mg, 1.63 mmol) at room temperature. After 2 h, the 
excess of oxidant was quenched by addition of saturated aqueous Na2S2O3 (15 mL) and 
saturated aqueous NaHCO3 (15 mL). After 15 min vigorous stirring, the mixture was 
diluted with CH2Cl2, the organic layer was separated, and the aqueous layer was 
extracted with CH2Cl2. The combined extracts were dried over anhydrous Na2SO4, 
filtered, and concentrated. A solution of crude aldehyde (300 mg, 1.09 mmol) in dry THF 
(7 mL) was treated with vinylmagnesium bromide (2.7 mL, 1 M in THF) at −78 oC and 
stirred for 5 h before the temperature was raised to 0 oC and the reaction was quenched 
with saturated aqueous NH4Cl (10 mL). The reaction mixture was extracted with EtOAc, 
and the combined organic layers were dried over anhydrous Na2SO4 and concentrated 
under vacuum. The crude product was purified on silica gel column chromatography 
(eluent: 60% EtOAc in hexane), to give 77 and 78 (265 mg, 81%) as a mixture of 
diastereomers (1.5:1) as a colorless oil. 1H NMR (600 MHz, CDCl3) δ 6.08 – 5.96 (m, 1H, 
minor isomer), 5.81 – 5.71 (m, 2.5H, both isomers), 5.64 – 5.57 (m, 1.5H , major isomer), 
5.20 – 4.99 (m, 10H, both isomers), 4.79 (d, J = 3.6 Hz, 1.5H, major isomer), 4.73 (d, J = 
3.5 Hz, 1H, minor isomer), 4.45 (d, J = 5.3 Hz, 1.5 H, major isomer), 4.29 (br s, 2.5H, both 
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isomers), 3.60 – 3.51 (m, 3.5H, 2H minor isomer, 1H major isomer), 3.44 (s, 4.5H, major 
isomer), 3.43 (s, 3H, minor isomer), 3.41 (s, 4.5H, major isomer), 3.37 – 3.35 (m, 2.5H, 
both isomers), 3.37 (s, 4.5H, major isomer), 3.36 (s, 3H, minor isomer), 3.34 (s, 3H, minor 
isomer), 3.25 (s, 3H, minor isomer), 3.22 (s, 4.5H, major isomer), 3.05 (dd, J = 13.8, 6.9 
Hz, 1.5H, major isomer), 2.89 (dd, J = 13.3, 8.2 Hz, 1H, minor isomer), 2.63 (br s, 1H, 
minor isomer), 2.37 (dd, J = 13.4, 6.2 Hz, 1H, minor isomer), 2.26 (dd, J = 13.8, 7.9 Hz, 
1.5H, major isomer); 13C NMR (150 MHz, CDCl3) δ 138.8, 138.1, 133.0, 131.6, 119.7, 
119.1, 115.3, 114.3, 97.6, 97.5, 81.9, 81.0, 80.7, 80.1, 79.9, 79.8, 73.7, 72.0, 71.4, 71.2, 
61.8, 61.5, 58.6, 58.5, 55.2, 52.6, 52.4, 33.7, 33.3; HRMS (ESI) m/z calcd for C15H26O6Na 
[M+Na]+, 325.1627; found, 325.1635. 
Methyl 2,3,4-Tri-O-methyl-4,6-(prop-2-en-1,3-diyl)-β-L-glycero-α-D-galacto-
nonopyranoside (79) and Methyl 2,3,4-Tri-O-methyl-4,6-(prop-2-en-1,3-diyl)-α-D-
glycero-α-D-galacto-nonopyranoside (80). 
A solution of 77 and 78 (210 mg, 0.69 mmol) in anhydrous CH2Cl2 (42 mL) was 
treated with Grubbs 2nd generation catalyst (11 mg, 5% weight) and heated to reflux for 
1 h.  The reaction mixture was concentrated to give the crude product, which was purified 
by silica gel chromatography (eluent: CH2Cl2/EtOAc, 1:1) to give 79 (113 mg, 60%) and 
80 (70 mg, 37%) as colorless oils. 
(79). [α] 22 D = + 160.9 (c 0.55, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 5.67 – 5.63 
(m, 1H), 5.61 – 5.58 (m, 1H), 4.92 (d, J = 3.6 Hz, 1H), 4.39 (d, J = 6.2 Hz, 1H), 3.69 (dd, 
J = 10.0, 3.6 Hz, 1H), 3.57 (d, J = 8.0 Hz, 1H), 3.51 (s, 3H), 3.48 (d, J = 5.4 Hz, 3H), 3.39 
(s, 3H), 3.37 (s, 3H), 3.34 (d, J = 10.0 Hz, 1H), 2.94 – 2.90 (m, 1H, H-9), 2.31 (d, J = 3.1 
Hz, 1H), 2.01 – 1.96 (m, 1H, H-9′); 13C NMR (150 MHz, CDCl3) δ 129.2, 123.7, 97.9, 85.2, 
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79.7, 77.1, 75.7, 68.6, 62.1, 58.8, 55.2, 53.7, 28.9; HRMS (ESI) m/z calcd for C13H22O6Na 
[M+Na]+, 297.1314; found, 297.1309. 
(80). [α] 22 D = +35.6 (c 1.30, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 5.94 (ddd, J = 
9.7, 4.8, 3.1 Hz, 1H), 5.71 – 5.61 (m, 1H), 5.03 (d, J = 3.5 Hz, 1H), 4.08 – 4.02 (m, 1H), 
3.75 – 3.70 (m, 2H, O-H), 3.59 (d, J = 10.5 Hz, 1H), 3.51 (s, 3H), 3.49 (s, 3H), 3.41 (s, 
3H), 3.39 (s, 3H), 3.36 (d, J = 10.2 Hz, 1H), 3.06 – 3.03 (m, 1H, H-9), 1.93 – 1.89 (m, 1H, 
H-9′); 13C NMR (150 MHz, CDCl3) δ 130.0, 123.2, 98.3, 85.1, 79.3, 78.1, 70.2, 65.6, 62.2, 
58.9, 55.5, 53.3, 29.1; HRMS (ESI) m/z calcd for C13H22O6Na [M+Na]+, 297.1314; found, 
297.1316. 
Methyl 2,3,4-Tri-O-methyl-4,6-(propan-1,3-diyl)-β-L-glycero-D-galacto-
nonopyranoside (81). 
A stirred solution of 79 (30 mg, 0.11 mmol) in CH3OH (2.0 mL) was treated with 
20% Pd(OH)2/C (3.0 mg) at room temperature and stirred under 1 atm of H2 (balloon) for 
0.5 h. The reaction mixture was filtered through Celite and the combined filtrates were 
evaporated under vacuum. The crude product was purified using silica gel column 
chromatography (eluent: 40% EtOAC in hexane) to give 81 (30 mg, quantitative) as a 
colorless oil. [α] 22 D = +120.0 (c 1.50, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 4.94 (d, J = 
3.7 Hz, 1H), 3.87 (td, J = 10.7, 4.9 Hz, 1H), 3.67 (dd, J = 10.0, 3.7 Hz, 1H), 3.50 (s, 6H), 
3.43 (s, 3H), 3.41 (s, 3H), 3.27 (d, J = 10.1 Hz, 1H), 3.25 (d, J = 9.3 Hz, 1H), 2.47 (dd, J 
= 14.6, 1.7 Hz, 1H, H-9), 2.27 (br s, 1H), 2.01 (d, J = 9.5 Hz, 1H), 1.58 (dd, J = 8.9, 4.8 
Hz, 1H), 1.49 – 1.34 (m, 1H′), 1.32 – 1.18 (m, 1H′), 1.08 (td, J = 14.3, 4.1 Hz, 1H, H-9′); 
13C NMR (150 MHz, CDCl3) δ 98.1, 85.5, 79.8, 77.8, 77.5, 68.2, 62.1, 59.0, 55.2, 52.0, 
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31.5, 26.7, 18.6; HRMS (ESI) m/z calcd for C13H24O6Na [M+Na]+, 299.1471; found, 
299.1465. 
Methyl 2,3,4-Tri-O-methyl-4,6-(propan-1,3-diyl)-α-D-glycero-D-galacto-
nonopyranoside (82). 
Compound 82 (25 mg, 81%) was prepared by hydrogenation of 80 (30 mg) 
analogously to 81. [α] 22 = +102.5 (c 0.95, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 4.98 (d, 
J = 3.7 Hz, 1H), 4.40 (d, J = 9.1 Hz, 1H), 3.97 (d, J = 4.9 Hz, 1H), 3.70 (dd, J = 10.2, 3.7 
Hz, 1H), 3.50 (s, 3H), 3.49 (s, 3H), 3.47 (s, 3H), 3.42 (d, J = 3.3 Hz, 1H), 3.41 (s, 3H), 
3.22 (d, J = 10.1 Hz, 1H), 2.57 (dd, J = 14.8, 2.5 Hz, 1H, H-9), 1.97 (d, J = 14.4 Hz, 1H), 
1.70 – 1.58 (m, 1H), 1.48 – 1.42 (m, 2H′, H-8′), 1.08 (td, J = 14.0, 3.3 Hz, 1H, H-9′); 13C 
NMR (150 MHz, CDCl3) δ 98.4, 85.1, 79.9, 79.6, 71.2, 68.9, 62.2, 59.0, 55.4, 52.1, 32.5, 
26.7, 14.4; HRMS (ESI) m/z calcd for C13H24O6Na [M+Na]+, 299.1471; found, 299.1472. 
Methyl 2,3,4,6-Tetra-O-methyl-4,6-(propan-1,3-diyl)-β-L-glycero-D-galacto-
nonopyranoside (49). 
To a stirred solution of alcohol 42 (30 mg, 0.11 mmol) in dry DMF (1.0 mL) was 
added NaH (60%, 9 mg, 0.22 mmol) followed by MeI (14 μL, 0.22 mmol) at 0 °C. The 
reaction mixture was stirred at 0 °C for 0.5 h before TLC (40 % ethyl acetate in hexane) 
showed completion. The reaction mixture was quenched with water, extracted with 
EtOAc, and washed with brine. The combined extracts were dried over Na2SO4 and 
concentrated under vacuum. Column chromatography on silica gel (eluent: 30% ethyl 
acetate in hexane) afforded 49 (28 mg, 90%) as a colorless oil. [α] 22 D = +111.2 (c 1.20, 
CH2Cl2); In CHCl3: 1H NMR (600 MHz, CDCl3) δ 4.95 (d, J = 3.8 Hz, 1H), 3.68 (dd, J = 
10.0, 3.8 Hz, 1H), 3.50 (s, 3H), 3.49  (s, 3H), 3.46 (s, 3H), 3.42 (s, 6H), 3.40 (ddd, J = 
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10.8, 9.2, 4.9 Hz, 1H), 3.36 (d, J = 9.2 Hz, 1H), 3.25 (d, J = 10.0 Hz, 1H), 2.46 (dddd, J = 
14.6, 3.3, 2.6, 1.9 Hz, 1H, H-9eq), 2.07 (ddddd, J = 12.9, 4.9, 3.6, 2.9, 1.9 Hz, 1H), 1.55 
(ddddd, J = 13.7, 4.4, 4.0, 2.9, 2.6 Hz, 1H), 1.38 ((tddd, J = 13.7, 13.6, 3.6, 3.3 Hz, 1H), 
1.15 (dddd, J = 13.6, 12.9, 10.8, 4.4 Hz, 1H), 1.02 (ddd, J = 14.6, 13.7, 4.0 Hz, 1H, H-
9ax); 13C NMR (150 MHz, CDCl3) δ 97.7, 85.6, 79.8, 78.4, 77.5, 77.2, 62.1, 58.9, 58.7, 
54.9, 51.8, 30.6, 26.5, 18.5; HRMS (ESI) m/z calcd for C14H26O6Na [M+Na]+, 313.1627; 
found, 313.1614. 
In C6D6: 1H NMR (600 MHz, C6D6) δ 4.87 (d, J = 3.7 Hz, 1H), 3.78 (dd, J = 10.0, 
3.7 Hz, 1H), 3.60 (ddd, J = 10.9, 9.2, 4.8 Hz, 1H), 3.44 (d, J = 9.2 Hz, 1H), 3.43 (s, 3H), 
3.38 (s, 3H), 3.36 (s, 3H), 3.32 (d, J = 10.0 Hz, 1H), 3.31 (s, 3H), 3.18 (s, 3H), 2.19 (dddd, 
J = 14.6, 3.3, 2.6, 2.1, 1H), 1.95 (ddddd, J = 12.6, 4.8, 3.7, 2.9, 2.1 Hz, 1H), 1.23 (qdd, J 
= 13.5, 3.7, 3.4 Hz, 1H), 1.20 (ddddd, J = 13.5, 4.5, 4.4, 2.9, 2.8 Hz, 1H), 1.12 (dddd, J = 
13.5, 12.6, 10.9, 4.5 Hz, 1H), 0.55 (ddd, J = 14.6, 13.5, 4.4 Hz, 1H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 4.89 (d, J = 3.8 Hz, 1H), 3.58 (dd, J = 
10.1, 3.8 Hz, 1H), 3.48 (s, 6H), 3.41 (s, 3H), 3.40 (s, 3H), 3.39 (ddd, J = 10.8, 9.2, 4.8 Hz, 
1H), 3.38 (s, 3H), 3.35 (d, J = 9.2 Hz, 1H), 3.24 (d, J = 10.1 Hz, 1H), 2.46 (dddd, J = 14.7, 
3.3, 2.6, 2.1 Hz, 1H), 2.07 (ddddd, J = 12.8, 4.8, 3.8, 2.9, 2.1 Hz, 1H), 1.57 (ddddd, J = 
13.7, 4.4, 4.1, 2.9, 2.6 Hz, 1H), 1.38 (qdd, J = 13.7, 3.8, 3.3 Hz, 1H), 1.15 (dddd, J = 13.7, 
12.8, 10.8, 4.4 Hz, 1H), 1.11 (ddd, J = 14.7, 13.7, 4.1 Hz, 1H). 
Methyl 2,3,4,6-Tetra-O-methyl-4,6-(propan-1,3-diyl)-α-D-glycero-D-galacto-
nonopyranoside (46). 
Compound 9 (14 mg, 70%) was synthesized from 82 (20 mg) analogously to 49. 
[α] 22 = +10.4 (c 0.30, CH2Cl2); In CHCl3: 1H NMR (600 MHz, CDCl3) δ 4.95 (d, J = 3.8 
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Hz, 1H), 3.85 (dd, J = 10.0, 3.8 Hz, 1H), 3.51 (td, J = 3.1, 3.0, 1H), 3.50 (s, 3H), 3.48 (s, 
3H), 3.44 (s, 3H), 3.41 (s, 3H), 3.40 (d, J= 3.1 Hz, 1H),  3.33 (s, 3H), 3.19 (d, J = 10.0 Hz, 
1H), 2.57 (ddd, J = 14.7, 3.4, 3.3 Hz, 1H, H-9eq), 2.09 (ddt, J = 14.3, 3.1, 2.8 Hz, 1H), 
1.64 (ddddd, J = 14.1, 13.7, 13.5, 3.4, 2.8 Hz, 1H), 1.35 (dqd, J = 13.5, 3.3, 2.8 Hz, 1H), 
1.26 (dddd, J = 14.3, 14.1, 3.3, 3.1 Hz, 1H-7ax), 1.02 (ddd, J = 14.7, 13.7, 3.3 Hz, 1H, H-
9ax); 13C NMR (150 MHz, CDCl3) δ 98.5, 86.7, 79.7, 77.3, 72.5, 62.0, 58.9, 57.9, 55.4, 
51.8, 27.6, 27.3, 15.1; HRMS (ESI) m/z calcd for C14H26O6Na [M+Na]+, 313.1627; found, 
313.1617. 
In C6D6: 1H NMR (600 MHz, C6D6) δ 4.85 (d, J = 3.7 Hz, 1H), 3.88 (dd, J = 10.0, 
3.7 Hz, 1H), 3.53 (s, 3H), 3.49 (s, 3H), 3.48 (dt, J = 3.2, 3.1, 1H), 3.39 (s, 3H), 3.35 (d, J 
= 3.2 Hz, 1H), 3.25 (d, J = 10.0 Hz, 1H), 3.19 (s, 3H), 3.16 (s, 3H), 2.41 (ddd, J = 14.6, 
3.4, 3.2 Hz, 1H, H-9), 1.89 (ddt, J = 14.3, 3.1, 2.9 Hz, 1H), 1.85 (dddt, J = 13.5, 13.4, 3.4, 
2.9 Hz, 1H), 1.10 (dqd, J = 13.4, 3.2, 2.9 Hz, 1H), 1.03 (dddd, J = 14.3, 13.5, 3.2, 3.1 Hz, 
1H), 0.63 (ddd, J = 14.6, 13.5, 3.2 Hz, 1H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 4.91 (d, J = 3.8 Hz, 1H), 3.64 (dd, J = 
10.1, 3.8 Hz, 1H. H-2), 3.51 (dt, J = 3.3, 3.2 Hz, 1H), 3.48 (d, J = 3.2 Hz, 1H), 3.48 (s, 
3H), 3.47 (s, 3H), 3.40 (s, 3H), 3.37 (s, 3H), 3.30 (s, 3H), 3.20 (d, J = 10.1 Hz, 1H), 2.55 
(ddd, J = 14.7, 3.1, 2.8 Hz, 1H), 2.06 (dq, J = 14.4, 3.3 Hz, 1H), 1.58 (dtdd, J = 14.0, 13.3, 
3.3, 3.1 Hz, 1H), 1.35 (dddt, J = 13.3, 3.3, 3.0, 2.8 Hz, 1H), 1.36 (dddd, J = 14.4, 14.0, 
3.3, 3.0 Hz, 1H), 1.13 (ddd, 14.7, 13.3, 2.8 Hz, 1H). 
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Methyl 4-C-Allyl-7,8-dideoxy-2,3,4-tri-O-methyl-α-D-glycero-D-gluco-7-en-
octopyranoside (83) and Methyl 4-C-Allyl-7,8-dideoxy-2,3,4-tri-O-methyl-β-L-
glycero-D-gluco-7-en-octopyranoside (84). 
A mixture of alcohol 74 (0.15 g, 0.56 mmol) and Dess-Martin Periodinane (0.36 g, 
0.84 mmol) in anhydrous CH2Cl2 (5.7 mL) was stirred for 2.5 h before addition of CH2Cl2 
(5.0 mL) and a mixture of saturated aqueous NaHCO3, saturated aqueous Na2S2O3, and 
H2O (1:1:1, 7.5 mL). The reaction mixture was stirred for another 0.5 h before the organic 
layer was separated. The aqueous layer was extracted with CH2Cl2, and the combined 
organic layers were washed with brine before it was dried over anhydrous Na2SO4 and 
concentrated to dryness. The residue was dissolved in anhydrous THF (3.9 mL), cooled 
to 0 °C, and treated with vinyl magnesium bromide in THF (1 M, 1.4 mL, 1.4 mmol). The 
reaction mixture was stirred for 25 min before it was quenched with saturated aqueous 
NH4Cl and extracted with ethyl acetate. The combined organic layers were dried over 
anhydrous Na2SO4 and concentrated to dryness. The crude residue (83:84 = 0.4:1.0) was 
then purified by column chromatography over silica gel, eluting with hexane/ethyl acetate 
(7:3 to 1:1), to give 83 (0.02 g, 12%) and 84 (0.08 g, 48%) as colorless oils.    
(83). [α] 22 D = +103.6 (c 0.4, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 6.16 – 6.08 (m, 
1H), 5.98 – 5.90 (m, 1H), 5.39 (d, J = 17.2 Hz, 1H), 5.26 – 5.17 (m, 2H), 5.12 (d, J = 10.2 
Hz, 1H), 4.74 (d, J = 4.0 Hz, 1H), 4.43 (dd, J = 9.3, 5.6 Hz, 1H), 3.63 (d, J = 9.8 Hz, 1H), 
3.59 (s, 3H), 3.51 – 3.44 (m, 7H), 3.37 (s, 3H), 3.31 (dd, J = 9.8, 4.0 Hz, 1H), 2.87 (dd, J 
= 15.3, 5.9 Hz, 1H), 2.64 (dd, J = 15.3, 8.1 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ 138.47, 
133.91, 118.07, 116.04, 97.01, 82.84, 81.45, 81.02, 71.55, 71.47, 60.51, 58.81, 55.53, 
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52.42, 31.59; HRMS (ESI) m/z calcd for C15H26O6Na [M+Na]+, 325.1627; found, 
325.1630. 
(84). [α] 22 D = +80.5 (c 0.6, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 6.20 – 6.10 (m, 
1H), 5.99 (ddd, J = 17.1, 10.5, 5.3 Hz, 1H), 5.36 (dt, J = 17.2, 1.5 Hz, 1H), 5.20 – 5.13 
(m, 2H), 5.06 (dd, J = 10.2, 0.9 Hz, 1H), 4.83 (d, J = 4.0 Hz, 1H), 4.52 – 4.46 (m, 1H), 
3.66 (d, J = 9.9 Hz, 1H), 3.61 (d, J = 3.4 Hz, 1H), 3.59 (s, 3H), 3.48 (s, J = 10.7 Hz, 3H), 
3.40 (s, J = 4.7 Hz, 3H), 3.38 (dd, J = 9.9, 4.0 Hz, 1H), 3.35 (s, 3H), 2.79 – 2.72 (m, 1H), 
2.59 (dd, J = 15.2, 8.1 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ 134.77, 117.04, 97.20, 
81.53, 81.45, 78.85, 72.00, 61.52, 60.60, 58.96, 55.26, 51.30, 32.15; HRMS (ESI) m/z 
calcd for C15H26O6Na [M+Na]+, 325.1627; found, 325.1630. 
Methyl 2,3,4-Tri-O-methyl-4,6-(prop-2-en-1,3-diyl)-α-D-glycero-α-D-gluco-
nonopyranoside (85).  
A mixture of 83 (9 mg, 0.03 mmol) and Grubbs 2nd generation catalyst (1 mg, 10% 
weight) in anhydrous CH2Cl2 (1.2 mL) was heated to reflux for 1 h before concentration. 
The crude residue was purified by silica gel chromatography, eluting with hexane/ethyl 
acetate (7:3 to 1:1), to give 85 (0.006 g, 76%) as a colorless oil. [α] 22 D = +80.0 (c 0.4, 
CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 5.73 – 5.64 (m, 2H), 4.86 (d, J = 4.1 Hz, 1H), 4.41 
– 4.35 (m, 1H), 4.00 (d, J = 4.7 Hz, 1H), 3.70 (d, J = 9.1 Hz, 1H), 3.60 (s, 3H), 3.50 (s, 
3H), 3.44 (s, 3H), 3.37 (s, 3H), 3.36 (dd, J = 9.2, 4.2 Hz, 1H), 2.35 – 2.25 (m, 2H), 2.20 – 
2.14 (m, 1H); 13C NMR (150 MHz, CDCl3) δ 128.28, 125.09, 97.39, 82.31, 77.45, 66.12, 
65.05, 60.83, 58.98, 55.33, 51.08, 26.12; HRMS (ESI) m/z calcd for C13H22O6Na [M+Na]+, 
297.1314; found, 297.1318. 
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 Methyl 2,3,4-Tri-O-methyl-4,6-(prop-2-en-1,3-diyl)-β-L-glycero-α-D-gluco-
nonopyranoside (86). 
Compound 86 was synthesized, by the same procedure as described for the 
compound 85 from diene 84 (9 mg, 0.03 mmol) and Grubbs 2nd generation catalyst (1 
mg, 10% weight) in anhydrous CH2Cl2 (1.2 mL). After purification by silica gel column 
chromatography, eluting with hexane/ethyl acetate (1:1 to 2:8), 86 (0.006 g, 75%) was 
obtained as a colorless oil. [α] 22 D = +213.3 (c 0.4, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 
5.93 – 5.88 (m, 1H), 5.80 – 5.75 (m, 1H), 4.79 (d, J = 4.1 Hz, 1H), 3.91 – 3.84 (m, 2H), 
3.64 (d, J = 9.3 Hz, 1H), 3.59 (s, 3H), 3.48 (s, 3H), 3.45 (s, 3H), 3.39 (s, 3H), 3.27 (dd, J 
= 9.3, 4.1 Hz, 1H), 2.68 (d, J = 11.3 Hz, 1H), 2.58 (dd, J = 19.2, 5.5 Hz, 1H), 2.15 – 2.08 
(m, 1H); 13C NMR (150 MHz, CDCl3) δ 127.28, 124.49, 97.21, 84.85, 82.50, 76.00, 68.84, 
67.08, 60.70, 58.72, 55.44, 52.12, 23.31. HRMS (ESI) m/z calcd for C13H22O6Na [M+Na]+, 
297.1314; found, 297.1321. 
Methyl 2,3,4,6-Tetra-O-methyl-4,6-(propan-1,3-diyl)-α-D-glycero-D-gluco-
nonopyranoside (54).  
A mixture of 85 (6 mg, 0.02 mmol) and 20% Pd(OH)2 (3 mg) in CH3OH (0.4 mL) 
was stirred under H2 atmosphere (1 atm) over night at room temperature, then filtered 
through Celite before concentration to dryness. The resultant crude compound 87 was 
dissolved in anhydrous DMF (0.2 mL) and cooled to 0 °C before addition of 60% NaH 
(0.002 g, 0.04 mmol) followed by MeI (2.6 µL, 0.04 mmol). The reaction mixture was 
stirred under an argon atmosphere for 2 h and cooled to 0 °C before quenching with H2O. 
The reaction mixture was partitioned between ethyl acetate and H2O, the organic layer 
was separated, and the aqueous layer was extracted with ethyl acetate. The combined 
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organic layers were dried over anhydrous Na2SO4 before concentration to dryness. The 
residue was purified by column chromatography over silica gel, eluting with hexane/ethyl 
acetate (7:3 to 1:1), to afford 54 (4.7 mg, 76%) as a colorless oil. [α] 22 D = +150.0 (c 0.3, 
CH2Cl2); In CHCl3: 1H NMR (600 MHz, CDCl3) δ 4.87 (d, J = 3.9 Hz, 1H), 3.96 (d, J = 3.1 
Hz, 1H. H-5), 3.63 (d, J = 9.5 Hz, 1H), 3.58 (s, 3H), 3.49 (s, 3H), 3.46 (ddd, J = 11.7, 4.4, 
3.1 Hz, 1H), 3.46(s, 3H), 3.39 (s, 3H), 3.38 (s, 3H), 3.30 (dd, J = 9.5, 3.9 Hz, 1H), 1.94 
(ddd, J = 13.7, 3.4, 3.4 Hz, 1H, H-9eq), 1.82 (dddd, J = 11.9, 4.4, 3.4, 3.0, 1H), 1.62 (dddt, 
J = 12.3, 3.9, 3.6, 3.4, 1H), 1.52 (dddd, J = 12.8, 11.9, 11.7, 3.6 Hz, 1H), 1.46 (ddddd, J 
= 13.1, 12.8, 12.3, 3.3, 3.0 Hz, 1H), 1.39 (dddd, J = 13.7, 13.1, 3.9 Hz, 1H, H-9ax); 13C 
NMR (150 MHz, CDCl3) δ 97.48, 82.48, 82.05, 78.31, 76.60, 66.11, 60.72, 58.86, 56.63, 
55.23, 50.46, 25.08, 23.23, 19.01; HRMS (ESI) m/z calcd for C14H26O6Na [M+Na]+, 
313.1627; found, 313.1630. 
In C6D6: 1H NMR (600 MHz, C6D6) δ 4.72 (d, J = 4.0 Hz, 1H), 4.17 (d, J = 3.0 Hz, 
1H), 3.81 (d, J = 9.4 Hz, 1H), 3.59 (ddd, J = 11.0, 5.0, 3.0, 1H), 3.50 (s, 3H), 3.30 (s, 3H), 
3.26 (dd, J = 9.4, 4.0 Hz, 1H), 3.23 (s, 6H), 3.17 (s, 3H), 2.20 – 2.14 (m, 1H), 1.88 – 1.80 
(m, 2H), 1.54 – 1.44 (m, 3H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 4.86 (d, J = 4.0 Hz, 1H), 3.94 (d, J = 3.1 
Hz, 1H), 3.54 (d, J = 9.5 Hz, 1H), 3.53 (s, 3H), 3.48 (ddd, J = 11.6, 4.5, 3.1 Hz, 1H), 3.44 
(s, 3H), 3.41 (s, 3H), 3.374 (s, 3H), 3.369 (s, 3H), 3.33 (dd, J = 9.5, 4.0 Hz, 1H), 1.93 (br 
d, J = 14.1 Hz, 1H), 1.76 (br d, J = 11.9 Hz, 1H), 1.60 (br d, J = 12.3 Hz, 1H), 1.52 (dddd, 
J = 12.7, 11.9, 4.5, 3.4 Hz, 1H), 1.46 (dddt, J = 12.7, 12.6, 12.3, 3.1 Hz, 1H), 1.39 (ddd, 
J = 14.1, 12.6, 3.4 Hz, 1H). 
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 Methyl 2,3,4,6-Tetra-O-methyl-4,6-(propan-1,3-diyl)-β-L-glycero-D-gluco-
nonopyranoside (56). 
A solution of 86 (0.006 g, 0.02 mmol) and 20% Pd(OH)2 (0.003 g) in CH3OH (0.4 
mL) was stirred under H2 atmosphere (1 atm) overnight followed by filtration through 
Celite and concentration to dryness. The resultant crude alcohol 88 was dissolved in 
anhydrous DMF (0.2 mL) and cooled to 0 °C before addition of 60% NaH (0.002 g, 0.04 
mmol) followed by MeI (2.6 µL, 0.04 mmol). The reaction mixture was then stirred under 
an argon atmosphere for 3 h and cooled to 0 °C before quenching with H2O. The crude 
compound 56 was obtained by following the same workup as described for compound 
54. The residue was purified by column chromatography over silica gel, eluting with 
hexane/ethyl acetate (7:3 to 1:1), to afford 56 (5.2 mg, 78 %) as a colorless oil. [α] 22 D = 
+99.4 (c 0.3, CH2Cl2); In CHCl3: 1H NMR (600 MHz, CDCl3) δ 4.75 (d, J = 3.8 Hz, 1H), 
3.87 (br s, 1H. H-5), 3.71 (d, J = 9.6 Hz, 1H), 3.58 (s, 3H), 3.49 (s,3H), 3.41 (s, 3H), 3.39 
– 3.33 (m, 6H), 3.35 (q, J = 2.8 Hz, 1H,  H-6eq), 3.25 (dd, J = 9.6, 3.8 Hz, 1H), 1.95 (br d, 
J = 14.1 Hz, 1H), 1.82 (dtd, J = 14.0, 3.3, 2.8 Hz, 1H), 1.76 (dddt, J = 13.5, 13.3, 13.0, 
3.3 Hz, 1H), 1.50 (dddd, J = 14.0, 13.5, 3.6, 2.8 Hz, 1H), 1.39 (ddd, J = 14.1, 13.3, 3.7 
Hz, 1H, H-9ax), 1.33 (ddddd, J = 13.0, 3.7, 3.6, 3.3, 3.2 Hz, 1H); 13C NMR (150 MHz, 
CDCl3) δ 97.38, 81.45, 80.89, 78.79, 76.43, 64.65, 60.89, 58.96, 57.42, 55.33, 50.58, 
25.13, 24.96, 15.37; HRMS (ESI) m/z calcd for C14H26O6Na [M+Na]+, 313.1627; found, 
313.1635. 
In C6D6: 1H NMR (600 MHz, C6D6) δ 4.63 (d, J = 3.8 Hz, 1H), 4.15 (br s, 1H), 3.99 
(d, J = 9.6 Hz, 1H), 3.58 (s, 3H), 3.48 (q, J = 2.8 Hz, 1H), 3.39 (s, 3H), 3.27 (s, 3H), 3.26 
(dd, J = 9.6, 2.8 Hz, 1H), 3.20 (s, 3H), 3.17 (s, 3H), 2.33 (ddd, J = 14.1, 3.4, 3.3 Hz, 1H), 
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2.24 (ddddd, J = 13.9, 13.3, 13.2, 3.3, 3.1 Hz, 1H), 1.89 (dddd, J = 13.9, 3.2, 3.1, 2.8 Hz, 
1H), 1.70 (tdd, J = 13.9, 3.7, 2.8 Hz, H-7ax), 1.58 (ddd, J = 14.1, 13.3, 3.6 Hz, 1H), 1.38 
(ddddd, J = 13.2, 3.7, 3.6, 3.4, 3.2 Hz, 1H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 4.80 (d, J = 3.8 Hz, 1H), 3.86 (br s, 1H), 
3.64 (d, J = 9.6 Hz, 1H), 3.53 (s, 3H), 3.45 (s, 3H), 3.39 (s, 3H), 3.36 (q, J = 2.7 Hz, 1H), 
3.34 (s, 3H), 3.34 (s, 3H) 3.27 (dd, J = 9.6, 3.8 Hz, 1H. H-2), 1.90 (dt, J = 14.1, 3.3 Hz, 
1H), 1.78 (dtd, J = 14.0, 3.0, 2.7 Hz, 1H), 1.74 (ddddd, J = 13.6, 13.3, 13.1, 3.3, 3.0 Hz, 
1H), 1.55 (dddd, J = 14.0, 13.6, 3.8, 2.7 Hz, 1H), 1.44 (ddd, J = 14.1, 13.1, 3.8 Hz, 1H), 
1.31 (dtdd, J = 13.3, 3.8, 3.3, 3.0 Hz, 1H). 
Methyl 4-C-Allyl-6-O-benzyl-2,3-di-O-methyl-α-D-galactopyranoside (91) and 
Methyl 4-C-Allyl-6-O-benzyl-2,3-di-O-methyl-α-D-glucopyranoside (92). 
A mixture of alcohol 89165, 385 (0.53 g, 1.70 mmol) and Dess-Martin Periodinane 
(0.94 g, 2.21 mmol) in anhydrous CH2Cl2 (23.0 mL) was stirred overnight under an argon 
atmosphere before dilution with CH2Cl2 and addition of a mixture of saturated aqueous 
NaHCO3, saturated aqueous Na2S2O3, and H2O (1:1:1, 60 mL). The reaction mixture was 
then stirred for another 0.5 h before the organic layer was separated. The organic layer 
was dried over anhydrous Na2SO4 and concentrated to dryness. The resultant crude 
ketone 90 was dissolved in anhydrous THF (8.0 mL) and cooled to 0 °C before a freshly 
prepared solution of allyl magnesium chloride in THF (1 M, 12.0 mL, 12.00 mmol) was 
added. The reaction mixture was stirred for 15 min at 0 °C before it was quenched with 
saturated aqueous NH4Cl and extracted with ethyl acetate. The combined organic layers 
were washed with brine, and the organic layer was dried over anhydrous Na2SO4 before 
concentration. The residue (91:92 = 2.8:1) was purified by column chromatography over 
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silica gel, eluting with hexane/ethyl acetate (7:3 to 1:1), to obtain 91 (0.36 g, 60 %) and 
92 (0.13 g, 22 %) as colorless oils. 
(91)  [α] 22 D = +101.3 (c 1.30, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 7.35 – 7.24 
(m, 5H), 5.72 (ddt, J = 17.5, 10.1, 7.5 Hz, 1H), 5.05 (dd, J = 10.1, 1.1 Hz, 1H, H-9), 5.00 
(dd, J = 17.0, 1.3 Hz, 1H, H-9′), 4.89 (d, J = 3.7 Hz, 1H), 4.59 (d, J = 12.0 Hz, 1H), 4.54 
(d, J = 12.0 Hz, 1H), 3.81 (dd, J = 10.6, 2.6 Hz, 1H), 3.77 (dd, J = 10.6, 4.9 Hz, 1H′), 3.76 
– 3.73 (m, 1H), 3.66 (dd, J = 9.5, 3.7 Hz, 1H), 3.59 (s, 3H), 3.49 (s, 3H), 3.41 (s, 3H), 3.40 
(d, J = 9.2 Hz, 1H), 3.09 (s, 1H), 2.62 (dd, J = 14.3, 7.4 Hz, 1H), 2.17 (dd, J = 14.3, 7.6 
Hz, 1H′); 13C NMR (150 MHz, CDCl3) δ 137.6, 132.5, 128.4, 127.8, 118.8, 97.6, 80.1, 
78.9, 76.0, 73.7, 69.7, 69.1, 61.3, 58.7, 55.3, 39.9; HRMS (ESI) m/z calcd for C19H28O6Na 
[M+Na]+, 375.1784; found, 375.1786. 
(92). [α] 22 D = +85.1 (c 0.85, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.26 (m, 
5H), 6.01 – 5.90 (m, 1H), 5.16 – 5.06 (m, 2H), 4.84 (d, J = 3.9 Hz, 1H), 4.53 (br m, 2H), 
3.99 – 3.92 (m, 1H), 3.77 (dd, J = 9.9, 4.8 Hz, 1H), 3.62 (dd, J = 9.9, 2.5 Hz, 1H), 3.60 (s, 
3H), 3.49 (s, 3H), 3.48 – 3.47 (m, 1H), 3.44 (s, 3H), 3.27 (dd, J = 10.1, 3.9 Hz, 1H), 2.84 
(br s, 1H), 2.60 (dd, J = 14.4, 6.2 Hz, 1H), 2.33 (dd, J = 14.5, 8.5 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 137.8, 134.4, 128.7, 128.4, 128.0, 127.7, 127.5, 118.2, 97.2, 85.7, 80.1, 
74.8, 73.3, 71.9, 69.1, 61.9, 58.8, 55.0, 34.1; HRMS (ESI) m/z calcd for C19H28O6Na 
[M+Na]+, 375.1784; found, 375.1777. 
Methyl 4-C-Allyl-6-O-benzyl-2,3,4-tri-O-methyl-α-D-galactopyranoside (93). 
To a stirred solution of alcohol 91 (0.2 g, 0.56 mmol) in dry DMF (5 mL) was added 
NaH (60%, 0.045 g, 1.13 mmol) followed by MeI (0.24 mL, 3.84 mmol) dropwise at 0 °C 
(ice-water bath). The reaction mixture was stirred at 0 °C for 0.5 h before it was quenched 
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with water (5 mL), extracted with EtOAc, and washed with brine. The combined extracts 
were dried over anhydrous Na2SO4 and concentrated under vacuum. Column 
chromatography on silica gel (eluent: 20% ethyl acetate in hexane) afforded 93 (0.19 g, 
93%) as a colorless oil. [α] 22 D = +84.4 (c 2.50, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 
7.34 – 7.23 (m, 5H), 5.76 (ddt, J = 17.4, 10.2, 7.5 Hz, 1H), 5.15 – 5.05 (m, 2H), 4.90 (d, 
J = 3.7 Hz, 1H), 4.63 (d, J = 12.1 Hz, 1H), 4.48 (d, J = 12.1 Hz, 1H), 3.86 – 3.81 (m, 1H), 
3.81 (dd, J = 10.6, 2.9 Hz, 1H), 3.69 (dd, J = 10.0, 3.7 Hz, 1H), 3.58 – 3.56 (m, 1H), 3.57 
(s, 3H), 3.53 (d, J = 10.1 Hz, 1H), 3.51 (s, 3H), 3.44 (s, 3H), 3.43 (s, 3H), 2.98 (dd, J = 
13.7, 7.8 Hz, 1H), 2.16 (dd, J = 13.6, 7.1 Hz, 1H);  13C NMR (100 MHz, CDCl3) δ 138.4, 
132.3, 128.3, 127.5, 119.3, 97.4, 80.9, 80.2, 79.3, 73.4, 72.2, 68.8, 61.8, 58.7, 55.2, 52.8, 
33.7;  HRMS (ESI) m/z calcd for C20H30O6Na [M+Na]+, 389.1940; found, 389.1933. 
Methyl 4-C-Allyl-6-O-benzyl-2,3,4-tri-O-methyl-α-D-glucopyranoside (94). 
A solution of alcohol 92 (0.076 g, 0.22 mmol) in anhydrous DMF (0.8 mL) was 
cooled to 0 °C before addition of 60% NaH (0.017 g, 0.43 mmol) followed by MeI (27.0 
µL, 0.43 mmol). The reaction mixture was stirred under an argon atmosphere for 0.5 h at 
room temperature. The reaction mixture was cooled to 0 °C before it was quenched with 
H2O and extracted with ethyl acetate. The organic layer was washed with brine, dried 
over anhydrous Na2SO4, and concentrated to dryness. The crude residue was purified by 
column chromatography over silica gel (eluting with hexane/ethyl acetate 9:1 to 1:1) to 
obtain 94 (0.068 g, 86 %) as a sticky gum. [α] 22 D = +71.9 (c 1.1, CH2Cl2); 1H NMR (400 
MHz, CDCl3) δ 7.35 – 7.24 (m, 5H), 5.94 (dddd, J = 17.2, 10.1, 8.8, 5.2 Hz, 1H), 5.07 (d, 
J = 17.2 Hz, 1H), 4.99 (d, J = 10.1 Hz, 1H), 4.84 (d, J = 4.0 Hz, 1H), 4.61 (d, J = 12.1 Hz, 
1H), 4.51 (d, J = 12.1 Hz, 1H), 4.07 (d, J = 7.9 Hz, 1H), 3.75 – 3.69 (m, 2H), 3.67 – 3.61 
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(m, 1H), 3.60 (s, 3H), 3.50 (s, 3H), 3.47 (s, 3H), 3.38 – 3.33 (m, 4H), 2.70 – 2.60 (m, 1H), 
2.39 (dd, J = 15.2, 8.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 138.61, 134.97, 128.43, 
127.57, 127.43, 116.83, 97.00, 81.47, 80.95, 78.56, 73.37, 71.35, 69.24, 60.70, 58.93, 
55.07, 50.84, 32.83; HRMS (ESI) m/z calcd for C20H30O6Na [M+Na]+, 389.1940; found, 
389.1935. 
Methyl 6-O-Benzyl-4-C-(2-hydroxyethyl)-2,3,4-tri-O-methyl-α-D-galactopyranoside 
(95). 
Ozone was bubbled through a solution of olefin 93 (0.18 g, 0.49 mmol) in 
CH2Cl2/MeOH (30 mL/20 mL) at -78 oC until the solution turned to a persistent blue color. 
Ar gas was bubbled through the solution for 5 min to remove excess ozone before NaBH4 
(0.18 g, 4.90 mmol) was added at −78 oC. The reaction mixture was slowly brought to 
room temperature, stirred for 10 h, and concentrated under reduced pressure. The crude 
reaction mixture was dissolved in ethyl acetate and washed with aqueous hydrochloric 
acid (1 M), brine, dried over Na2SO4, and concentrated to dryness. Silica gel column 
chromatography (eluent: hexane/ethyl acetate = 3:2) afforded 95 (129 mg, 71%) as a 
colorless oil. [α] 22 D = +55.8 (c 2.75, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.25 
(m, 5H), 4.88 (d, J = 3.7 Hz, 1H), 4.59 (d, J = 11.9 Hz, 1H), 4.50 (d, J = 11.9 Hz, 1H), 3.93 
(t, J = 5.0 Hz, 1H), 3.85 (dd, J = 10.2, 4.7 Hz, 1H), 3.76 – 3.66 (m, 3H), 3.57 (d, J = 10.6 
Hz, 1H), 3.55 (s, 3H), 3.54 – 3.51 (m, 1H), 3.50 (s, 3H), 3.43 (s, 6H), 2.47 (dt, J = 13.8, 
6.1 Hz, 1H), 2.17 (br s, 1H), 1.71 (dt, J = 14.3, 7.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) 
δ 137.8, 128.42 127.75 127.7, 97.5, 81.4, 80.0, 78.7, 73.5, 72.1, 69.3, 61.9, 58.7, 58.4, 
55.3, 52.8, 31.4; HRMS (ESI) m/z calcd for C19H30O7Na [M+Na]+, 393.1889; found, 
393.1888. 
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Methyl 6-O-benzyl-4-C-(2-hydroxyethyl)-2,3,4-tri-O-methyl-α-D-glucopyranoside 
(96).  
A solution of alkene 94 (0.051 g, 0.14 mmol) in a 2:1 mixture of CH2Cl2/CH3OH 
(14.2 mL) was cooled to -78 °C before being sparged with ozone until a persistent blue 
was color observed. The solution was then purged with argon and treated with NaBH4 
(0.053 g, 1.39 mmol) at -78 °C. The reaction mixture was then stirred at room temperature 
for 4 h before concentration. The crude residue was dissolved in ethyl acetate and 
washed with 1 N HCl. The organic layer was dried over anhydrous Na2SO4 and 
concentrated. The crude was purified using silica gel column chromatography, eluting 
with hexane/ethyl acetate (1:1 to 1:4), to afford 96 (0.043g, 85 %) as a colorless oil; [α]22 
D
 = +86.2 (c 1.2, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.27 (m, 5H), 4.83 (d, J = 
3.9 Hz, 1H), 4.63 (d, J = 12.2 Hz, 1H), 4.50 (d, J = 12.1 Hz, 1H), 4.13 (dd, J = 8.1, 1.1 Hz, 
1H), 3.89 (d, J = 9.8 Hz, 1H), 3.84 – 3.76 (m, 1H), 3.73 (dd, J = 10.6, 1.4 Hz, 1H), 3.67 – 
3.59 (m, 4H), 3.53 – 3.46 (m, 8H), 3.31 (s, 3H), 2.09 – 1.99 (m, 1H), 1.62 – 1.53 (m, 1H); 
13C NMR (100 MHz, CDCl3) δ 138.29, 128.53, 127.75, 127.50, 97.16, 81.26, 78.89, 78.77, 
73.55, 70.30, 68.33, 61.21, 59.17, 58.19, 55.21, 49.82, 33.86; HRMS (ESI) m/z calcd for 
C19H30O7Na [M+Na]+, 393.1889; found, 393.1895. 
Methyl 6-O-Benzyl-2,3,4-tri-O-methyl-4-C-(p-tolunesulfonyloxyethyl)-α-D-
galactopyranoside (97). 
To a stirred solution of alcohol 95 (0.07 g, 0.18 mmol) in pyridine (1 mL) was added 
tosyl chloride (0.043 g, 0.22 mmol) and DMAP (2.5 mg, 0.018 mmol) at room temperature. 
The reaction mixture was stirred at room temperature for 12 h before TLC (40% ethyl 
acetate in hexane) showed completion. The reaction mixture was concentrated to 
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dryness, and the residue was dissolved in ethyl acetate, washed with 1 N HCl, washed 
with brine, and dried over anhydrous Na2SO4. The organic layer was concentrated under 
vacuum and the residue was purified by silica gel column chromatography, eluting with 
40 % EtOAc in hexane, to afford 97 (65 mg, 66%) as a colorless oil. [α] 22 D = +55.5 (c 
1.70, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.77 – 7.75 (m, 2H), 7.37 – 7.24 (m, 7H), 
4.84 (d, J = 3.6 Hz, 1H), 4.50 (d, J = 11.9 Hz, 1H), 4.44 (d, J = 11.9 Hz, 1H), 4.16 (td, J = 
9.4, 6.5 Hz, 1H), 4.06 (td, J = 9.5, 5.7 Hz, 1H), 3.72 (dd, J = 10.2, 4.4 Hz, 1H), 3.66 – 3.60 
(m, 2H), 3.52 – 3.47 (m, 1H), 3.48 (s, 3H), 3.45 (s, 3H), 3.39 (s, 3H), 3.38 (s, 3H), 3.35 
(d, J = 9.8 Hz, 1H), 2.59 – 2.50 (m, 1H), 2.41 (s, 3H), 1.95 – 1.84 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 144.9, 137.9, 132.8, 129.9, 128.4, 127.9, 127.6, 127.5, 97.4, 81.6, 79.8, 
77.9, 73.4, 71.9, 69.0, 66.4, 61.8, 58.8, 55.4, 52.9, 28.6, 21.6; HRMS (ESI) m/z calcd for 
C26H36O9SNa [M+Na]+, 547.1978; found, 547.1953. 
Methyl 4-C,6-O-(Ethan-1,2-diyl)-2,3,4-tri-O-methyl-α-D-galacto-octopyranoside (13). 
A solution of tosylate 97 (0.060 g, 0.011 mmol) in CH3OH:EtOAc (2 mL, 1:1) was 
treated with Pd(OH)2/C (20 mg, 20 wt%) and stirred under 1 atm of H2 (balloon) for 1 h, 
then filtered  through Celite. The combined filtrates were evaporated under vacuum to 
give a crude alcohol (0.05g, 0.011 mmol), which was taken up in dry DMF (1.0 mL), 
treated with NaH (14 mg, 0.034 mmol, 60% in oil) at 0 oC and stirred for 1 h at room 
temperature. The reaction mixture was poured into iced water and extracted with EtOAc.  
The extracts were washed with brine, dried over Na2SO4, and concentrated under 
vacuum. The residue was purified by silica gel column chromatography (eluent: ethyl 
acetate/hexane 5% to 20%) to afford 50 (24 mg, 80%) as a colorless oil. [α] 22 D = +138.9 
(c 1.10, CH2Cl2); In CHCl3: 1H NMR (600 MHz, CDCl3) δ 4.88 (d, J = 3.8 Hz, 1H), 3.73 
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(ddd, J = 11.5, 5.0, 1.5 Hz, 1H), 3.70 (dd, J = 9.9, 3.8 Hz, 1H), 3.66 (dd, J = 9.7, 5.8 Hz, 
1H), 3.62 – 3.61 (m, 1H), 3.61 – 3.60 (m, 1H), 3.52 (s, 3H), 3.50 (s, 6H), 3.49 (ddd, J = 
12.7, 11.5, 2.1 Hz, 1H), 3.39 (s, 3H), 3.31 (d, J = 9.9 Hz, 1H), 2.41 (ddd, J = 14.8, 2.1, 
1.5 Hz, 1H), 1.45 (ddd, J = 14.8, 12.7, 5.0 Hz, 1H);  13C NMR (150 MHz, CDCl3) δ 98.4, 
85.2, 79.9, 74.2, 68.9, 64.2, 62.9, 62.1, 58.9, 55.3, 52.2, 27.9; HRMS (ESI) m/z calcd for 
C12H22O6Na [M+Na]+, 285.1314; found, 285.1323. 
In C6D6: 1H NMR (600 MHz, C6D6) δ 4.75 (d, J = 3.7 Hz, 1H), 3.93 (dd, J = 10.5, 
10.0 Hz, 1H), 3.80 (dd, J = 10.0, 4.8 Hz, 1H), 3.77 (dd, J = 10.0, 3.7 Hz, 1H), 3.73 (dd, J 
= 10.5, 4.8 Hz, 1H), 3.52 (ddd, J = 11.4, 5.0, 1.4 Hz, 1H), 3.38 (ddd, J = 12.6, 11.4, 2.1 
Hz, 1H), 3.37 (s, 3H), 3.33 (d, J = 10.0 Hz, 1H), 3.32 (s, 3H), 3.14 (s, 3H), 3.08 (s, 3H), 
2.01 (ddd, J = 14.7, 2.1, 1.4 Hz, 1H), 1.07 (ddd, J = 14.7, 12.6, 5.0 Hz, 1H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 4.86 (d, J = 3.8 Hz, 1H), 3.71 (ddd, J = 
11.5, 5.0, 1.5 Hz, 1H, 7eq), 3.66-3.62(m, Hz, 1H), 3.62 (dd, J = 10.0, 3.8 Hz, 1H), 3.55 – 
3.53 (m, 2H), 3.51 (s, 3H), 3.47 (ddd, J = 12.7, 11.5, 2.1 Hz, 1H), 3.49 (s, 3H), 3.47 (s, 
3H), 3.37 (s, 3H), 3.31 (d, J = 10.0 Hz, 1H), 2.44 (ddd, J = 14.9, 2.1, 1.5 Hz, 1H), 1.49 
(ddd, J = 14.9, 12.7, 5.0 Hz, 1H). 
Methyl 4-C,6-O-(Ethan-1,2-diyl)-2,3,4-tri-O-methyl-α-D-gluco-octopyranoside (52) 
and Methyl 6-O-Benzyl-3-O,4-C-(ethan-1,2-diyl)-2,4-di-O-methyl-α-D-gluco-
octopyranoside (100). 
Compound 96 (7.2 mg, 0.019 mmol) was dissolved in anhydrous pyridine (0.2 mL) 
and cooled to 0 °C before addition of MsCl (1.9 µL, 0.024 mmol). The reaction mixture 
was stirred for 1.5 h at 0 °C before it was diluted with ethyl acetate and washed with H2O. 
The organic layer was separated, dried over anhydrous Na2SO4, and concentrated to 
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dryness. The resultant residue and 20% Pd(OH)2 (3 mg) were stirred in a 1:1 mixture of 
CH2Cl2/CH3OH (0.3 mL) under 1 atm of H2 atmosphere for 6 h. The reaction mixture was 
filtered through Celite and concentrated to dryness. The residue was purified by column 
chromatography, eluting with hexane/ethyl acetate (7:3 to 1:1), to obtain 52 (0.0011 g, 
21%) and 100 (0.0012g, 23%) as colorless oils. 
(52). [α] 22 D = +72.0 (c 0.2, CH2Cl2); In CHCl3: 1H NMR (600 MHz, CDCl3) δ 4.87 
(d, J = 3.8 Hz, 1H), 3.83 (dd, J = 12.4, 1.7 Hz, 1H), 3.80 (dt, J = 11.2, 3.2 Hz, 1H), 3.76 
(dd, J = 12.4, 1.6 Hz, 1H), 3.68 (d, J = 9.5 Hz, 1H), 3.66 – 3.62 (m, 1H), 3.59 (s, 3H), 3.52 
(br s, 1H), 3.50 (s, 3H), 3.42 (s, 3H), 3.40 (s, 3H), 3.34 (dd, J = 9.5, 3.8 Hz, 1H), 1.89 – 
1.86 (m, 2H); 13C NMR (151 MHz, CDCl3) δ 97.72, 81.86, 81.31, 73.75, 66.16, 65.17, 
63.28, 60.63, 58.88, 55.44, 50.58, 25.27; HRMS (ESI) m/z calcd for C12H22O6Na [M+Na]+, 
285.1314; found, 285.1325. 
In C6D6: 1H NMR (600 MHz, C6D6) δ 4.68 (d, J = 3.7 Hz, 1H), 3.90 – 3.89 (m, 2H), 
3.81 (d, J = 9.5 Hz, 1H), 3.80 (dt, J = 11.0, 3.5 Hz, 1H), 3.72 – 3.66 (m, 1H), 3.50 (br s, 
1H), 3.47 (s, 3H), 3.25 (dd, J = 9.5, 3.7 Hz, 1H), 3.15 (s, 6H), 3.08 (s, 3H), 1.98 – 1.95 
(m, 2H). 
In CD3OD: 1H NMR (600 MHz, CD3OD) δ 4.86 (d, J = 3.8, 1H), δ 3.80 (dd, J = 
12.4, 1.7 Hz, 1H), 3.71 (dt, J =11.3, 3.6 Hz, 1H), 3.67 (dd, J = 12.4, 1.6, 1H), 3.65 – 3.63 
(m, 1H), 3.61 (d, J = 9.5 Hz, 1H), 3.54 (s, 3H), 3.52 (br s, 1H), 3.46 (s, 3H), 3.39 (s, 3H), 
3.38 (s, 3H), 3.33 (dd, J = 9.5, 3.8 Hz, 1H), 1.85 – 1.82 (m, 2H). 
(100). [α]D22 = +74.0 (c 0.3, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.27 (m, 
5H), 4.84 (d, J = 3.7 Hz, 1H), 4.66 (d, J = 12.1 Hz, 1H), 4.56 (d, J = 12.1 Hz, 1H), 4.36 (d, 
J = 8.1 Hz, 1H), 4.23 (dd, J = 7.8, 1.8 Hz, 1H), 4.04 – 3.98 (m, 2H), 3.81 (dd, J = 10.7, 
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2.0 Hz, 1H), 3.60 – 3.57 (m, 1H), 3.54 (s, 3H), 3.49 (s, 3H), 3.30 (s, 3H), 3.12 (dd, J = 8.2, 
3.7 Hz, 1H), 2.16 (dt, J = 13.1, 9.9 Hz, 1H), 1.78 (ddd, J = 13.3, 5.8, 3.4 Hz, 1H); 13C NMR 
(150 MHz, CDCl3) δ 138.35, 129.73, 128.58, 128.51, 127.73, 127.60, 97.41, 83.10, 79.84, 
79.18, 73.59, 69.31, 66.56, 66.05, 58.87, 55.60, 51.18, 31.92; HRMS (ESI) m/z calcd for 
C18H26O6Na [M+Na]+, 361.1627; found, 361.1627. 
Phenyl 2,3,6-tri-O-benzyl-1-thio-β-D-galactopyranoside (105). 
Compound 1 was synthesized as described in the literature.202 1H NMR (600 MHz, 
CDCl3) δ 7.59 – 7.57 (m, 2H), 7.42 – 7.41 (m, 2H), 7.36 – 7.21 (m, 13H), 7.25 – 7.23 (m, 
3H), 4.83 (d, J = 10.3 Hz, 1H), 4.75 (d, J = 10.3 Hz, 1H), 4.73 (d, J = 11.6 Hz, 1H), 4.69 
(d, J = 11.6 Hz, 1H), 4.64 (d, J = 9.9 Hz, 1H), 4.57 (br s, 2H), 4.11 (d, J = 3.2 Hz, 1H), 
3.81 (dd, J = 5.7, 10.0 Hz, 1H), 3.78 (dd, J = 5.8, 10.0 Hz, 1H), 3.76 (t, J = 9.5 Hz, 1H), 
3.61 – 3.60 (m, 1H), 3.58 (dd, J = 3.3, 9.5 Hz, 1H), 2.55 (s, 1H).  1H NMR (600 MHz, 
C6D6) δ 7.68 (dd, J = 8.2, 1.0 Hz, 2H), 7.40 (d, J = 7.6 Hz, 1H, 2H), 7.23 (d, J = 7.6 Hz, 
1H, 2H), 7.17 – 6.96 (m, 13H), 6.91 (t, J = 7.4 Hz, 1H), 4.85 (d, J = 10.8 Hz, 1H), 4.67 (d, 
J = 10.8 Hz, 1H), 4.57 (d, J = 9.8 Hz, 1H), 4.34 – 4.26 (m, 4H), 3.83 (t, J = 9.3 Hz, 1H), 
3.79 (d, J = 2.7 Hz, 1H), 3.75 (dd, J = 9.8, 5.8 Hz, 1H), 3.72 (dd, J = 9.8, 6.1 Hz, 1H), 3.25 
(t, J = 5.9 Hz, 1H), 3.20 (dd, J = 8.9, 3.2 Hz, 1H), 2.39 (s, 1H).  IR (neat) ν 3480 cm−1 (O-
H). 
Phenyl (6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-galactopyranoside (6S-D-105). 
Compound 6S-D-105 (0.40 g, 72%) was synthesized from compound 114 
analogously to 105.  1H NMR (600 MHz, CDCl3) δ 7.59 – 7.57 (m, 2H), 7.42 – 7.40 (m, 
2H), 7.36 – 7.21 (m, 13H), 7.25 – 7.23 (m, 3H), 4.83 (d, J = 10.3 Hz, 1H), 4.75 (d, J = 
10.3 Hz, 1H), 4.73 (d, J = 11.6 Hz, 1H), 4.69 (d, J = 11.6 Hz,  1H), 4.64 (d, J = 9.9 Hz, 
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1H), 4.56 (br s, 2H), 4.10 (d, J = 3.1 Hz, 1H), 3.76 (d, J = 2.9 Hz, 1H), 3.75 (t, J = 9.5 Hz, 
1H), 3.60 – 3.59 (m, 1H), 3.58 (dd, J = 3.2, 9.3 Hz, 1H).  1H NMR (600 MHz, C6D6) δ 7.69 
– 7.68 (m,  2H), 7.41 – 7.40 (m, 2H), 7.23 – 6.89 (m, 16H), 4.84 (d, J = 10.8 Hz, 1H), 4.66 
(d, J = 10.8 Hz, 1H), 4.57 (d, J = 9.8 Hz, 1H), 4.31 (d, J = 11.9 Hz, 1H), 4.29 – 4.27 (m, 
3H), 3.82 (t, J = 9.2 Hz, 1H), 3.78 (d, J = 3.1 Hz, 1H), 3.70 (d, J = 6.2 Hz, 1H), 3.23 – 3.22 
(m, 1H), 3.19 (dd, J = 8.9, 3.2 Hz, 1H).  HRMS (ESI) m/z calcd for C33H33DO5SNa 
[M+Na]+, 566.2087; found, 566.2079.   
Phenyl 2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (106). 
Compound 129 (0.01 g, 0.015 mmol) was dissolved in anhydrous methanol (0.5 
mL) and cooled to 0 °C before it was treated with Na (catalytic amount). The reaction 
mixture was stirred under an argon atmosphere at room temperature overnight, quenched 
with Amberlyst-15 (pH ~ 4), filtered, and concentrated to dryness. The crude residue was 
purified by silica gel column chromatography, eluting with hexane/ethyl acetate (19:1 to 
4:1) to afford compound 106 (0.005 g, 62%) with spectral data consistent with the 
literature.386   1H NMR (600 MHz, CDCl3) δ 7.58 – 7.55 (m, 2H), 7.43 – 7.24 (m, 18H), 
4.92 (d, J = 11.4 Hz, 1H), 4.92 (d, J = 10.2 Hz, 1H), 4.79 (d, J = 11.4 Hz, 1H), 4.75 (d, J 
= 10.2 Hz, 1H,), 4.70 (d, J = 9.6 Hz, 1H), 4.60 (d, J = 11.9 Hz, 1H), 4.56 (d, J = 11.9 Hz, 
1H), 3.80 (dd, J = 10.4, 4.1 Hz, 1H), 3.76 (dd, J = 10.4, 5.3 Hz, 1H), 3.66 (dd, J = 9.6, 8.9 
Hz, 1H), 3.54 (dd, J = 8.9, 8.8 Hz, 1H), 3.50 (ddd, J = 9.6, 5.3, 4.1 Hz, 1H), 3.49 (dd, J = 
9.6, 8.8 Hz, 1H), 2.54 (br s, 1H).  1H NMR (600 MHz, C6D6) δ 7.69 – 7.65 (m, 2H), 7.45 – 
7.42 (m, 2H), 7.31 – 6.94 (m, 16H), 4.94 (d, J = 10.6 Hz, 1H), 4.87 (d, J = 11.7 Hz, 1H), 
4.76 (d, J = 11.7 Hz, 1H), 4.69 (d, J = 10.6 Hz, 1H), 4.64 (d, J = 9.7 Hz, 1H), 4.33 (d, J = 
11.9 Hz, 1H), 4.30 (d, J = 11.9 Hz, 1H), 3.66 (dd, J = 9.8, 8.9 Hz, 1H), 3.64 (dd, J = 10.4, 
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3.7 Hz, 1H), 3.60 (dd, J = 10.4, 5.3 Hz, 1H), 3.51 (dd, J = 9.7, 8.7 Hz, 1H), 3.43 (dd, J = 
8.9, 8.7 Hz, 1H), 3.22 (ddd, J = 9.8, 5.3, 3.7 Hz, 1H), 2.23 (s, 1H).  IR (neat) ν 3441 cm−1 
(O-H). 
Phenyl (6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (6S-D-106). 
Compound 6S-D-106 (0.011 g, 60%) was synthesized from 6S-D-129 (21.7 mg, 
0.034 mmol) analogously to 106.  1H NMR (600 MHz, CDCl3) δ 7.58 – 7.53 (m, 1H), 7.44 
– 7.22 (m, 18H), 4.91 (d, J = 11.4 Hz, 1H), 4.91 (d, J = 10.4 Hz, 1H), 4.78 (d, J = 11.4 Hz, 
1H), 4.74 (d, J = 10.4 Hz, 1H), 4.69 (d, J = 9.6 Hz, 1H), 4.59 (d, J = 12.0 Hz, 1H), 4.56 (d, 
J = 12.0 Hz, 1H), 3.74 (d, J = 5.4 Hz, 1H), 3.66 (dd, J = 9.6, 8.8 Hz, 1H), 3.54 (t, J = 8.8 
Hz, 1H), 3.48 (dd, J = 9.6, 8.8 Hz, 1H), 3.48 (dd, J = 9.6, 5.4 Hz, 1H), 2.53 (br s, 1H).  1H 
NMR (600 MHz, C6D6) δ 7.71 – 7.64 (m, 2H), 7.46 – 7.41 (m, 2H), 7.30 – 6.93 (m, 16H), 
4.94 (d, J = 10.6 Hz, 1H), 4.87 (d, J = 11.7 Hz, 1H), 4.75 (d, J = 11.7 Hz, 1H), 4.69 (d, J 
= 10.6 Hz, 1H), 4.64 (d, J = 9.7 Hz, 1H), 4.32 (d, J = 12.2 Hz, 1H), 4.30 (d, J = 12.2 Hz, 
1H), 3.65 (ddd, J = 9.7, 8.8, 2.9 Hz, 1H), 3.57 (d, J = 5.3 Hz, 1H), 3.51 (dd, J = 9.7, 8.7 
Hz, 1H), 3.42 (t, J = 8.8 Hz, 1H), 3.22 (dd, J = 9.7, 5.3 Hz, 1H), 2.19 (d, J = 2.9 Hz, 1H).  
HRMS (ESI) m/z calcd for C33H33DO5SNa [M+Na]+, 566.2087; found, 566.2083. 
Ethyl 2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (107).   
Compound 107 was synthesized as described in the literature.203  1H NMR (600 
MHz, CDCl3) δ 7.40 – 7.26 (m, 15H), 4.93 (d, J = 11.0Hz, 1H), 4.92 (d, J = 10.2 Hz, 1H), 
4.87 (d, J = 11.0 Hz, 1H), 4.86 (d, J = 10.9 Hz, 1H), 4.75 (d, J = 10.2 Hz, 1H), 4.66 (d, J 
= 10.9 Hz, 1H), 4.51 (d, J = 9.9 Hz, 1H), 3.87 (dd, J = 12.2, 2.7 Hz, 1H), 3.71 (dd, J = 9.1, 
8.8 Hz, 1H), 3.70 (dd, J = 12.2, 4.8 Hz, 1H), 3.58 (dd, J = 9.6, 9.1 Hz, 1H), 3.41 (dd, J = 
9.9, 8.8 Hz, 1H), 3.38 (ddd, J = 9.6, 4.8, 2.7 Hz, 1H) 2.81 – 2.70 (m, 2H), 1.82 (br s, 1H), 
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1.33 (t, J = 7.4 Hz, 3H).  1H NMR (600 MHz, C6D6) δ 7.45 – 7.42 (m, 2H), 7.35 – 7.31 (m, 
2H), 7.26 – 7.23 (m, 2H), 7.19 – 7.05 (m, 9H), 4.99 (d, J = 10.6 Hz, 1H), 4.93 (d, J = 11.2 
Hz, 1H), 4.85 (d, J = 11.2 Hz, 1H), 4.83 (d, J = 11.2 Hz, 1H), 4.74 (d, J = 10.6 Hz, 1H), 
4.61 (d, J = 11.2 Hz, 1H), 4.36 (d, J = 9.7 Hz, 1H), 3.77 – 3.71 (m, 1H), 3.66 – 3.56 (m, 
3H), 3.43 (dd, J = 9.7, 8.4 Hz, 1H), 3.13 – 3.09 (m, 1H), 1.60 (br s, 1H) 2.56 – 2.42 (m, 
2H), 1.11 (t, J = 7.4 Hz, 3H).  IR (neat) ν 3484 cm−1 (O-H). 
Ethyl (6S)-[6-2H1]-2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (6S-D-107).   
A solution of compound 116 (0.105 g, 0.27 mmol) in anhydrous methanol (1.0 mL) 
was cooled to 0 °C and treated with Na (cat) and stirred under an argon atmosphere at 
room temperature for 1.5 h. Then the reaction was quenched with Amberlyst-15 resin (pH 
~7) and filtered through cotton before it was concentrated to dryness. The crude residue 
was dissolved in anhydrous pyridine (0.8 mL) and treated with tritylchloride (84 µL, 0.32 
mmol) at room temperature. The reaction mixture was stirred in dark at room temperature 
for 3 days. The reaction was then quenched with methanol (~ 70 µL), stirred for 1 h, and 
concentrated to dryness. The crude residue was dissolved in chloroform, washed with 
cold aqueous saturated NaHCO3, and cold brine. The organic layer was dried over 
anhydrous Na2SO4 and concentrated to dryness. The crude residue was dissolved in 
anhydrous DMF (0.9 mL) and cooled to 0 °C before it was treated with 60% NaH in 
mineral oil (48 mg, 1.2 mmol) followed by benzyl bromide (141 µL, 1.2 mmol). The 
reaction mixture was stirred under an argon atmosphere at room temperature for 6 h. The 
reaction mixture was cooled to 0 °C before it was quenched with water. The aqueous 
layer was extracted with ethyl acetate. The combined organic layers were washed with 
brine, dried over anhydrous Na2SO4 and concentrated to dryness. The crude residue was 
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passed through a short pad of silica, eluting with hexane/ethyl acetate (7:3) and 
concentrated. The residue was dissolved in a mixture of glacial acetic acid and water (4:1, 
1.3 mL) and heated at 80 °C for 2.5 h. The reaction mixture was concentrated to dryness 
and purified using silica gel column chromatography, eluting with hexane/ethyl acetate 
(4:1 to 7:2), obtain compound 6S-D-107 (0.045 g, 35%).  1H NMR (400 MHz, CDCl3) δ 
7.40 – 7.25 (m, 15H), 4.94 (d, J = 10.9 Hz, 1H), 4.92 (d, J = 10.2 Hz, 1H), 4.87 (d, J = 
10.9 Hz, 1H), 4.87 (d, J = 10.9 Hz, 1H), 4.75 (d, J = 10.2 Hz, 1H), 4.66 (d, J = 10.9 Hz, 
1H), 4.51 (d, J = 9.8 Hz, 1H), 3.72 (t, J = 9.0 Hz, 1H), 3.68 (d, J = 4.9 Hz, 1H), 3.58 (dd, 
J = 9.7, 9.0 Hz, 1H), 3.41 (dd, J = 9.8, 8.8 Hz, 1H), 3.38 (dd, J = 9.7, 4.9 Hz, 1H), 2.84 – 
2.69 (m, 2H), 1.33 (t, J = 7.4 Hz, 3H).  HRMS (ESI) m/z calcd for C29H33DO5SNa [M+Na]+, 
518.2087; found, 518.2066. 
(6S)-l,6-Anhydro-2,3,4-tri-O-acetyl-6-bromo-β-D-galactopyranose (109). 
A mixture of l,6-anhydro-2,3,4-tri-O-acetyl-β-D-galactopyranose 108387 (0.77 g, 
2.67 mmol) and N-bromosuccinimide (1.9 g, 10.6 mmol)) in trifluorotoluene (40 mL) was 
refluxed over a 300-W heat lamp for 8 h. After 8h, the solvent was evaporated under 
reduced pressure and the crude product dissolved in EtOAc (50 mL). The solution was 
successively washed with aqueous saturated Na2S2O3, aqueous saturated NaHCO3, and 
dried over Na2SO4. Evaporation of the solvent under reduced pressure gave a crude 
product which was purified through silica-gel column chromatography (eluent: 20% EtOAc 
in hexane) to give 109 (0.73g, 75%) as a yellowish oil. [α] 22 D = −63.6 (c 1.50, CH2Cl2); 
1H NMR (400 MHz, CDCl3) δ 6.60 (s, 1H), 5.81 (s, 1H), 5.29 – 5.20 (m, 2H), 4.74 (dd, J 
= 4.0, 1.3 Hz, 1H), 4.71 (br s, 1H), 2.14 (s, 3H), 2.13 (s, 3H), 2.05 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 169.2, 169.1, 168.9, 101.7, 82.6, 79.6, 69.3, 66.9, 64.4, 20.7 (2), 20.5; 
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HRMS (ESI) m/z calcd for C12H1579BrO8Na [M+Na]+, 388.9848; found, 388.9849; calcd 
for C12H1581BrO8Na [M+Na]+, 390.9828; found, 390.9828. 
(6S)-[6-2H1]-l,6-Anhydro-2,3,4-tri-O-acetyl-β-D-galactopyranose (110). 
To a solution of 109 (2.3 g, 6.26 mmol) and azobisisobutyronitrile (0.1 g, 0.63 
mmol) in toluene (170 mL) was added freshly prepared tri-n-butyltin deuteride214 (5.5 g, 
18.79 mmol) and the reaction mixture was refluxed for 0.5 h. The cooled reaction mixture 
was evaporated in vacuo to give a crude product which was purified on silica-gel column 
chromatography (eluent: 40% EtOAc in hexane) to give 110 (1.4 g, 77%) as a colorless 
oil. [α] 22 D = −10.0 (c 1.15, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 5.42 (s, 1H), 5.29 – 5.20 
(m, 2H), 4.75 (s, 1H), 4.45 (d, J = 2.7 Hz, 1H), 4.31 (s, 1H), 2.12 (s, 6H), 2.02 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 169.5, 169.3, 169.2, 98.9, 72.0, 71.0, 67.4, 64.2 (t, J = 23.5 
Hz), 20.8, 20.7, 20.5; HRMS (ESI) m/z calcd for C12H15DO8Na [M+Na]+, 312.0806; found, 
312.0818. 
(6S)-[6-2H1]-1,2,3,4,6-Penta-O-acetyl-α-D-galactopyranose (111). 
To a solution of compound 110 (1.4 g, 4.84 mmol) in MeOH (20 mL) was added 
Na (catalytic amount) slowly and the reaction mixture was stirred for 7 h, then neutralized 
with Amberlite® IR120, filtered, and concentrated under reduced pressure to give (6S)-[6-
2H1]-1,6-anhydrogalactose. A solution of (6S)-[6-2H1]-1,6-anhydrogalactose (0.73 g, 4.47 
mmol) in Ac2O (20 mL) was treated with conc.H2SO4 (0.35 mL) at 0 oC and stirred for 3 
h. The reaction mixture was poured into a saturated aqueous NaOAc solution (50 mL) 
and extracted with CHCl3 (3 × 20 mL), washed with brine (10 mL), dried over Na2SO4, 
and concentrated under high vacuum to give the crude product. Column chromatography 
(eluent: 30% EtOAc in hexane) on silica-gel yielded 111 (1.5 g, 81% over 2 steps) as a 
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colorless syrup with spectral data consistent with the literature.207  1H NMR (400 MHz, 
CDCl3) δ 6.29 (d, J = 2.2 Hz, 1H), 5.42 (s, 1H), 5.29 – 5.19 (m, 2H), 4.27 (d, J = 6.4 Hz, 
1H), 3.99 (d, J = 6.5 Hz, 1H), 2.09 (s, 3H), 2.08 (s, 3H), 1.96 (d, J = 2.5 Hz, 3H), 1.95 (d, 
J = 3.9 Hz, 3H), 1.93 (s, 3H). 
Phenyl (6S)-[6-2H1]-2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranoside (112).   
To a stirred solution of (6S)-[6-2H1]-1,2,3,4,6-penta-O-acetyl-α-D-galactopyranose 
111 (1.5 g, 3.83 mmol) and thiophenol (047 mL, 4.59 mmol) in CH2Cl2 was added 
BF3·Et2O (1.9 mL, 7.66 mmol) at 0 oC. The reaction mixture was stirred at room 
temperature for 22 h, then quenched with aqueous saturated NaHCO3 solution (50 mL) 
and extracted with CH2Cl2 (3 × 25 mL), dried over Na2SO4, and concentrated under high 
vacuum. The crude product was purified on silica-gel column (eluent: 20% EtOAc in 
hexane) chromatography to give 112388 (900 mg, 56%) as a colorless oil. 1H NMR (400 
MHz, CDCl3) δ 7.51 – 7.48 (m, 2H), 7.30 – 7.28 (m, 3H), 5.40 (d, J = 2.8 Hz, 1H), 5.22 (t, 
J = 10.0 Hz, 1H), 5.03 (dd, J = 9.9, 3.3 Hz, 1H), 4.70 (d, J = 10.0 Hz, 1H), 4.17 (d, J = 6.5 
Hz, 1H), 3.92 (d, J = 6.8 Hz, 1H), 2.09 (s, 3H), 2.08 (s, 3H), 2.02 (s, 3H), 1.96 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 170.3, 170.2, 170.0, 169.4, 132.5, 132.4, 128.9, 128.1, 86.6, 
74.3, 72.0, 67.2, 61.3 (t, J = 22.2 Hz), 20.8, 20.6, 20.6, 20.6; HRMS (ESI) m/z calcd for 
C20H23DO9SNa [M+Na]+, 464.1101; found, 464.1114. 
Phenyl 2,3-di-O-benzyl-4,6-O-benzylidene-(6S)-[6-2H1]-1-thio-β-D-
galactopyranoside (114).  
To a stirred solution of 112 (0.9 g, 2.04 mmol) in MeOH (10.0 mL) was added Na 
metal (catalytic amount) slowly.  The reaction mixture was stirred for 2 h, then neutralized 
with Amberlite® IR120, filtered, and concentrated under reduced pressure to give a crude 
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thiogalactoside. The crude residue was dissolved in dry CH3CN (30 mL) and treated with 
benzaldehyde dimethylacetal (0.41 mL, 2.75 mmol) followed by camphorsulfonic acid (4.2 
mg, 0.18 mmol) at room temperature. The reaction mixture was stirred for 2.5 h, then 
neutralized with triethylamine (0.5 mL), and concentrated under reduced pressure to give 
a crude compound 113. After filtration through a short silica-gel column, compound 113 
(0.52 g) was dissolved in dry DMF (10 mL) then treated with NaH (0.17 g, 4.15 mmol) 
and BnBr (2.27 g, 1.6 mL, 13.3 mmol) at 0 oC. The resulting solution was warmed to room 
temperature and stirred for 0.5 h.  Upon completion of the reaction (TLC), the excess NaH 
was quenched using sat. NH4Cl solution. The product was extracted with EtOAc (3 × 25 
mL), the combined organic layer was washed with brine (10 mL), dried over Na2SO4, and 
concentrated under high vacuum. The crude product was purified on silica-gel column 
chromatography (30% EtOAc in hexane) to give 114 (0.63 g, 81%) as a colorless oil. 1H 
NMR (400 MHz, CDCl3) δ 7.72 – 7.71 (m, 2H), 7.55 – 7.53 (m, 2H), 7.43 – 7.18 (m, 16H), 
5.50 (s, 1H), 4.74 – 4.68 (m, 4H), 4.62 (d, J = 9.5 Hz, 1H), 4.16 (d, J = 3.2 Hz, 1H), 3.98 
(br s, 1H), 3.91 (t, J = 9.4 Hz, 1H), 3.63 (dd, J = 9.2, 3.3 Hz, 1H), 3.42 (br s, 1H); 13C NMR 
(150 MHz, CDCl3) δ 138.6, 138.2, 138.0, 132.9, 132.8, 129.2, 129.0, 128.6, 128.5, 128.4, 
128.3, 128.0, 127.9, 127.6, 126.8, 101.5, 86.7, 8.5, 75.6, 75.5, 73.8, 72.0, 69.9, 69.3 (t, J 
= 21.7 Hz). HRMS (ESI) m/z calcd for C33H31DO5SNa [M+Na]+, 564.1931; found, 
564.1927. 
Ethyl (6S)-[6-2H1]-2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside (116). 
Compound 115150 (0.1 g, 0.346 mmol) was dissolved in anhydrous dichloroethane 
(10.5 mL) and treated with (ethylthio)trimethylsilane (167 µL, 1.03 mmol) followed by ZnI2 
(332 mg, 1.03 mmol). The reaction mixture was stirred under an argon atmosphere at 
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room temperature for 3 h before it was diluted with ethyl acetate and filtered through 
Celite. The organic layer was washed with aqueous saturated NaHCO3, brine, dried over 
anhydrous Na2SO4, and concentrated to dryness. The crude residue was dissolved in a 
mixture of THF:H2O (1:1, 20 mL), and treated with K2CO3 (200 mg, 1.44 mmol) and stirred 
for 15 min. The reaction mixture was then diluted with ethyl acetate and washed with 
water, brine, and treated with anhydrous Na2SO4 before it was concentrated to dryness. 
Then the crude residue was passed through a short pad of silica gel, eluting with 
hexane/ethyl acetate (1:1), and the eluent was concentrated to dryness. The residue (60 
mg) was dissolved in pyridine (1.4 mL), treated with acetic anhydride (0.7 mL), and stirred 
overnight under an argon atmosphere at room temperature. The reaction mixture was 
then concentrated to dryness and the crude reaction mixture was purified by silica gel 
column chromatography, eluting with hexane/ethyl acetate (7:3), to obtain 116 (0.051 g, 
40%). 1H NMR (400 MHz, CDCl3) δ 5.22 (t, J = 9.4 Hz, 1H), 5.08 (dd, J = 10.0, 9.4 Hz, 
1H), 5.03 (dd, J = 10.0, 9.4 Hz, 1H), 4.49 (d, J = 10.0 Hz, 1H), 4.22 (d, J = 5.0 Hz, 1H), 
3.70 (dd, J = 10.0, 5.0 Hz, 1H), 2.78 – 2.63 (m, 2H), 2.07 (s, J = 2.8 Hz, 3H), 2.06 (s, 3H), 
2.02 (s, J = 3.5 Hz, 3H), 2.00 (s, J = 3.1 Hz, 3H), 1.27 (t, J = 7.5 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 170.6, 170.2, 169.4, 83.5, 75.9, 73.9, 69.8, 68.3, 61.9 (t, J = 22.8 Hz), 
24.2, 20.7, 20.6, 20.6, 14.8. HRMS (ESI) m/z calcd for C16H23DO9SNa [M+Na]+, 
416.1102; found, 416.1098. 
Phenyl 4-O-acetyl-2,3,6-tri-O-benzyl-1-thio-β-D-galactopyranoside (117).229  
Compound 13 was synthesized as described in the literature.228   NMR (600 MHz, 
CDCl3) δ 7.60 – 7.58 (m, 2H), 7.42 – 7.40 (m, 2H), 7.37 – 7.25 (m, 16H), 5.65 (br s, 1H), 
4.78 (d, J = 11.3 Hz, 1H), 4.77 (d, J = 10.3 Hz, 1H), 4.75 (d, J = 10.0 Hz, 1H), 4.71 – 4.67 
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(m, 1H), 4.57 (d, J = 11.7 Hz, 1H), 4.50 (d, J = 11.0 Hz, 1H), 4.47 (d, J = 11.7 Hz, 1H), 
3.77 – 3.76 (m, 1H), 3.67 – 3.66 (m, 2H), 3.64 (dd, J = 9.5, 6.0 Hz, 1H), 3.55 (dd, J = 9.5, 
6.7 Hz, 1H), 2.09 (s, 3H).  1H NMR (600 MHz, C6D6) δ 7.65 – 7.61 (m, 2H), 7.39 (t, J = 
7.6 Hz, 2H), 7.31 (d, J = 7.3 Hz, 2H), 7.25 (d, J = 7.4 Hz, 2H), 7.17 – 7.01 (m, 10H), 6.99 
– 6.91 (m, 2H), 5.58 (dd, J = 3.3, 1.1 Hz, 1H), 4.80 (d, J = 10.7 Hz, 1H), 4.75 (d, J = 10.7 
Hz, 1H), 4.66 (d, J = 11.2 Hz, 1H), 4.56 (d, J = 9.7 Hz, 1H), 4.28 (d, J = 11.6 Hz, 2H), 
4.17 (d, J = 11.9 Hz, 1H), 3.80 (t, J = 9.5 Hz, 1H), 3.47 (dd, J = 9.4, 6.1 Hz, 1H), 3.42 (dd, 
J = 9.4, 6.5 Hz, 1H), 3.33 (dd, J = 9.2, 3.3 Hz, 1H),  3.32 (ddd, J = 6.5, 6.1, 1.1 Hz, 1H), 
1.65 (s, 3H).  IR (neat) ν 1742 cm−1 (C=O). 
Phenyl 4-O-acetyl-(6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-galactopyranoside (6S-
D-117).   
Compound 6S-D-117 (0.021 g, 81%) was synthesized from 6S-D-105 analogously 
to 13.  1H NMR (600 MHz, CDCl3) δ 7.60 – 7.57 (m, 2H), 7.41 – 7.23 (m, 18H), 5.63 (d, J 
= 1.6 Hz, 1H), 4.79  (d, J = 11.1 Hz, 1H), 4.78 (d, J = 10.2 Hz, 1H), 4.75 (d, J = 10.2 Hz, 
1H), 4.72 – 4.68 (m, 1H), 4.55 (d, J = 11.7 Hz, 1H), 4.49 (d, J = 11.0 Hz, 1H), 4.45 (d, J 
= 11.7 Hz, 1H), 3.76 (d, J = 6.1 Hz, 1H), 3.68 – 3.66 (m, 2H), 3.61 (d, J = 6.0 Hz, 1H), 
2.10 (s, 3H).  1H NMR (600 MHz, C6D6) δ 7.65 – 7.62 (m, 2H), 7.40 (d, J = 7.6 Hz, 2H), 
7.31 (d, J = 7.5 Hz, 2H), 7.24 (t, J = 10.8 Hz, 2H), 7.18 – 6.91 (m, 12H), 5.58 (d, J = 3.2 
Hz, 1H), 4.80 (d, J = 10.7 Hz, 1H), 4.75 (d, J = 10.7 Hz, 1H), 4.66 (d, J = 11.2 Hz, 1H), 
4.56 (d, J = 9.7 Hz, 1H), 4.28 (d, J = 11.4 Hz, 2H), 4.17 (d, J = 11.9 Hz, 1H), 3.79 (t, J = 
9.4 Hz, 1H), 3.47 – 3.45 (m, 1H), 3.35 – 3.26 (m, 1H), 1.65 (s, 3H). 
HRMS (ESI) m/z calcd for C35H35DO6SNa [M+Na]+, 608.2193; found, 608.2191. 
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Phenyl 2,3,6-tri-O-benzyl-4-O-pivolyl-1-thio-β-D-galactopyranoside (118).229   
A solution of 105 (0.050 g, 2.77 mmol) in dry pyridine (0.5 mL) was treated with 
pivaloyl chloride (0.25 mL) at room temperature and stirred at 80 oC for 1 h. The solvents 
were evaporated under high vacuum to give a crude residue. The crude product was 
purified by silica gel column chromatography (eluent: 20 % ethyl acetate in hexane) to 
afford 118 (0.045 g, 78%) as a colorless oil. D22 = +6.6 (c 0.50, CH2Cl2);  1H NMR (600 
MHz, CDCl3) δ 7.59 – 7.57 (m, 2H), 7.37 – 7.24 (m, 18H), 5.63 (d, J = 2.9 Hz, 1H), 4.73 
(d, J = 10.6 Hz, 1H), 4.71 (d, J = 10.6 Hz, 1H), 4.67 (d, J = 10.3 Hz, 1H), 4.63 (d, J = 9.5 
Hz, 1H), 4.54 (d, J = 11.7 Hz, 1H), 4.47 (d, J = 11.8 Hz, 1H), 4.45 (d, J = 11.0 Hz, 1H), 
3.81 (t, J = 6.3 Hz, 1H), 3.65 (dd, J = 9.2, 3.3 Hz, 1H), 3.62 (dd, J = 9.5, 6.1 Hz, 1H), 3.57 
(t, J = 9.2 Hz, 1H), 3.49 (dd, J = 9.5, 6.7 Hz, 1H), 1.14 (s, 9H); 13C NMR (150 MHz, CDCl3) 
δ 177.4, 138.1, 137.8, 137.6, 133.2, 132.3, 128.8, 128.4, 128.3, 128.2, 128.2, 128.1, 
127.9, 127.8, 127.7, 127.6, 127.4, 87.0, 81.4, 76.3, 76.1, 75.6, 73.7, 71.6, 68.2, 66.3, 
39.0, 27.1.   1H NMR (600 MHz, C6D6) δ 7.66 – 7.63 (m, 2H), 7.40 (d, J = 8.0 Hz, 2H), 
7.30 – 7.24 (m, 4H), 7.18 – 6.91 (m, 12H), 5.56 (d, J = 3.2 Hz, 1H), 4.78 (d, J = 10.8 Hz, 
1H), 4.76 (d, J = 10.9 Hz, 1H), 4.58 (d, J = 11.0 Hz, 1H), 4.49 (d, J = 9.9 Hz, 1H), 4.30 (d, 
J = 11.9 Hz, 1H), 4.22 (d, J = 11.9 Hz, 1H), 4.20 (d, J = 11.8 Hz, 1H), 3.69 (t, J = 9.4 Hz, 
1H), 3.49 (dd, J = 9.2, 6.0 Hz, 1H), 3.42 (dd, J = 9.2, 6.8 Hz), 3.37 – 3.35 (m, 1H), 3.27 
(dd, J = 9.0, 3.2 Hz, 1H), 1.08 (s, 9H).  IR (neat) ν 1732 cm−1 (C=O).  HRMS (ESI) m/z 
calcd for C38H42O6SNa [M+Na]+, 649.2600; found, 649.2584. 
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Phenyl 4-O-pivaloyl-(6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-galactopyranoside 
(6S-D-118). 
Compound 6S-D-118 (0.011 g, 90%) was synthesized from 6S-D-105 analogously 
to 118.  1H NMR (600 MHz, CDCl3) δ 7.59 – 7.57 (m, 2H), 7.37 – 7.23 (m, 18H), 5.63 (d, 
J = 3.1 Hz, 1H), 4.73 (d, J = 10.4 Hz, 1H),  4.70 (d, J = 10.4 Hz, 1H), 4.66 (d, J = 10.3 Hz, 
1H), 4.64 (d, J = 9.7 Hz, 1H), 4.54 (d, J = 11.7 Hz, 1H), 4.48 (d, J = 11.8, 1H), 4.44 (d, J 
= 11.0 Hz, 1H), 3.80 (d, J = 6.1 Hz, 1H), 3.64 (dd, J = 9.1, 3.2 Hz, 1H), 3.60 (d, J = 6.1 
Hz, 1H), 3.56 (t, J = 9.3 Hz, 1H), 1.14 (s, 9H).  1H NMR (600 MHz, C6D6) δ 7.66 – 7.6 (m, 
2H), 7.40 (d, J = 7.1 Hz, 2H), 7.30 – 7.25 (m, 4H), 7.17 – 6.91 (m, 12H), 5.56 (d, J = 3.2 
Hz, 1H), 4.79 (d, J = 10.9 Hz, 1H), 4.76 (d, J = 10.9 Hz, 1H), 4.58 (d, J = 11.0 Hz, 1H), 
4.49 (d, J = 9.7 Hz, 1H), 4.30 (d, J = 11.9 Hz, 1H), 4.21 (d, J = 11.5 Hz, 1H), 4.20 (d, J = 
11.5 Hz, 1H), 3.70 (t, J = 9.4 Hz, 1H), 3.47 (d, J = 6.0 Hz, 1H), 3.36 (d, J = 5.9 Hz, 1H), 
3.27 (dd, J = 9.0, 3.3 Hz, 1H), 1.08 (s, 9H).  HRMS (ESI) m/z calcd for C38H41DO6SNa 
[M+Na]+, 650.2663; found, 650.2662. 
Phenyl 2,3,6-tri-O-benzyl-4-O-trifluoroacetyl-1-thio-β-D-galactopyranoside (119).229   
To a stirred solution of 105 (0.05 g, 0.092 mmol) in dry CH2Cl2 (1.0 mL) were added 
pyridine (0.030 mL, 0.18 mmol), trifluoroacetic anhydride (0.026 mL, 0.18 mmol), and 
DMAP (1.0 mg, 0.009 mmol) at 0 oC. The reaction mixture stirred was stirred for 0.5 h 
before it was quenched with water (5 mL) and extracted with CH2Cl2 (3 X 10 mL). The 
combined extracts were washed with 1 N HCl (5.0 mL) solution, dried over Na2SO4, and 
concentrated under high vacuum. Silica gel column chromatography (eluent: 10% ethyl 
acetate in hexane) afforded 119 (0.038 g, 65%) as a colorless oil. D22 = −6.9 (c 0.80, 
CH2Cl2);  1H NMR (600 MHz, CDCl3) δ 7.56 – 7.52 (m, 2H), 7.37 – 7.23 (m, 18H), 5.74 
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(dd, J = 3.2, 0.9 Hz, 1H), 4.75 (d, J = 11.2 Hz, 1H), 4.68 (d, J = 10.2 Hz, 1H), 4.65 (d, J = 
9.5 Hz, 1H), 4.64 (d, J = 9.9 Hz, 1H), 4.52 (d, J = 11.3 Hz, 1H), 4.50 (d, J = 11.7 Hz, 1H), 
4.45 (d, J = 11.7 Hz, 1H), 3.82 (ddd, J = 8.2, 5.6, 1.0 Hz, 1H), 3.70 (dd, J = 9.1, 3.2 Hz, 
1H), 3.67 (dd, J = 9.3, 5.6 Hz, 1H), 3.61 (t, J = 9.5 Hz, 1H), 3.49 (dd, J = 9.3, 8.3 Hz, 1H); 
13C NMR (150 MHz, CDCl3) δ 156.8 (q, J = 42.7 Hz, COCF3), 137.9, 137.1, 137.1, 132.8, 
132.1, 128.9, 128.5, 128.4, 128.3, 128.2, 128.0, 128.0, 127.9, 127.8, 127.7, 114.5 (q, J = 
285.8 Hz, CF3CO), 87.4, 80.5, 76.0, 75.7, 74.7, 73.8, 72.3, 71.3, 67.0; 19F NMR (376 MHz, 
CDCl3) δ −74.7 (COCF3).  1H NMR (600 MHz, C6D6) δ 7.59 (d, J = 7.6 Hz, 2H), 7.32 (d, J 
= 7.4 Hz, 2H), 7.19 – 6.91 (m, 16H), 5.57 (d, J = 3.1 Hz, 1H), 4.63 (d, J = 10.7 Hz, 1H), 
4.53 (d, J = 10.8 Hz, 1H), 4.45 (d, J = 11.4 Hz, 1H), 4.37 (d, J = 9.5 Hz, 1H), 4.19 (d, J = 
11.4 Hz, 1H), 4.15 (d, J = 11.7 Hz, 1H), 4.06 (d, J = 11.7 Hz, 1H), 3.71 (t, J = 9.4 Hz, 1H), 
3.34 (dd, J = 9.1, 5.7 Hz, 1H), 3.31 (dd, J = 9.1, 8.1 Hz, 1H), 3.24 (dd, J = 9.1, 3.2 Hz, 
1H), 3.19 – 3.15 (m, 1H).  IR (neat) ν 1790 cm−1 (C=O).  HRMS (ESI) m/z calcd for 
C35H33O6F3SNa [M+Na]+, 661.1848; found, 661.1844. 
Phenyl 4-O-trifluoroacetyl-(6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-
galactopyranoside (6S-D-119). 
Compound 6S-D-119 (0.021 g, 87%) was synthesized from 6S-D-105 analogously 
to 119.  1H NMR (600 MHz, CDCl3) δ 7.56 – 7. 52 (m, 2H), 7.37 – 7.24 (m, 18H), 5.74 (d, 
J = 3.0 Hz, 1H), 4.75 (d, J = 11.2 Hz, 1H), 4.68 (d, J = 10.2 Hz, 1H), 4.65 (d, J = 9.5 Hz, 
1H), 4.64 (d, J = 9.9 Hz, 1H), 4.52 (d, J = 11.6 Hz, 1H), 4.50 (d, J = 11.6 Hz, 1H), 4.45 (d, 
J = 11.6 Hz, 1H), 3.81 (d, J = 5.6 Hz, 1H), 3.70 (dd, J = 9.1, 3.2 Hz, 1H), 3.65 (d, J = 5.6 
Hz, 1H), 3.61 (t, J = 9.4 Hz, 1H).  1H NMR (600 MHz, C6D6) δ 7.61 – 7.58 (m, 2H), 7.33 
(d, J = 7.2 Hz, 2H), 7.21 – 6.92 (m, 16H), 5.58 (d, J = 3.0 Hz, 1H), 4.63 (d, J = 10.8 Hz, 
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1H), 4.53 (d, J = 10.8 Hz, 1H), 4.45 (d, J = 11.4 Hz, 1H), 4.38 (d, J = 9.7 Hz, 1H), 4.19 (d, 
J = 11.4 Hz, 1H), 4.16 (d, J = 11.8 Hz, 1H), 4.06 (d, J = 11.8 Hz, 1H), 3.71 (t, J = 9.4 Hz, 
1H), 3.32 (d, J = 5.6 Hz, 1H), 3.25 (dd, J = 9.1, 3.2 Hz, 1H), 3.17 (d, J = 5.7 Hz, 1H).  
HRMS (ESI) m/z calcd for C35H32F3DO6SNa [M+Na]+, 662.1910; found, 662.1905. 
Phenyl 2,3,6-tri-O-benzyl-4-O-trichloroacetyl-1-thio-β-D-galactopyranoside (120).229  
Compound 120 (0.058 g, 92%) was synthesized from 105 analogously to 119, as 
a colorless oil. [α] 22 D = −8.0 (c 1.80, CH2Cl2);  1H NMR (600 MHz, CDCl3) δ 7.59 – 7.52 
(m, 2H), 7.39 – 7.21 (m, 18H), 5.71 (d, J = 2.9 Hz, 1H), 4.80 (d, J = 11.4 Hz, 1H), 4.65 (d, 
J = 10.6 Hz, 1H), 4.64 (d, J = 9.9 Hz, 1H), 4.62 (d, J = 10.3 Hz, 1H), 4.54 (d, J = 11.6 Hz, 
1H), 4.51 (d, J = 11.4 Hz, 1H), 4.49 (d, J = 11.4 Hz, 1H ), 3.87 (dd, J = 7.9, 6.0 Hz, 1H), 
3.74 – 3.72 (m, 1H), 3.71 (dd, J = 9.2, 5.7 Hz, 1H), 3.68 (t, J = 9.3 Hz, 1H), 3.59 (dd, J = 
9.2, 8.2 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ 161.3, 137.9, 137.3, 137.3, 132.6, 132.3, 
129.0, 128.6, 128.3, 128.3, 128.3, 128.1, 128.0, 127.9, 127.8, 127.6, 89.9, 87.1, 80.9, 
75.6, 75.6, 75.2, 73.9, 72.2, 72.1, 67.3.  1H NMR (600 MHz, C6D6) δ 7.62 – 7.60 (m, 2H), 
7.33 (d, J = 7.4 Hz, 2H), 7.24 – 7.19 (m, 4H), 7.16 – 7.07 (m, 11H), 6.95 – 6.91 (m, 1H), 
5.53 (d, J = 3.0 Hz, 1H), 4.69 (d, J = 10.8 Hz, 1H), 4.66 (d, J = 10.8 Hz, 1H), 4.52 (d, J = 
11.4 Hz, 1H), 4.38 (d, J = 9.9 Hz, 1H), 4.23 (d, J = 11.7 Hz, 1H), 4.19 (d, J = 11.4 Hz, 
1H), 4.18 (d, J = 11.7 Hz, 1H), 3.79 (t, J = 9.4 Hz, 1H), 3.46 (m, 1H), 3.43 (m, 1H), 3.29 
– 3.28 (m, 1H), 3.28 – 3.25 (m, 1H).  IR (neat) ν 1769 cm−1 (C=O).  HRMS (ESI) m/z calcd 
for C35H33O6Cl3SNa [M+Na]+, 709.0961; found, 709.0955. 
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Phenyl 4-O-trichloroacetyl-(6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-
galactopyranoside (6S-D-120). 
Compound 6S-D-120 (0.029 g, 90%) was synthesized from 6S-D-105 analogously 
to 105.  1H NMR (600 MHz, CDCl3) δ 7.59 – 7.52 (m, 2H), 7.39 – 7.21 (m, 18H), 5.70 (d, 
J = 2.9 Hz, 1H), 4.79 (d, J = 11.2 Hz, 1H), 4.65 (d, J = 10.9 Hz, 1H), 4.63 (d, J = 9.9 Hz, 
1H), 4.62 (d, J = 10.6 Hz, 1H), 4.53 (t, J = 11.6 Hz, 1H), 4.52 (d, J = 11.6 Hz, 1H), 4.49 
(d, J = 11.4 Hz, 1H), 3.86 (d, J = 5.7 Hz, 1H), 3.72 (dd, J = 9.1, 3.0 Hz, 1H), 3.69 (d, J = 
5.7, 1H, H), 3.68 (t, J = 9.3 Hz, 1H).  1H NMR (600 MHz, C6D6) δ 7.63 – 7.59 (m, 2H), 
7.33 (d, J = 7.4 Hz, 2H), 7.23 – 7.20 (m, 4H), 7.17 – 6.90 (m, 12H), 5.53 (d, J = 3.0 Hz, 
1H), 4.69 (d, J = 10.8 Hz, 1H), 4.66 (d, J = 10.8 Hz, 1H), 4.52 (d, J = 11.3 Hz, 1H), 4.39 
(d, J = 9.7 Hz, 1H H-1), 4.22 (d, J = 11.7 Hz, 1H), 4.19 (d, J = 11.4 Hz, 1H), 4.17 (d, J = 
11.8 Hz, 1H), 3.79 (t, J = 9.4 Hz, 1H), 3.43 (d, J = 5.7 Hz, 1H, H), 3.29 – 3.26 (m, 2H).  
HRMS (ESI) m/z calcd for C35H32Cl3DO6SNa [M+Na]+, 710.1024; found, 710.1016. 
Phenyl 4-O-benzoyl-2,3,6-tri-O-benzyl-1-thio-β-D-galactopyranoside (121).229 
Compound 121 was synthesized as described in the literature.228  1H NMR (600 
MHz, CDCl3) δ 8.01 – 7.93 (m, 2H), 7.66 – 7.65 (m, 2H), 7.61 – 7.59 (m, 1H), 7.47 – 7.45 
(m, 2H), 7.40 – 7.39 (m, 2H), 7.35 – 7.22 (m, 16H), 5.91 (d, J = 3.0 Hz 1H), 4.87 (d, J = 
11.4 Hz, 1H), 4.74 (br s, 2H), 4.70 (d, J = 9.5 Hz, 1H), 4.54 (d, J = 11.0 Hz, 1H), 4.52 (d, 
J = 10.6 Hz, 1H), 4.46 (d, J = 10.6 Hz, 1H), 3.92 – 3.89 (m, 1H), 3.77 (d, J = 9.2, 3.3 Hz, 
1H), 3.72 (t, J = 9.4 Hz, 1H), 3.69 (dd, J = 9.6, 5.8 Hz, 1H), 3.59 (dd, J = 9.6, 6.8 Hz, 1H).  
1H NMR (600 MHz, C6D6) δ 8.11 (d, J = 8.1 Hz, 2H), 7.70 (dd, J = 12.2, 5.2 Hz, 2H), 7.39 
(d, J = 7.9 Hz, 2H), 7.26 (d, J = 7.9 Hz, 2H), 7.20 (d, J = 7.9 Hz, 2H), 7.17 – 6.95 (m, 
15H), 5.87 (d, J = 3.1 Hz, 1H), 4.75 (d, J = 11.4 Hz, 1H), 4.72 (d, J = 10.9 Hz, 1H), 4.67 
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(d, J = 10.9 Hz, 1H), 4.54 (d, J = 9.7 Hz, 1H), 4.31 (d, J = 11.4 Hz, 1H), 4.19 (d, J = 11.8 
Hz, 1H), 4.12 (d, J = 11.9 Hz, 1H), 3.83 (t, J = 9.4 Hz, 1H), 3.53 (dd, J = 9.3, 6.1 Hz, 1H), 
3.49 (dd, J = 9.3, 6.6 Hz, 1H), 3.42 (t, J = 4.8 Hz, 1H), 3.42 – 3.40 (m, 1H).  IR (neat) ν 
1722 cm−1 (C=O). 
Phenyl 4-O-benzoyl-(6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-galactopyranoside 
(6S-D-121).  
Compound 6S-D-121 (0.021 g, 84%) was synthesized analogously as 121 from 
6S-D-105.  1H NMR (600 MHz, CDCl3) δ 8.02 – 7.99 (m, 2H), 7.67 – 7.64 (m, 2H), 7.61 – 
7.59 (m, 1H), 7.47 – 7.45 (m, 2H), 7.40 – 7.39 (m, 2H), 7.37 – 7.21 (m, 16H), 5.91 (d, J = 
3.1 Hz, 1H), 4.87 (d, J = 11.2 Hz, 1H), 4.74 (br s, 2H), 4.71 (d, J = 9.5 Hz, 1H), 4.54 (d, J 
= 11.2 Hz, 1H ), 4.52 (d, J = 11.8 Hz, 1H), 4.46 (d, J = 11.8 Hz, 1H), 3.90 (d, J = 6.0 Hz, 
1H), 3.77 (dd, J = 9.1, 3.2 Hz, 1H), 3.72 (t, J = 9.3 Hz, 1H), 3.69 (d, J = 6.0 Hz, 1H).  1H 
NMR (600 MHz, C6D6) δ 8.11 (d, J = 7.7 Hz, 2H), 7.70 (d, J = 7.3 Hz, 2H), 7.39 (d, J = 
7.5 Hz, 2H), 7.26 (d, J = 7.4 Hz, 2H), 7.20 (d, J = 7.5 Hz, 2H), 7.14 (t, J = 7.6 Hz, 2H), 
7.09 – 6.94 (m, 13H), 5.87 (d, J = 3.1 Hz, 1H), 4.75 (d, J = 11.4 Hz, 1H), 4.72 (d, J = 10.9 
Hz, 1H), 4.67 (d, J = 10.9 Hz, 1H), 4.54 (d, J = 9.7 Hz, 1H), 4.31 (d, J = 11.4 Hz, 1H), 
4.19 (d, J = 11.9 Hz, 1H), 4.12 (d, J = 11.9 Hz, 1H), 3.83 (t, J = 9.4 Hz, 1H), 3.51 (d, J = 
6.0 Hz, 1H), 3.42 – 3.40 (m, 2H).  HRMS (ESI) m/z calcd for C40H37DO6SNa [M+Na]+, 
670.2350; found, 670.2344. 
Phenyl 4-O-(p-methylbenzoyl)-2,3,6-tri-O-benzyl-1-thio-β-D-galactopyranoside 
(122).229 
Compound 122 (0.057 g, 95%) was synthesized from 105 analogously to 123, as 
a colorless oil. D22 = +20.9 (c 0.55, CH2Cl2);  1H NMR (600 MHz, CDCl3) δ 7.89 – 7.88 
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(m, 2H), 7.64 – 7.63 (m, 2H), 7.38 – 7.21 (m, 20H), 5.87 (d, J = 3.0 Hz, 1H), 4.84 (d, J = 
11.2 Hz, 1H), 4.71 (br s, 2H), 4.69 (d, J = 9.5 Hz, 1H), 4.53 (d, J = 11.0 Hz, 1H), 4.51 (d, 
J = 11.7 Hz, 1H), 4.45 (d, J = 11.7 Hz, 1H), 3.89 – 3.87 (m, 1H), 3.74 (dd, J = 9.1, 3.2 Hz, 
1H), 3.69 (t, J = 9.2 Hz, 1H), 3.68 (dd, J = 9.5, 5.9 Hz, 1H), 3.57 (dd, J = 9.5, 6.8 Hz, 1H), 
2.44 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 165.7, 143.9, 138.3, 137.6, 132.9, 132.8, 
130.0, 129.1, 128.8, 128.4, 128.3, 128.3, 128.2, 128.2, 127.9, 127.7, 127.7, 127.6, 127.0, 
87.1, 81.4, 76.5, 76.4, 75.7, 73.7, 71.7, 68.5, 67.1, 21.7.  1H NMR (600 MHz, C6D6) δ 8.09 
(d, J = 8.0 Hz, 2H), 7.74 – 7.70 (m, 2H), 7.39 (d, J = 7.6 Hz, 2H), 7.28 (d, J = 7.6 Hz, 2H), 
7.21 (t, J = 8.6 Hz, 2H), 7.15 (dd, J = 15.7, 8.0 Hz, 2H), 7.12 – 6.95 (m, 10H), 6.84 (d, J 
= 8.0 Hz, 2H), 5.88 (d, J = 3.2 Hz, 1H), 4.77 (d, J = 11.4 Hz, 1H), 4.73 (d, J = 10.9 Hz, 
1H), 4.67 (d, J  = 10.9 Hz, 1H), 4.55 (d, J = 9.7 Hz, 1H), 4.32 (d, J = 11.8 Hz, 1H), 4.20 
(d, J = 11.8 Hz, 1H), 4.14 (d, J = 10.8 Hz, 1H), 3.86 (t, J = 9.4 Hz, 1H), 3.56 (dd, J = 9.4, 
6.2, Hz, 1H), 3.52 (dd, J = 9.4, 6.5 Hz, 1H), 3.45 – 3.43 (m, 1H), 3.42 – 3.41 (m, 1H) 1.90 
(s, 3H).  IR (neat) ν 1720 cm−1 (C=O).  HRMS (ESI) m/z calcd for C41H40O6SNa [M+Na]+, 
683.2443; found, 683.2446. 
Phenyl 4-O-(p-methylbenzoyl)-(6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-
galactopyranoside (6S-D-122). 
Compound 6S-D-122 (0.016 g, 65%) was synthesized from 6S-D-105 analogously 
to 122. 1H NMR (600 MHz, CDCl3) δ 7.88 (d, J = 8.1 Hz, 2H), 7.64 – 7.63 (m, 2H), 7.39 – 
7.19 (m, 20H), 5.86 (d, J = 3.0 Hz, 1H), 4.83 (d, J = 11.1 Hz, 1H), 4.70 (br s, 2H), 4.68 (d, 
J = 9.5 Hz, 1H), 4.50 (d, J = 11.1 Hz, 1H), 4.49 (d, J = 11.8 Hz, 1H), 4.43 (d, J = 11.8 Hz, 
1H), 3.87 (d, J = 5.9 Hz, 1H), 3.74 (dd, J = 9.1, 3.2 Hz, 1H), 3.68 (t, J = 9.3 Hz, 1H), 3.66 
(d, J = 6.0 Hz, 1H), 2.44 (s, 3H).  1H NMR (600 MHz, C6D6) δ 8.09 (d, J = 8.2 Hz, 2H), 
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7.75 – 7.67 (m, 2H), 7.39 (d, J = 7.2 Hz, 2H), 7.28 (d, J = 7.2 Hz, 2H), 7.22 (d, J = 7.2 Hz, 
1H), 7.14 (t, J = 7.6 Hz, 2H), 7.11 – 6.95 (m, 10H), 6.84 (d, J = 8.1 Hz, 2H), 5.88 (d, J = 
3.1 Hz, 1H), 4.77 (d, J = 11.4 Hz, 1H), 4.73 (d, J = 10.9 Hz, 1H), 4.67 (d, J = 10.8 Hz, 
1H), 4.55 (d, J = 9.7 Hz, 1H), 4.32 (d, J = 11.4 Hz, 1H), 4.19 (d, J = 11.9 Hz, 1H), 4.14 (d, 
J = 11.9 Hz, 1H), 3.87 (t, J = 9.4 Hz, 1H), 3.54 (d, J = 6.2 Hz, 1H), 3.44 – 3.41 (m, 2H), 
1.90 (s, 3H).  HRMS (ESI) m/z calcd for C41H39DO6SNa [M+Na]+, 684.2506; found, 
684.2499. 
Phenyl 4-O-(p-methoxybenzoyl)-2,3,6-tri-O-benzyl-1-thio--D-galactopyranoside 
(123).229 
To a stirred solution of 105 (0.050 g, 0.092 mmol) in dry pyridine (1.0 mL) was 
added 4-methoxy benzoyl chloride (0.025 mL, 0.184 mmol) and DMAP (1.0 mg, 0.009 
mmol) at room temperature.  The reaction mixture was stirred for 8 h before the solvents 
were evaporated under high vacuum to give a crude product, which was dissolved in 
CH2Cl2 (10 mL) and washed with 1 N HCl (5 mL) solution, followed by sat. NaHCO3 
solution, dried over Na2SO4, and concentrated under high vacuum. Silica gel column 
chromatography (eluent: 20 % ethyl acetate in hexane) afforded 123127 (0.050 g, 80%) 
as a colorless oil.  1H NMR (600 MHz, CDCl3) δ 7.97 – 7.95 (m, 2H), 7.66 – 7.62 (m, 2H), 
7.40 – 7.39 (m, 2H), 7.36 – 7.20 (m, 16H), 6.94 – 6.92 (m, 2H), 5.87 (d, J = 3.0 Hz, 1H), 
4.86 (d, J = 11.4 Hz, 1H),  4.74 (br s, 2H), 4.71 (d, J = 9.2 Hz, 1H), 4.53 (d, J = 11.0, 1H), 
4.50 (d, J = 11.7 Hz, 1H), 4.46 (d, J = 11.7 Hz, 1H), 3.89 (s, 3H), 3.89 – 3.87 (m, 1H), 
3.75 (dd, J = 9.2, 2.9 Hz, 1H), 3.71 (t, J = 9.2 Hz, 1H), 3.69 (dd, J = 9.6, 6.1 Hz, 1H), 3.59 
(dd, J = 9.6, 6.5 Hz, 1H).  1H NMR (600 MHz, C6D6) δ 8.11 (d, J = 8.7 Hz, 2H), 7.71 (d, J 
= 7.4 Hz, 2H), 7.40 (d, J = 7.4 Hz, 2H), 7.29 (d, J = 7.4 Hz, 2H), 7.23 (d, J = 7.3 Hz, 2H), 
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7.17 – 6.93 (m, 12H), 6.56 (d, J = 8.8 Hz, 2H), 5.88 (d, J = 3.0 Hz, 1H), 4.79 (d, J = 11.4 
Hz, 1 H), 4.76 (d, J = 10.8 Hz, 1H), 4.71 (d, J = 10.8 Hz, 1H), 4.57 (d, J = 9.7 Hz, 1H), 
4.33 (d, J = 11.4 Hz, 1H), 4.21 (d, J = 11.9 Hz, 1H), 4.15 (d, J = 11.8 Hz, 1H), 3.87 (t, J = 
9.4 Hz, 1H), 3.57 (dd, J = 9.4, 6.2 Hz, 1H), 3.54 (dd, J = 9.4, 6.4 Hz, 1H), 3.47 – 3.41 (m, 
2H), 3.08 (s, 3H).  IR (neat) ν 1728 cm−1 (C=O). 
Phenyl 4-O-(p-methoxybenzoyl)-(6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-
galactopyranoside (6S-D-123). 
Compound 6S-D-123 (0.009 g, 71%) was synthesized from 6S-D-105 analogously 
to 123. 1H NMR (600 MHz, CDCl3) δ 7.98 – 7.91 (m, 2H), 7.69 – 7.58 (m, 2H), 7.39 – 7.18 
(m, 18H), 6.91 (d, J = 8.9 Hz, 2H), 5.85 (d, J = 3.1 Hz, 1H), 4.83 (d, J = 11.2 Hz, 1H), 4.72 
(br s, 2H), 4.68 (d, J = 9.5 Hz, 1H), 4.51 (d, J =  (dd, J = 11.6 Hz OCH2Ph, 4.49 (d, J = 
11.6 Hz, 1H ), 4.44 (d, J = 11.7 Hz, 1H), 3.89 (s, 3H), 3.87 – 3.85 (m, 1H), 3.73 (dd, J = 
9.2, 3.2 Hz, 1H), 3.69 (t, J = 9.3 Hz, 1H), 3.66 (d, J = 6.2 Hz, 1H).  1H NMR (600 MHz, 
C6D6) δ 8.11 (d, J = 8.8 Hz, 2H), 7.71 (d, J = 7.3 Hz, 2H), 7.40 (d, J = 7.5 Hz, 2H), 7.29 
(d, J = 7.4 Hz, 2H), 7.23 (d, J = 7.3 Hz, 2H), 7.17 – 6.93 (m, 12H), 6.55 (d, J = 8.8 Hz, 
2H), 5.88 (d, J = 3.1 Hz, 1H), 4.79 (d, J = 11.4 Hz, 1H), 4.76 (d, J = 10.8 Hz, 1H), 4.71 (d, 
J = 10.8 Hz, 1H), 4.57 (d, J = 9.7 Hz, 1H), 4.33 (d, J = 11.4 Hz, 1H), 4.21 (d, J = 11.9 Hz, 
1H), 4.15 (d, J = 11.9 Hz, 1H), 3.87 (t, J = 9.4 Hz, 1H), 3.55 (d, J = 6.1 Hz, 1H), 3.45 – 
3.41 (m, 2H), 3.08 (s, 3H).  HRMS (ESI) m/z calcd for C41H39DO7SNa [M+Na]+, 700.2455; 
found, 700.2449. 
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Phenyl 4-O-(p-nitrobenzoyl)-2,3,6-tri-O-benzyl-1-thio-β-D-galactopyranoside 
(124).229 
Compound 124 (0.053 g, 84%) was synthesized from 105 analogously to 123, as 
a colorless oil.  [α] 22 D = +19.5 (c 1.95, CH2Cl2);  1H NMR (600 MHz, CDCl3) δ 8.26 – 8.24 
(m, 2H), 8.07 – 8.06 (m, 2H), 7.65 – 7.63 (m, 2H), 7.39 – 7.19 (m, 18H), 5.90 (d, J = 2.3 
Hz, 1H), 4.83 (d, J = 10.6 Hz, 1H), 4.78 (d, J = 10.3 Hz, 1H), 4.73 (d, J = 10.3 Hz, 1H), 
4.70 (d, J = 9.5 Hz, 1H), 4.54 (d, J = 11.0 Hz, 1H), 4.52 (d, J = 11.7 Hz, 1H), 4.43 (d, J = 
11.7 Hz, 1H), 3.91 (t, J = 6.1 Hz, 1H), 3.78 (dd, J = 9.2, 3.3 Hz, 1H), 3.69 (dd, J = 9.5, 5.7 
Hz, 1H), 3.64 (t, J = 9.4 Hz, 1H), 3.56 (dd, J = 9.5, 7.2 Hz, 1H); 13C NMR (150 MHz, 
CDCl3) δ 163.8, 150.6, 138.1, 137.3, 137.3, 135.1, 133.3, 132.5, 130.9, 128.8, 128.4, 
128.2, 128.1, 127.9, 127.9, 127.9, 127.8, 123.5, 87.1, 81.3, 76.5, 75.8, 75.7, 73.7, 72.1, 
68.5, 67.9.   1H NMR (600 MHz, C6D6) δ 7.70 – 7.65 (m, 4H), 7.59 – 7.55 (m, 2H), 7.41 
(d, J = 7.3 Hz, 2H), 7.25 (d, J = 7.2 Hz, 2H), 7.15 (dd, J = 16.1, 7.8 Hz, 4H), 7.08 – 6.91 
(m, 10H), 5.79 (d, J = 3.1 Hz, 1H), 4.85 (d, J = 10.7 Hz, 1H), 4.77 (d, J = 10.8 Hz, 1H), 
4.67 (d, J = 11.1 Hz, 1H), 4.52 (d, J = 9.7 Hz, 1H), 4.28 (d, J = 11.0 Hz, 1H), 4.24 (d, J = 
11.0 Hz, 1H), 4.13 (d, J = 11.9 Hz, 1H), 3.73 (t, J = 9.3 Hz, 1H), 3.47 (dd, J = 8.9, 5.6 Hz, 
1H), 3.42 (dd,  J = 8.9, 7.0 Hz, 1H), 3.41 – 3.39 (m, 1H), 3.38 – 3.37 (m, 1H).  IR (neat) ν 
1729 cm−1 (C=O).  HRMS (ESI) m/z calcd for C40H37NO8SNa [M+Na]+, 714.2138; found, 
714.2120. 
Phenyl 4-O-(p-nitrobenzoyl)-(6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-
galactopyranoside (6S-D-124). 
Compound 6S-D-124 (0.010 g, 83%) was synthesized from 6S-D-105 analogously 
to 124.  1H NMR (600 MHz, CDCl3) δ 8.26 – 8.24 (m, 2H), 8.07 – 8.06 (m, 2H), 7.65 – 
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7.64 (m, 2H), 7.44 – 7.18 (m, 18H), 5.90 (d, J = 3.1 Hz, 1H), 4.83 (d, J = 11.0 Hz, 1H), 
4.78 (d, J = 10.8 Hz, 1H), 4.73 (d, J = 10.3 Hz, 1H), 4.70 (d, J = 9.7 Hz, 1H), 4.54 (d, J = 
11.0 Hz, 1H), 4.52 (d, J = 11.7 Hz, 1H), 4.43 (d, J = 11.8 Hz, 1H), 3.91 (d, J = 5.7 Hz, 
1H), 3.78 (dd, J = 9.1, 3.1 Hz, 1H), 3.67 (d, J = 5.7 Hz, 1H), 3.64 (t, J = 9.4 Hz, 1H).  1H 
NMR (600 MHz, C6D6) δ 7.69 – 7.65 (m, 4H), 7.59 – 7.55 (m,  2H), 7.41 (d, J = 7.3 Hz, 
2H), 7.25 (d, J = 7.3 Hz, 2H), 7.18 – 6.90 (m, 14H), 5.78 (d, J = 3.1 Hz, 1H), 4.85 (d, J = 
10.7 Hz, 1H), 4.77 (d, J = 10.8 Hz, 1H), 4.67 (d, J = 11.1 Hz, 1H), 4.51 (d, J = 9.7 Hz, 
1H), 4.28 (d, J = 11.1 Hz, 1H), 4.24 (d, J = 12.0 Hz, 1H), 4.12 (d, J = 11.9 Hz, 1H), 3.72 
(t, J = 9.4 Hz, 1H), 3.45 (d, J = 5.7 Hz, 1H, H), 3.40 – 3.35 (m, 2H).  HRMS (ESI) m/z 
calcd for C40H36NDO8SNa [M+Na]+, 715.2200; found, 715.2206. 
Phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-galactopyranoside (125). 
Compound 125 was synthesized as described in the literature.216  1H NMR (600 
MHz, CDCl3) δ 7.58 – 7.56 (m, 2H), 7.39 – 7.27 (m, 21H), 7.20 – 7.18 (m, 2H), 4.98 (d, J 
= 11.7 Hz, 1H), 4.79 (d, J = 10.3 Hz, 1H), 4.75 (d, J = 11.7 Hz, 1H), 4.74 – 4.73 (m, 1H), 
4.73 (d, J = 11.7 Hz, 1H), 4.65 (d, J = 9.9 Hz, 1H), 4.61 (d, J = 11.7 Hz, 1H), 4.47 (d, J = 
11.7 Hz, 1H), 4.43 (d, J = 11.7 Hz, 1H), 3.99 (dd, J = 2.8, 1.0 Hz, 1H), 3.95 (t, J = 9.5 Hz, 
1H), 3.67 (m, 1H), 3.65 (m, 1H), 3.63 – 3.62 (m, 1H), 3.61 (dd, J = 2.8, 9.2, 1H).  1H NMR 
(600 MHz, C6D6) δ 7.70 – 7.67 (m, 2H), 7.37 (d, J = 7.2 Hz, 2H), 7.30 (d, J = 7.2 Hz, 2H), 
7.21 (d, J = 7.2 Hz, 2H), 7.18 (d, J = 7.1 Hz, 2H), 7.14 – 7.09 (m, 8H), 7.05 (dt, J = 14.7, 
7.4 Hz, 4H), 6.99 – 6.89 (m, 3H), 4.95 (d, J = 11.4 Hz, 1H), 4.79 (d, J = 10.7 Hz, 1H), 4.64 
(d, J = 10.8 Hz, 1H), 4.59 (d, J = 9.6 Hz, 1H), 4.52 (d, J = 11.4 Hz, 1H), 4.42 (d, J = 11.9 
Hz, 1H), 4.37 (d, J = 11.9 Hz, 1H), 4.22 (d, J = 11.8 Hz, 1H), 4.16 (d, J = 11.8 Hz, 1H), 
4.11 (t, J = 9.4 Hz, 1H), 3.78 (dd, J = 2.9, 1.1 Hz, 1H), 3.66 (dd, J = 9.1, 7.4 Hz, 1H), 3.57 
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(dd, J = 9.1, 5.7 Hz, 1H), 3.32 (ddd, J = 7.3, 5.7, 1.0 Hz, 1H), 3.29 (dd, J = 9.2, 2.8 Hz, 
1H). 
Phenyl (6S)-[6-2H1]-2,3,4,6-tetra-O-benzyl-1-thio-β-D-galactopyranoside (6S-D-125). 
Compound 6S-D-125 (0.012 g, 70%) was synthesized from 6S-D-105 analogously 
to 125.  1H NMR (600 MHz, CDCl3) δ 7.58 – 7.56 (m, 2H), 7.40 – 7.26 (m, 21H ), 7.21 – 
7.16 (m, 2H), 4.97 (d, J = 11.5 Hz, 1H), 4.79 (d, J = 10.2 Hz, 1H), 4.75 (d, J = 11.7 Hz, 
1H), 4.74 – 4.73 (m, 1H), 4.72 (d, J = 11.7 Hz, 1H), 4.65 (d, J = 9.7 Hz, 1H), 4.61 (d, J = 
11.5 Hz, 1H), 4.48 (d, J = 11.7 Hz, 1H), 4.42 (d, J = 11.7 Hz, 1H), 3.99 (d, J = 2.6 Hz, 
1H), 3.94 (t, J = 9.5 Hz, 1H), 3.65 (d, J = 5.8 Hz, 1H, H), 3.62 – 3.61 (m, 2H).  1H NMR 
(600 MHz, C6D6) δ 7.70 – 7.67 (m, 2H), 7.37 (d, J = 7.6 Hz, 2H), 7.30 (d, J = 7.5 Hz, 2H), 
7.21 – 7.16 (m, 4H), 7.15 – 7.02 (m, 12H), 6.99 – 6.89 (m, 3H), 4.95 (d, J = 11.4 Hz, 1H), 
4.79 (d, J = 10.7 Hz, 1H), 4.64 (d, J = 10.8 Hz, 1H), 4.59 (d, J = 9.6 Hz, 1H), 4.52 (d, J = 
11.4 Hz, 1H), 4.42 (d, J = 11.9 Hz, 1H), 4.37 (d, J = 11.9 Hz, 1H), 4.22 (d, J = 11.9 Hz, 
1H), 4.16 (d, J = 11.8 Hz, 1H), 4.11 (t, J = 9.4 Hz, 1H), 3.78 (d, J = 2.6 Hz, 1H), 3.55 (d, 
J = 5.6 Hz, 1H), 3.33 – 3.26 (m, 2H).  HRMS (ESI) m/z calcd for C40H39DO5SNa [M+Na]+, 
656.2557; found, 656.2548. 
Phenyl 2,3,6-tri-O-benzyl-4-O-(1′,1′,1′-trifluoroethyl)-1-thio-β-D-galactopyranoside 
(126).229 
To a solution of phenyl 2,3,6-tri-O-benzyl-1-thio-D-glucopyranoside 106 (0.05 g, 
0.092 mmol) in dry CH2Cl2 was added pyridine (0.03 mL, 0.37 mmol) and 
trifluoromethanesulfonic anhydride (0.02 mL, 0.12 mmol) at 0 oC. The reaction mixture 
was stirred for 1 h before it was quenched with water. The reaction mixture was diluted 
with CH2Cl2 (10 mL), washed with brine (5.0 mL), dried over Na2SO4, and concentrated 
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under high vacuum. Without further purification, the triflate was dissolved in dry DMF (1.0 
mL) and freshly prepared sodium trifluoroethoxide (0.03 g, 0.27 mmol) was added at room 
temperature.  The reaction mixture was stirred for 4 h at room temperature before TLC 
(10% ethyl acetate in hexane) showed completion. The reaction mixture was quenched 
with saturated aqueous NH4Cl solution, extracted with ethyl acetate (2 X 10 mL), dried 
over Na2SO4, and concentrated. Silica gel column chromatography (eluent: 20 % EtOAc 
in hexane) afforded 126 (0.035 g, 61% over 2 steps) as a semi-solid. [α]D22 = −11.0 (c 
0.55, CH2Cl2);  1H NMR (600 MHz, CDCl3) δ 7.56 – 7.55 (m, 2H), 7.37 – 7.21 (m, 18H), 
4.79 (d, J = 10.2 Hz, 1H), 4.75 (d, J = 11.7 Hz, 1H), 4.68 – 4.67 (m, 1H ), 4.66 (d, J = 10.3 
Hz, 1H), 4.61 (d, J = 9.5 Hz, 1H), 4.52 (d, J = 11.7 Hz, 1H), 4.49 (d, J = 11.7 Hz, 1H), 
4.28 (dq, J = 12.1, 8.9 Hz, 1H), 3.93 (d, J = 2.2 Hz, 1H), 3.92 – 3.88 (m, 1H), 3.85 (t, J = 
9.5 Hz, 1H), 3.74 (d, J = 9.2, 7.7 Hz, 1H),  3.69 (dd, J = 9.2, 5.5 Hz, 1H), 3.61 – 3.59 (m, 
1H), 3.57 (dd, J = 9.2, 2.6 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ 138.1, 137.8, 137.7, 
133.8, 131.5, 129.7, 128.9, 128.8, 128.5, 128.4, 128.4, 128.3, 128.0, 127.9, 127.9, 127.8, 
127.7, 127.5, 127.2, 124.7, 122.8, 87.7, 83.7, 77.1, 76.6, 76.0, 75.6, 73.6, 73.4, 69.4 (q, 
J = 34.1 Hz, CF3CH2), 68.1; 19F NMR (376 MHz, CDCl3) δ −74.7 (t, J = 8.7 Hz, CF3CH2O).  
1H NMR (600 MHz, C6D6) δ 7.66 (d, J = 8.2 Hz, 2H), 7.35 (d, J = 7.6 Hz, 2H), 7.19 (d, J 
= 7.6 Hz, 2H), 7.16 – 7.00 (m, 13H), 6.93 (dd, J = 10.6, 4.2 Hz, 1H), 4.80 (d, J = 10.7 Hz, 
1H), 4.54 (d, J = 10.7 Hz, 1H), 4.48 (d, J = 9.9 Hz, 1H), 4.38 (d, J = 11.1 Hz, 1H), 4.23 – 
4.19 (m, 3H), 4.14 (dt, J = 17.8, 8.9 Hz, 1H), 3.95 (t, J = 9.4 Hz, 1H), 3.68 (dd, J = 9.1, 
7.6 Hz, 1H), 3.66 – 3.60 (m, 1H), 3.57 (d, J = 1.7 Hz, 1H), 3.55 (dd, J = 9.1, 5.7 Hz, 1H), 
3.22 – 3.18 (m, 1H), 3.15 (dd, J = 9.2, 2.6 Hz, 1H).  HRMS (ESI) m/z calcd for 
C35H35O5F3SNa [M+Na]+, 647.2055; found, 647.2067. 
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Phenyl (6S)-[6-2H1]-2,3,6-tri-O-benzyl-4-O-(1′,1′,1′-trifluoroethyl)-1-thio-β-D-
galactopyranoside (6S-D-126). 
Compound 6S-D-126 (0.005 g, 30% over 2 steps) was synthesized from 6S-D-106 
analogously to 126.  1H NMR (600 MHz, CDCl3) δ 7.56 – 7.55 (m, 2H), 7.37 – 7.21 (m, 
18H), 4.78 (d, J = 10.1 Hz, 1H), 4.75 (d, J = 11.1 Hz, 1H), 4.67 (d, J = 11.8 Hz, 1H), 4.65 
(d, J = 10.2 Hz, 1H), 4.60 (d, J = 9.7 Hz, 1H), 4.51 (d, J = 11.7 Hz, 1H), 4.49 (d, J = 11.6 
Hz, 1H), 4.27 (dq, J = 12.0, 9.0 Hz, 1H), 3.93 (d, J = 2.3 Hz, 1H), 3.92 – 3.87 (m, 1H), 
3.84 (t, J = 9.4 Hz, 1H), 3.66 (d, J = 5.5 Hz, 1H, H), 3.60 – 3.59 (m, 1H), 3.57 (dd, J = 9.5, 
2.6 Hz, 1H).  1H NMR (600 MHz, C6D6) δ 7.67 (d, J = 7.4 Hz, 2H), 7.35 (d, J = 7.4 Hz, 
2H), 7.21 -7.19 (m, 2H), 7.16 – 6.90 (m, 14H), 4.80 (d, J = 10.7 Hz, 1H), 4.54 (d, J = 10.6 
Hz, 1H), 4.48 (d, J = 9.6 Hz, 1H), 4.37 (d, J = 11.8 Hz, 1H), 4.22 – 4.19 (m, 3H), 4.18 – 
4.10 (m, 1H), 3.95 (t, J = 9.4 Hz, 1H), 3.66 – 3.60 (m, 1H), 3.57 (d, J = 2.3 Hz, 1H), 3.53 
(d, J = 5.6 Hz, 1H, H), 3.19 (d, J = 6.0 Hz, 1H), 3.15 (dd, J = 9.2, 2.7 Hz, 1H).  HRMS 
(ESI) m/z calcd for C35H34DF3O5SNa [M+Na]+, 648.2118; found, 648.2102. 
Phenyl 4-O-acetyl-2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (127). 
Compound 127 was synthesized as described in the literature.389  1H NMR (600 
MHz, CDCl3) δ 7.59 – 7.55 (m, 2H), 7.41 – 7.21 (m, 18H), 5.01 (dd, J = 9.4, 8.7 Hz, 1H), 
4.88 (d, J = 10.3 Hz, 1H), 4.81 (d, J = 11.4 Hz, 1H), 4.70 (d, J = 10.3 Hz, 1H), 4.69 (d, J 
= 9.8 Hz, 1H), 4.64 (d, J = 11.4 Hz, 1H), 4.51 (s, 2H), 3.67 (dd, J = 9.4, 8.8 Hz, 1H), 3.61 
– 3.57 (m, 3H), 3.55 (dd, J = 9.8, 8.8 Hz, 1H), 1.85 (s, 3H).  1H NMR (600 MHz, C6D6) δ 
7.69 – 7.64 (m, 2H), 7.43 – 7.39 (m, 2H), 7.33 – 7.29 (m, 2H), 7.28 – 7.24 (m, 2H), 7.21 
– 6.94 (m, 12H), 5.33 (dd, J = 10.6, 9.2 Hz, 1H), 4.86 (d, J = 10.9 Hz, 1H), 4.76 (d, J = 
11.8 Hz, 1H), 4.64 (d, J = 9.6 Hz, 1H), 4.59 – 4.57 (m, 2H), 4.31 (s, 2H), 3.58 (dd, J = 
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10.6, 3.2 Hz, 1H), 3.54 (dd, J = 10.6, 5.8 Hz, 1H), 3.52 (dd, J = 9.2, 8.7 Hz, 1H), 3.48 (dd, 
J = 9.6, 8.7 Hz, 1H), 3.36 (ddd, J = 10.1, 5.8, 3.2 Hz, 1H), 1.54 (s, 3H).  IR (neat) ν 1745 
cm−1 (C=O). 
Phenyl 2,3,6-tri-O-benzyl-4-O-trifluoroacetyl-1-thio-β-D-glucopyranoside (128). 
Compound 106 (0.009 g, 0.016 mmol) was dissolved in anhydrous pyridine (0.05 
ml) and cooled to 0 °C before the addition of trifluoroacetic anhydride (4.5 µl, 0.032 mmol). 
The reaction mixture was then stirred for 4 h under an argon atmosphere and 
concentrated to dryness. The crude residue was purified by silica gel column 
chromatography, eluting with hexane/ethyl acetate (7:3), to obtain 128 (0.008 g, 74%) as 
a colorless oil. [α]D22 = +37.0 (c 0.33, CH2Cl2);  1H NMR (600 MHz, CDCl3) δ 7.57 – 7.54 
(m, 2H), 7.41 – 7.17 (m, 18H), 5.24 (dd, J = 9.8, 9.6 Hz, 1H), 4.91 (d, J = 10.2 Hz, 1H), 
4.81 (d, J = 10.8 Hz, 1H), 4.70 (d, J = 10.2 Hz, 1H), 4.69 (d, J = 9.8 Hz, 1H), 4.62 (d, J = 
10.8 Hz, 1H), 4.54 (d, J = 11.6 Hz, 1H), 4.47 (d, J = 11.6 Hz, 1H), 3.77 (dd, J = 9.6, 8.8 
Hz, 1H), 3.69 (ddd, J = 9.8, 4.7, 3.6 Hz, 1H), 3.62 (dd, J = 10.7, 3.6 Hz, 1H), 3.58 (dd, J 
= 10.7, 4.7 Hz, 1H), 3.58 (dd, J = 9.8, 8.8 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ 156.5 
(d, J = 42.5 Hz), 137.8, 137.6, 137.5, 133.2, 132.4, 129.2, 128.6, 128.5, 128.3, 128.2, 
128.1, 128.01, 127.95, 127.9, 114.6 (d, J = 285.8 Hz), 87.9, 83.2, 80.8, 76.5, 75.9, 75.7, 
74.7, 73.9, 69.1; 19F NMR (376 MHz, CDCl3) δ -75.0 (OCOCF3).  1H NMR (600 MHz, 
C6D6) δ 7.61 – 7.55 (m, 2H), 7.40 – 7.36 (m, 2H), 7.27 – 6.94 (m, 16H), 5.40 (dd, J = 10.0, 
9.5 Hz, 1H), 4.83 (d, J = 10.6 Hz, 1H), 4.71 (d, J = 11.3 Hz, 1H), 4.55 (d, J = 11.3 Hz, 
1H), 4.50 (d, J = 10.6 Hz, 1H), 4.46 (d, J = 9.7 Hz, 1H), 4.26 (d, J = 12.0 Hz, 1H), 4.18 (d, 
J = 12.0 Hz, 1H), 3.43 (dd, J = 9.5, 8.7 Hz, 1H), 3.37 (dd, J = 10.6, 3.5 Hz, 1H), 3.34 (dd, 
J = 9.7, 8.7 Hz, 1H), 3.30 (dd, J = 10.6, 4.3 Hz, 1H), 3.00 (ddd, J = 10.0, 4.3, 3.5 Hz, 1H).  
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IR (neat) ν 1793 cm−1 (C=O).  HRMS (ESI) m/z calcd for C35H33O6SF3Na [M+Na]+, 
661.1848; found, 661.1843. 
Phenyl 4-O-benzoyl-2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (129). 
Compound 105 (0.010 g, 0.018 mmol) was dissolved in anhydrous 
dichloromethane (0.5 mL) and cooled to 0 °C. Anhydrous pyridine (15 µL, 0.18 mmol) 
was added followed by Tf2O (10 µL, 0.060 mmol) and the reaction mixture stirred for 1.5 
h before it was quenched with water at 0 °C. The reaction mixture was diluted with water 
and extracted with dichloromethane. The combined organic layers were dried over 
anhydrous Na2SO4 and concentrated to dryness. The crude residue was then dissolved 
in anhydrous DMF (0.15 mL), and sodium benzoate (7.9 mg, 0.055 mmol) was added. 
The reaction mixture was stirred under an argon atmosphere at room temperature for 3 
h then diluted with water and extracted with ethyl acetate. The organic layer was 
separated, dried over anhydrous Na2SO4, and concentrated to dryness. The crude 
residue was purified by column chromatography over silica gel, eluting with hexane/ethyl 
acetate (8:2) to obtain 129 (0.008 g, 71%) with spectral data consistent with the 
literature.228  1H NMR (600 MHz, CDCl3) δ 7.98 – 7.93 (m, 2H), 7.64 – 7.53 (m, 3H), 7.44 
– 7.04 (m, 20H), 5.29 (dd, J = 10.1, 9.4 Hz, 1H), 4.90 (d, J = 10.2 Hz, 1H), 4.77 (d, J = 
9.8 Hz, 1H), 4.75 (d, J = 11.0 Hz, 1H), 4.74 (d, J = 10.2 Hz, 1H), 4.62 (d, J = 11.0 Hz, 
1H), 4.49 (d, J = 11.6 Hz, 1H), 4.46 (d, J = 11.6 Hz, 1H), 3.83 (dd, J = 9.4, 8.7 Hz, 1H), 
3.79 – 3.75 (m, 1H), 3.66 – 3.64 (m, 2H), 3.62 (dd, J = 9.8, 8.7 Hz, 1H).  1H NMR (600 
MHz, C6D6) δ 8.07 – 8.04 (m, 2H), 7.73 – 7.68 (m, 2H), 7.45 – 7.42 (m, 2H), 7.27 – 6.94 
(m, 19H), 5.65 (dd, J = 10.0, 9.4 Hz, 1H), 4.89 (d, J = 10.8 Hz, 1H), 4.72 (d, J = 9.8 Hz, 
1H), 4.72 (d, J = 11.4 Hz, 1H), 4.62 (d, J = 11.4 Hz, 1H), 4.61 (d, J = 10.8 Hz, 1H), 4.26 
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– 4.20 (m, 2H), 3.68 (dd, J = 9.4, 8.6 Hz, 1H), 3.62 (dd, J = 10.7, 2.9 Hz, 1H), 3.58 (dd, J 
= 10.7, 6.0 Hz, 1H), 3.54 (dd, J = 9.8, 8.6 Hz, 1H), 3.48 (ddd, J = 10.0, 6.0, 2.9 Hz, 1H).  
IR (neat) ν 1726 cm−1 (C=O). 
Phenyl 4-O-benzoyl-(6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (6S-
D-129). 
Compound 6S-D-129 (0.030 g, 74%) was synthesized from 6S-D-106 analogously 
to 129.  1H NMR (600 MHz, CDCl3) δ 7.97 – 7.93 (m, 2H), 7.62 – 7.54 (m, 3H), 7.45 – 
7.04 (m, 20H), 5.29 (dd, J = 10.0, 9.4 Hz, 1H), 4.90 (d, J = 10.2 Hz, 1H), 4.77 (d, J = 9.8 
Hz, 1H), 4.77 (d, J = 10.9 Hz, 1H), 4.74 (d, J = 10.2 Hz, 1H), 4.62 (d, J = 10.9 Hz, 1H), 
4.49 (d, J = 11.7 Hz, 1H), 4.46 (d, J = 11.7 Hz, 1H), 3.83 (dd, J = 9.4, 8.8 Hz, 1H), 3.76 
(dd, J = 10.0, 6.4 Hz, 1H), 3.65 – 3.60 (m, 2H).  1H NMR (600 MHz, C6D6) δ 8.07 – 8.03 
(m, 2H), 7.73 – 7.68 (m, 2H), 7.46 – 7.41 (m, 2H), 7.27 – 6.92 (m, 19H), 5.64 (dd, J = 
10.0, 9.4 Hz, 1H), 4.89 (d, J = 10.7 Hz, 1H), 4.72 (d, J = 9.8 Hz, 1H), 4.72 (d, J = 11.4 Hz, 
1H), 4.62 (d, J = 11.4 Hz, 1H), 4.61 (d, J = 10.7 Hz, 1H), 4.25 (d, J = 11.8 Hz, 1H), 4.22 
(d, J = 11.8 Hz, 1H), 3.68 (dd, J = 9.4, 8.7 Hz, 1H), 3.56 (d, J = 6.1 Hz, 1H), 3.54 (dd, J = 
9.8, 8.7 Hz, 1H), 3.47 (dd, J = 10.0, 6.1 Hz, 1H).  HRMS (ESI) m/z calcd for 
C40H37DO6SNa [M+Na]+, 670.2350; found, 6703.2354. 
Phenyl 4-O-benzenesulfonyl-2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (130). 
Compound 106 (0.007 g, 0.014 mmol) and 4-dimethylaminopyridine (catalytic 
amount) were dissolved in anhydrous pyridine (0.1 mL) and cooled to 0 °C. 
Benzenesulfonyl chloride (5 µL, 0.039 mmol) was added at 0 °C and the reaction mixture 
was stirred overnight under an argon atmosphere at room temperature. The reaction 
mixture was concentrated to dryness and the crude residue was dissolve in ethyl acetate 
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and filtered through a cotton plug before the organic layer was concentrated to dryness. 
The crude residue was then purified by silica gel column chromatography, eluting with 
hexane/ethyl acetate (9:1 to 4:1) to obtain 130 (0.005 g, 57%) as a colorless oil. [α]D22 = 
+13.3 (c 0.15, CH2Cl2);  1H NMR (600 MHz, CDCl3) δ 7.88 – 7.81 (m, 2H), 7.59 – 7.16 
(m, 23H), 4.82 (dd, J = 9.9, 9.2 Hz, 1H), 4.81 (d, J = 10.2 Hz, 1H), 4.70 (d, J = 11.2 Hz, 
1H), 4.63 (d, J = 9.8 Hz, 1H), 4.60 (d, J = 10.2 Hz, 1H), 4.55 (d, J = 11.2 Hz, 1H), 4.49 (d, 
J = 11.6 Hz, 1H), 4.46 (d, J = 11.6 Hz, 1H), 3.71 (dd, J = 10.8, 2.1 Hz, 1H), 3.66 (dd, J = 
9.2, 8.7 Hz, 1H), 3.62 (ddd, J = 9.9, 5.6, 2.1 Hz, 1H), 3.54 (dd, J = 9.8, 8.7 Hz, 1H), 3.51 
(dd, J = 10.8, 5.6 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ 133.7, 132.2, 129.1, 129.1, 
128.5, 128.5, 128.3, 128.1, 127.8, 127.7, 127.6, 127.5, 87.5, 83.7, 81.0, 78.0, 77.8, 75.6, 
75.4, 73.5, 68.9.  1H NMR (600 MHz, C6D6) δ 7.83 – 7.77 (m, 2H), 7.67 – 7.64 (m, 2H), 
7.43 – 6.60 (m, 23H), 5.08 (dd, J = 9.9, 9.1 Hz, 1H), 4.80 (d, J = 10.4 Hz, 1H), 4.64 (d, J 
= 11.7 Hz, 1H) , 4.49 (d, J = 9.4 Hz, 1H), 4.47 (d, J = 11.7 Hz, 1H), 4.44 (d, J = 10.4 Hz, 
1H), 4.38 (d, J = 11.4 Hz, 1H), 4.36 (d, J = 11.4 Hz, 1H), 3.81 (dd, J = 10.8, 2.0 Hz, 1H), 
3.69 (dd, J = 10.8, 5.3 Hz, 1H), 3.45 – 3.35 (m, 2H), 3.24 (ddd, J = 9.9, 5.3, 2.0 Hz, 1H).  
IR (neat) ν 1360 cm−1 (S=O), 1188 cm−1 (S=O).  HRMS (ESI) m/z calcd for C39H38O7S2Na 
[M+Na]+, 705.1957; found, 705.1954. 
Phenyl 4-O-benzenesulfonyl-(6S)-[6-2H1]-2,3,6-tri-O-benzyl-1-thio-β-D-
glucopyranoside (6S-D-130). 
Compound 6S-D-130 (0.005 mg, 62 %) was synthesized from 6S-D-106 
analogously to 130.  1H NMR (600 MHz, CDCl3) δ 7.87 – 7.81 (m, 2H), 7.60 – 7.17 (m, 
23H), 4.81 (dd, J = 9.9, 9.2 Hz, 1H), 4.81 (d, J = 10.1 Hz, 1H), 4.70 (d, J = 10.8 Hz, 1H), 
4.64 (d, J = 9.7 Hz, 1H), 4.60 (d, J = 10.1 Hz, 1H), 4.55 (d, J = 10.8 Hz, 1H), 4.49 (d, J = 
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11.8 Hz, 1H), 4.45 (d, J = 11.8 Hz, 1H), 3.66 (dd, J = 9.2, 8.7 Hz, 1H), 3.61 (dd, J = 9.9, 
5.7 Hz, 1H), 3.54 (dd, J = 9.7, 8.7 Hz, 1H), 3.50 (d, J = 5.7 Hz, 1H).  1H NMR (600 MHz, 
C6D6) δ 7.82 – 7.79 (m, 2H), 7.67 – 7.64 (m, 2H), 7.43 – 6.62 (m, 21H), 5.07 (dd, J = 9.9, 
9.0 Hz, 1H), 4.80 (d, J = 10.6 Hz, 1H), 4.64 (d, J = 11.6 Hz, 1H), 4.49 (d, J = 9.5 Hz, 1H), 
4.47 (d, J = 11.6 Hz, 1H), 4.45 (d, J = 10.6 Hz, 1H), 4.39 (d, J = 11.5 Hz, 1H), 4.36 (d, J 
= 11.5 Hz, 1H), 3.67 (d, J = 5.3 Hz, 1H), 3.44 – 3.36 (m, 2H), 3.24 (dd, J = 9.9, 5.3 Hz, 
1H).  HRMS (ESI) m/z calcd for C39H37DO7S2Na [M+Na]+, 706.2019; found, 706.2014. 
Phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (131). 
Compound 131 was synthesized as described in the literature.217  1H NMR (600 
MHz, CDCl3) δ 7.61 – 7.58 (m, 2H), 7.41 – 7.18 (m, 23H), 4.90 (d, J = 10.9 Hz, 1H), 4.89 
(d, J = 10.1 Hz, 1H), 4.85 (d, J = 10.9 Hz, 1H), 4.83 (d, J = 10.9 Hz, 1H), 4.73 (d, J = 10.1 
Hz, 1H), 4.67 (d, J = 9.8 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.60 (d, J = 10.9 Hz, 1H), 
4.55 (d, J = 12.0 Hz, 1H), 3.80 (dd, J = 10.8, 1.9 Hz, 1H), 3.73 (dd, J = 10.8, 4.8 Hz, 1H), 
3.71 (dd, J = 8.9, 8.8 Hz, 1H), 3.66 (dd, J = 9.6, 8.9 Hz, 1H), 3.52 (dd, J = 9.8, 8.8 Hz, 
1H), 3.51 (ddd, J = 9.6, 4.8, 1.9 Hz, 1H).  1H NMR (600 MHz, C6D6) δ 7.73 – 7.70 (m, 2H), 
7.46 – 7.42 (m, 2H), 7.35 – 7.27 (m, 4H), 7.23 – 6.95 (m, 17H), 4.95 (d, J = 10.7 Hz, 1H), 
4.89 (d, J = 11.3 Hz, 1H), 4.83 – 4.79 (m, 2H), 4.72 (d, J = 10.7 Hz, 1H), 4.65 (d, J = 9.6 
Hz, 1H), 4.56 (d, J = 11.3 Hz, 1H), 4.44 (d, J = 12.0 Hz, 1H), 4.35 (d, J = 12.0 Hz, 1H), 
3.70 (dd, J = 9.8, 9.0 Hz, 1H), 3.64 – 3.62 (m, 2H), 3.61 (dd, J = 9.0, 8.7 Hz, 1H), 3.56 
(dd, J = 9.6, 8.7 Hz, 1H), 3.27 – 3.23 (m, 1H). 
Phenyl (6S)-[6-2H1]-2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (6S-D-131). 
A solution of compound 6S-D-106 (0005 g, 0.008 mmol) in anhydrous DMF (0.2 
mL) was cooled to 0 °C and treated with NaH (60%, 1 mg, 0.025 mmol) and benzyl 
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bromide (5.1 µl, 0.025 mmol), respectively. The reaction mixture was then stirred for 3.5 
h under an argon atmosphere at room temperature and quenched with water at 0 °C. The 
aqueous layer was extracted with ethyl acetate, and the organic layer was washed with 
brine, treated with anhydrous Na2SO4 and concentrated to dryness. The crude residue 
was purified by silica gel column chromatography, eluting with hexane/ethyl acetate (19:1 
to 4:1) to obtain 6S-D-131 (0.004 g, 80%).  1H NMR (600 MHz, CDCl3) δ 7.60 – 7.56 (m, 
2H), 7.41 – 7.17 (m, 23H), 4.90 (d, J = 10.9 Hz, 1H), 4.89 (d, J = 10.3 Hz, 1H), 4.85 (d, J 
= 11.0 Hz, 1H), 4.83 (d, J = 10.8 Hz, 1H), 4.73 (d, J = 10.3 Hz, 1H), 4.67 (d, J = 9.8 Hz, 
1H), 4.61 (d, J = 12.0 Hz, 1H), 4.59 (d, J = 10.8 Hz, 1H), 4.55 (d, J = 12.0 Hz, 1H), 3.73 
– 3.69 (m, 2H), 3.67 – 3.61 (m, 1H), 3.51 (dd, J = 9.8, 8.7 Hz, 1H), 3.50 (dd, J = 9.7, 4.9 
Hz, 1H).  1H NMR (600 MHz, C6D6) δ 7.75 – 7.67 (m, 2H), 7.46 – 7.41 (m, 2H), 7.35 – 
6.93 (m, 21H), 4.96 (d, J = 10.5 Hz, 1H), 4.89 (d, J = 11.4 Hz, 1H), 4.83 – 4.78 (m, 2H), 
4.72 (d, J = 10.7 Hz, 1H), 4.65 (d, J = 9.6 Hz, 1H), 4.56 (d, J = 11.4 Hz, 1H), 4.43 (d, J = 
12.0 Hz, 1H), 4.36 (d, J = 12.0 Hz, 1H), 3.70 (dd, J = 9.7, 9.2 Hz, 1H), 3.63 – 3.59 (m, 
2H), 3.56 (dd, J = 9.6, 8.8 Hz, 1H), 3.25 (dd, J = 9.7, 4.5 Hz, 1H).  HRMS (ESI) m/z calcd 
for C40H39DO5SNa [M+Na]+, 656.2557; found, 656.2559. 
Ethyl 6-O-acetyl-2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (132). 
Compound 132  was synthesized as described in the literature.203  1H NMR (600 
MHz, CDCl3) δ 7.39 – 7.24 (m, 15H), 4.95 (d, J = 10.9 Hz, 1H), 4.93 (d, J = 10.2 Hz, 1H), 
4.86 (d, J = 10.8 Hz, 1H), 4.85 (d, J = 10.9 Hz, 1H), 4.74 (d, J = 10.2 Hz, 1H), 4.57 (d, J 
= 10.8 Hz, 1H), 4.47 (d, J = 9.8 Hz, 1H), 4.33 (dd, J = 11.9, 1.9 Hz, 1H), 4.20 (dd, J = 
11.9, 5.1 Hz, 1H), 3.71 (dd, J = 8.8, 8.7 Hz, 1H), 3.54 (dd, J = 9.8, 8.7 Hz, 1H), 3.51 (ddd, 
J = 9.8, 5.1, 1.9 Hz, 1H), 3.44 (dd, J = 9.8, 8.8 Hz, 1H), 2.81 – 2.70 (m, 2H), 2.04 (s, 3H), 
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1.33 (t, J = 7.4 Hz, 3H).  1H NMR (600 MHz, C6D6) δ 7.43 – 7.40 (m, 2H), 7.34 – 7.32 (m, 
2H), 7.27 – 7.25 (m, 2H), 7.20 – 7.05 (m, 9H), 4.99 (d, J = 10.6 Hz, 1H), 4.95 (d, J = 11.2 
Hz, 1H), 4.81 (d, J = 11.2 Hz, 1H), 4.81 (d, J = 11.2 Hz, 1H), 4.70 (d, J = 10.6 Hz, 1H), 
4.49 (d, J = 11.2 Hz, 1H), 4.43 (dd, J = 11.9, 2.2 Hz, 1H), 4.35 (d, J = 9.7 Hz, 1H), 4.26 
(dd, J = 11.9, 5.4 Hz, 1H), 3.61 (dd, J = 8.9, 8.8 Hz, 1H), 3.48 (dd, J = 9.8, 8.8 Hz, 1H), 
3.47 (dd, J = 9.7, 8.9 Hz, 1H), 3.26 (ddd, J = 9.8, 5.4, 2.2 Hz, 1H), 2.59 (dq, J = 12.6, 7.4 
Hz, 1H), 2.49 (dq, J = 12.6, 7.4 Hz, 1H), 1.64 (s, 3H1.13 (t, J = 7.4 Hz, 3H).  IR (neat) ν 
1742 cm−1 (C=O). 
Ethyl 2,3,4-tri-O-benzyl-6-O-pivolyl-1-thio-β-D-glucopyranoside (133). 
Compound 107203 (0.008 g, 0.016 mmol) was dissolved in anhydrous pyridine 
(0.05 mL) and treated with pivolyl chloride (2.5 µl, 0.020 mmol). The reaction mixture was 
then stirred under an argon atmosphere at room temperature overnight and concentrated 
to dryness. The crude residue was purified by silica gel column chromatography, eluting 
with hexane/ethyl acetate (4:1 to 7:3) to obtain 133 (0.007 g, 92%) as a colorless oil. [α]D22 
= +14.0 (c 0.57, CH2Cl2);   1H NMR (600 MHz, CDCl3) δ 7.39 – 7.25 (m, 15H), 4.94 (d, J 
= 10.8 Hz, 1H), 4.93 (d, J = 10.2 Hz, 1H), 4.88 (d, J = 10.7 Hz, 1H), 4.85 (d, J = 10.8 Hz, 
1H), 4.74 (d, J = 10.2 Hz, 1H), 4.58 (d, J = 10.7 Hz, 1H), 4.48 (d, J = 9.8 Hz, 1H), 4.44 
(dd, J = 11.9, 1.8 Hz, 1H), 4.12 (dd, J = 11.9, 5.6 Hz, 1H), 3.71 (dd, J = 8.8, 8.7 Hz, 1H), 
3.53 (ddd, J = 9.9, 5.6, 1.8 Hz, 1H), 3.50 (dd, J = 9.9, 8.7 Hz, 1H), 3.44 (dd, J = 9.8, 8.8 
Hz, 1H), 2.78 (dq, J = 12.7, 7.4 Hz, 1H), 2.70 (dq, J = 12.7, 7.4 Hz, 1H), 1.32 (t, J = 7.4 
Hz, 3H), 1.21 (s, 9H); 13C NMR (150 MHz, CDCl3) δ 178.2, 138.4, 138.0, 137.8, 128.7, 
128.6, 128.6, 128.4, 128.2, 128.0, 128.0, 127.9, 86.7, 84.8, 81.9, 78.2, 76.0, 75.7, 75.4, 
63.5, 27.4, 24.9, 15.4.  1H NMR (600 MHz, C6D6) δ 7.45 – 7.41 (m, 2H), 7.35 – 7.31 (m, 
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2H), 7.27 (dd, J = 8.5, 1.7 Hz, 2H), 7.19 – 7.05 (m, 9H), 4.99 (d, J = 10.6 Hz, 1H), 4.95 
(d, J = 11.2 Hz, 1H), 4.85 (d, J = 11.1 Hz, 1H), 4.82 (d, J = 11.2 Hz, 1H), 4.71 (d, J = 10.6 
Hz, 1H), 4.55 (dd, J = 11.9, 2.1 Hz, 1H), 4.50 (d, J = 11.1 Hz, 1H), 4.34 (d, J = 9.7 Hz, 
1H), 4.23 (dd, J = 11.9, 5.7 Hz, 1H), 3.60 (dd, J = 9.0, 8.8 Hz, 1H), 3.48 (dd, J = 9.7, 8.8 
Hz, 1H), 3.46 (dd, J = 9.8, 9.0 Hz, 1H), 3.26 (ddd, J = 9.8, 5.7, 2.1 Hz, 1H), 2.63 (dq, J = 
12.7, 7.4 Hz, 1H), 2.49 (dq, J = 12.7, 7.4 Hz, 1H), 1.18 (s, 9H), 1.16 (t, J = 7.4 Hz, 3H).  
IR (neat) ν 1731 cm−1 (C=O).  HRMS (ESI) m/z calcd for C34H42O6SNa [M+Na]+, 
601.2600; found, 601.2602. 
Ethyl 2,3,4-tri-O-benzyl-6-O-trifluoroacetyl-1-thio-β-D-glucopyranoside (134). 
Compound 134 was synthesized using the same procedure as described for the 
synthesis of the compound 128 from compound 107 (0.007 g, 0.014 mmol) and 
trifluoroacetic anhydride (3.8 µL, 0.028 mmol) in anhydrous pyridine (0.05 mL). After 
purification by silica gel column chromatography, eluting with hexane/ethyl acetate (7:3) 
134 (6.0 mg, 72 %) was obtained as a colorless oil. [α]D22 = +16.6 (c 0.31, CH2Cl2);  1H 
NMR (600 MHz, CDCl3) δ 7.39 – 7.23 (m, 15H), 4.96 (d, J = 10.9 Hz, 1H), 4.93 (d, J = 
10.2 Hz, 1H), 4.90 (d, J = 11.1 Hz, 1H), 4.85 (d, J = 10.9 Hz, 1H), 4.74 (d, J = 10.2 Hz, 
1H), 4.56 (d, J = 11.1 Hz, 1H), 4.54 (dd, J = 11.6, 2.1 Hz, 1H), 4.48 (d, J = 9.8 Hz, 1H), 
4.32 (dd, J = 11.6, 6.3 Hz, 1H), 3.72 (dd, J = 8.9, 8.8 Hz, 1H), 3.58 (ddd, J = 9.9, 6.3, 2.1 
Hz, 1H), 3.49 (dd, J = 9.9, 8.9 Hz, 1H), 3.45 (dd, J = 9.8, 8.8 Hz, 1H), 2.75 (dq, J = 12.8, 
7.4 Hz, 1H), 2.68 (dq, J = 12.8, 7.4 Hz, 1H), 1.30 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, 
CDCl3) δ 157.27 (q, J = 42.5 Hz), 138.3, 137.9, 137.5, 128.8, 128.7, 128.6, 128.4, 128.3, 
128.2, 128.1, 127.98, 127.95, 114.6 (q, J = 285.4 Hz), 86.7, 85.2, 81.8, 76.3, 76.0, 75.7, 
75.3, 66.7, 25.1, 15.2; 19F NMR (376 MHz, CDCl3) δ -74.9(COCF3).  1H NMR (600 MHz, 
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C6D6) δ 7.42 – 7.39 (m, 2H), 7.32 – 7.28 (m, 2H), 7.20 – 7.06 (m, 11H), 4.95 (d, J = 10.6 
Hz, 1H), 4.92 (d, J = 11.2 Hz, 1H), 4.75 (d, J = 11.4 Hz, 1H), 4.75 (d, J = 11.2 Hz, 1H), 
4.65 (d, J = 10.6 Hz, 1H), 4.34 (d, J = 11.4 Hz, 1H), 4.24 (dd, J = 11.3, 2.4 Hz, 1H), 4.23 
(d, J = 9.7 Hz, 1H), 4.05 (dd, J = 11.5, 6.3 Hz, 1H), 3.51 (dd, J = 8.9, 8.8 Hz, 1H), 3.37 
(dd, J = 9.7, 8.8 Hz, 1H), 3.26 (dd, J = 9.9, 8.9 Hz, 1H), 3.07 (ddd, J = 9.9, 6.3, 2.2 Hz, 
1H), 2.55 (dq, J = 12.8, 7.4 Hz, 1H), 2.43 (dq, J = 12.8, 7.4 Hz, 1H), 1.12 (t, J = 7.4 Hz, 
3H).  IR (neat) ν 1790 cm−1 (C=O).  HRMS (ESI) m/z calcd for C31H33O6SF3Na [M+Na]+, 
613.1848; found, 613.1850. 
Ethyl 6-O-benzoyl-2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (135). 
Compound 135 was synthesized as described in the literature.390  1H NMR (600 
MHz, CDCl3) δ 8.07 – 8.04 (m, 2H), 7.60 – 7.56 (m, 1H), 7.49 – 7.40 (m, 4H), 7.39 – 7.24 
(m, 13H), 4.99 (d, J = 10.8 Hz, 1H), 4.97 (d, J = 10.2 Hz, 1H), 4.91 (d, J = 10.8 Hz, 1H), 
4.90 (d, J = 10.8 Hz, 1H), 4.79 (d, J = 10.2 Hz, 1H), 4.66 – 4.63 (m, 1H), 4.64 (d, J = 10.8 
Hz, 1H), 4.55 (d, J = 9.8 Hz, 1H), 4.48 – 4.44 (m, 1H), 3.78 (t, J = 8.8 Hz, 1H), 3.69 – 3.67 
(m, 2H), 3.52 (dd, J = 9.8, 8.8 Hz, 1H), 2.79 (dq, J = 12.7, 7.5 Hz, 1H), 2.73 (dq, J = 12.7, 
7.5 Hz, 1H), 1.32 (d, J = 7.5 Hz, 3H).   1H NMR (600 MHz, C6D6) δ 8.18 – 8.16 (m, 2H), 
7.43 – 7.40 (m, 2H), 7.34 – 7.31 (m, 2H), 7.28 – 7.25 (m, 2H), 7.20 – 7.01 (m, 12H), 4.98 
(d, J = 10.6 Hz, 1H), 4.96 (d, J = 11.2 Hz, 1H), 4.83 (d, J = 11.2 Hz, 1H), 4.81 (d, J = 11.1 
Hz, 1H), 4.71 (d, J = 10.6 Hz, 1H), 4.65 (dd, J = 11.8, 2.3 Hz, 1H), 4.52 (d, J = 11.1 Hz, 
1H), 4.51 (dd, J = 11.8, 5.6 Hz, 1H), 4.38 (d, J = 9.7 Hz, 1H), 3.64 (dd, J = 9.0, 8.8 Hz, 
1H), 3.56 (dd, J = 9.8, 9.0 Hz, 1H), 3.51 (dd, J = 9.6, 8.8 Hz, 1H), 3.36 (ddd, J = 9.8, 5.6, 
2.3 Hz, 1H), 2.59 (dq, J = 12.7, 7.4 Hz, 1H), 2.46 (dq, J = 12.7, 7.5 Hz, 1H), 1.11 (d, J = 
7.5 Hz, 3H).  IR (neat) ν 1721 cm−1 (C=O) 
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Ethyl (6S)-[6-2H1]-6-O-benzoyl-2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (6S-D-
135). 
Compound 6S-D-135 (0.007 g, 60%) was synthesized from 6S-D-107 analogously 
to 135.  1H NMR (600 MHz, CDCl3) δ 8.04 – 8.01 (m, 2H), 7.58 – 7.54 (m, 1H), 7.46 – 
7.24 (m, 17H), 4.97 (d, J = 10.8 Hz, 1H), 4.94 (d, J = 10.2 Hz, 1H), 4.89 (d, J = 10.7 Hz, 
1H), 4.87 (d, J = 10.8 Hz, 2H), 4.76 (d, J = 10.2 Hz, 1H), 4.62 (d, J = 10.7 Hz, 1H), 4.53 
(d, J = 9.8 Hz, 1H), 4.42 – 4.40 (m, 1H, H), 3.76 (dd, J = 8.8, 8.7 Hz, 1H), 3.66 – 3.64 (m, 
2H), 3.49 (dd, J = 9.7, 8.8 Hz, 1H), 2.77 (dq, J = 12.7, 7.5 Hz, 1H), 2.70 (dq, J = 12.7, 7.5 
Hz, 1H), 1.29 (t, J = 7.5 Hz, 3H).  1H NMR (600 MHz, C6D6) δ 8.19 – 8.16 (m, 2H), 7.44 – 
7.41 (m, 2H), 7.35 – 7.32 (m, 2H), 7.28 – 7.25 (m, 2H), 7.20 – 7.01 (m, 12H), 4.99 (d, J = 
10.6 Hz, 1H), 4.96 (d, J = 11.3 Hz, 1H), 4.83 (d, J = 11.3 Hz, 1H), 4.81 (d, J = 11.1 Hz, 
1H), 4.71 (d, J = 10.6 Hz, 1H), 4.52 (d, J = 11.1 Hz, 1H), 4.49 (d, J = 5.6 Hz, 1H), 4.37 (d, 
J = 9.7 Hz, 1H), 3.64 (dd, J = 8.9, 8.8 Hz, 1H), 3.55 (dd, J = 9.8, 8.9 Hz, 1H), 3.51 (dd, J 
= 9.6, 8.8 Hz, 1H), 3.35 (dd, J = 9.8, 5.6 Hz, 1H), 2.59 (dq, J = 12.8, 7.5 Hz, 1H), 2.46 
(dq, J = 12.8, 7.5 Hz, 1H), 1.11 (t, J = 7.5 Hz, 3H).  HRMS (ESI) m/z calcd for 
C36H37DO6SNa [M+Na]+, 622.2350; found, 622.2358. 
Ethyl 2,3,4-tri-O-benzyl-6-O-p-methylbenzoyl-1-thio-β-D-glucopyranoside (136). 
Compound 107 (0.015 g, 0.030 mmol) was dissolved anhydrous pyridine (0.1 mL) 
and cooled to 0 °C before the addition of p-methylbenzoyl chloride (5.6 µL, 0.061 mmol). 
The reaction mixture was then warmed up to room temperature and stirred overnight 
under an argon atmosphere. The reaction mixture was then diluted with ethyl acetate and 
washed with aqueous hydrochloric acid (1 M), saturated aqueous NaHCO3, and brine. 
The organic layer was separated and dried over anhydrous Na2SO4 and concentrated to 
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dryness. The resultant crude residue was purified using silica gel column 
chromatography, eluting with hexane/ethyl acetate (6:1 to 4:1), to afford the compound 
136 (0.018 g, 95%) as a white semi solid. [α]D22 = +20.5 (c 0.6, CH2Cl2);  1H NMR (600 
MHz, CDCl3) δ 7.92 – 7.90 (m, 2H), 7.39 – 7.37 (m, 2H), 7.35 – 7.21 (m, 17H), 4.95 (d, J 
= 10.8 Hz, 1H), 4.93 (d, J = 10.2 Hz, 1H), 4.87 (d, J = 10.7 Hz, 1H), 4.86 (d, J = 10.8 Hz, 
1H), 4.75 (d, J = 10.2 Hz, 1H), 4.60 (d, J = 10.7 Hz, 1H), 4.59 (dd, J = 12.0, 1.6 Hz, 1H), 
4.51 (d, J = 9.8 Hz, 1H), 4.40 (dd, J = 12.0, 5.2 Hz, 1H), 3.74 (t, J = 8.8 Hz, 1H), 3.67 – 
3.63 (m, 2H), 3.48 (dd, J = 9.8, 8.8 Hz, 1H), 2.76 (dq, J = 12.8, 7.4 Hz, 1H), 2.69 (dq, J = 
12.8, 7.4 Hz, 1H), 2.40 (s, 3H), 1.28 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 
166.4, 143.9, 138.4, 138.0, 137.7, 129.8, 129.2, 128.7, 128.6, 128.4, 128.2, 128.2, 128.1, 
128.0, 128.0, 127.4, 86.8, 85.2, 82.0, 78.1, 77.3, 76.1, 75.7, 75.4, 63.8, 25.2, 21.8, 15.3.  
1H NMR (600 MHz, C6D6) δ 8.17 – 8.14 (m, 2H), 7.44 – 7.41 (m, 2H), 7.35 – 7.32 (m, 2H), 
7.29 – 7.27 (m, 2H), 7.19 – 7.03 (m, 9H), 6.89 – 6.86 (m, 2H), 4.99 (d, J = 10.6 Hz, 1H), 
4.96 (d, J = 11.2 Hz, 1H), 4.83 (d, J = 11.2 Hz, 1H), 4.82 (d, J = 11.0 Hz, 1H), 4.71 (d, J 
= 10.6 Hz, 1H), 4.68 (dd, J = 11.8, 2.2 Hz, 1H), 4.54 (dd, J = 11.8, 5.7 Hz, 1H), 4.53 (d, J 
= 11.0 Hz, 1H), 4.38 (d, J = 9.7 Hz, 1H), 3.64 (dd, J = 8.9, 8.8 Hz, 1H), 3.56 (dd, J = 9.8, 
8.9 Hz, 1H), 3.51 (dd, J = 9.7, 8.8 Hz, 1H), 3.37 (ddd, J = 9.8, 5.7, 2.2 Hz, 1H), 2.61 (dq, 
J = 12.7, 7.4 Hz, 1H), 2.48 (dq, J = 12.7, 7.4 Hz, 1H), 1.95 (s, 3H), 1.13 (t, J = 7.4 Hz, 
1H).  IR (neat) ν 1718 cm−1 (C=O).  HRMS (ESI) m/z calcd for C37H40O6SNa [M+Na]+, 
635.2443; found, 635.2474. 
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Ethyl (6S)-[6-2H1]-6-O-p-methylbenzoyl-2,3,4-tri-O-benzyl-1-thio-β-D-
glucopyranoside (6S-D-136). 
Compound 6S-D-136 (0.003 g, 76%) was synthesized from 6S-D-107 analogously 
to 136.  1H NMR (600 MHz, CDCl3) δ 8.00 – 7.85 (m, 2H), 7.42 – 7.20 (m, 19H), 4.99 – 
4.92 (m, 2H), 4.90 – 4.84 (m, 2H), 4.76 (d, J = 10.1 Hz, 1H), 4.61 (d, J = 10.7 Hz, 1H), 
4.52 (d, J = 9.7 Hz, 1H), 4.39 (d, J = 5.0 Hz, 1H), 3.75 (t, J = 8.8 Hz, 1H), 3.68 – 3.61 (m, 
2H), 3.49 (dd, J = 9.7, 8.8 Hz, 1H), 2.82 – 2.65 (m, 2H), 2.41 (s, 3H), 1.29 (t, J = 7.4 Hz, 
3H).  1H NMR (600 MHz, C6D6) δ 8.18 – 8.14 (m, 2H), 7.44 – 7.41 (m, 2H), 7.35 – 7.26 
(m, 4H), 7.20 – 7.02 (m, 9H), 6.89 – 6.86 (m, 2H), 4.99 (d, J = 10.5 Hz, 1H), 4.96 (d, J = 
11.0 Hz, 1H), 4.83 (d, J = 11.0 Hz, 1H), 4.82 (d, J = 11.1 Hz, 1H), 4.71 (d, J = 10.5 Hz, 
1H), 4.53 (d, J = 11.1 Hz, 1H), 4.51 (d, J = 5.8 Hz, 1H, H), 4.38 (d, J = 9.7 Hz, 1H), 3.64 
(t, J = 8.8 Hz, 1H), 3.56 (dd, J = 9.8, 8.8 Hz, 1H), 3.51 (dd, J = 9.7, 8.8 Hz, 1H), 3.37 (dd, 
J = 9.8, 5.8 Hz, 1H), 2.65 – 2.57 (m, 1H), 2.51 – 2.45 (m, 1H), 1.95 (s, 3H), 1.13 (t, J = 
7.4 Hz, 3H).  HRMS (ESI) m/z calcd for C37H39DO6SNa [M+Na]+, 636.2506; found, 
636.2508. 
Ethyl 2,3,4-tri-O-benzyl-6-O-p-methoxybenzoyl-1-thio-β-D-glucopyranoside (137). 
  Compound 137 was synthesized by the same procedure as described for the 
compound 136 from compound 107 (0.015 g, 0.030 mmol) and p-methoxybenzoyl 
chloride (0.010 g, 0.061 mmol) in anhydrous pyridine (0.1 mL). After purification by silica 
gel column chromatography, eluting with hexane/ethyl acetate (6:1 to 4:1), compound 
137 (0.015 g, 77%) was obtained as a white semi solid. [α]D22 = +23.4 (c 0.7, CH2Cl2);  1H 
NMR (600 MHz, CDCl3) δ 8.00 – 7.97 (m, 2H), 7.41 – 7.37 (m, 2H), 7.36 – 7.23 (m, 13H), 
6.93 – 6.90 (m, 2H), 4.96 (d, J = 10.8 Hz, 1H), 4.94 (d, J = 10.2 Hz, 1H), 4.88 (d, J = 10.8 
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Hz, 1H), 4.87 (d, J = 10.8 Hz, 1H), 4.76 (d, J = 10.2 Hz, 1H), 4.61 (d, J = 10.8 Hz, 1H), 
4.58 (dd, J = 11.8, 1.7 Hz, 1H), 4.52 (d, J = 9.8 Hz, 1H), 4.41 (dd, J = 11.8, 5.2 Hz, 1H), 
3.87 (s, 3H), 3.75 (dd, J = 8.9, 8.8 Hz, 1H), 3.67 – 3.63 (m, 2H), 3.49 (dd, J = 9.8, 8.8 Hz, 
1H), 2.80 – 2.67 (m, 2H), 1.30 (t, J = 7.4 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 166.1, 
163.6, 138.4, 138.0, 137.7, 131.7, 128.6, 128.6, 128.4, 128.3, 128.1, 128.1, 128.0, 128.0, 
122.5, 113.7, 86.8, 85.2, 82.0, 78.1, 77.3, 76.1, 75.7, 75.4, 63.7, 55.6, 25.2, 15.3.  1H 
NMR (600 MHz, C6D6) δ 8.21 – 8.18 (m, 2H), 7.44 – 7.41 (m, 2H), 7.35 – 7.32 (m, 2H), 
7.31 – 7.28 (m, 2H), 7.20 – 7.02 (m, 9H), 6.65 – 6.60 (m, 2H), 5.00 (d, J = 10.6 Hz, 1H), 
4.96 (d, J = 11.3 Hz, 1H), 4.84 (d, J = 11.3 Hz, 1H), 4.83 (d, J = 11.0 Hz, 1H), 4.73 (d, J 
= 10.6 Hz, 1H), 4.69 (dd, J = 11.8, 2.2 Hz, 1H), 4.56 (dd, J = 11.8, 5.6 Hz, 1H), 4.55 (d, J 
= 11.0 Hz, 1H), 4.39 (d, J = 9.7 Hz, 1H), 3.65 (dd, J = 8.9, 8.7 Hz, 1H), 3.59 (dd, J = 9.8, 
8.9 Hz, 1H), 3.54 (dd, J = 9.7, 8.7 Hz, 1H), 3.38 (ddd, J = 9.8, 5.6, 2.2 Hz, 1H), 3.13 (s, 
3H), 2.62 (dq, J = 12.7, 7.4 Hz, 1H), 2.49 (dq, J = 12.7, 7.4 Hz, 1H), 1.13 (t, J = 7.4 Hz, 
3H).  IR (neat) ν 1714 cm−1 (C=O).  HRMS (ESI) m/z calcd for C37H40O7SNa [M+Na]+, 
651.2392; found, 651.2399. 
Ethyl (6S)-[6-2H1]-6-O-p-methoxybenzoyl-2,3,4-tri-O-benzyl-1-thio-β-D-
glucopyranoside (6S-D-137). 
Compound 6S-D-137 (0.004 g, 60%) was synthesized from 6S-D-107 analogously 
to 137.  1H NMR (600 MHz, CDCl3) δ 8.01 – 7.96 (m, 2H), 7.44 – 7.22 (m, 15H), 6.94 – 
6.88 (m, 2H), 4.96 (d, J = 10.8 Hz, 1H), 4.94 (d, J = 10.2 Hz, 1H), 4.88 (d, J = 10.8 Hz, 
1H), 4.87 (d, J = 10.8 Hz, 1H), 4.76 (d, J = 10.2 Hz, 1H), 4.61 (d, J = 10.8 Hz, 1H), 4.52 
(d, J = 9.8 Hz, 1H), 4.39 (d, J = 5.0 Hz, 1H, H6), 3.87 (s, 3H), 3.75 (t, J = 8.8 Hz, 1H), 
3.68 – 3.61 (m, 2H), 3.49 (dd, J = 9.7, 8.8 Hz, 1H), 2.77 (dq, J = 12.7, 7.4 Hz, 1H), 2.70 
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(dq, J = 12.7, 7.4 Hz, 1H), 1.30 (t, J = 7.4 Hz, 3H).  1H NMR (600 MHz, C6D6) δ 8.22 – 
8.17 (m, 2H), 7.45 – 7.40 (m, 2H), 7.35 – 7.32 (m, 2H), 7.30 – 7.28 (m, 2H), 7.20 – 7.02 
(m, 9H), 6.64 – 6.60 (m, 2H), 5.00 (d, J = 10.8 Hz, 1H), 4.96 (d, J = 11.2 Hz, 1H), 4.84 (d, 
J = 11.2 Hz, 1H), 4.83 (d, J = 11.0 Hz, 1H), 4.72 (d, J = 11.0 Hz, 1H), 4.55 (d, J = 10.8 
Hz, 1H), 4.53 (d, J = 5.6 Hz, 1H, H6), 4.39 (d, J = 9.7 Hz, 1H), 3.65 (dd, J = 8.9, 8.7 Hz, 
1H), 3.58 (dd, J = 9.7, 8.9 Hz, 1H), 3.53 (dd, J = 9.7, 8.7 Hz, 1H), 3.38 (dd, J = 9.7, 5.7 
Hz, 1H), 3.13 (s, 3H, ), 2.62 (dq, J = 12.7, 7.4 Hz, 1H), 2.49 (dq, J = 12.7, 7.4 Hz, 1H), 
1.13 (t, J = 7.4 Hz, 3H).  HRMS (ESI) m/z calcd for C37H39DO7SNa [M+Na]+, 652.2455; 
found, 652.2468. 
Ethyl 6-O-p-nitrobenzoyl-2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (138). 
Compound 138 was synthesized using the same procedure as described for the 
synthesis of the compound 136 from compound 107 (0.015 g, 0.030 mmol) and p-
nitrobenzoyl chloride (0.011 g, 0.061 mmol) in anhydrous pyridine (0.1 mL). After 
chromatographic purification using silica gel (hexane/ethyl acetate 6:1 to 4:1), compound 
138 (0.019 g, 96 %) was obtained as a white semi solid. [α]D22 = +29.7 (c 1.2, CH2Cl2);  
1H NMR (600 MHz, CDCl3) δ 8.29 – 8.26 (m, 2H), 8.17 – 8.14 (m, 2H), 7.41 – 7.20 (m, 
15H), 4.98 (d, J = 10.8 Hz, 1H), 4.95 (d, J = 10.2 Hz, 1H), 4.90 (d, J = 11.0 Hz, 1H), 4.88 
(d, J = 10.8 Hz, 1H), 4.77 (d, J = 10.2 Hz, 1H), 4.62 (dd, J = 11.8, 2.2 Hz, 1H), 4.62 (d, J 
= 11.0 Hz, 1H), 4.53 (d, J = 9.8 Hz, 1H), 4.44 (dd, J = 11.8, 5.4 Hz, 1H), 3.77 (t, J = 8.8 
Hz, 1H), 3.66 (ddd, J = 9.8, 5.4, 2.2 Hz, 1H), 3.61 (dd, J = 9.8, 8.8 Hz, 1H), 3.49 (dd, J = 
9.8, 8.8 Hz, 1H), 2.76 (dq, J = 12.7, 7.4 Hz, 1H), 2.70 (dq, J = 12.7, 7.4 Hz, 1H, 1H), 1.29 
(t, J = 7.4 Hz, 3H). 13C NMR (150 MHz, CDCl3) δ 164.4, 150.7, 138.3, 137.9, 137.6, 135.4, 
130.9,128.7, 128.6, 128.4, 128.2, 128.2, 128.1, 128.0, 123.6, 86.8, 85.4, 81.9, 77.6, 76.9, 
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76.1, 75.7, 75.2, 64.8, 25.3, 15.3.  1H NMR (600 MHz, C6D6) δ 7.76 – 7.73 (m, 2H), 7.66 
– 7.63 (m, 2H), 7.45 – 7.41 (m, 2H), 7.36 – 7.33 (m, 2H), 7.26 – 7.23 (m, 2H), 7.20 – 6.97 
(m, 9H), 5.02 (d, J = 10.6 Hz, 1H), 5.00 (d, J = 11.1 Hz, 1H), 4.85 (d, J = 11.2 Hz, 1H), 
4.83 (d, J = 11.1 Hz, 1H), 4.74 (d, J = 10.6 Hz, 1H), 4.56 (dd, J = 11.8, 2.3 Hz, 1H), 4.51 
(d, J = 11.2 Hz, 1H), 4.40 (dd, J = 11.8, 5.6 Hz, 1H), 4.37 (d, J = 9.7 Hz, 1H), 3.66 (t, J = 
8.8 Hz, 1H), 3.53 (dd, J = 9.7, 8.8 Hz, 1H), 3.50 (dd, J = 9.8, 8.8 Hz, 1H), 3.31 (ddd, J = 
9.8, 5.6, 2.3 Hz, 1H), 2.57 (dq, J = 12.7, 7.4 Hz, 1H), 2.46 (dq, J = 12.7, 7.4 Hz, 1H), 1.09 
(t, J = 7.4 Hz, 3H).  IR (neat) ν 1726 cm−1 (C=O).  HRMS (ESI) m/z calcd for 
C36H37NO8SNa [M+Na]+, 666.2138; found, 666.2148. 
Ethyl (6S)-[6-2H1]-6-O-p-nitrobenzoyl-2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside 
(6S-D-138). 
Compound 6S-D-138 (0.004 g, 100%) was synthesized from 6S-D-107 
analogously to 138.  1H NMR (600 MHz, CDCl3) δ 8.31 – 8.25 (m, 2H), 8.18 – 8.12 (m, 
2H), 7.44 – 7.19 (m, 15H), 4.98 (d, J = 10.8 Hz, 1H), 4.95 (d, J = 10.2 Hz, 1H), 4.90 (d, J 
= 11.0 Hz, 1H), 4.87 (d, J = 10.8 Hz, 1H), 4.76 (d, J = 10.2 Hz, 1H), 4.61 (d, J = 11.0 Hz, 
1H), 4.52 (d, J = 9.8 Hz, 1H), 4.42 (d, J = 5.4 Hz, 1H), 3.76 (t, J = 8.8 Hz, 1H), 3.65 (dd, 
J = 9.8, 5.4 Hz, 1H), 3.60 (dd, J = 9.8, 8.8 Hz, 1H), 3.48 (dd, J = 9.7, 8.8 Hz, 1H), 2.76 
(dq, J = 12.7, 7.4 Hz, 1H), 2.70 (dq, J = 12.7, 7.4 Hz, 1H), 1.29 (t, J = 7.4 Hz, 1H).  1H 
NMR (600 MHz, C6D6) δ 7.76 – 7.72 (m, 2H), 7.66 – 7.63 (m, 2H), 7.45 – 7.41 (m, 2H), 
7.36 – 7.33 (m, 2H), 7.26 – 7.22 (m, 2H), 7.20 – 6.97 (m, 9H), 5.02 (d, J = 10.7 Hz, 1H), 
5.00 (d, J = 11.2 Hz, 1H), 4.85 (d, J = 11.3 Hz, 1H), 4.83 (d, J = 11.2 Hz, 1H), 4.74 (d, J 
= 10.7 Hz, 1H), 4.51 (d, J = 11.3 Hz, 1H), 4.38 (d, J = 5.5 Hz, 1H), 4.37 (d, J = 9.6 Hz, 
1H), 3.66 (t, J = 8.8 Hz, 1H), 3.53 (dd, J = 9.6, 8.8 Hz, 1H), 3.50 (dd, J = 9.8, 8.8 Hz, 1H), 
247 
 
3.30 (dd, J = 9.8, 5.5 Hz, 1H), 2.57 (dq, J = 12.8, 7.4 Hz, 1H), 2.46 (dq, J = 12.8, 7.4 Hz, 
1H), 1.09 (t, J = 7.4 Hz, 3H).  HRMS (ESI) m/z calcd for C36H36DNO8SNa [M+Na]+, 
667.2200; found, 667.2196 
Ethyl 2,3,4-tri-O-benzyl-6-O-(N-phenylcarbamoyl)-1-thio-β-D-glucopyranoside 
(139). 
Compound 107 (0.010 g, 0.020 mmol) was dissolved in anhydrous pyridine (0.4 
mL) and cooled to 0 °C before the addition of phenyl isothiocyanate (13.3 µL, 0.120 
mmol). The reaction mixture was then stirred for 48 h under an argon atmosphere and 
concentrated to dryness. The crude reaction mixture was dissolved in ethyl acetate and 
filtered through cotton before it was concentrated to dryness. The crude residue was 
purified over silica gel column chromatography, eluting with hexane/ethyl acetate (9:1 to 
4:1), to afford the compound 139 (0.011 g, 87%) as a white solid with m.p 119-121 0 °C. 
[α]D22 = +3.5 (c 0.2, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 7.39 – 7.25 (m, 19H), 7.09 – 
7.06 (m, 1H), 6.57 (br s, 1H), 4.96 (d, J = 10.9 Hz, 1H), 4.93 (d, J = 10.2 Hz, 1H), 4.87 (d, 
J = 10.9 Hz, 1H), 4.86 (d, J = 10.7 Hz, 1H), 4.75 (d, J = 10.2 Hz, 1H), 4.63 (d, J = 10.7 
Hz, 1H), 4.49 (d, J = 9.8 Hz, 1H), 4.41 – 4.35 (m, 2H), 3.73 (t, J = 8.8 Hz, 1H), 3.58 – 3.52 
(m, 2H), 3.45 (dd, J = 9.8, 8.8 Hz, 1H), 2.81 – 2.70 (m, 2H), 1.31 (t, J = 7.4 Hz, 3H); 13C 
NMR (150 MHz, CDCl3) δ 153.1, 138.5, 138.0, 137.8, 137.7, 129.2, 128.7, 128.63, 128.6, 
128.5, 128.2, 128.1, 127.9, 123.7, 118.7, 86.8, 85.4, 81.9, 77.2, 75.9, 75.7, 75.2, 63.9, 
29.9, 25.3, 15.2.  1H NMR (600 MHz, C6D6) δ 7.47 – 7.40 (m, 2H), 7.39 – 7.30 (m, 4H), 
7.29 – 7.01 (m, 13H), 6.86 – 6.79 (m, 1H), 6.06 (br s, 1H), 5.01 (d, J = 10.6 Hz, 1H), 4.98 
(d, J = 11.4 Hz, 1H), 4.86 (d, J = 11.4 Hz, 1H), 4.83 (d, J = 11.0 Hz, 1H), 4.73 (d, J = 10.6 
Hz, 1H), 4.58 (d, J = 11.0 Hz, 1H), 4.46 (dd, J = 11.7, 4.6 Hz, 1H), 4.43 (dd, J = 11.8, 2.5 
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Hz, 1H), 4.39 (d, J = 9.7 Hz, 1H), 3.66 (dd, J = 9.0, 8.8 Hz, 1H), 3.57 – 3.52 (m, 2H), 3.29 
(ddd, J = 9.8, 4.6, 2.5 Hz, 1H), 2.62 (dq, J = 12.6, 7.4 Hz, 1H), 2.52 (dq, J = 12.6, 7.4 Hz, 
1H), 1.13 (t, J = 7.4 Hz, 3H).  IR (neat) ν 3329 cm−1 (N-H), 1716 cm−1 (C=O).  HRMS (ESI) 
m/z calcd for C36H39NO6SNa [M+Na]+, 636.2396; found, 636.2374. 
Ethyl 2,3,4-tri-O-benzyl-(6S)-[6-2H1]-6-O-(N-phenylcarbamoyl)-1-thio-β-D-
glucopyranoside (6S-D-139). 
Compound 6S-D-139 (0.004 g, 100%) was synthesized from 6S-D-107 
analogously to 139.  1H NMR (600 MHz, CDCl3) δ 7.31 (m, 19H), 7.10 – 7.05 (m, 1H), 
6.57 (br s, 1H), 4.96 (d, J = 10.8 Hz, 1H), 4.93 (d, J = 10.0 Hz, 1H), 4.87 (d, J = 10.8 Hz, 
1H), 4.86 (d, J = 10.6 Hz, 1H), 4.75 (d, J = 10.0 Hz, 1H), 4.62 (d, J = 10.6 Hz, 1H), 4.49 
(d, J = 9.8 Hz, 1H), 4.35 (d, J = 4.5 Hz, 1H, H), 3.72 (t, J = 8.8 Hz, 1H), 3.59 – 3.50 (m, 
2H), 3.44 (dd, J = 9.8, 9.0 Hz, 1H), 2.87 – 2.66 (m, 2H), 1.31 (t, J = 7.4 Hz, 3H).  1H NMR 
(600 MHz, C6D6) δ 7.45 – 7.41 (m, 2H), 7.37 – 7.32 (m, 4H), 7.30 – 7.02 (m, 13H), 6.84 
– 6.79 (m, 1H), 6.04 (br s, 1H), 5.01 (d, J = 10.5 Hz, 1H), 4.98 (d, J = 11.2 Hz, 1H), 4.86 
(d, J = 11.2 Hz, 1H), 4.83 (d, J = 11.0 Hz, 1H), 4.73 (d, J = 10.5 Hz, 1H), 4.58 (d, J = 11.0 
Hz, 1H), 4.44 (d, J = 4.9 Hz, 1H), 4.38 (d, J = 9.6 Hz, 1H), 3.66 (t, J = 8.7 Hz, 1H), 3.56 – 
3.52 (m, 2H), 3.29 (dd, J = 9.8, 4.9 Hz, 1H), 2.62 (dq, J = 12.6, 7.4 Hz, 1H), 2.52 (dd, J = 
12.6, 7.4 Hz, 1H), 1.13 (t, J = 7.4 Hz, 3H).  HRMS (ESI) m/z calcd for C36H38DNO6SNa 
[M+Na]+, 637.2459; found, 637.2466. 
Ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (140). 
Compound 140 was synthesized as described in the literature.217  1H NMR (600 
MHz, CDCl3) δ 7.40 – 7.26 (m, 18H), 7.19 – 7.16 (m, 2H), 4.93 (d, J = 10.9 Hz, 1H), 4.92 
(d, J = 10.1 Hz, 1H), 4.86 (d, J = 10.9 Hz, 1H), 4.82 (d, J = 10.7 Hz, 1H), 4.75 (d, J = 10.1 
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Hz, 1H), 4.61 (d, J = 12.1 Hz, 1H), 4.57 (d, J = 10.7 Hz, 1H), 4.56 (d, J = 12.1 Hz, 1H), 
4.47 (d, J = 9.8 Hz, 1H), 3.76 (dd, J = 10.8, 1.9 Hz, 1H), 3.69 (dd, J = 9.0, 8.9 Hz, 1H), 
3.69 (dd, J = 10.8, 5.0 Hz, 1H), 3.62 (dd, J = 9.8, 9.0 Hz, 1H), 3.48 (ddd, J = 9.8, 5.0, 1.9 
Hz, 1H), 3.45 (dd, J = 9.8, 8.9 Hz, 1H), 2.81 (dd, J = 12.7, 7.5 Hz, 1H), 2.75 (dd, J = 12.7, 
7.5 Hz, 1H), 1.34 (d, J = 7.5 Hz, 3H).  1H NMR (600 MHz, C6D6) δ 7.40 – 7.00 (m, 20H), 
4.94 (d, J = 10.7 Hz, 1H), 4.89 (d, J = 11.3 Hz, 1H), 4.81 (d, J = 11.2 Hz, 1H), 4.79 (d, J 
= 11.3 Hz, 1H), 4.67 (d, J = 10.7 Hz, 1H), 4.55 (d, J = 11.2 Hz, 1H), 4.41 (d, J = 12.2 Hz, 
1H), 4.36 (d, J = 9.7 Hz, 1H), 4.34 (d, J = 12.2 Hz, 1H), 3.67 (dd, J = 9.7, 9.1 Hz, 1H), 
3.61 – 3.60 (m, 2H), 3.60 (dd, J = 9.1, 8.7 Hz, 1H), 3.46 (dd, J = 9.7, 8.7 Hz, 1H), 3.28 – 
3.24 (m, 1H), 2.59 (dq, J = 12.6, 7.4 Hz, 1H), 2.48 (dq, J = 12.6, 7.4 Hz, 1H), 1.11 (t, J = 
7.4 Hz, 3H). 
Ethyl (6S)-[6-2H1]-2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (6S-D-140). 
Compound 6S-D-140 was synthesized, by the same procedure as described for 
6S-D-131 from 6S-D-107 (0.010 g, 0.020 mmol), NaH (1.0 mg, 0.025 mmol) and benzyl 
bromide (2.8 µl, 0.024 mmol) in anhydrous DMF (0.1 ml). After purification by silica gel 
column chromatography, eluting with hexane/ethyl acetate (7:1 to 7:3), gave the title 
compound (0.011 g, 94%).  1H NMR (600 MHz, CDCl3) δ 7.40 – 7.26 (m, 18H), 7.19 – 
7.15 (m, 2H), 4.93 (d, J = 11.0 Hz, 1H), 4.92 (d, J = 10.2 Hz, 1H), 4.85 (d, J = 10.9 Hz, 
1H), 4.82 (d, J = 10.8 Hz, 1H), 4.75 (d, J = 10.2 Hz, 1H), 4.60 (d, J = 12.2 Hz, 1H), 4.57 
(d, J = 10.8 Hz, 1H), 4.56 (d, J = 12.2 Hz, 1H), 4.47 (d, J = 9.8 Hz, 1H), 3.69 (dd, J = 9.0, 
8.9 Hz, 1H), 3.66 (d, J = 5.0 Hz, 1H), 3.61 (dd, J = 9.8, 9.0 Hz, 1H), 3.47 (dd, J = 9.8, 5.0 
Hz, 1H), 3.45 (dd, J = 9.8, 8.9 Hz, 1H), 2.80 (dd, J = 12.7, 7.5 Hz, 1H), 2.75 (dd, J = 12.7, 
7.5 Hz, 1H), 1.34 (d, J = 7.5 Hz, 3H).  1H NMR (600 MHz, C6D6) δ 7.39 – 7.00 (m, 20H), 
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4.94 (d, J = 10.7 Hz, 1H), 4.89 (d, J = 11.3 Hz, 1H), 4.81 (d, J = 11.3 Hz, 1H), 4.79 (d, J 
= 11.3 Hz, 1H), 4.67 (d, J = 10.7 Hz, 1H), 4.55 (d, J = 11.3 Hz, 1H), 4.41 (d, J = 12.2 Hz, 
1H), 4.36 (d, J = 9.7 Hz, 1H), 4.35 (d, J = 12.2 Hz, 1H), 3.67 (dd, J = 9.7, 9.1 Hz, 1H), 
3.60 (dd, J = 9.1, 8.7 Hz, 1H), 3.59 (d, J = 4.6 Hz, 1H), 3.46 (dd, J = 9.7, 8.7 Hz, 1H), 3.26 
(dd, J = 9.7, 4.6 Hz, 1H), 2.59 (dq, J = 12.6, 7.4 Hz, 1H), 2.48 (dq, J = 12.6, 7.4 Hz, 1H), 
1.11 (t, J = 7.4 Hz, 3H). HRMS (ESI) m/z calcd for C36H39DO5SNa [M+Na]+, 608.2557; 
found, 608.2551. 
Methyl (1-Adamantanyl 5-N,4-O-carbonyl-3,5-dideoxy-2-thio-D-glycero-α-D-
galacto-non-2-ulopyranoside)onate (182). 
A solution of compound 180 (1.9 g, 3.0 mmol) in anhydrous THF (12.7 ml) was 
treated with di-tertbutyl dicarbonate (6.81 g, 31.2 mmol) and DMAP (153 mg, 1.25 mmol) 
and stirred overnight at 60 °C before it was concentrated to dryness. The crude reaction 
mixture was passed through a short pad of silica to obtain 181 (~1.4 g), which was then 
treated with NaOMe (cat.) in anhydrous methanol (9 ml) and stirred for 1.5 h. The reaction 
mixture was quenched with Amberlyst-15 (pH = ~4) and filtered through Celite and 
concentrated to dryness. The crude residue was then treated with 1.5 M HCl in methanol 
(22 ml, 33 mmol) for 2.5 h and concentrated to dryness. The crude residue and NaHCO3 
(0.8 g, 9.5 mmol) were dissolved in MeCN (8 mL) and H2O (16 mL) and cooled to 0 °C.  
Then, a solution of 4-nitrophenyl chloroformate (0.94 g, 4.7 mmol) in MeCN (8 ml) was 
added to a vigorously stirred reaction mixture through a dropping funnel. Then the 
reaction mixture was stirred for 3 h at 0 °C before it was extracted with ethyl acetate (3 
times). Combined organic layers were washed with brine, dried over anhydrous Na2SO4, 
and concentrated to dryness. The crude residue was purified using silica gel 
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chromatography, eluting with hexane/ethyl acetate (10:1 to 6:1), to obtain 182 (470 mg, 
34% from 180). [α]RTD = +30.4 (c 1.7, MeOH); 1H NMR (600 MHz, CD3OD) δ 4.04 (dd, J 
= 9.8, 2.0 Hz, 1H), 3.85 (s, 3H), 3.86 – 3.79 (m, 2H), 3.69 – 3.64 (m, 1H), 3.57 (dd, J = 
11.2, 9.8 Hz, 1H), 3.52 (dd, J = 8.8, 2.0 Hz, 1H), 2.97 (dd, J = 11.7, 3.7 Hz, 1H), 2.09 (dd, 
J = 12.7, 11.8 Hz, 1H), 2.04 – 1.92 (br m, 9H), 1.73 – 1.65 (br s, 6H); 13C NMR (150 MHz, 
CD3OD) δ 171.4, 160.8, 85.5, 77.8, 71.4, 70.0, 63.2, 57.0, 52.4, 50.4, 43.4, 38.8, 35.7, 
29.9. ESIHRMS Calcd for C21H31NO8SNa [M + Na]+, 480.1668; found, 480.1668. 
Methyl (1-Adamantanyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-3,5-
dideoxy-2-thio-D-glycero-α-D-galacto-non-2-ulopyranoside)onate (183α). 
A solution of 182 (400 mg, 0.87 mmol) in pyrindene (8 ml) was treated with acetic 
anhydride (9 ml) and stirred overnight at room temperature before it was concentrated to 
dryness. The crude reaction mixture was dissolved in anhydrous CH2Cl2, treated with 
EtN-(i-Pr)2 (1.5 ml, 8.6 mmol) and cooled to 0 °C before it was treated with acetyl chloride 
(0.51 ml, 7.1 mmol). Reaction mixture was warmed to room temperature (~ 20 min) and 
poured into a saturated aqueous NaHCO3 solution, organic layer was separated, and the 
aqueous layer was extracted with CH2Cl2 (2 times). Combined organic layers were 
washed with brine, dried over anhydrous Na2SO4, and concentrated to dryness. The 
crude residue was purified by silica gel column chromatography, eluting with hexane/ethyl 
acetate (3:1 to 1:1), to obtain 183α (0.54 g, 84% in two steps). [α]RTD = +37.2 (c 4.2, 
CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 5.58 (d, J = 8.0, 1H), 5.41 (ddd, J = 8.4, 6.0, 2.8 
Hz, 1H), 4.51 (d, J = 9.6, 1H), 4.36 (dd, J = 12.3, 2.9 Hz, 1H), 3.86 – 3.76 (m, 1H), 3.79 
(s, 3H), 3.68 – 3.58 (m, 1H), 2.97 (dd, J = 12.0, 3.6 Hz, 1H), 2.46 (s, 3H), 2.14 (s, 3H), 
2.13 (s, 3H), 2.13 – 2.08 (m, 1H), 2.01 (s, 3H), 1.99 – 1.84 (m, 9H), 1.72 – 1.61 (m, 6H); 
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13C NMR (150 MHz, CDCl3) δ 171.8, 170.6, 170.3, 170.0, 169.9, 153.4, 84.9, 76.4, 75.5, 
71.9, 69.8, 62.5, 59.5, 53.0, 51.3, 43.6, 38.6, 35.9, 29.9, 24.7, 21.1, 21.0, 20.7. ESIHRMS 
Calcd for C29H39NO12SNa [M + Na]+, 648.2073; found, 648.2091. 
General Protocol for Pseudo Kinetic Experiment in Dichloromethane. 
N-acetyl-5-N,4-O-oxozolidinone protected adamantanyl thiosialoside 183α or 
183β336 (50.0 mg, 0.08 mmol), internal standard, acetylated-methyl-2-phthalimido-2-
deoxy-β-D-glucopyranoside 184353 (3.3 mg, 0.007 mmol) ~10 mol %, and sialidation 
acceptor 2-PrOH in anhydrous CH2Cl2 (1.45 ml) were stirred with pre-activated, acid 
washed 4 Å molecular sieves (157 mg) at room temperature for 0.5 h followed by another 
0.5 h at -78 °C. Then the reaction was activated with N-iodosuccinimide followed by 
trifluoromethanesulfonic acid at -78 °C (time = 0 min). The sampling was started after two 
minutes (time = 2 min). During every three minutes time intervals (t = 2, 5, 8, 11, 14, 17, 
and 20 min), aliquots of reaction mixture were taken out using 20 μL Kimble microcapillary 
pipettes (sampling volume ~ 5 μL) and quenched with 9 mM Et3N in acetonitrile solution 
(1 ml). The samples were filtered through Millipore LG-0.20 μm syringe filters. All the 
aliquots were analyzed using an ultra-high-performance liquid chromatography (UHPLC) 
coupled mass spectrometer (ESI-MS) equipped with a tunable ultra-violet (TUV) detector 
at the wave length (λ) of 205 nm. After 20.5 min, reaction mixture was quenched with Et3N 
(16 μl, 0.12 mmol). Then, reaction mixture was diluted with dichloromethane and washed 
with aqueous saturated Na2S2O3, aqueous saturated NaHCO3, brine, and dried over 
anhydrous Na2SO4 before it was concentrated to dryness. 1H-NMR spectrum of the crude 
reaction mixture was recorded to ensure <10% conversion of the donor. 
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Pseudo-first-order Kinetic Experiments with Respect to the Acceptor, 2-Proponol. 
A series of pseudo first-order kinetic experiments with respect to the glycosyl 
acceptor, 2-propanol, was conducted separately on sialyl donors 183β and 183α in 
dichloromethane at -78 °C using general protocol. Thus, the acceptor, 2-propanol 
concentrations was varied as 0.022, 0.028, 0.034, 0.039 and 0.045 mol dm-3, while 
keeping a constant concentration of glycosyl donor at 0.056 mol dm-3. 
Kinetic Experiments by Changing the Acetonitrile Percentage in Dichloromethane. 
Series of kinetic experiments were conducted separately on sialyl donors 183β 
and 183α with 2-proponol as the acceptor. Here, the general protocol was modified to 
keep constant donor (0.056 mol dm-3) and acceptor (0.028 mol dm-3) concentrations, 
while the acetonitrile percentage was varied from 0 to 40% in dichloromethane at -78 °C. 
The crude reaction mixtures from multiple kinetic runs were combined and purified 
using silica gel chromatography, eluting with hexanes/ethyl acetate 3:1 to 1:1, to obtain a 
mixture of O-sialosides 185α and 185β. 
Methyl (2-propyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-3,5-dideoxy-D-
glycero-α-D-galacto-non-2-ulopyranoside)onate (185α). 
1H NMR (600 MHz, CDCl3) δ 5.59 (dd, J = 8.2, 1.6 Hz, 1H), 5.43 (ddd, J = 8.2, 6.7, 
2.9 Hz, 1H), 4.57 (dd, J = 9.4, 1.6 Hz, 1H), 4.37 (dd, J = 12.3, 2.9 Hz, 1H), 4.05 (dd, J = 
12.3, 6.7 Hz, 1H), 4.00 – 3.95 (m, 1H), 3.94 (ddd, J = 14.0, 11.2, 3.5 Hz, 1H), 3.79 (s, 
3H), 3.66 (dd, J = 11.1, 9.4 Hz, 1H), 2.83 (dd, J = 12.1, 3.6 Hz, 1H), 2.48 (s, 3H), 2.13 (s, 
3H), 2.12 (s, 3H), 2.03 (s, 3H) 2.02 (t, J = 12.8 Hz, 1H), 1.25 (d, J = 6.1 Hz, 3H), 1.08 (d, 
J = 6.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 172.0, 170.6, 170.1, 170.0, 169.3 (3JC1,H3ax 
= 6.1 Hz), 153.7, 99.2, 75.2, 75.1, 71.7, 69.8, 69.1, 67.5, 63.0, 59.2, 52.7, 37.0, 24.7, 
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24.6, 22.9, 21.1, 20.9, 20.7. ESIHRMS Calcd for C29H40NO12S [M + Na]+, 540.1693; 
found, 540.1699. 
Methyl (2-propyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-3,5-dideoxy-D-
glycero-α-D-galacto-non-2-ulopyranoside)onate (185β). 
1H NMR (600 MHz, CDCl3 δ 5.54 (m, 1H), 5.28 – 5.18 (m, 1H), 4.70 (dd, J = 12.2, 
2.4 Hz, 1H),  4.52 (td, J = 12.0, 3.7 Hz, 1H), 4.37 (dd, J = 9.1, 1.6 Hz, 1H), 4.22 – 4.07 
(m, 2H), 3.80 (s, 3H), 3.66 (t, J = 10.3 Hz, 1H), 2.71 (dd, J = 12.1, 3.6 Hz, 1H), 2.44 (s, 
3H), 2.12 (s, 3H), 2.11 (s, 3H), 2.04 (s, 3H), 1.97 (t, J = 12.4 Hz, 1H), 1.23 (d, J = 6.3 Hz, 
3H), 1.04 (d, J = 6.1 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 172.3, 171.1, 170.5, 169.8, 
167.4 (3JC1,H3ax = 2.5 Hz), 153.8, 97.3, 75.0, 74.9, 73.5, 72.4, 67.6, 59.4, 52.7, 43.5, 36.9, 
35.9, 29.8, 29.6, 24.1, 22.5, 21.1, 20.7, 20.7. ESIHRMS Calcd for C29H40NO12S [M + Na]+, 
540.1693; found, 540.1699. 
1-Adamantanyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-β-
D-galacto-non-2-ulopyranosidonic acid (191). 
A mixture of 190332 (1.00 g, 1.56 mmol) and anhydrous pyridine (14.2 mL) was 
added to anhydrous LiI (0.75 g, 5.58 mmol) under an argon atmosphere. The reaction 
mixture was heated to reflux for 3.5 h before it was cooled to room temperature and 
concentrated under reduced pressure. The residue was dissolved in CH2Cl2, and the 
organic layer was washed with 1N HCl and brine, dired and evaporated to dryness. The 
crude residue was purified by chromatography over neutral alumina, eluting with ethyl 
acetate/glacial acetic acid 20:1 to 10:1, to obtain the carboxylic acid 191 (0.51 g, 68%). 
[α]RTD = -51.6 (c 2.7, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 5.55 (d, J = 10.3 Hz, 1H), 5.42 
– 5.39 (m, 1H), 5.36 (dt, J = 11.4, 4.4 Hz, 1H), 5.25 – 5.21 (m, 1H), 4.72 (d, J = 11.2 Hz, 
1H), 4.49 (dd, J = 10.6, 2.7 Hz, 1H), 4.13 (dd, J = 12.5, 8.1 Hz, 1H), 4.10 (q, J = 10.6 Hz, 
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1H), 2.60 (dd, J = 13.7, 4.5 Hz, 1H), 2.12 – 2.07 (m, 7H), 2.02 (s, 3H), 2.02 (s, 3H), 2.01 
– 1.94 (m, 9H), 1.88 (s, 3H), 1.65 (s, 6H); 13C NMR (150 MHz, CDCl3) δ 171.7, 171.2, 
171.1, 170.8, 170.7, 170.3, 85.5, 72.9, 72.2, 69.3, 68.8, 63.4, 51.1, 49.6, 43.7, 39.6, 36.0, 
30.0, 23.2, 21.5, 21.0, 20.9, 20.8. ESIHRMS Calcd for C29H40NO12S [M - H]-, 626.2271; 
found, 626.2279. 
2-Hydroxymethylbenzyl (1-adamantanyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-
dideoxy-2-thio-D-glycero-β-D-galacto-non-2-ulopyranosid)onate (192). 
A solution of N,N'-dicyclohexylcarbodiimide (0.10 g, 0.47 mmol) in anhydrous 
CH2Cl2 (0.3 mL) was added to a mixture of 191 (0.18 g, 0.29 mmol), 1,2-
benzenedimethanol (0.16 g, 1.17 mmol) and hydroxybenzotriazole (0.08 g, 0.59 mmol) in 
anhydrous CH2Cl2 (0.4 mL) at 0 0C.  The reaction mixture was stirred for 5 min then 
warmed to room temperature and stirred for 48 h under an argon atmosphere. The 
reaction mixture was then filtered through Celite, and the organic layer was diluted with 
CH2Cl2 before washing with sat. NaHCO3, water, and brine. The organic layer was 
evaporated to dryness and purified by silica gel chromatography, eluting with 
hexane/ethyl acetate 3:1 to 3:2, to give 192 (0.15 g, 70 %). [α]RTD = - 51.0 (c 1.1, CH2Cl2); 
1H NMR (600 MHz, CDCl3) δ 7.46 (d, J = 7.3 Hz, 1H), 7.42 (d, J = 7.5 Hz, 1H), 7.38 – 
7.35 (m, 1H), 7.31 – 7.28 (m, 1H), 5.45 – 5.43 (m, 1H), 5.43 – 5.34 (m, 3H), 5.29 (dt, J = 
10.5, 4.5 Hz, 1H), 5.18 – 5.15 (m, 1H), 4.87 (dd, J = 12.3, 1.6 Hz, 1H), 4.80 (s, 2H), 4.50 
(dd, J = 10.5, 2.6 Hz, 1H), 4.28 (dd, J = 12.3, 8.7 Hz, 1H), 4.05 (q, J = 10.4 Hz, 1H), 2.56 
(br s, 1H), 2.49 (dd, J = 13.7, 4.7 Hz, 1H), 2.12 (s, 3H), 2.06 (s, 3H), 1.99 (s, 7H), 1.90 (s, 
3H), 1.85 (s, 2H), 1.84 – 1.74 (m, 7H), 1.63 – 1.53 (m, 6H); 13C NMR (150 MHz, CDCl3) 
δ 171.3, 171.0, 170.7, 170.4, 170.3, 169.2, 140.2, 132.8, 130.8, 129.4, 129.3, 128.1, 86.4, 
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73.7, 73.0, 69.4, 69.0, 65.9, 63.2, 62.9, 51.0, 49.8, 43.6, 39.9, 35.9, 29.9, 23.3, 21.2, 21.0, 
20.9, 20.8; ESIHRMS Calcd for C37H49NO13SNa [M + Na]+, 770.2822; found, 770.2830. 
1-Adamantanyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-α-
D-galacto-non-2-ulopyranosidonic acid (193). 
A mixture of 18017,21 (0.10 g, 0.16 mmol) and anhydrous pyridine (1.4 mL) was 
added to anhydrous LiI (0.07 g, 0.56 mmol) under an argon atmosphere.  The reaction 
mixture was heated to reflux for 4 h under an argon atmosphere before it was cooled to 
room temperature and concentrated to dryness under reduced pressure. The residue was 
dissolved in CH2Cl2, and the organic layer was washed with 1N HCl, brine, and anhydrous 
Na2SO4 before drying over Na2SO4 and evaporation to dryness. The crude residue was 
then purified by chromatography over neutral alumina (eluting with ethyl acetate/glacial 
acetic acid 20:1 to 10:1) to give the carboxylic acid 193 (0.07 g, 70%). 
A solution of 180332, 352 (0.98 g, 1.52 mmol), methanol (9.8 mL) and 1N NaOH (19.5 
mL) was stirred for 24 h, then co-evaporated with ethanol (×2) and toluene (×3). The 
crude residue was dissolved in pyridine (8.9 mL), treated with acetic anhydride (10.3 mL) 
at 0 0C, and stirred overnight at room temperature. The reaction mixture was then treated 
with methanol (15.0 mL) at 0 0C and stirred at room temperature for 30 min. After 
concentration, the crude residue was purified by chromatography over using neutral 
alumina, eluting with ethyl acetate/acetic acid 20:1 to 10:1, to afford 193 (0.94 g, 73%). 
[α]RTD = + 20.3 (c 2.6, CHCl3); 1H NMR (600 MHz, CDCl3) δ 6.36 (s, 1H), 5.31 (s, 2H), 
4.86 (dt, J = 11.1, 4.4 Hz, 1H), 4.38 (d, J = 12.0 Hz, 1H), 4.21 – 4.16 (m, 2H), 4.05 (q, J 
= 10.4 Hz, 1H), 2.71 (dd, J = 12.6, 4.2 Hz, 1H), 2.15 (s, 3H), 2.14 (s, 3H), 2.04 (s, 3H), 
2.02 – 1.96 (m, 13H), 1.88 (s, 3H), 1.65 (s, 6H); 13C NMR (150 MHz, CDCl3) δ 171.8, 
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171.7, 171.3, 170.71, 170.67, 170.4, 84.4, 74.4, 70.6, 70.1, 68.2, 62.1, 51.1, 48.7, 43.5, 
39.8, 35.9, 29.8, 22.8, 21.1, 21.0, 20.82, 20.76; ESIHRMS Calcd for C29H41NO12SNa [M 
+ Na]+, 650.2247; found, 650.2247. 
2-Hydroxymethylbenzyl (1-adamantanyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-
dideoxy-2-thio-D-glycero-α-D-galacto-non-2-ulopyranosid)onate (194). 
Compound 194 was prepared by the same procedure as compound 192 from acid 
193 (0.50 g, 0.80 mmol), 1,2-benzenedimethanol (0.44 g, 3.19 mmol), 
hydroxybenzotriazole (0.22 g, 1.6 mmol) and N,N'-dicyclohexylcarbodiimide (0.26 g, 1.27 
mmol) in anhydrous CH2Cl2 (2.0 mL). After chromatographic purification (gradient elution 
with hexanes/acetone 3:1 to 3:2), 194 (0.21 g, 35 %) was obtained. [α]RTD = - 4.3 (c 1.2, 
CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 7.46 (d, J = 7.4 Hz, 1H), 7.41 – 7.35 (m, 2H), 7.30 
(t, J = 7.3 Hz, 1H), 5.42 (d, J = 11.9 Hz, 2H), 5.28 (dd, J = 8.6, 1.6 Hz, 1H), 5.26 – 5.22 
(m, 1H), 5.19 (d, J = 12.1 Hz, 1H), 5.16 (d, J = 9.9 Hz, 1H), 4.79 (d, J = 12.8 Hz, 1H), 4.75 
(d, J = 12.8 Hz, 1H), 4.73 (dt, J = 11.4, 4.4 Hz, 1H), 4.32 (dd, J = 12.5, 2.4 Hz, 1H), 4.12 
(dd, J = 12.5, 4.5 Hz, 1H), 4.06 (dd, J = 10.8, 1.5 Hz, 1H), 3.94 (q, J = 10.3 Hz, 1H), 2.67 
(dd, J = 12.8, 4.6 Hz, 1H), 2.19 (s, 3H), 2.11 (s, 3H), 2.01 (s, 3H), 1.98 (s, 3H), 1.99-1.91 
(m, 7H), 1.86 (s, 3H), 1.89 – 1.79 (m, 3H), 1.62 (s, 6H); 13C NMR (150 MHz, CDCl3) δ 
171.3, 170.8, 170.3, 170.2, 170.1, 169.3, 140.3, 132.6, 131.3, 129.6, 129.2, 128.2, 84.8, 
74.1, 69.8, 69.5, 67.5, 66.0, 63.1, 62.0, 51.6, 49.4, 43.7, 40.1, 36.1, 30.1, 23.4, 21.3, 21.1, 
21.0, 20.9; ESIHRMS Calcd for C37H49NO13SNa [M + Na]+, 770.2822; found, 770.2792. 
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2-Hydroxymethylbenzyl (1-adamantanyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-
carbonyl-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-ulopyranosid)onate 
(194). 
A mixture of 183β332 (0.60 g, 0.96 mmol) and anhydrous pyridine (8.7 mL) was 
added to LiI (0.46 g, 3.43 mmol) under an argon atmosphere, and the mixture heated to 
reflux at 135 0C for 3.5 h under argon.  After cooling to room temperature and drying under 
reduced pressure, the residue was dissolved in CH2Cl2, and the organic layer was 
washed with 1N HCl and brine before evaporation to dryness. A solution of N,N'-
dicyclohexylcarbodiimide (0.32 g, 1.53 mmol) in anhydrous CH2Cl2 (1.0 mL) was added 
to a stirred solution of the resulting residue, 1,2-benzenedimethanol (0.53 g, 3.83 mmol) 
and hydroxybenzotriazole (0.26 g, 1.92 mmol) in anhydrous CH2Cl2 (1.4 mL) at 0 0C.  The 
mixture was stirred for 5 min before warming to room temperature and stirring for another 
36 h under an argon atmosphere.  The crude product was obtained by following the same 
workup as described for compound 192, and was purified by silica gel chromatography, 
eluting with hexane/ethyl acetate 3:1 to 1:1, to afford 196 (0.37 g, 53%). [α]RTD = - 39.6 (c 
3.1, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.47 (d, J = 7.1 Hz, 1H), 7.42 (d, J = 7.4 Hz, 
1H), 7.40 – 7.35 (m, 1H), 7.33 – 7.27 (m, 1H), 5.71 – 5.68 (m, J = 3.5 Hz, 1H), 5.43 (d, J 
= 12.1 Hz, 1H), 5.34 (d, J = 12.1 Hz, 1H), 5.27 – 5.21 (m, 1H), 4.79 (s, 2H), 4.75 – 4.66 
(m, 2H), 4.60 (dd, J = 12.2, 2.3 Hz, 1H), 4.12 (dd, J = 12.2, 7.6 Hz, 1H), 3.67 (dd, J = 
11.3, 9.3 Hz, 1H), 2.77 (dd, J = 12.9, 3.6 Hz, 1H), 2.62 (br s, 1H), 2.48 (s, 3H), 2.22 (t, J 
= 12.9 Hz, 1H), 2.10 (s, 3H), 2.03 (s, 3H), 2.00 (s, 3H), 1.92 (br s, 3H), 1.87 – 1.72 (m, 
6H), 1.65 – 1.53 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 172.4, 170.8, 170.7, 169.7, 168.8, 
153.7, 140.2, 132.5, 130.8, 129.4, 129.2, 127.9, 85.8, 75.1, 74.3, 72.7, 71.7, 66.0, 63.0, 
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62.8, 60.3, 51.4, 43.6, 38.2, 35.8, 29.8, 24.7, 21.2, 20.7, 20.6. ESIHRMS Calcd for 
C36H45NO13SNa [M + Na]+, 754.2509; found, 754.2491. 
2-Hydroxymethylbenzyl (1-adamantanyl 4,7,8,9-tetra-O-acetyl-3,5-dideoxy-5-
isothiocyanato-2-thio-D-glycero-β-D-galacto-non-2-ulopyranosid)onate (199). 
A solution of 197366, 391 (0.24g, 0.38 mmol) in anhydrous pyridine (3.4 mL) was 
added to anhydrous LiI (0.18 g, 1.36 mmol) under an inert atmosphere, and the mixture 
heated to reflux for 2 h before cooling to room temperature and concentration to dryness. 
The resultant residue was dissolved in CH2Cl2, and the organic layer was washed with 
1N HCl and brine before evaporation to dryness. A stirred solution of the residue, 1,2-
benzenedimethanol (0.21 g, 1.51 mmol) and hydroxybenzotriazole (0.10 g, 0.76 mmol) in 
anhydrous CH2Cl2 (0.6 mL) was treated with a solution of N,N'-dicyclohexylcarbodiimide 
(0.12 g, 0.61 mmol) in anhydrous CH2Cl2 (0.4 mL) at 0 0C and stirred for 5 min before 
warming up to room temperature and stirring for 48 h.  The reaction mixture was worked 
up as described for compound 192, and the resultant residue was purified by silica gel 
chromatography, eluting with toluene/acetone 5:1, and then by preparative HPLC, eluting 
by hexanes/ethyl acetate 9:1 to 4:6 over 50 min, to give 199 (0.12 g, 43%). [α]RTD = - 90.5 
(c 1.01, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.46 (d, J = 7.3 Hz, 1H), 7.41 (d, J = 7.4 
Hz, 1H), 7.36 (dt, J = 7.5, 3.7 Hz, 1H), 7.30 (dt, J = 7.5, 3.8 Hz, 1H), 5.46 (dd, J = 4.7, 2.4 
Hz, 1H), 5.43 – 5.31 (m, 3H), 5.28 – 5.23 (m, 1H), 4.77 (s, 2H), 4.60 (dd, J = 12.5, 2.2 Hz, 
1H), 4.48 (dd, J = 10.3, 2.4 Hz, 1H), 4.27 (dd, J = 12.5, 6.8 Hz, 1H), 3.65 (t, J = 10.1 Hz, 
1H), 2.60 (dd, J = 13.8, 4.7 Hz, 1H), 2.45 (br s, 1H), 2.13 (s, 3H), 2.10 (s, 3H), 2.08 (s, 
3H), 2.02 (s, 3H), 1.90 (s, 4H), 1.86 – 1.70 (m, 6H), 1.63– 1.51 (m, 6H); 13C NMR (100 
MHz, CDCl3) δ 170.8, 170.4, 169.7, 169.5, 169.0, 140.3, 139.6, 132.6, 130.8, 129.5, 
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129.3, 128.1, 86.1, 71.3, 71.1, 69.8, 69.6, 66.0, 63.0, 62.4, 57.4, 51.2, 43.5, 39.3, 35.9, 
29.9, 21.2, 21.1, 20.9, 20.7; ESIHRMS Calcd for C36H45NO12S2Na [M + Na]+, 770.2281; 
found, 770.2263. 
General Procedure for cyclization reactions. 
A solution of substrate (0.008 M) in anhydrous CH2Cl2 was stirred under argon at 
room temperature with freshly activated AW-300 moleular sieves (100 mg/mL) for 30 min 
and then at – 40 0C for another 30 min.  N-Iodosuccinimide (2.4 equiv) and TfOH (1 equiv) 
were then added respectively and the reaction mixture stirred for 2 h before Et3N (~1.5 
equiv) was added.  The reaction mixture was diluted with CH2Cl2, filtered through Celite, 
washed with saturated aqueous NaHCO3, saturated aqueous Na2S2O3, brine, and finally 
concentrated to dryness. The crude residue was purified by silica gel column 
chromatography to obtain mixtures of cyclized products from which the pure anomers 
were obtained by preparative HPLC. 
2-Hydroxymethylbenzyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-
α-D-galacto-non-2-ulopyranosidonic acid spirolactone (200α) and 2-
Hydroxymethylbenzyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-β-
D-galacto-non-2-ulopyranosidonic acid spirolactone (200β). 
From 192.  According to the general procedure for cyclization, compounds 200α 
and 200β were prepared using peracetylated thioglycoside donor 192 (0.051 g, 0.068 
mmol), freshly activated AW-300 moleular sieves (0.880 g), anhydrous CH2Cl2 (8.4 mL), 
N-iodosuccinimide (0.036 g, 0.162 mmol) and TfOH (5.9 μL, 0.066 mmol).  The crude 
residue was purified using silica gel column chromatography (gradient elution with 
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toluene/2-propanol 14:1 to 6:1) to give 200α and 200β (0.022 g, 58%) as a mixture (1:2.4, 
α:β) of anomers. 
From 194.  The cyclization reaction was carried using the general procedure for 
cyclization using donor 194 (0.013 g, 0.017 mmol), AW-300 molecular sieves (0.221 g), 
anhydrous CH2Cl2 (2.1 mL), N-idodosuccinimide (0.009 g, 0.040 mmol) and TfOH (1.5 
μL, 0.017 mmol) to afford 200α and 200β (0.008 g, 76%) as a mixture (1:5, α:β) of 
anomers. 
Purification.  The combined mixtures of products from the cyclization of 192 and 
194 was separated by preparative HPLC, gradient elution with hexanes/ethyl acetate 1:1 
to 1:4 over 30 min, to obtain pure 200α and 200β. UHPLC was used to analyze the pure 
samples of 200α and 200β (UHPLC method, flow rate: 0.35 mL/min; Initial: CH3CN 30% 
in H2O; 10.5 min: CH3CN 30% in H2O; 15.0 min: CH3CN 100%; tR (min):  200β = 6.08, 
200α = 7.37). 
2-Hydroxymethylbenzyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-
α-D-galacto-non-2-ulopyranosidonic acid spirolactone (200α). 
[α]RTD = + 39.4 (c 1.1, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 7.34 (t, J = 7.4 Hz, 
1H), 7.29 (t, J = 7.3 Hz, 1H), 7.22 (d, J = 7.4 Hz, 1H), 7.14 (d, J = 7.2 Hz, 1H), 6.12 (d, J 
= 10.0 Hz, 1H), 6.04 (d, J = 13.0 Hz, 1H), 5.51 (ddd, J = 8.4, 5.5, 2.6 Hz, 1H), 5.34 (dd, J 
= 9.2, 2.0 Hz, 1H), 5.23 (d, J = 15.1 Hz, 1H), 5.11 (td, J = 11.8, 4.7 Hz, 1H), 4.98 (d, J = 
13.1 Hz, 1H), 4.86 (d, J = 15.2 Hz, 1H), 4.62 (d, J = 10.5 Hz, 1H), 4.26 (dd, J = 12.5, 2.5 
Hz, 1H), 4.21 (q, J =10.4 Hz, 1H), 4.09 (dd, J = 12.5, 5.6 Hz, 1H), 2.70 (dd, J = 13.0, 4.7 
Hz, 1H), 2.16 (s, 3H), 2.13 (s, 3H), 2.08 (t, J = 12.8 Hz, 1H), 2.02 (s, 6H), 1.87 (s, 3H); 
13C NMR (150 MHz, CDCl3) δ 172.2 (3JC1,H3ax = 6.5 Hz), 170.8, 170.7, 170.5, 170.2, 169.9, 
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134.8, 133.9, 129.5, 129.3, 128.8, 128.4, 99.3, 73.7, 71.9, 69.0, 68.8, 68.2, 67.1, 62.6, 
49.2, 37.2, 23.1, 21.2, 21.04, 21.02, 20.9; ESIHRMS Calcd for C27H33NO13Na [M + Na]+, 
602.1850; found, 602.1824. 
2-Hydroxymethylbenzyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-
β-D-galacto-non-2-ulopyranosidonic acid spirolactone (200β). 
[α]RTD = - 32.2 (c 1.5, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 7.30 – 7.25 (m, 2H), 
7.19 (d, J = 8.1 Hz, 1H), 7.12 (d, J = 6.6 Hz, 1H), 5.66 (d, J = 13.5 Hz, 1H), 5.60 (d, J = 
9.3 Hz, 1H), 5.43 (d, J = 4.7 Hz, 1H), 5.40 (d, J = 13.4 Hz, 1H), 5.34 – 5.24 (m, 2H), 4.81 
(dd, J = 12.4, 2.3 Hz, 1H), 4.46 (d, J = 13.4 Hz, 1H), 4.16 – 4.05 (m, 3H), 2.35 (dd, J = 
13.3, 4.9 Hz, 1H), 2.14 (s, 3H), 2.04 – 2.02 (m, 4H), 2.00 (s, 3H), 1.99 (s, 3H), 1.86 (s, 
3H); 13C NMR (150 MHz, CDCl3) δ 171.2, 170.70, 170.67, 170.4, 170.3, 168.1(3JC1,H3ax = 
0.0 Hz), 135.9, 133.0, 132.1, 128.9, 128.8, 128.1, 97.7, 71.6, 69.4, 69.0, 68.2, 67.1, 62.2, 
49.6, 36.0, 23.3, 21.1, 21.0, 20.9; ESIHRMS Calcd for C27H33NO13Na [M + Na]+, 
602.1850; found, 602.1846. 
2-Hydroxymethylbenzyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-3,5-
dideoxy-D-glycero-α-D-galacto-non-2-ulopyranosidonic acid spirolactone (201α) 
and 2-Hydroxymethylbenzyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-3,5-
dideoxy-D-glycero-β-D-galacto-non-2-ulopyranosidonic acid spirolactone (201β). 
The general procedure for cyclization was used to synthesize a mixture of 201α 
and 201β from 196 (0.044 g, 0.060 mmol), AW-300 molecular sieves (0.781 g), anhydrous 
CH2Cl2 (7.5 mL), N-idodosuccinimide (0.032 g, 0.141 mmol) and TfOH (5.2 μL, 0.059 
mmol). After silica gel chromatography using hexanes/ethyl acetate as eluent, products 
201α and 201β (0.014 g, 42%) were obtained as a mixture (1:0.4, α:β) of anomers. 
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2-Hydroxymethylbenzyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-3,5-
dideoxy-D-glycero-α-D-galacto-non-2-ulopyranosidonic acid spirolactone (201α). 
After preparative HPLC of the mixture of cyclized anomers (eluting with 
hexanes/ethyl acetate 7:3 to 1:1 over 40 min), an analytical sample of 201α was obtained. 
Recrystallization from CH2Cl2/Hexanes (3:7) gave crystals of 201α suitable for X-ray 
analysis. Mp 208 0C; [α]RTD = + 63.4 (c 1.4, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 7.36 – 
7.28 (m, 2H), 7.23 (d, J = 7.2 Hz, 1H), 7.17 (d, J = 6.9 Hz, 1H), 5.96 (d, J = 13.0 Hz, 1H), 
5.61 (dd, J = 8.6, 1.6 Hz, 1H), 5.53 – 5.48 (m, 1H), 5.32 (d, J = 14.8 Hz, 1H), 5.14 (d, J = 
13.0 Hz, 1H), 4.84 (d, J = 14.8 Hz, 1H), 4.78 (dd, J = 9.4, 1.6 Hz, 1H), 4.42 (dd, J = 12.3, 
2.9 Hz, 1H), 4.29 (ddd, J = 13.4, 11.3, 3.7 Hz, 1H), 4.08 (dd, J = 12.3, 6.8 Hz, 1H), 3.80 
(t, J = 10.3 Hz, 1H), 2.89 (dd, J = 12.3, 3.8 Hz, 1H), 2.51 (s, 3H), 2.19 – 2.17 (m, 4H), 
2.09 (s, 3H), 2.03 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 172.2, 170.8, 170.4 (3JC1,H3ax = 
5.5 Hz), 170.2, 170.1, 153.7, 134.1, 134.1, 130.1, 129.4, 128.9, 128.6, 99.1, 76.3, 74.4, 
71.6, 71.4, 69.4, 68.9, 63.3, 59.0, 35.4, 24.8, 21.17, 21.15, 20.9; ESIHRMS Calcd for 
C26H29NO13Na [M + Na]+, 586.1537; found, 586.1535. 
2-Hydroxymethylbenzyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-3,5-
dideoxy-D-glycero-β-D-galacto-non-2-ulopyranosidonic acid spirolactone (201β). 
After preparative HPLC of the mixture of cyclized anomers (eluting with 
hexanes/ethyl acetate 7:3 to 1:1 over 40 min), an analytical sample of 201β was obtained. 
[α]RTD = - 5.9 (c 0.4, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 7.36 – 7.29 (m, 2H), 7.27 – 
7.24 (m, 1H), 7.17 (d, J = 7.1 Hz, 1H), 5.69 – 5.64 (m, 2H), 5.52 (d, J = 13.0 Hz, 1H), 5.40 
(ddd, J = 7.4, 4.5, 2.8 Hz, 1H), 5.36 (d, J = 13.6 Hz, 1H), 4.69 (dd, J = 12.3, 2.6 Hz, 1H), 
4.59 (td, J = 12.4, 3.7 Hz, 1H), 4.53 (dd, J = 9.4, 1.4 Hz, 1H), 4.49 (d, J = 13.0 Hz, 1H), 
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4.11 (dd, J = 12.2, 7.6 Hz, 1H), 3.72 (dd, J = 11.1, 9.6 Hz, 1H), 2.59 (dd, J = 12.5, 3.8 Hz, 
1H), 2.51 (s, 3H), 2.24 (t, J = 12.6 Hz, 1H), 2.15 (s, 3H), 2.11 (s, 3H), 2.02 (s, 3H); 13C 
NMR (150 MHz, CDCl3) δ 172.3, 171.0, 170.7, 170.1, 167.9 (3JC1,H3ax = 0.0 Hz), 153.9, 
136.3, 133.2, 132.5, 129.3, 128.8, 127.8, 97.0, 75.2, 74.5, 72.9, 71.7, 69.2, 67.6, 62.8, 
59.6, 34.9, 24.8, 21.2, 21.0, 20.9; ESIHRMS Calcd for C26H29NO13Na [M + Na]+, 
586.1537; found, 586.1530. 
2-Hydroxymethylbenzyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-
α-D-galacto-non-2-ulopyranosidonic acid spirolactone (202α) and 2-
Hydroxymethylbenzyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-β-
D-galacto-non-2-ulopyranosidonic acid spirolactone (202β). 
Cyclization of compound 199 was conducted by the general procedure for 
cyclization using sialyl donor 199 (0.031 g, 0.041 mmol), AW-300 molecular sieves (0.540 
g), anhydrous CH2Cl2 (5.2 mL), N-idodosuccinimide (0.022 g, 0.097 mmol) and TfOH (3.6 
μL, 0.041 mmol), and afforded a mixture of 202α and 202β (0.04 g, 20 %, 1:0.4, α:β). 
2-Hydroxymethylbenzyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-
α-D-galacto-non-2-ulopyranosidonic acid spirolactone (202α). 
Preparative HPLC of the mixture of cyclized anomers (eluting with hexanes/ethyl 
acetate 9:1 to 7:3 over 50 min) afforded an analytical sample of 202α. [α]RTD = +13.3 (c 
0.06, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 7.32 – 7.29 (m, 2H), 7.22 (dd, J = 5.4, 3.5 
Hz, 1H), 7.15 (dd, J = 5.3, 3.5 Hz, 1H), 5.77 (d, J = 13.2 Hz, 1H), 5.53 (dd, J = 9.5, 1.4 
Hz, 1H), 5.48 (ddd, J = 9.5, 4.2, 2.3 Hz, 1H), 5.37 (d, J = 14.2 Hz, 1H), 5.21 (d, J = 13.1 
Hz, 1H), 5.15 (ddd, J = 11.9, 10.0, 4.9 Hz, 1H), 4.69 (d, J = 14.2 Hz, 1H), 4.34 (dd, J = 
12.6, 2.3 Hz, 1H), 4.21 (dd, J = 12.6, 4.2 Hz, 1H), 4.15 (dd, J = 10.5, 1.4 Hz, 1H), 3.64 (t, 
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J = 10.2 Hz, 1H), 2.68 (dd, J = 13.1, 4.9 Hz, 1H), 2.21 (s, 3H), 2.14 (s, 3H), 2.12 (s, 3H), 
2.09 (s, 3H), 1.77 (t, J = 12.5 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ 170.9, 170.0, 170.0, 
169.5, 140.7, 135.1, 133.4, 131.5, 129.1, 128.9, 128.4, 98.3, 72.2, 70.4, 69.8, 68.8, 67.9, 
67.6, 61.8, 56.6, 36.2, 21.2, 21.1, 20.9, 20.9; ESIHRMS Calcd for C26H29NO12SNa [M + 
Na]+, 602.1308; found, 602.1306. 
2-Hydroxymethylbenzyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-
β-D-galacto-non-2-ulopyranosidonic acid spirolactone (202β). 
Preparative HPLC of the mixture of cyclized anomers (eluting with hexanes/ethyl 
acetate 9:1 to 7:3 over 50 min) afforded an analytical sample of 202β. [α]RTD = -40.0 (c 
0.03, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 7.31 (dd, J = 5.6, 3.3 Hz, 1H), 7.23 – 7.21 
(m, 1H), 7.16 – 7.14 (m, 1H), 5.65 (d, J = 13.7 Hz, 1H), 5.56 (d, J = 7.3 Hz, 1H), 5.41 – 
5.34 (m, 3H), 5.30 (d, J = 13.4 Hz, 1H), 4.58 (dd, J = 12.7, 2.4 Hz, 1H), 4.47 (d, J = 13.5 
Hz, 1H), 4.17 (dd, J = 12.7, 5.3 Hz, 1H), 4.08 (dd, J = 10.5, 1.4 Hz, 1H), 3.65 (t, J = 10.2 
Hz, 1H), 2.48 (dd, J = 13.5, 5.0 Hz, 1H), 2.19 (s, 3H), 2.11 (s, 3H), 2.08 (s, 3H), 2.05 (s, 
3H), 1.89 (t, J = 12.5 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ 170.8, 170.2, 169.9, 169.7, 
167.8, 140.6, 135.6, 132.9, 132.0, 129.1, 129.0, 128.2, 97.8, 70.4, 70.4, 69.9, 69.8, 69.7, 
68.2, 68.2, 68.0, 67.4, 61.7, 56.8, 35.5, 21.13, 21.11, 20.94, 20.87. ESIHRMS Calcd for 
C26H29NO12SNa [M + Na]+, 602.1308; found, 602.1307. 
Conversion of 202α to 200α. 
To a stirred solution of lactone 202α (0.002 g, 0.003 mmol), 18-crown-6 (0.0001 g, 
0.0003 mmol) and thioacetic acid (0.0003 g, 0.004 mmol) in anhydrous THF (0.03 mL), 
potassium tert-butoxide (0.0001 g, 0.001 mmol) was added under an argon atmosphere.  
The reaction mixture was stirred at 60 0C for 4 h, then cooled to room temperature, diluted 
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with ethyl acetate, washed with 1N HCl, saturated aqueous NaHCO3, brine, and 
concentrated to dryness.  UHPLC analysis revealed the product to be identical to 200α. 
 Conversion of 202β to 200β. 
To a stirred solution of lactone 202β (0.002 g, 0.003 mmol), 18-crown-6 (0.0001 g, 
0.0003 mmol) and thioacetic acid (0.0003 g, 0.004 mmol) in anhydrous THF (0.03 mL), 
potassium tert-butoxide (0.0001 g, 0.001 mmol) was added under an argon atmosphere.  
The reaction mixture was stirred at 60 0C for 4 h, then cooled to room temperature, diluted 
with ethyl acetate, washed with 1N HCl, saturated aqueous NaHCO3, brine, and 
concentrated to dryness.  UHPLC analysis revealed the product to be identical to 200β. 
General Procedure for Competition kinetic experiments. 
Thiosialyl donors (cation clock precursor) 192, 194, 196, and 199 were separately 
used in series of competition kinetic experiments. First, thiosialyl donor (0.013 mmol, 
0.008 M) was co-evaporated with toluene (×3) and kept in vacuum overnight. AW-300 
molecular sieves (174 mg, 102 mg/mL) anhydrous CH2Cl2 (1.7 mL), and 2-propanol 
(range specified for each donor - Tables 26-29) were added to the reaction flask under 
argon atmosphere and stirred at room temperature for 0.5 h before it was cooled to -40 
°C. Then the reaction mixture was stirred for another 0.5 h at -40 °C under argon 
atmosphere. The reaction mixture was then activated by adding N-Iodosuccinimide (7 
mg, 0.031 mmol) followed by the addition of trifluoromethanesulfonic acid (TfOH) (1.2 μl, 
0.013 mmol), and the reaction mixture was stirred under argon at -40 0C for 2 h until the 
completion of the reaction. The reaction mixture was quenched with triethylamine (3.0 μl), 
diluted with CH2Cl2 (2 mL), and filtered through a pad of Celite. Organic layer was diluted 
again with CH2Cl2 (8.0 mL), washed with saturated aqueous NaHCO3, saturated aqueous 
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Na2S2O3, brine solution, and concentrated to dryness. The crude residue was dissolved 
in CH2Cl2 (0.5 mL), and an aliquot (20 μl) was diluted with acetonitrile (1.0 mL) and used 
in UHPLC/UV/MS analysis at the wavelength (λ) of 205 nm. 
Competition Kinetics with Peracetylated β-Thiosialyl Cation Clock Precursor (193) 
at -40 °C. 
Following the general procedure for competition kinetic experiments, β-
thioglycoside 192 (0.010 g, 0.013 mmol) was used in series of experiments by changing 
the concentration of 2-propanol (1.5-30 equiv. – Table 26). All the kinetic runs were 
analyzed using the UHPLC method, flow rate: 0.35 mL/min; Initial: CH3CN 30% in H2O; 
10.5 min: CH3CN 30% in H2O; 15.0 min: CH3CN 100%; tR (min):  200β = 6.08, 207β = 
6.53, 200α = 7.37, 207α = 9.37. Relative ratios of O-sialosides with respect to the cyclized 
products were determined using the integrated peaks of the TUV trace (Table 26).  
Competition Kinetics with Peracetylated α-Thiosialyl Cation Clock Precursor (194) 
at -40 °C. 
Analogously to the competition kinetics of donor 192, a series of competition kinetic 
experiments was conducted using α-thioglycoside 194 (0.010 g, 0.013 mmol) and 2-
propanol (1.5-10 equiv.). The crude reaction mixtures were analyzed using identical 
UHPLC method as for the donor 192 (Table 27). 
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2-Hydroxymethylbenzyl (2-propyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-
D-glycero-α-D-galacto-non-2-ulopyranosid)onate (207α) and 2-
Hydroxymethylbenzyl (2-propyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-
glycero-β-D-galacto-non-2-ulopyranosid)onate (207β). 
Pooling of crude reaction mixtures of kinetic runs from donor 3 and 194 followed 
by chromatographic purification using silica gel (eluting with hexanes/ethyl acetate 1:1 to 
1:9) and further purification using preparative HPLC (eluting with hexanes/ethyl acetate 
9:1 to 4:6 over 50 min) gave an analytical sample of pure 207α and 207β.  
(207α). [α]RTD = - 5.5 (c 0.8, CH2Cl2), 1H NMR (600 MHz, CDCl3) δ 7.45 (m, 1H), 
7.38 (m, 2H), 7.32 (m, 1H), 5.45 (d, J = 11.9 Hz, 1H), 5.29 (s, 2H), 5.25 (d, J = 9.0 Hz, 
1H), 5.15 (d, J = 11.9 Hz, 1H), 4.82 – 4.78 (m, 1H), 4.77 (s, 2H), 4.32 (d, J = 11.5 Hz, 
1H), 4.14 – 3.98 (m, 4H), 2.80 (br s, 1H), 2.60 (dd, J = 12.7, 4.6 Hz, 1H), 2.15 (s, 3H), 
2.12 (s, 3H), 2.03 (s, 3H), 1.99 (s, 3H), 1.87 (m, 4H), 1.21 (d, J = 6.1 Hz, 3H), 0.99 (d, J 
= 6.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 171.4, 170.8, 170.4, 170.4, 170.3, 168.2 
(3JC1,H3ax =6.0 Hz), 140.1, 132.7, 131.1, 129.6, 129.1, 128.3, 99.0, 72.6, 69.6, 69.4, 68.8, 
67.6, 65.7, 63.1, 62.5, 49.2, 38.5, 24.7, 23.4, 23.2, 21.3, 21.1, 21.0, 20.9. ESIHRMS Calcd 
for C30H41N3O16Na [M + Na]+, 662.2425; found, 662.2413. 
(207β). [α]RTD = - 1.3 (c 0.3, CH2Cl2), 1H NMR (600 MHz, CDCl3) δ 7.46 (m, 1H), 
7.40 – 7.35 (m, 2H), 7.30 (m, 1H), 5.40 – 5.26 (m, 4H), 5.26 – 5.21 (m, 1H), 5.20 – 5.17 
(m, 1H), 4.77 (d, J = 3.9 Hz, 1H), 4.73 (dd, J = 12.3, 2.4 Hz, 1H), 4.08 – 4.00 (m, 4H), 
2.49 (dd, J = 13.1, 4.8 Hz, 1H), 2.13 (s, 3H), 2.04 (s, 3H), 2.00 (s, 3H), 1.99 (s, 3H), 1.87 
(s, 3H), 1.82 (t, J = 12.1 Hz, 1H), 1.16 (d, J = 6.1 Hz, 3H), 0.97 (d, J = 6.0 Hz, 3H); 13C 
NMR (150 MHz, CDCl3) δ 171.2, 171.0, 171.0, 170.4, 170.3, 167.7 (3JC1,H3ax = 0.0 Hz), 
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140.1, 132.7, 130.5, 129.4, 128.8, 128.1, 98.2, 72.1, 72.1, 69.0, 68.8, 67.56, 65.57, 62.9, 
62.6, 49.8, 38.2, 24.3, 23.3, 22.8, 21.2, 21.1, 21.0, 20.9. ESIHRMS Calcd for 
C30H41N3O16Na [M + Na]+, 662.2425; found, 662.2407. 
Competition Kinetics with 5-N,4-O-oxazolidinone protected β-Thiosialyl Cation 
Clock Precursor (196) at -40 0C. 
The general procedure for competition kinetic experiments was applied in a series 
of kinetic experiments using sialyl donor 196 (0.010 g, 0.013 mmol) and 2-propanol (1.5-
25.0 equiv). The crude reaction mixtures from kinetic runs were analyzed using UHPLC 
(flow rate: 0.35 mL/min; Initial: CH3CN 35% in H2O; 12.0 min: CH3CN 35% in H2O; 15.0 
min: CH3CN 100%; tR (min):  201β = 8.68, 201α = 9.10, 208β = 9.72, 208α = 11.27). 
Relative ratios of O-glycosides with respect to cyclized products were determined by 
integrating the corresponding peaks of UV spectra (Table 28). 
2-Hydroxymethylbenzyl (2-propyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-
3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranosid)onate (208α) and 2-
Hydroxymethylbenzyl (2-propyl 5-acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-
3,5-dideoxy-D-glycero-β-D-galacto-non-2-ulopyranosid)onate (208β). 
 . The crude reaction mixtures from multiple kinetic runs were combined and purified 
using silica gel chromatography (eluting with hexanes/ethyl acetate 3:1 to 1:1) to afford a 
mixture of 208α and 208β, which was further purified by HPLC (eluting with hexanes/ethyl 
acetate 9:1 to 1:1 for 50 min) to afford analytical samples of pure 208α and 208β.  
(208α). [α]RTD = + 1.5 (c 1.0, CH2Cl2), 1H NMR (600 MHz, CDCl3) δ 7.44 – 7.28 (m, 
4H), 5.54 (dd, J = 7.7, 1.5 Hz, 1H), 5.38 – 5.29 (m, 3H), 4.74 (s, 2H), 4.54 (dd, J = 9.4, 
1.5 Hz, 1H), 4.35 (dd, J = 12.3, 2.8 Hz, 1H), 4.02 (dd, J = 12.3, 7.0 Hz, 1H), 4.00 – 3.90 
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(m, 2H), 3.67 (dd, J = 11.2, 9.4 Hz, 1H), 2.85 (dd, J = 12.0, 3.5 Hz, 1H), 2.47 (s, 3H), 2.33 
(br s, 1H), 2.12 (s, 3H), 2.11 (s, 3H), 2.03 – 2.00 (m, 4H), 1.21 (d, J = 6.0 Hz, 3H), 0.95 
(d, J = 6.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 172.3, 170.8, 170.6, 170.2, 168.9 
(3JC1,H3ax = 6.4 Hz), 153.9, 139.7, 132.7, 130.6, 129.6, 129.4, 128.5, 99.4, 75.6, 75.1, 72.0, 
70.0, 69.7, 65.6, 63.2, 63.2, 59.3, 37.1, 24.9, 24.8, 23.1, 21.3, 21.0, 20.9. ESIHRMS Calcd 
for C26H29NO13Na [M + Na]+, 646.2112; found, 646.2110. 
(208β). [α]RTD = - 20.0 (c 0.1, CH2Cl2), 1H NMR (600 MHz, CDCl3) δ 7.47 – 7.28 
(m, 4H), 5.60 (dd, J = 4.0, 2.1 Hz, 1H), 5.36 (s, 2H), 5.25 – 5.22 (m, 1H), 4.78 (s, 2H), 
4.57 (dd, J = 12.2, 2.5 Hz, 1H), 4.51 (ddd, J = 12.5, 11.3, 3.7 Hz, 1H), 4.37 (dd, J = 9.4, 
2.0 Hz, 1H), 4.07 (hept, J = 6.0 Hz, 1H), 4.01 (dd, J = 12.2, 7.7 Hz, 1H), 3.65 (dd, J = 
11.2, 9.5 Hz, 1H), 2.73 (dd, J = 12.1, 3.7 Hz, 1H), 2.49 (s, 3H), 2.09 (s, 3H), 2.07 (s, 1H), 
2.04 – 1.99 (m, 4H), 1.16 (d, J = 6.2 Hz, 3H), 0.98 (d, J = 6.0 Hz, 3H); 13C NMR (150 
MHz, CDCl3) δ 172.5, 171.1, 171.0, 170.0, 167.2 (3JC1,H3ax = 0.0 Hz), 153.9, 140.1, 132.7, 
130.6, 129.6, 129.0, 128.2, 98.0, 75.1, 74.8, 73.2, 71.8, 67.9, 65.9, 63.0, 62.9, 59.6, 37.2, 
24.9, 24.4, 22.8, 21.3, 20.9, 20.8. ESIHRMS Calcd for C26H29NO13Na [M + Na]+, 
646.2112; found, 646.2103. 
Competition Kinetics with 5-Isothiocyanate Protected β-Thioglycoside Cation 
Clock Precursor (199) at -40 °C. 
Thioglycoside donor (199) (0.010 g, 0.013 mmol) and the acceptor 2-propanol (1.5-
15 equiv) were used in series of kinetic runs following the general procedure for 
competition kinetic experiments. The crude reaction mixtures from kinetic runs were 
analyzed using UHPLC (flow rate: 0.35 mL/min; Initial: CH3CN 39% in H2O; 10.0 min: 
CH3CN 39% in H2O; 12.0 min: CH3CN 41% in H2O; 22.0 min: CH3CN 41% in H2O; 24.0 
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min: CH3CN 100%; tR (min):  202α/202β = 17.13, 209β = 17.87, 209α = 19.53). Relative 
ratios of O-glycosides with respect to cyclized products were determined by integrating 
the corresponding peaks of UV spectra (Table 29). 
2-Hydroxymethylbenzyl (2-propyl 4,7,8,9-tetra-O-acetyl-3,5-dideoxy-5-
isothiocyanato-D-glycero-α-D-galacto-non-2-ulopyranosid)onate (209α). 
Pooling of crude reaction mixtures of the kinetic runs of donor 199 followed by 
chromatographic purification using silica gel (eluting with hexanes/ethyl acetate 2:1) gave 
a mixture of 209α and 209β, which was further purified using preparative HPLC (eluting 
by hexanes/ethyl acetate 8:2 to 6:4 over 50 min) to afford pure sample of 209α. [α]RTD = 
- 18.8 (c 0.2, CH2Cl2), 1H NMR (600 MHz, CDCl3) δ 7.47 – 7.26 (m, 1H), 5.51 – 5.44 (m, 
1H), 5.44 (d, J = 11.5 Hz, 1H), 5.36 (ddd, J = 9.1, 4.3, 2.4 Hz, 1H), 5.14 (d, J = 11.9 Hz, 
1H), 4.82 (d, J = 4.2 Hz, 1H), 4.80 – 4.75 (m, 1H), 4.30 (ddd, J = 12.7, 10.2, 2.5 Hz, 1H), 
4.19 (dd, J = 12.6, 4.4 Hz, 1H), 4.03 (dd, J = 10.5, 1.6 Hz, 1H), 3.95 (hept, J = 6.0 Hz, 
1H), 3.55 (t, J = 10.2 Hz, 1H), 2.71 (dd, J = 12.9, 4.7 Hz, 1H), 2.21 (s, 3H), 2.16 (s, 3H), 
2.10 (s, 3H), 2.08 (s, 3H), 1.67 (t, J = 12.6 Hz, 1H), 1.18 (d, J = 6.0 Hz, 3H), 0.95 (d, J = 
6.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 170.9, 170.2, 170.1, 169.5, 167.5 (3JC1,H3ax = 
8.3 Hz), 140.1, 139.8, 132.2, 130.8, 129.5, 128.7, 128.1, 98.6, 71.6, 70.2, 69.3, 68.0, 
67.6, 65.8, 62.9, 61.8, 56.4, 37.9, 24.5, 22.9, 21.1, 21.0, 20.8, 20.7. ESIHRMS Calcd for 
C29H37NO13Na [M + Na]+, 662.1883; found, 662.1873. 
2-Hydroxymethylbenzyl (2-propyl 4,7,8,9-tetra-O-acetyl-3,5-dideoxy-5-
isothiocyanato-D-glycero-β-D-galacto-non-2-ulopyranosid)onate (209β). 
Pooling of crude reaction mixtures of the kinetic runs of donor 199 followed by 
chromatographic purification using silica gel (eluting with hexanes/ethyl acetate 2:1) gave 
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a mixture of 209α and 209β, which was further purified using preparative HPLC (eluting 
by hexanes/ethyl acetate 20:7 to 6:4 over 50 min) to afford an analytical sample of 209β. 
[α]RTD = - 37.9 (c 0.6, CH2Cl2), 1H NMR (600 MHz, CDCl3) δ 7.47 – 7.26 (m, 1H), 5.46 
(dd, J = 6.4, 1.8 Hz, 1H), 5.34 – 5.25 (m, 4H), 4.75 (d, J = 1.3 Hz, 2H), 4.54 (dd, J = 12.6, 
2.4 Hz, 1H), 4.12 (dd, J = 12.6, 6.0 Hz, 1H), 3.96 (dd, J = 10.4, 1.8 Hz, 1H), 3.90 (h, J = 
6.1 Hz, 1H), 3.61 (t, J = 10.1 Hz, 1H), 2.58 (dd, J = 13.2, 4.9 Hz, 1H), 2.14 (s, 3H), 2.10 
(s, 3H), 2.07 (s, 3H), 2.03 (s, 3H), 1.62 (dd, J = 13.1, 11.6 Hz, 1H), 1.11 (d, J = 6.2 Hz, 
3H), 0.98 (d, J = 6.0 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 170.8, 170.1, 169.5, 169.5, 
167.1 (3JC1,H3ax = 0.0 Hz), 140.0, 140.0, 132.4, 130.3, 129.3, 128.8, 128.0, 97.9, 70.4, 
70.1, 69.5, 68.7, 67.9, 65.6, 62.7, 61.9, 56.8, 37.3, 24.0, 22.5, 20.99, 20.97, 20.7, 20.6. 
ESIHRMS Calcd for C29H37NO13Na [M + Na]+, 662.1883; found, 662.1865. 
2-Hydroxymethylbenzyl (Acetyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-
amino-D-glycero-β-D-galacto-non-2-ulopyranosid)onate (211). 
A solution of 194 (0.057 g, 0.076 mmol) in anhydrous CH3CN/CH2Cl2 (3:7, 9.8 mL) 
was stirred at room temperature with AW300 molecular sieves (1.022 g) for 30 min before 
being cooled to -40 0C and stirred for another 30 min. N-Iodosuccinimide (0.048 g, 0.180 
mmol) and TfOH (6.7 μL, 0.075 mmol) were added and reaction mixture was stirred at-
40 0C under argon for 4.5 h before triethylamine (17.0 μL) was added. The reaction 
mixture was diluted with CH2Cl2, filtered through Celite, washed with saturated aqueous 
NaHCO3, saturated Na2S2O3, brine, and concentrated to dryness.  The residue was 
purified by silica gel chromatography, eluting with hexanes/ethyl acetate 1:1 to 1:8 
followed by toluene/ethanol 6:1 containing 1 % triethylanime, to afford 200β (0.015 g, 40 
%) and 211 (0.002 g, 4%). [α]RTD = - 12.0 (c 0.2, CH2Cl2); 1H NMR (600 MHz, CDCl3) δ 
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7.47 (d, J = 7.2 Hz, 1H), 7.39 – 7.35 (m, 2H), 7.32 – 7.28 (m, 1H), 5.75 (d, J = 9.0 Hz, 
1H), 5.45 (td, J = 10.9, 5.1 Hz, 1H), 5.36 (d, J = 12.2 Hz, 1H), 5.29 (d, J = 12.3 Hz, 1H), 
5.27– 5.24 (m, 2H), 5.16 – 5.12 (m, 1H), 4.75 (s, 2H), 4.53 (dd, J = 12.4, 2.3 Hz, 1H), 
4.14 – 4.07 (m, 2H), 3.76 (q, J = 9.9 Hz, 1H), 2.71 (dd, J = 13.5, 5.0 Hz, 1H), 2.10 (s, 3H), 
2.07– 2.03 (m, 4H), 2.02 (s, 3H), 2.00 (s, 3H), 1.99 (s, 3H), 1.89 (s, 3H); 13C NMR (150 
MHz, CDCl3) δ 171.4, 171.14, 171.08, 171.0, 170.8, 170.7, 168.1 (3JC1,H3ax = 0.0 Hz), 
140.4, 132.9, 130.4, 129.4, 129.4, 128.0, 84.2, 71.8, 70.9, 68.9, 68.5, 66.7, 62.8, 62.6, 
50.7, 35.8, 23.4, 23.3, 21.2, 21.0, 20.9; ESIHRMS Calcd for C29H38N2O14Na [M + Na]+, 
661.2221; found, 661.2209 
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ABSTRACT 
INFLUENCE OF SIDE CHAIN CONFORMATION ON THE MECHANISM(S) OF 
GLYCOSYLATION REACTIONS; 
INVESTIGATION OF SIALIDATION REACTION MECHANISM(S) BY KINETIC 
STUDIES 
by 
HARSHA CHANDHANA AMARASEKARA 
May 2019 
Advisor: Dr. David Crich 
Major: Chemistry (Organic) 
Degree: Doctor of Philosophy 
Glycosylation, being the key reaction of glycobiology and carbohydrate chemistry, 
demands robust and stereoselective glycosylation methods. The rational development of 
such methods necessitates knowledge of the glycosylation reaction mechanism and the 
factors influencing glycosylation reactions. The work discussed in this dissertation is 
focused on studying glycosylation reaction mechanisms and exploring the key factors 
influencing them. 
Chapter one reviews the background to the research, starting with a brief 
introduction of the significance of carbohydrates as structural and energy-storage 
materials. The significance of cell surface carbohydrates and their roles in communication 
and related processes are discussed along with examples of their applications in biology 
and therapeutics. Approaches to the synthesis of carbohydrates, glycosylation reactions, 
and their mechanisms are then discussed. The stability of glycosyl oxocarbenium ions 
and the influence of protecting groups on oxocarbenium ions are also discussed. This 
chapter ends with a short description of neighboring group participation. 
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Chapter two describes the synthesis of a series of oxabicyclo[4.4.0]decane type 
compounds as models representing the ideal gg, gt, and tg conformations of the 
pyranoside side chain, and the derivation of experimental limiting coupling constants from 
them. The preparation of the model compounds, NMR analysis, triage of some 
compounds on the grounds of lack of conformational purity, derivation of correction 
factors, and finally, the application of limiting coupling constants in the calculation of side 
chain population are described. The absence of negative populations on the application 
of the limiting coupling constants to a series of literature compounds reveals the reliability 
of the new limiting data set. 
Chapter three discusses the influence of protecting groups on the modulation of 
side chain conformation and the subsequent impact on the glycosylation reactions. The 
synthesis of a series of 4-O-derivatives of galacto- and glucopyranosides and 6-O- 
derivatives of glucopyranosides, their NMR analysis, and calculation of their side chain 
populations, and their correlation with the anomeric reactivity are discussed. Both aroyl 
and alkanoyl esters modulate the side chain population and moderate the electron-
withdrawing effects of the ester, whereas, the 4-O-esters of glucopyranosides change the 
side chain conformation to support the electron-withdrawing effect of the ester. In both 
the galacto- and glucopyranose 4-O-series, highly electron-withdrawing esters, such as 
trifluoroacetyl and trichloroacetyl esters, modulate the side chain conformation to 
reinforce the electron-withdrawing effect of the esters. The glucopyranose 6-O-series did 
not show any significant modulatory effects as a function of protecting groups. Overall, 
this study reveals small but consistent changes in the side chain population, with 
corresponding small influences on glycosylation reactions. 
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Chapter four starts with a brief introduction to the biological importance of sialic 
acid glycosides, their occurrence, and synthesis. Approaches to stereoselective 
sialidation reactions are discussed, and recent advances in sialic acid chemistry along 
with manipulation of protecting groups in obtaining better α-selectivity are presented. 
Sialidation reaction mechanisms and the influence of protecting groups and additives, 
such as acetonitrile, are also surveyed. This chapter ends with a critical note on the 
significance of kinetic studies and the identification of intermediates in describing 
sialidation reaction mechanisms. 
Chapter five describes a series of direct kinetic experiments on N-acetyl-
oxazolidinone protected α- and β- thiosialyl donors designed to probe the influence of 
acceptor concentration and acetonitrile concentration in sialidation reactions. The 
synthesis of the thiosialyl donors, pseudo-first order kinetic experiments with respect to 
the acceptor, and kinetics experiments varying the acetonitrile percentage at constant 
donor and acceptor concentrations are reported. Both the α- and β-O-sialidation reactions 
strongly dependent on the acceptor concentration, revealing SN2 or SN2-like reaction 
pathways via β-sialyl triflate intermediate. The rate of the α-O-siliadation reaction also 
depends on the concentration of acetonitrile, indicating the likely participation of 
acetonitrile in the form of a β-sialyl nitrilium ion, which then undergoes SN2 type reactions 
giving α-O-sialosides. Overall, this study recommends using the highest possible 
concentrations of the glycosyl acceptor and donor and employing acetonitrile as a 
cosolvent in the reaction medium to obtain better α-selectivities. 
Chapter six describes the development of a cation clock reaction to probe the 
kinetics of sialidation reactions as an alternative to direct kinetic experiments. The 
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synthesis of a series of cation clock donors is described. Study of the intramolecular 
glycosylation (cyclization) reactions reveals an SN2 type mechanism for the cyclization. 
This chapter also describes a series of competition kinetic experiments conducted by 
changing the acceptor concentration, revealing a considerable dependence on acceptor 
concentration in the formation of the α-O-sialosides. Hence, α-O-sialidation reactions 
follow SN2 type reaction pathways, and increasing the electron-withdrawing effect of the 
protecting groups favors the SN2 end of the reaction to a greater extent. The use of 
acetonitrile in sialidation reactions led to the isolation and characterization of a β-
acetamide, which is strong evidence in support of the participation of acetonitrile in the 
form of β-sialyl nitrilium ions. Overall, the evidence presented in this study is consistent 
with the direct kinetic experiments.  
The dissertation ends with a conclusion chapter and a complete set of 
experimental data for the studies discussed. 
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